homocysteine has been researched along with Cardiovascular Diseases in 1278 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (0.16) | 18.7374 |
1990's | 159 (12.44) | 18.2507 |
2000's | 707 (55.32) | 29.6817 |
2010's | 339 (26.53) | 24.3611 |
2020's | 71 (5.56) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Gao, F; Lv, L; Zhao, W | 1 |
Haque, A; Lang, X; Mu, L; Wu, HE; Xia, J; Yu, F; Zhang, XY | 1 |
Bao, F; Cong, H; Cui, M; Ju, S; Shi, X | 1 |
Berbert, A | 1 |
Abdelmoula, L; Ben Ahmed, H; Ben Tekaya, A; Bouden, S; Bouzid, K; Mahmoud, I; Rouached, L; Saidane, O; Tekaya, R | 1 |
Ala, A; Banach, M; Ghaffari, S; Nabavi, SM; Rezabakhsh, A; Sadat-Ebrahimi, SR | 1 |
Matsha, TE; Raghubeer, S | 1 |
Guieu, R; Mottola, G; Ruf, J | 1 |
Kaushik, P; Kumar Singh, N; Kumari, M; Suri, A | 1 |
Bosscher, D; Fava, F; Mattivi, F; Nissen, L; Pedrolli, C; Scholz, M; Stanstrup, J; Tuohy, KM; Ulaszewska, MM; Vermeiren, J | 1 |
Dong, Y; Hocher, B; Hong, X; Krämer, BK; Li, J; Lv, Y; Reichetzeder, C; Xie, M; Yang, Y; Zheng, C; Zou, Z | 1 |
Gil, APR; Katsa, ME | 1 |
Herrmann, M; Herrmann, W | 1 |
Chen, L; Chen, X; Gao, F; He, H; Hu, Q; Lin, Y; Ma, H; Yang, W; Zhao, W | 1 |
Ahmed, Z; Andrews, SC; Iqbal, K; Khan, MS; Qadir, SA; Saeedullah, A; Shahzad, B; Shahzad, M | 1 |
Guo, H; He, M; He, S; Jiang, H; Li, W; Liu, X; Long, P; Wang, H; Wu, T; Yu, K; Yuan, Y; Zhang, X; Zhang, Y; Zhang, Z | 1 |
Broberg, K; Grahn, K; Gustavsson, P; Lindfors, P; Ljungman, P; Selander, J; Sjöström, M; Wiebert, P | 1 |
Baptista, J; Ferin, R; Lima, A; Pavão, ML | 1 |
Bosio, E; Burger, D; Carnagarin, R; Chan, J; Lugo-Gavidia, LM; Matthews, VB; Nolde, JM; Robinson, S; Schlaich, MP | 1 |
Acosta, FM; Aguilera, CM; Gil, A; Llamas-Elvira, JM; Martinez-Tellez, B; Mendez-Gutierrez, A; Osuna-Prieto, FJ; Ruiz, JR; Sanchez-Delgado, G | 1 |
Guéant, JL; Guéant-Rodriguez, RM; Oussalah, A; Rosenberg, I; Zuily, S | 1 |
Kowalcze, K; Krysiak, R; Okopień, B | 1 |
Chen, K; Chen, W; Jiang, X; Li, D; Liu, C; Lu, J; Ma, Z; Shen, Y; Tian, H | 1 |
Isaikina, MA; Khasieva, SA; Mironova, OI | 1 |
Gurecká, R; Koborová, I; Podracká, Ľ; Repiská, G; Šebeková, K | 1 |
Chen, Y; Gao, L; He, Y; Hu, W; Li, J; Peng, H; Wang, F; Yan, X; Zhang, J; Zhang, M | 1 |
Gospodarczyk, A; Gospodarczyk, N; Marczewski, K; Tkocz, M; Widuch, M; Zalejska-Fiolka, J | 1 |
Bronstein, MD; Donato, J; Glezer, A; Jallad, RS; Santana, MR | 1 |
Park, HY; Song, BM; Song, S | 1 |
Gu, HQ; Li, H; Li, ZX; Liu, W; Ma, XL; Wang, YJ | 1 |
Bastani, NE; Dagnelie, PC; Elshorbagy, AK; Eussen, SJPM; Grootswagers, P; Kožich, V; Olsen, T; Refsum, H; Retterstøl, K; Stehouwer, CD; Stolt, ETK; Tore, EC; van Greevenbroek, MMJ; Vinknes, KJ | 1 |
Al-Khlaiwi, T; Almushawah, A; Alsomali, A; Habib, SA; Habib, SS | 1 |
Čerkez Habek, J; Gulin, D; Habek, D; Jerković Gulin, S; Vuković Bobić, M | 1 |
Bae, GS; Chu, H; Kim, CH; Kim, Y; Lee, S; Leem, J; Wi, M | 1 |
Duan, XL; Wang, LB; Wang, XH; Wu, CY | 1 |
Chu, C; Gao, K; Hu, J; Ma, Q; Mu, J; Wang, K; Wang, Y; Yan, Y; Yuan, Y; Zheng, W | 1 |
Kiouri, E; Kosmas, N; Pavlakis, G; Rallidi, T; Rallidis, LS; Zolindaki, M | 1 |
Andreeva-Gateva, PA; Dimova, II; Mihaleva, ID | 1 |
Bucciantini, M; Caselli, A; Garagna, S; Giorgetti, S; Leri, M; Luti, S; Marchese, L; Natalello, A; Paoli, P; Rebuzzini, P; Stefani, M | 1 |
Behringer, S; Gründemann, C; Hannibal, L; Hettich, M; Huber, R; Lederer, AK; Maul-Pavicic, A; Müller, A; Samstag, Y; Schmiech, M; Simmet, T; Spiekerkoetter, U; Steinborn, C; Zimmermann-Klemd, AM | 1 |
Liu, G; Liu, YS; Ma, FF; Qi, YC; Wang, L; Wei, M; Zheng, MQ | 1 |
Afshari, JT; Azarpazhooh, MR; Fard, MH; Rezaieyazdi, Z; Saghafi, M; Salari, M; Sedighi, S; Tabrizi, PS | 1 |
Abdulle, AE; Al-Hashmi, K; Al-Lawati, I; Al-Maqbali, M; Al-Rawas, AM; Al-Saleh, M; Al-Siyabi, S; Bourgonje, AR; Bulthuis, MLC; Enriquez, MB; Gordijn, SJ; Mulder, DJ; Saleh, J; van Goor, H | 1 |
Rai, PS; Satyamoorthy, K; Sharma, AR; Shashikiran, U; Shetty, R; Uk, AR | 1 |
Laganà, AS; Rizzo, G | 1 |
Al Sheikh, MH; Chathoth, S; Latif, R; Mumtaz, S; Nasser Al Naimi, S | 1 |
Azzini, E; Polito, A; Ruggeri, S | 1 |
Aguilar, D; Chan, W; Deshmukh, AA; Sonawane, K; Suarez-Almazor, ME; Zhu, Y | 1 |
Balint, B; Guéant, JL; Guéant-Rodriguez, RM; Jepchumba, VK | 1 |
Abolghasemi, R; Afzal, G; Polroudi Moghaddam, M; Sabaghian, T; Saffaei, A; Samadian, F; Sistanizad, M; Ziaie, S | 1 |
Calderón-Larrañaga, A; Hooshmand, B; Marengoni, A; Refsum, H; Saadeh, M; Smith, AD; Vetrano, DL | 1 |
Ponti, G; Ruini, C; Tomasi, A | 1 |
Al-Bayyari, N; Alkhalidy, H; Eaton, A; Hailat, R; Subih, H | 1 |
Dostović, Z; Ibrahimagić, OĆ; Kunić, S; Smajlović, D; Tupković, E; Vidović, M | 1 |
Celejewska, A; Izdebska, M; Paprotny, Ł; Solski, J; Szewczak, D; Wianowska, D | 1 |
de Groot, LCPGM; Kiefte-de Jong, JC; Lips, P; Oliai Araghi, S; Ploegmakers, KJ; Stricker, BH; Swart, KMA; Uitterlinden, AG; van der Velde, N; van Dijk, SC; van Schoor, NM; Zillikens, MC | 1 |
Barrón-Vivanco, BS; Bernal-Hernández, YY; González-Arias, CA; López-Guarnido, O; Medina-Díaz, IM; Murillo-González, FE; Ortega-Cervantes, L; Ponce-Gallegos, J; Ponce-Ruiz, N; Rojas-García, AE | 1 |
Domi, E; Hoxha, B; Hoxha, M; Zappacosta, B | 1 |
Cynober, L; Deutz, NEP; Engelen, MPKJ; Ligthart-Melis, GC; Simbo, SY; Ten Have, GAM; Thaden, JJ | 1 |
Costa Dias Pitangueira, J; de Oliveira Leite, L; Ferreira Damascena, N; Ribas de Farias Costa, P | 1 |
Bodys-Cupak, I; Kamińska, A; Kurowska, A; Majda, A; Suder, M; Zalewska-Puchała, J | 1 |
Dragnić, S; Kraljević, I; Mikhailidis, DP; Muzurović, E; Solak, M | 1 |
Deharo, P; Fromonot, J; Guieu, R; Marlinge, M; Mottola, G; Paganelli, F; Ruf, J | 1 |
Alli, AL; Chori, BS; Danladi, B; Inyang, BA; Nwegbu, MM; Odili, AN; Okoh, MP | 1 |
Guéant, JL; Jeannesson, E; Levy, J; Oussalah, A; Rodriguez-Guéant, RM; Wahl, D; Ziuly, S | 1 |
Felix, JF; Geurtsen, ML; Heil, SG; Jaddoe, VWV; Monasso, GS; Santos, S | 1 |
Asbaghi, O; Ashtary-Larky, D; Bagheri, R; Ghanavati, M; Kashkooli, S; Kooti, W; Mombaini, D; Tinsley, GM; Wong, A | 1 |
Chen, JY; Shih, CC; Shih, YL | 1 |
Gupta, M; Meehan-Atrash, J; Strongin, RM | 1 |
Burgess, S; Carter, P; Larsson, SC; Mason, AM; Yuan, S | 1 |
Tsikas, D | 1 |
Strongin, RM | 1 |
Cameron-Smith, D; Franzke, B; Gillies, NA; Hofmann, M; Milan, AM; Oesen, S; Roy, NC; Schober-Halper, B; Strasser, EM; Tosevska, A; Wagner, KH; Wessner, B | 1 |
Katsiki, N; Mikhailidis, DP; Perez-Martinez, P | 1 |
Fisberg, RM; Marchioni, DM; Miranda, AM; Steluti, J | 1 |
Bhadelia, RA; Johnson, EJ; Lichtenstein, AH; Roe, AJ; Rogers, GT; Rosenberg, IH; Scott, TM; Smith, CE; Zeisel, SH; Zhang, S | 1 |
da Silva, JS; de Assis, AM; Dos Santos, JP; Gonçalves, CA; Kolling, J; Longoni, A; Meira-Martins, LA; Pettenuzzo, LF; Siebert, C; Wyse, AT | 1 |
Chen, MF; Chen, PC; Chien, KL; Hsu, HC; Lee, YT; Lin, HJ; Luo, JL; Su, TC | 1 |
Abdallah, S; Abdel Hay, R; Ali, S; AlKaffas, M; Kadry, D; Rashed, L | 1 |
Singh, SA; Srinivasan, K; Venkatesh, R | 1 |
Chen, WL; Kao, TW; Liaw, FY; Lin, YY; Peng, TC; Shih, MT; Wu, LW; Yang, HF | 1 |
Cho, YK; Kim, HS | 1 |
Javn, SB; Loganathan, S; Mala, K; Ramachandran, S; Sundari, M; Thomas, S | 1 |
Jin, HZ; Wang, WM | 1 |
Aissa, AF; Amaral, CLD; Antunes, LMG; Bianchi, MLP; Curi, R; Hernandes, LC; Machado, CDS; Santos, PWDS; Venancio, VP | 1 |
He, F; Li, T; Wang, W; Wang, Z; Yuan, S; Zhao, H; Zhong, K | 1 |
Kurathong, S; Prommool, S; Teepprasan, T; Trakarnvanich, T; Wang, Y | 1 |
Azad, MAK; Huang, P; Liu, G; Ren, W; Teklebrh, T; Yan, W; Yin, Y; Zhou, X | 1 |
Fu, S; Liu, C; Luo, L; Ye, P | 1 |
Almada, MORDV; Antonini, SRR; Bueno, AC; Coelho-Landell, CA; Czernisz, ÉS; de Carvalho, LM; Ferriani, VPL; Izumi, C; Jordão, AA; Monteiro, JP; Rosa, JC; Salomão, RG | 1 |
Bessonov, VV; Bogdanova, AA; Hong, J; Isakov, VA; Kazlova, V; Lin, Y; Sentsova, TB; Tutelyan, VA; Velliquette, RA | 1 |
Holló, G | 1 |
Kim, J; Lee, SK; Shin, C; Yoon, DW | 1 |
Granic, A; Hill, TR; Jagger, C; Martin-Ruiz, C; Mathers, JC; Mendonça, N; Seal, CJ | 1 |
Kim, H; Kim, J; Kwon, Y; Roh, H | 1 |
Barreca, D; Caccamo, D; Currò, M; Di Mauro, D; Ientile, R; Rizzo, G; Trimarchi, F; Vecchio, M; Visalli, G | 1 |
Ng, GA; Ng, LL; Yuyun, MF | 1 |
Barhwal, K; Das, SK; Dhar, P; Hota, SK; Sharma, VK; Singh, SB | 1 |
Kang, SS; Rosenson, RS | 1 |
Ebrahimpour, A; Moazezi, Z; Moein, S; Qujeq, D; Vaghari-Tabari, M | 1 |
Albert, CM; Christen, WG; Cook, NR; Manson, JE; Van Denburgh, M; Zaharris, E | 1 |
Andreeva, VA; Ducros, V; Fezeu, LK; Galan, P; Guéant, JL; Guilland, JC; Hercberg, S | 1 |
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
Dornyei, G; Koller, A; Kovacs, I; Kovacs, N; Lelbach, A; Szenasi, A | 1 |
Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 1 |
Chrysant, GS; Chrysant, SG | 1 |
Huang, YC; Tsai, TY; Yen, H | 1 |
Krysiak, R; Okopień, B; Szkróbka, W | 1 |
Djuric, D; Jakovljevic, V; Srejovic, I; Zivkovic, V | 1 |
Chhatwal, J; Deshmukh, AA; Sonawane, K | 1 |
Heo, JS; Kim, J; Lee, S; Lim, JY; Pyo, S; Shin, C; Yoon, DW | 1 |
Jakubowski, H | 3 |
Al-Bayyari, N; Al-Zeidaneen, S; Hailat, R; Hamadneh, J | 1 |
Bahrami Asl, F; Khorsandi, H; Poorolajal, J; Samadi, MT; Tayebinia, H | 1 |
Chrysohoou, C; Critselis, E; Drosatos, A; Foscolou, A; Katsimardos, A; Panagiotakos, DB; Pitsavos, C; Rallidis, LS; Tousoulis, D; Tsirebolos, G | 1 |
Chen, Z; Dong, Y; Kang, Y; Shao, L; Tian, Y; Wang, J; Wang, X; Wang, Z; Zhang, L; Zheng, C | 1 |
Armborst, D; Bitterlich, N; Lemperle, M; Metzner, C; Siener, R | 1 |
Barroso, M; Castro, R; Esse, R; Tavares de Almeida, I | 1 |
Capelli, I; Cappuccilli, M; Cianciolo, G; Gasperoni, L; La Manna, G; Tondolo, F; Zappulo, F | 1 |
Cao, S; Fei, X; Luo, Z; Qin, B; Sui, X; Wang, F; Xin, Y; Xu, N; Yang, J; Yang, Z; Zhang, Y; Zhang, Z; Zhao, H; Zhao, X | 1 |
Campbell, MS; Charnigo, RJ; Fleenor, BS; I M, K; Ouyang, A; Westgate, PM | 1 |
Persil-Ozkan, O; Yigit, E; Yigit, Z | 1 |
Bednarska-Czerwińska, A; Kowalcze, K; Krysiak, R; Okopień, B | 1 |
Herrmann, M; Herrmann, W; Hoffmann, MM; Kleber, ME; März, W; Pusceddu, I; Scharnagl, H; Winklhofer-Roob, BM | 1 |
Accorsi, P; Casalini, G; D'Ardes, D; dell'Isola, M; Di Iorio, G; Di Nicola, M; Iuliani, O; Lattanzio, L; Santilli, F; Vadini, F | 1 |
Garg, MK; Kulkarni, MV; Mahalle, N; Naik, SS | 1 |
Gialernios, T; Karpanou, E; Kyvelou, SM; Stefanadis, C; Tzamou, V; Vyssoulis, G | 1 |
Ahluwalia, N; Blacher, J; Faure, P; Galan, P; Hercberg, S; Julia, C; Szabo de Edelenyi, F | 1 |
Attia, JR; Carru, C; Mangoni, AA; McEvoy, M; Zinellu, A | 2 |
Han, C; Jo, I; Jo, SA; Jung, JM; Kwon, DY; Park, MH | 1 |
Cesana, BM; Lanzarotto, F; Lanzini, A; Mazzoncini, E; Ricci, C; Villanacci, V; Zanini, B | 1 |
Akioka, Y; Chikamoto, H; Hamatani, R; Hattori, M; Otsu, M | 1 |
Dichi, I; Lozovoy, MA; Miglioranza, LH; Morimoto, HK; Oliveira, SR; Simão, AN; Simão, TN; Venturini, D | 1 |
Hoey, L; McNulty, H; Pentieva, K; Strain, J; Ward, M | 1 |
Georgiades, A; Park, SB | 1 |
D'Almeida, V; Fonseca, FL; Gomes de Torres Rossi, R; Hix, S; Miranda, R; Ribeiro, R; Saccardo Sarni, RO; Suano de Souza, FI | 1 |
Chu, L; Dong, N; Wang, B; Xiao, L | 1 |
Deshmukh, U; Katre, P; Yajnik, CS | 1 |
Birou, S; Daida, H; Dohi, S; Egusa, G; Hiro, T; Hirobe, K; Iida, M; Ishibashi, S; Kihara, S; Kinoshita, M; Maruyama, C; Ohta, T; Okamura, T; Sasaki, J; Teramoto, T; Yamashita, S; Yokode, M; Yokote, K | 1 |
Gaikwad, NW | 1 |
Caetano, M; D'Almeida, V; Hilário, MO; Ortiz, TT; Sarni, RO; Souza, FS; Terreri, MT | 1 |
Joseph, J; Loscalzo, J | 1 |
Li, D | 1 |
Bamonti, F; Bonara, P; Calvelli, L; Cighetti, G; De Giuseppe, R; de Liso, F; Gregori, D; Maiavacca, R; Noce, CD; Novembrino, C; Patrini, L; Pellegatta, M; Schiraldi, G; Vigna, L | 1 |
Li, X; Ling, W; Wang, M; Xia, M; Xiao, Y; Zhang, Y | 1 |
Amer, M; Qayyum, R | 1 |
Ananthanarayanan, PH; Harichandrakumar, KT; Ikkruthi, S; Nandeesha, H; Rajappa, M; Satheesh, S; Sundar, I | 1 |
Al-Ghamdi, A; Al-Waili, A; Al-Waili, N; Al-Waili, T; Ansari, MJ; Salom, K | 1 |
Farid, E; Megahed, H; Saleh, N; Samir, N | 1 |
Subbotina, TF; Zhloba, AA | 1 |
Barbieri, F; Bruzzese, D; Capalbo, D; Di Mase, R; Esposito, A; Mattace Raso, G; Meli, R; Salerno, M | 1 |
Fenger, M; Grarup, N; Hansen, T; Husemoen, LL; Jørgensen, T; Linneberg, A; Pedersen, O; Sandholt, CH; Skaaby, T; Thuesen, BH | 1 |
Alex, AM; Banerjee, M; Paul, B; Saradalekshmi, KR | 1 |
Debreceni, B; Debreceni, L | 2 |
Berg, JT; Fliser, D; Friedrich, A; Geisel, J; Heine, GH; Hummel, B; Obeid, R; Rogacev, KS; Roth, HJ; Zawada, AM | 1 |
Mommoh, MO; Orluwene, CG | 1 |
Assies, J; Lok, A; Mocking, RJ; Pouwer, F; Ruhé, HG; Schene, AH | 1 |
McCarthy, MJ | 1 |
Chun, OK; Chung, SJ; Fernandez, ML; Koo, SI; McCullough, ML; Song, WO; Wang, Y | 1 |
Ananthanarayanan, PH; Rajendiran, S; Sravan Kumar, P | 1 |
Chen, X; Dong, J; Kong, W; Lu, M; Niu, X; Xiao, Y; Zhang, R | 1 |
Malone, FD | 1 |
Aryan, Z; Esteghamati, A; Nakhjavani, M | 1 |
Abina, J; Annuk, M; Kaart, T; Kaldmäe, M; Viigimaa, M; Zemtsovskaja, G | 1 |
Baszczuk, A; Kopczyński, Z | 1 |
Jin, L; Li, H; Liu, J; Wang, L; Zhou, Y | 1 |
Barhoumi, A; Daher, RT; Karam, PE; Majdalani, MN; Yazbeck, N | 1 |
Cao, J; Gu, D; Hao, Y; Hu, Y; Li, H; Liu, X; Lu, X; Mo, X; Peng, X; Wang, L | 1 |
Domellöf, M; Hernell, O; Lönnerdal, B; Timby, N | 1 |
Baierle, M; Bordignon, S; Breusing, N; Duarte, MM; Emanuelli, T; Garcia, SC; Grune, T; Oldenburg, L; Somacal, S; Trentini, CM; Veit, JC; Vencato, PH; Zibetti, M | 1 |
Boreham, CA; Cardwell, CR; Draffin, CR; Gallagher, AM; Hunter, SJ; McCourt, HJ; McKinley, MC; Murray, LJ; Neville, CE; Woodside, JV; Young, IS | 1 |
Craciun, EC; Crisan, D; Dronca, E; Grigorescu, M; Leach, NV; Lupsor, M; Para, I; Rusu, R; Sampelean, DP; Tarau, R; Vesa, SC | 1 |
Alba, A; Cámara, R; Giménez, C; Hernández-Mijares, A; Rubio, O; Sarnago, A; Vayá, A | 1 |
Almonacid Urrego, CC; González Devia, LJ; Huérfano, MJ; Mendieta Zerón, H; Monroy Romero, PA; Orjuela, OL | 1 |
Bai, Y; Cao, R; Wang, X; Wu, H; Xiao, W; Yang, X; Ye, P; Zhang, Y | 1 |
Akalın, N; Akay, H; Harmankaya, Ö; Köroğlu, M; Kumbasar, B | 1 |
Cheng, LM; Hsu, TR; Huang, YH; Lin, HY; Lo, MY; Lu, YH; Niu, DM; Wu, TJ | 1 |
Bartell, T; Chen, Z; Hong, X; Hou, F; Huo, Y; Ji, Y; Kong, X; Tang, G; Wang, B; Wang, G; Wang, X; Xu, X | 1 |
Abbasian, S; Abdi, K; Babaei, M; Dashti, N; Gerayeshnejad, S; Lamei, N; Nazari, F | 1 |
Kanchi, MM; Koh, WP; Rane, G; Wang, R; Wang, X; Yuan, JM | 1 |
Fan, Y; Man, CF; Peng, HY; Xu, J | 1 |
Alam, SF; Ganguly, P | 1 |
De Buyzere, ML; Debruyne, E; Hébert, JR; Huybrechts, I; Langlois, M; Marcos, A; Rietzschel, ER; Shivappa, N | 1 |
Losada, M; Manresa, N; Mulero, J; Zafrilla, P | 1 |
Baggott, JE; Tamura, T | 1 |
de Lange, Z; Nienaber-Rousseau, C; Pieters, M | 1 |
Buring, JE; Christen, WG; Cook, NR; Ridker, PM | 1 |
Bamba, M; Hirota, T; Miyajima, A; Muto, T | 1 |
Baracat, EC; Fernandes, CE; Lakryc, EM; Machado, RB; Soares, JM | 1 |
Jednacz, E; Rutkowska-Sak, L | 1 |
Fu, S; Luo, L; Xiao, W; Ye, P | 1 |
Apaydin, S; Bozabali, S; Dincel, N; Gun, ZH; Mir, S; Özdemir, K; Sozeri, B; Yilmaz, E | 1 |
Cass, A; Gallagher, MP; Jardine, MJ; Kang, A; Kulshrestha, S; Navaneethan, SD; Nigwekar, SU; Ninomiya, T; Perkovic, V; Strippoli, GF; Zoungas, S | 1 |
Luft, FC | 2 |
Carrasco-Luna, J; Codoñer-Franch, P; González-Carrascosa, R; Navarro-Solera, M; Pin-Arboledas, G; Soriano, JM | 1 |
Pawlak, R | 1 |
de la Vega-Prieto, MJ; González-Reimers, E; Hernández-Betancor, I; Martín-Ponce, E; Martínez-Riera, A; Santolaria, F; Viña-Rodríguez, JJ | 1 |
de la Cruz, AP; Del Pozo, EP; Florea, D; Molina-López, J; Quintero-Osso, B; Rodríguez-Elvira, M | 1 |
Asmer, I; Barak, M; Cassel, A; Flugelman, MY; Karkabi, B; Karkabi, K; Remer, E; Rozenberg, O; Shiran, A; Zittan, E | 1 |
Gilowski, W; Krysiak, R; Okopien, B; Szkrobka, W | 1 |
Athyros, V; Doumas, M; Karagiannis, A; Papademetriou, V | 1 |
Katsiki, N; Kolovou, G | 1 |
Kan, MY; Lai, WK | 1 |
Assies, J; Bockting, CL; Koeter, MW; Lok, A; Mocking, RJ; Pouwer, F; Ruhé, HG; Schene, AH; Visser, I | 1 |
Chen, Q; Li, F; Song, X; Zhang, J; Zhou, L | 1 |
Bu, X; Chen, Q; Kong, F; Liu, Y; Wang, G; Xu, J; Zhang, Y | 1 |
Bruschetta, D; Caccamo, D; Currò, M; D'Amico, F; Di Mauro, D; Ientile, R; Trimarchi, F; Vecchio, M | 1 |
Akalin, N; Akay, H; Erturk, K; Harmankaya, O; Kaptanogullari, H; Kocoglu, H; Okuturlar, Y | 1 |
Abd-Allah, GM; Hassan, MH | 1 |
Asimi, S; Chen, Q; Huang, T; Li, D; Li, K | 1 |
Chen, CS; Hsiao, SM; Huang, MF; Hwang, SJ; Kuo, MC; Liu, TL; Tsai, JC; Yang, YH; Yeh, YC | 1 |
Banderali, G; Cefalo, G; Giovannini, M; Lassandro, C; Moretti, F; Radaelli, G; Salvatici, E; Verduci, E | 1 |
Dabass, A; Holguin, F; Marsh, GM; Rager, J; Sharma, RK; Talbott, EO; Venkat, A | 1 |
Cybulska, B; Kłosiewicz-Latoszek, L | 1 |
Beilin, LJ; Burke, V; Hodgson, JM; Mori, TA; Puddey, IB; Zilkens, RR | 1 |
Afriyie-Gyawu, E; Ampofo-Yeboah, A; Ifebi, E; Kyte, B; Shrestha, S; Zhang, J | 1 |
Akbari, P; Almassinokiani, F; Kashanian, M; Mossayebi, E; Sadeghian, E | 1 |
Ibusuki, R; Kairupan, TS; Kanouchi, H; Kheradmand, M; Kuwabara, K; Maenohara, S; Mantjoro, EM; Nakahata, N; Nerome, Y; Niimura, H; Nindita, Y; Ogawa, S; Owaki, T; Shimatani, K; Takezaki, T; Toyota, K | 1 |
Cheng, PJ; Duan, T; Hsiao, CH; Huang, SY; Peng, HH; Su, SY | 1 |
Baguet, JP; Borel, AL; Ducros, V; Faure, P; Halimi, S; Lévy, P; Monneret, D; Pépin, JL; Tamisier, R | 1 |
Ding, X; Gong, Q; He, Y; Li, S; Liu, C; Liu, Z; Mao, X; Na, R; Qu, Y; Wang, H; Xing, X; Xu, R | 1 |
González-Gross, M; Lopez-Torres, O; Maroto-Sánchez, B; Palacios, G | 1 |
Buckner, SL; Loenneke, JP; Loprinzi, PD | 1 |
Kumarathurai, P; Larsen, BS; Nielsen, OW; Petersen, JF; Sabbah, M; Sajadieh, A | 1 |
Bucci, F; De Negri, F; Fruzzetti, F; Gadducci, A; Ghiadoni, L; Giannarelli, C; Perini, D; Taddei, S; Virdis, A | 1 |
Zulli, A | 1 |
Wakabayashi, I | 1 |
Mendioroz Iriarte, M; Muruzabal Pérez, J; Pulido Fontes, L; Pulido Fontes, M; Quesada Jiménez, P | 1 |
Adamovski, M; Bernal, RT; da Silva, NN; Debortoli, G; Gonçalves, Mde C; Mastroeni, MF; Mastroeni, SS; Rondó, PH; Veugelers, PJ | 1 |
Cass, A; Gallagher, MP; Jardine, MJ; Kang, A; Kulshrestha, S; Navaneethan, SD; Nigwekar, SU; Perkovic, V; Strippoli, GF; Zoungas, S | 1 |
Jansson, JH; Johansson, L; Lind, M; Nilsson, TK | 1 |
Cha, BY; Cho, HS; Han, JH; Kim, ES; Lee, SW; Moon, SD; Shin, J | 1 |
Bastida, S; Celada, P; Delgado-Pando, G; Jiménez-Colmenero, F; Olmedilla-Alonso, B; Rodilla, ME; Sánchez-Muniz, FJ | 1 |
Dang, SN; Lan, X; Yan, H; Zhao, YL | 1 |
Barhwal, K; Chaurasia, OP; Hota, SK; Kumar, A; Kumar, B; Vashishtha, V | 1 |
Ekwaru, JP; Loehr, SA; Mastroeni, MF; Mastroeni, SS; Pham, TM; Veugelers, PJ | 1 |
Cook, NR; Paynter, NP | 1 |
Gupta, T; Kavishwar, A; Sahu, A; Singh, RK | 1 |
Červeňová, T; Drgová, A; Halašová, E; Lehotský, J; Mahmood, S; Škovierová, H; Sopková, J; Vidomanová, E | 1 |
Chang, SH; Chen, CC; Chen, DY; Hsieh, IC; Hsieh, MJ; Lee, CH; Tsai, ML; Wang, CY; Yang, CH; Yeh, JK | 1 |
Bravo-Soto, GA; Madrid, T | 1 |
Abdelkhalek, TM; Haiba, MM; Hanafi, MY; Kamel, MA; Moussa, YY; Oriquat, GA; Saad, MI; Tawfik, SH | 1 |
Nichols, J | 1 |
Belcaro, G; Cornelli, U; Dugall, M; Feragalli, B; Hosoi, M; Ledda, A; Luzzi, R | 1 |
Arshad, M; Bukhari, SA; Ghani, MJ; Haque, A; Huma, T; Ibrahim, Z; Javed, S; Masoud, MS; Qasim, M; Rajoka, MI | 1 |
Acien, AN; Al Rifai, M; Barr, GR; Benjamin, EJ; Bhatnagar, A; Blaha, MJ; DeFilippis, AP; Hall, ME; Jones, MR; Keith, R; Magid, HS; McEvoy, JW; Robertson, RM; Rodriguez, CJ | 1 |
Arteaga, C; Barahona, MJ; Barriendos, N; Curcó, N; De La Barrera, O; García, M; Giménez, N; Prat, C; Vives, P; Yordanov, S | 1 |
Haripriya, A; Nath, M; Ramulu, P; Ratukondla, B; Robin, AL; Shivakumar, C; Vardhan S, A; Vijayaraghavan, P | 1 |
Arslan, MI; Biswas, SK; Chhezom, K; Hoque, MM | 1 |
Abdel Hamid, SG; El-Mesallamy, HO; Gad, MZ | 1 |
Cho, L; Hazen, SL; Hoogwerf, BJ; Lauer, MS; Oliveira, LP; Shishehbor, MH; Sprecher, DL; Wolski, K | 1 |
Akgul, A; Arat, Z; Bilgic, A; Haberal, M; Ozdemir, FN; Sezer, S | 1 |
Escola, JM; Garcia Gallego, F; Robles, NR; Sanchez Munoz-Torrero, JF; Velasco Gemio, J | 1 |
Cai, Y; Jia, J; Li, S; Liu, G; Wang, W; Wang, Y; Yu, C | 1 |
Anderstam, B; Axelsson, J; Bárány, P; Carrero, JJ; Garibotto, G; Lindholm, B; Qureshi, AR; Stenvinkel, P; Suliman, ME; Valli, A | 1 |
Zsuga, J | 1 |
Moat, SJ | 1 |
Barbaresi, M; Bracci, M; Copertaro, A | 1 |
Zimny, J | 1 |
Vos, E | 1 |
Burke, GL; Jacobs, DR; Jenny, NS; Jiang, R; Nettleton, JA; Schulze, MB | 1 |
Baracaldo, C; Forero, Y; López, E; Poveda, E; Villarreal, E | 1 |
Clough, GF; Hanson, MA; Mann, GE; Rodford, JL; Siow, RC; Torrens, C | 1 |
Trabetti, E | 1 |
Blanco-Navarro, I; Blázquez-García, S; Granado-Lorencio, F; Herrero-Barbudo, C; Olmedilla-Alonso, B; Pérez-Sacristán, B | 1 |
Buckley, NS; Cooke, JP; Fliser, D; Kielstein, JT; Salpeter, SR | 1 |
Selhub, J | 2 |
Bleie, Ø; Ebbing, M; Nilsen, DW; Nordrehaug, JE; Nygård, O; Pedersen, EK; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Armstrong, DJ; Kumar, N | 1 |
Ajmi, T; Chaeib, L; Hammami, M; Issaoui, M; Kassab, A; Miled, A | 1 |
Aso, Y | 1 |
Klevay, LM | 1 |
Karamitsos, D; Ntaios, G; Savopoulos, C | 1 |
Chen, HM; Chien, YF; Hsu, CN; Hung, CS; Hwang, JJ; Lin, JW; Tsai, RY | 1 |
Cascalheira, JF; Domingues, FC; Faria, MC; Parreira, MC; Viegas, AN | 1 |
Arenas Jiménez, MD | 1 |
Banfi, G; Cauci, S; Di Santolo, M; Stel, G | 1 |
Connor, D | 1 |
Dagenais, G; Held, C; Lonn, E; McQueen, M; Sheridan, P; Smith, S; Sumner, G; Yusuf, S | 1 |
Jelinek, H; Kerr, RG; Nwose, EU; Richards, RS; Tinley, R | 1 |
Bostom, AG; Carpenter, MA; Hunsicker, L; Jacques, PF; Kusek, JW; Levey, AS; McKenney, JL; Mercier, RY; Pfeffer, MA; Selhub, J | 1 |
Ahmed, R; Bakeet, MY; El-Gendi, SS; El-Hamed, EA; Ibrahim, FK | 1 |
Huang, WN; Tso, TK | 1 |
Aiello, AE; Colon Lopez, V; Ghosh, D; Haan, MN | 1 |
Abbate, R; Fedi, S; Giambene, B; Marcucci, R; Menchini, U; Prisco, D; Sodi, A; Sofi, F | 1 |
Choi, SW; Mason, JB; Sauer, J | 1 |
Del Giglio, M; Fantin, F; Girolomoni, G; Gisondi, P; Marino, F; Valbusa, F; Zamboni, M | 1 |
Albert, CM; Buring, JE; Cook, N; Grodstein, F; Kang, JH; Manson, J | 1 |
Choi, YM; Choue, R; Lim, HJ | 1 |
Alvarez, I; Boza, JJ; Fonollá, J; García-Valls, MJ; López-Huertas, E; Machado, FJ; Mármol, E; Marti, JL; Molina, D; Navas, M; Palacín, E; Remón, B | 1 |
de Kraker, AT; Kenemans, P; Kroeks, MV; Smolders, RG; van der Mooren, MJ | 1 |
Garlassi, E; Guaraldi, G; Marchini, S; Moriondo, V; Nardini, G; Orlando, G; Squillace, N; Stentarelli, C; Tebas, P; Ventura, P; Zona, S | 1 |
Righetti, M | 2 |
Bali, M; Cengel, A; Güz, G; Mutluay, R; Okyay, K; Sahinarslan, A; Sindel, S; Yalçin, R | 1 |
Abdallah, TB; Boubaker, K; Feki, M; Fellah, H; Hammami, MB; Kaabachi, N; Lacour, B; Mebazaa, A | 1 |
Burri, S; de Marchi, S; Hess, OM; Hullin, R; Martinelli, M; Maurer, M; Mohacsi, P | 1 |
Gnyp, W; Grela, W; Koszowski, B; Sobczak, A; Szołtysek-Bołdys, I; Zielińska-Danch, W | 1 |
Achour, A; Kerkeni, M; Letaief, A; Maaroufi, K; Miled, A; Trivin, F | 1 |
Lundberg, GD | 1 |
Badner, N; Beattie, S; Chan, MT; Devereaux, PJ; Forbes, A; Jamrozik, K; Leslie, K; Myles, PS; Paech, M; Peyton, P; Sessler, D; Silbert, BS; Tomlinson, J; Wallace, S | 1 |
Borch, K; Eriksson, O; Nägga, K; Petersson, F; Redéen, S; Ryberg, A | 1 |
Chen, JW; Chen, YH; Chen, YL; Huang, SL; Leu, HB; Lin, CP; Lin, SJ | 1 |
Collins, P; Cooney, MT; Daly, C; Fitzgerald, AP; Graham, IM; O'Callaghan, P | 1 |
Aktekin, LA; Başkan, BM; Bodur, H; Doğan, YP; Ozoran, K; Sivas, F | 1 |
Arnout, J; Cornelissen, VA; Fagard, RH; Holvoet, P | 1 |
Berenson, GS; Chen, W; Ruan, L; Srinivasan, SR; Sun, M; Toprak, A; Xu, J | 1 |
Baysan, O; Celebi, H; Haşimi, A; Köz, C; Serdaroğlu, M; Uzun, M; Yokuşoğlu, M | 1 |
Elmadfa, I; Singer, I | 1 |
Benjamin, EJ; D'Agostino, RB; Hayes, L; Jacques, P; Joseph, J; Levy, D; Pencina, MJ; Selhub, J; Tofler, GH; Vasan, RS; Wang, TJ | 1 |
Aguirre Errasti, C; Egurbide Arberas, MV; Martínez Berriotxoa, A | 1 |
Dierkes, J; Heinz, J; Kropf, S; Luley, C | 1 |
Agarwal, GG; Anand, P; Awasthi, S; Mahdi, A; Tiwari, M | 1 |
Cenikli, U; Demir, S; Güler, S; Kiroğlu, Y; Oncel, C; Tabak, E | 1 |
Amaral, TF; Moreira, PA; Tavares, NR | 1 |
Wierzbicki, AS | 2 |
Dankner, R; Farber, N; Geulayov, G; Novikov, I; Segev, S; Sela, BA | 1 |
Murphy, MM; Scott, JM; Varela-Moreiras, G | 1 |
Handy, DE; Joseph, J; Loscalzo, J | 1 |
Albert, CM; Cook, NR; Manson, JE; Song, Y; Van Denburgh, M | 1 |
Agostinelli, S; Chiarelli, F; D'Adamo, E; de Giorgis, T; Giannini, C; Mohn, A; Scarinci, A | 1 |
Atzori, L; Baule, A; Baule, GM; Bianco, P; Gentilini, A; Manca, A; Mereu, R; Muntoni, S; Satta, G | 1 |
Benndorf, RA; Böger, RH; Maas, R; Riederer, U; Schulze, F; Schwedhelm, E; Sullivan, LM; Vasan, RS; Xanthakis, V | 1 |
Bazzano, LA | 1 |
Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M | 1 |
Cagnacci, A; Cannoletta, M; Volpe, A | 1 |
Boroumand, MA; Djalali, M; Eshragian, MR; Khatami, MR; Shojaei, MH; Siassi, F | 1 |
Adamo, EB; Altavilla, D; Atteritano, M; Bitto, A; Burnett, BP; Cancellieri, F; Cannata, ML; Corrado, F; D'Anna, R; Di Stefano, V; Frisina, A; Frisina, N; Levy, RM; Lubrano, C; Marini, H; Marini, R; Mazzaferro, S; Minutoli, L; Polito, F; Squadrito, F | 1 |
Boldyrev, AA | 1 |
Ates, K; Ertek, S; Torun, AN | 1 |
Fenger, M; Husemoen, LL; Jørgensen, T; Linneberg, A; Thuesen, BH | 1 |
Hamer, M; Mishra, GD | 1 |
Acca, M; D'Erasmo, E; Francucci, CM; Petramala, L | 1 |
Melo, SS; Vannucchi, H | 1 |
Catena, C; Cavarape, A; Colussi, G; De Marchi, S; Dotto, L; Novehllo, M; Sechi, LA | 1 |
Bhat, DS; Fall, CH; Joglekar, CV; Johnston, C; Lubree, HG; Naik, SS; Ramdas, LV; Refsum, H; Thuse, NV; Yajnik, CS | 1 |
Assadi, M; Ebrahimi, A; Jafari, SM; Moradhaseli, F; Movahed, A; Nabipour, I; Obeidi, N; Sanjdideh, Z; Vahdat, K | 1 |
Connolly, GM; Cunningham, R; Maxwell, AP; McNamee, PT; Young, IS | 1 |
Alexandrov, AS; Kirilov, G; Lozanov, V; Mitev, V; Zacharieva, S | 1 |
Gómez-Sánchez, MP; Melero-Rubio, E; Merchán-Mayado, E; Párraga-Díaz, M; Pellicer-Villaescusa, S | 1 |
Hui, Z; Jinming, L; Mei, W; Rong, Y; Yongjun, L | 1 |
Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N | 1 |
Chmurzynska, A; Malinowska, A | 1 |
Grekas, D; Hatzitolios, A; Ntaios, G; Savopoulos, C | 1 |
Malinowska, J; Nowak, P; Olas, B | 1 |
Alder, R | 1 |
Seymen, HO; Seymen, P; Titiz, MI; Türkmen, MF; Yildiz, M | 1 |
Belló-Klein, A; Candido, GO; D'Almeida, V; Irigoyen, MC; Jacob, MH; Mendes, RH; Mostarda, C; Ribeiro, MF; Rigatto, K; Salemi, VM; Sirvente, RA | 1 |
Dokras, A; Mak, W | 1 |
Panagiotakos, DB; Vardavas, CI | 1 |
Cheng, LS; Prasad, AN; Rieder, MJ | 1 |
Abdallah, TB; Aderrahim, E; Elyounsi, F; Hamida, FB; Hedri, H; Helal, I; Kheder, A; Maiz, HB; Ouniss, M; Smaoui, W | 1 |
Chang, MH; Dowling, NF; Fan, AZ; Fang, J; Hayes, D; House, M; Mokdad, AH; Ned, R; Yesupriya, A | 1 |
Escobedo, JO; Lim, S; Samoei, GK; Sibrian-Vazquez, M; Strongin, RM | 1 |
Aydin, M; Gokkusu, C; Ozkok, E; Tulubas, F; Umman, B; Unlucerci, Y | 1 |
Komarov, AL; Panchenko, EP; Shakhmatova, OO | 1 |
Adair, LS; Borja, JB; Croteau-Chonka, DC; Gaulton, KJ; Kuzawa, CW; Lange, EM; Lange, LA; Levy, S; Li, Y; Marvelle, AF; McDade, TW; Mohlke, KL; Qin, L; Wang, Y | 1 |
Cho, E; Dougherty, L; Giovannucci, E; Jacques, PF; Lee, JE; Selhub, J; Zeisel, SH | 1 |
Gargoum, R; Maldonado, C; Metreveli, N; Rosenberger, D; Sen, U; Tyagi, N; Tyagi, S | 1 |
Borucki, K; Dierkes, J; Domröse, U; Heinz, J; Kropf, S; Luley, C; Neumann, KH; Westphal, S | 1 |
de Koning, L; Hu, FB | 1 |
Caouette, H; Crott, JW; Lai, CQ; Lee, YC; Ordovás, JM; Parnell, LD; Qiu, WQ; Rosenberg, IH; Shen, J; Troen, AM; Tucker, KL; Warodomwichit, D | 1 |
Adragna, NC | 1 |
Lip, GY; Peter, K | 1 |
Evans, A; Gey, KF; Gilchrist, SE; McKinley, MC; O'Doherty, MG; Skidmore, PM; Woodside, JV; Yarnell, JW; Young, IS | 1 |
Chung, WS; Ihm, SH; Kim, DB; Kim, HY; Kim, JH; Lee, JM; Park, CS; Seung, KB; Yoo, KD | 1 |
El Nahas, M; Feldt-Rasmussen, B; Kappelgaard, AM; Kober, L; Rustom, R; Wiedmann, J | 1 |
Dohi, Y; Ito, A; Itoh, T; Kajikuri, J; Koyama, K; Kumagai, H; Nakamura, H; Nishio, T; Ohte, N; Sano, A; Yamamoto, J | 1 |
Woodside, JV; Young, IS | 2 |
Davis, J; Leslie, R; Livingstone, C; Newton, LA; Sandhu, K | 1 |
Naruszewicz, M | 1 |
Chudek, J; Demkow, M; Dzielinska, Z; Januszewicz, A; Januszewicz, M; Makowiecka-Ciesla, M; Naruszewicz, M; Prejbisz, A; Ruzyllo, W; Tyczynski, P; Wiecek, A; Zielinski, T | 1 |
Dadyka, IV; Epifantseva, NN; Gorbatovskiĭ, IaA; Koriakin, AM | 1 |
Abbate, R; Bertoni, E; Caroti, L; Cellai, AP; Farsetti, S; Fedi, S; Larti, A; Marcucci, R; Rogolino, A; Rosso, G; Salvadori, M; Zanazzi, M | 1 |
Graham, IM; Hand, EB; Hughes, R; Kirby, B; Leong, T; Tobin, AM | 1 |
Chetrit, A; Dankner, R; Flyvbjerg, A; Frystyk, J; Murad, H; Raz, I; Sela, BA | 1 |
Aleksandrowicz, E; Larczynski, W; Neuwelt, A; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Łysiak-Szydłowska, W | 1 |
Bhopal, RS; Rafnsson, SB; Saravanan, P; Yajnik, CS | 1 |
Sarnak, MJ; Shastri, S | 1 |
Dahiya, K; Dhankhar, R; Sachdeva, A; Sethi, J; Singh, SB; Singh, V; Sood, S; Yadav, M | 1 |
Farbstein, D; Levy, AP | 1 |
Cakir, C; Cakir, E; Küçüközkan, T; Okuyan, E; Özkaya, E; Ustün, G | 1 |
Appel, LJ; Bazzano, LA; Guallar, E; Juraschek, S; Miller, ER; Pastor-Barriuso, R | 1 |
Majnarić-Trtica, L; Martinis, M; Reiner, Z; Vitale, B | 1 |
Caglar, GS; Demirtas, S; Karadag, D; Oztas, E; Pabuccu, R | 1 |
Carru, C; Deiana, L; Loriga, G; Pisanu, E; Sanna, M; Satta, AE; Scanu, B; Zinellu, A | 1 |
Rabbani, N; Thornalley, PJ | 1 |
Gong, YH; Hynan, LS; Qu, BX; Rosenberg, RN; Rossetti, H; Weiner, MF; Womack, KB | 1 |
Atabati, E; Ostovan, MA; Raisjalai, GA; Roozbeh, J; Sagheb, MM; Sohrabi, Z | 1 |
Blom, HJ; Smulders, Y | 1 |
Christensen, JH; Jørgensen, KA; Rasmussen, LE; Schmidt, EB; Svensson, M | 1 |
Finch, JM; Joseph, J | 1 |
Armitage, J; Bennett, D; Bønaa, KH; Clarke, R; Collins, R; Gaziano, JM; Guarino, P; Halsey, J; Jamison, R; Lewington, S; Lonn, E; Manson, JE; Mir, F; Nygård, O; Peto, R; Spence, JD | 1 |
Tice, JA | 1 |
Ahtiluoto, S; Hooshmand, B; Kåreholt, I; Kivipelto, M; Laatikainen, T; Leiviskä, J; Rusanen, M; Soininen, H; Solomon, A; Winblad, B | 1 |
Ebbing, M; Ueland, PM | 1 |
Sabanayagam, C; Shankar, A | 1 |
Chen, Y; Hou, F; Huo, Y; Langman, CB; Matossian, D; Qin, X; Wang, X; Xu, X | 1 |
Breilmann, J; Brunner, C; Neuhäuser-Berthold, M; Pons-Kühnemann, J; Richter, M | 1 |
Ballester-Asensio, E; Codoñer-Franch, P; del Valle-Pérez, R; Martínez-Pons, L; Navarro-Ruíz, A; Vallecillo-Hernández, J | 1 |
Aydin, M; Batioglu, S; Erdogan, G; Kilic, S; Yilmaz, N; Zulfikaroglu, E | 1 |
Steed, MM; Tyagi, SC | 1 |
Kang, YJ | 1 |
Froghifar, N; Gohari, M; Hosseini, S; Rajab, A; Shidfar, F; Shidfar, S; Vafa, M | 1 |
Hellmuth, C; Koletzko, B; Peissner, W | 1 |
Abraham, JM; Cho, L | 1 |
Akanji, AO; Al-Isa, AN; Thalib, L | 1 |
Cacciapuoti, F | 2 |
De Backer, G; De Bacquer, D; De Buyzere, M; Gillebert, T; Hoebeeck, LI; Huybrechts, I; Langlois, M; Maes, L; Rietzschel, ER | 1 |
Crott, JW; Huang, T; Lai, CQ; Lee, YC; Li, D; Ordovas, JM; Parnell, LD; Shen, J; Smith, CE; Tucker, KL | 1 |
Andrikopoulos, V; Barbatis, C; Bastounis, E; Drougou, A; Georgopoulos, S; Klonaris, C; Koliaraki, V; Lioupis, C; Mamalaki, A | 1 |
Badia, N; Carmona, P; Corella, D; Hernandez Mijares, A; Pérez, R; Vayá, A | 1 |
Anielska, E; Burdan, F; Dworzański, W; Jaskólska, A; Szumiło, M | 1 |
Chin, AV; Coakley, D; Coen, R; Cunningham, CJ; Hamilton, F; Lawlor, BA; Molloy, A; O'Connell, H; O'Luanaigh, C; Scott, J; Walsh, C; Walsh, JB | 1 |
Apeland, T; Bates, CJ; Drabløs, PA; Hervig, T; Mansoor, MA; Stakkestad, JA; Wentzel-Larsen, T | 1 |
Fischer, K; Huisman, MH; Sizoo, EM; Sutedja, NA; Van den Berg, LH; van der Schouw, YT; Veldink, JH | 1 |
Ching, CT; Chou, TR; Huang, SY; Shieh, HL; Sun, TP | 1 |
Castro, R; Handy, DE; Loscalzo, J | 1 |
Lu, Q; Rounds, S | 1 |
Cheng, Z; Durante, W; Gupta, S; Jiang, X; Kruger, WD; Madesh, M; Mallilankaraman, K; Praticò, D; Schafer, AI; Wang, H; Yang, X | 1 |
Clarke, R | 4 |
Borrione, P; Casasco, M; Fagnani, F; Parisi, A; Pigozzi, F; Rizzo, M; Spataro, A | 1 |
Chew, SC; Khor, GL; Loh, SP | 1 |
Alibegovic, AC; Dela, F; Højbjerre, L; Nielsen, LB; Sonne, MP; Stallknecht, B; Vaag, AA | 1 |
Hama, Y; Hasuike, Y; Hazeki, S; Hori, K; Kuragano, T; Nakanishi, T; Nanami, M; Nonoguchi, H; Otaki, Y; Tokuyama, M; Toyoda, K | 1 |
García-Alonso, FJ; Jorge-Vidal, V; Periago, MJ; Ros, G | 1 |
Abete, I; Martínez, JA; Navas-Carretero, S; Zulet, MA | 1 |
Grodnitskaya, EE; Kurtser, MA | 1 |
Ahluwalia, N; Blacher, J; Galan, P; Hercberg, S; Julia, C; Szabo de Edelenyi, F; Vergnaud, AC | 1 |
Deguchi, T; Hayashi, M; Masue, T; Nagata, C; Takeda, N; Wada, K; Yasuda, K | 1 |
Afonso, L; Burack, RC; Ference, B; Jacob, S; Niraj, A; Pradhan, J; Veeranna, V; Zalawadiya, SK | 1 |
Mangoni, AA; Woodman, RJ | 1 |
Allemann, Y; Burow, A; Hess, OM; Klaey, M; Shaw, SG; Wustmann, K | 1 |
Chaykovska, L; Hocher, B; Tsuprykov, O | 1 |
Afonso, L; Niraj, A; Panaich, S; Ramesh, K; Veeranna, V; Zalawadiya, S | 1 |
Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
Bocedi, A; Dawood, KF; Dessì, M; Fabrini, R; Federici, G; Fucci, G; Galli, F; Manca di Villahermosa, S; Massoud, R; Noce, A; Pastore, A; Ricci, G; Taccone-Gallucci, M; Zingaretti, V | 1 |
Almadadi, M; Aref, MA; Hedayati, M; Naghii, MR | 1 |
Baccarelli, A; Bollati, V; Cassano, PA; Clark, AG; Gaziano, JM; Litonjua, AA; Schwartz, J; Stover, PJ; Tucker, KL; Weiss, ST; Wells, MT; Wernimont, SM | 1 |
Badiou, S; Bargnoux, AS; Bosc, JY; Canaud, B; Chalabi, L; Cristol, JP; Jaussent, I; Leray-Moragues, H; Morena, M; Rodriguez, A | 1 |
Brazionis, L; Itsiopoulos, C; O'Dea, K; Walker, KZ | 1 |
Aydogan, S; Ozüm, Ü; Yapislar, H | 1 |
Głowacki, R; Jakubowski, H | 1 |
Hahn, A; Willers, J | 1 |
McNulty, H; Pentieva, K; Strain, JJ; Ward, M | 1 |
de Oliveira, GM; Luiz, RR; Rosa, G; Scorsatto, M; Uehara, SK | 1 |
Benghuzzi, H; Butler, K; Henry, OR; Jones, L; Taylor, HA; Tucci, M | 1 |
Spence, JD; Stampfer, MJ | 1 |
Abellán, J; Albaladejo, MD; Avilés, F; Bernabé, J; Cerdá, B; García-Viguera, C; Moreno, DA; Mulero, J; Parra, S; Zafrilla, P | 1 |
Karahan, O; Manduz, S; Yucel, O; Zorlu, A | 1 |
Kim, BH; Kim, CH; Kim, SK; Lee, CH; Lee, HS; Lee, KS; Oh, JM; Ryu, CS; Yun, KU | 1 |
Carru, C; Deiana, L; Scanu, B; Sotgia, S; Talanas, G; Terrosu, P; Zinellu, A | 1 |
Cai, LL; Guo, LL; Jin, HM; Liu, XL; Pan, Y; Shu, JL; Zhu, XJ | 1 |
Bennasar, M; del Monte, MC; Ferrero, JA; Resino, E; Roca, B | 1 |
Babicz, K; Malinowska, J; Olas, B; Oleszek, W; Stochmal, A | 1 |
Ahn, YK; Baek, SH; Byun, YS; Cho, KI; Choi, DJ; Choi, SW; Choi, YS; Jang, Y; Jeon, DW; Kim, JY; Kim, KS; Kim, YJ; Lee, SH; Min, PK; Rha, SW | 1 |
Bodamer, OA; Huemer, M; Mayr, D; Möslinger, D; Mühl, A; Schmid, I; Simma, B; Ulmer, H | 1 |
Aouni, Z; El Oudi, M; Machghoul, S; Mazigh, C | 1 |
Martin-Du Pan, RC; Mercan, D | 1 |
Agota, A; Joó, JG; Kriszbacher, I; Langmár, Z; Marosi, K; Nagy, ZB; Végh, V | 1 |
Almeida, OP; Arnolda, L; Beer, C; Flicker, L; Ford, AH; Garrido, GJ; Lautenschlager, NT | 1 |
DiSilvestro, RA; Joseph, EL; Kim, YM; Raimo, AE; Zhang, W | 1 |
Alexander, JS; Ganta, CV | 1 |
Aghdashi, EM; Fallah, S; Nouroozi, V; Samadikuchaksaraei, A; Seifi, M | 1 |
Bitla, A; P V L N Rao, S; Rajagopal, G; Reddy, AP; Sachan, A; Suresh, V; Venkata Harinarayan, C | 1 |
Bailey, L; Clarke, R; Flanders, WD; Friedman, JM; Khoury, MJ; Liu, T; Yang, Q; Yesupriya, A | 1 |
Ames, BN; Gildengoren, G; Krauss, RM; Lal, A; Lilienstein, J; McCann, JC; McHugh, T; Mietus-Snyder, ML; Olson, D; Shenvi, SV; Shigenaga, MK; Suh, JH | 1 |
Chang, YK; Choi, TI; Kang, JY; Lee, JY; Park, IK; Park, YK; Sung, SH | 1 |
Arheart, K; Clark, JD; Fleming, LE; Lee, DJ; Serdar, B; Wilkinson, JD | 1 |
Cassano, PA; Clark, AG; Gaziano, JM; Litonjua, AA; Stover, PJ; Tucker, KL; Vokonas, PS; Weiss, ST; Wells, MT; Wernimont, SM | 1 |
Bragg, F; Clarke, R; Lewington, S | 1 |
Malinowska, J; Olas, B; Oleszek, W; Stochmal, A | 1 |
Bandurski, T; Białecka, M; Budrewicz, S; Droździk, M; Dubaniewicz, M; Gorzkowska, A; Gołąb-Janowska, M; Honczarenko, K; Koziorowska-Gawron, E; Kurzawski, M; Mak, M; Robowski, P; Roszmann, A; Sitek, EJ; Sławek, J | 1 |
Burini, RC; de Oliveira, EP; Manda, RM; Michelin, E; Moreto, F; Teixeira, O; Torezan, GA | 1 |
Slot, O | 2 |
Içağasioğlu, S; Kiliçli, F; Korkmaz, S; Yildiz, G; Yilmaz, A | 1 |
Dąbrowski, W; Majdan, M; Nowicka-Stążka, P; Parada-Turska, J; Stążka, K; Turski, W | 1 |
Ebesunun, MO; Obajobi, EO | 1 |
Cao, YB; Chen, ZM; He, ZH; Hu, XL; Lan, XG; Lv, YD; Mao, GX; Wang, GF; Wang, YZ; Yan, J | 1 |
Il'icheva, OE; Kharlamova, UV | 1 |
Broda, G; Sygnowska, E; Waśkiewicz, A | 1 |
Andres-Lacueva, C; Arranz, S; Casas, R; Chiva-Blanch, G; Estruch, R; Guillén, M; Lamuela-Raventós, RM; Llorach, R; Ros, E; Urpi-Sarda, M; Valderas-Martinez, P | 1 |
Kurban, S; Mehmetoglu, I; Polat, H; Yerlikaya, FH | 1 |
D'Almeida, V; da Silva, NP; de Souza, FI; Fonseca, FL; Hix, S; Oliveira, AC; Pendezza, AI; Sarni, RO | 1 |
Cheng, X | 1 |
Trimmer, EE | 1 |
Kim, H; Kim, JK; Kim, SK; Kwak, HC; Lee, MY; Lim, CH; Oh, SJ; Park, K; Yang, JS | 1 |
Davis, G; Jagessar, A; Legall, G; Nayak, BS; Pinto Pereira, LM; Seemungal, T; Teelucksingh, S | 1 |
Chen, QR; Jiang, SQ; Xu, XP | 1 |
Acar, S; Demir, N; Gelecek, N; Ilçin, N; Ormen, M; Subaşi, SS | 1 |
Jakovljevic, M; Jaksic, N; Jevtovic, S; Mihaljevic, S; Mikulic, SK; Peles, AM; Sagud, M; Vuksan-Cusa, B; Zivkovic, M | 1 |
D'Almeida, V; De Lima, CS; De Souza, AW; Hix, S; Machado, LS; Oliveira, AC; Pinheiro, FA | 1 |
Fajardo, V; Varela-Moreiras, G | 1 |
Bopp, G; Hoefgen, B; Kallweit, U; Linnebank, M; Maier, W; Moskau, S; Schütz, CG; Semmler, A; Wüllner, U | 1 |
Chun, OK; Chung, SJ; Floegel, A; Koo, SI; Song, WO; Yang, M | 1 |
Ascaso, JF; Chaves, FJ; Folgado, J; Gonzalez, R; Lorente, R; Martínez-Hervás, S; Molina, M; Priego, A; Real, JT | 1 |
Chee, MW; Feng, L; Isaac, V; Krishnan, KR; Ng, TP; Sim, S | 1 |
Bornstein, S; Julius, U; Müller, G; Rodionov, RN; Tselmin, S | 1 |
Forman, DE | 1 |
Bostom, AG; Friedman, AN; Levey, AS; Rosenberg, IH; Selhub, J | 1 |
Anaya, F; Andrés, A; Arias, M; Campistol, JM; Capdevila, L; del Castillo, D; Escuín, F; Gil Vernet, JM; González Molina, M; Grinyo, JM; Lampreave, I; Marcén, R; Morales, JM; Oppenheimer, F; Pallardó, L; Valdés, F | 1 |
Cienfuegos, JA; de Irala, J; Diez-Caballero, A; Frühbeck, G; Gil, MJ; Gómez-Ambrosi, J; Orbe, J; Páramo, JA; Salvador, J | 1 |
Delport, R; Hillermann, R; Kotze, MJ; Loubser, L; Odendaal, HJ; Scholtz, CL; Thiart, R; Vermaak, WJ | 1 |
Glew, RH; Okolo, SN; Okorodudu, A; Shores, J; VanderJagt, DJ | 1 |
Hoffer, LJ | 1 |
Gómez, AL; Hesslink, R; Kraemer, WJ; Love, DM; Volek, JS; Weyers, AM; Wise, JA | 1 |
Bhanji, RA; Glew, RH; Kassam, HA; Okorodudu, A; VanderJagt, DJ | 1 |
Carlsson, CM; Stein, JH | 1 |
De Leo, V; La Marca, A; Morgante, G; Petraglia, F; Setacci, C; Setacci, F | 1 |
Atta, IA; Ben-Yehuda, A; Friedman, G; Goldschmidt, N; Haviv, YS; Shpichinetsky, V | 1 |
Bàràny, P; Bergström, J; Heimbürger, O; Lindholm, B; Stenvinkel, P; Suliman, ME | 1 |
Blom, HJ; Boers, GH; den Heijer, M; Kluijtmans, LA; Lievers, KJ; Trijbels, FJ; Verhoef, P | 1 |
Doshi, SN; Goodfellow, J; Lewis, MJ; McDowell, IF; Moat, SJ | 1 |
Chen, YF; Li, PL; Zou, AP | 1 |
Carluccio, F; Grune, T; Hampl, H; Riedel, E; Siems, W; Sommerburg, O; Stefanelli, G | 1 |
Fini, M; Galetta, P; Mercuro, G; Rosano, GM; Rossini, P; Vitale, C | 1 |
Benetos, A; Blacher, J; Guize, L; Kirzin, JM; Malmejac, A; Safar, ME | 1 |
Fitzgerald, T; Graham, I; Meleady, R; O'Callaghan, P | 1 |
Lee, TH | 1 |
Hansson, L; Hedner, T; Himmelmann, A | 1 |
Zhu, BT | 1 |
Arenas, IA; Bautista, LE; Martínez, LX; Peñuela, A | 1 |
Phillips, BG; Somers, VK | 1 |
Irvin-Jones, A | 1 |
Chang, JB; Chu, NF; Shen, MH; Wu, DM | 1 |
Bostom, AG; D'Agostino, RB; Jacques, PF; Lipinska, I; Mittleman, MA; Selhub, J; Tofler, GH; Wilson, PW | 1 |
Blom, HJ; De Bree, A; Kluijtmans, LA; Kromhout, D; Verschuren, WM | 1 |
Bertrais, S; de Courcy, GP; Ducros, V; Favier, A; Franchisseur, C; Galan, P; Guilland, JC; Hercberg, S; Maurel, M; Mennen, LI; Nicolas, JP; Zarebska, M | 1 |
Capuzzi, DM; Carey, C; Horton, K; Morgan, JM; Reese, D; Walker, K | 1 |
Oliveira, L; Pereira Miguel, JM; Pereirinha, A; Reis, MF | 1 |
Heo, YR; Lim, HS | 1 |
Archetti, S; Assanelli, D; Boldini, A; Bonanome, A; Bonetti, P; Brentana, L; Grassi, M; Padova, E; Pagnan, A; Xamin, A | 1 |
Bjorke Monsen, AL; Blom, H; Daly, LE; Donohue, C; Giesendorf, B; Graham, IM; Meleady, R; Refsum, H; Ueland, PM; Ulvik, A; Vollset, SE; Whitehead, AS; Zhang, Y | 1 |
El-Khairy, L; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Christ-Crain, M; Guglielmetti, M; Huber, PR; Meier, C; Müller, B; Riesen, W; Staub, JJ | 1 |
Blom, HJ; De Bree, A; Kromhout, D; Mennen, LI; Verschuren, WM | 1 |
Buirma, RJ; de Sauvage Nolting, PR; Defesche, JC; Hutten, BA; Kastelein, JJ; Lansberg, PJ | 1 |
Blom, HJ; Kluijtmans, LA; Lievers, KJ | 1 |
Castro, C; Chen, Z; Garrow, T; Genest, J; Laryea, MD; Lussier-Cacan, S; Mar, MH; Rozen, R; Schwahn, BC; Wendel, U; Zeisel, SH | 1 |
Mosca, L | 1 |
Ashton, EL; Liew, D; Magliano, DJ; McNeil, JJ; Sundararajan, V | 1 |
Schlienger, JL | 1 |
Miller, AL | 1 |
Bucci, A; Cuccurullo, F; Lapenna, D; Lattanzio, FM; Mezzetti, A; Pierdomenico, SD; Talone, L | 1 |
Ashfield-Watt, PA; Clark, ZE; Hill, MH; Lewis, MJ; McDowell, IF; Moat, SJ; Newcombe, RG; Powers, HJ; Pullin, CH; Whiting, JM | 1 |
Stone, NJ | 1 |
Dierkes, J; Luley, C; Rading, A; Westphal, S | 1 |
Gao, L; Tang, CS | 1 |
Graham, IM; O'Callaghan, P | 2 |
Alul, RH; Campione, AL; Longo, J; Lynch, SM; Marcotte, AL; Moore, MK; Wood, M | 1 |
Lökk, J | 1 |
Aro, A; Den Hond, E; German, JB; Griffin, BA; Mensink, RP; Mutanen, M; Pannemans, D; Stahl, W; ten Meer, HU | 1 |
Alper, CM; Mattes, RD | 1 |
Donker, AJ; Schalkwijk, CG; Stam, F; Stehouwer, CD; ter Wee, PM; van Guldener, C | 1 |
Dijck-Brouwer, DA; Fokkema, MR; Muskiet, FA; Reijngoud, DJ; van Doormaal, JJ | 1 |
Chang, JB; Chu, NF; Liang, YH; Shen, MH; Shieh, SM; Wu, DM | 1 |
Baró, L; Boza, JJ; Fonollá, J; Jiménez, J; López-Huertas, E; Lucena, A; Martínez-Férez, A; Peña, JL | 1 |
Lee, AJ; O'Dea, K; Rowley, KG; Yarmirr, D | 1 |
Law, M; Morris, J; Wald, DS; Wald, NJ | 1 |
Mallamaci, F; Tripepi, G; Zoccali, C | 1 |
Corretti, MC; Hesslink, R; Plotnick, GD; Vogel, RA; Wise, JA | 1 |
Bazzano, LA; He, J; Muntner, P; Vupputuri, S; Whelton, PK | 1 |
Acevedo, M; Jacobsen, DW; Minor, S; Pearce, GL; Sprecher, DL | 1 |
Bourque, C; Cohn, JS; Jones, PJ; Papamandjaris, AA; St-Onge, MP | 1 |
Jansson, JH | 2 |
Campos, H; Kim, MK; Ordovas, JM; Selhub, J | 1 |
Ben Abdallah, T; Ben Maiz, H; Feki, M; Fellah, H; Hsairi, M; Kaabachi, N; Lacour, B; Massy, ZA; Mebazaa, A; Sanhaji, H | 1 |
Blazicek, P; Ginter, E; Hladikova, V; Klvanova, J; Krajcovicova-Kudlackova, M; Spustova, V; Ursinyova, M | 1 |
Bełtowski, J; Jamroz, A; Wójcicka, G | 1 |
Fonseca, VA; Theuma, P | 1 |
Haberman, F; Mattson, MP | 1 |
Contino, L; Demicheli, M; Fiorini, T; Levis, A; Santi, R | 1 |
Blom, HJ; Camilo, ME; Castro, R; Jakobs, C; Jansen, EE; Ravasco, P; Rivera, I; Struys, EA; Tavares de Almeida, I | 1 |
Deussen, A | 1 |
Blom, HJ; Boers, GH; Riksen, NP; Rongen, GA; Russel, FG; Smits, P | 1 |
Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
Chan, S; Frohlich, J; Grewal, J; Mancini, GB | 1 |
D'Almeida, V; Martins, PJ; Perez, AB; Tufik, S; Vergani, N | 1 |
Kenemans, P; Sipkema, P; Smolders, RG; van der Mooren, MJ | 1 |
Balk, EM; Goudas, LC; Jordan, HS; Karas, RH; Kim, LU; Kupelnick, B; Lau, J | 1 |
Ballman, KV; Berger, PB; Ellison, RC; Jacques, PF; Rozen, R; Spotila, LD | 1 |
Cucinotta, D; Russo, GT | 1 |
Abbate, R; Brunelli, T; Evangelisti, L; Fedi, S; Gensini, GF; Giusti, B; Pepe, G; Porciani, MC; Sani, G; Yacoub, M | 1 |
Derbeneva, SA; Pogozheva, AV | 1 |
Czeizel, E; Kalina, A | 1 |
Borzone, L; Cancino, M; Casanueva, V; Cid, L; Cid, X | 1 |
Ozkan, E; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S | 1 |
Carrillo, E; Lanes, R; Palacios, A; Paoli, M; Villaroel, O | 1 |
Ajabnoor, MA; AL-Ama, MN; Banjar, Z; Rafee, AA; Sheweita, SA | 1 |
Armani, U; Bellocchio, A; Bertolini, S; Cantafora, A; Cerone, R; Masturzo, P; Minniti, G; Piana, A; Pisciotta, L; Reggiani, E | 1 |
Gaetti, E; Panini, R; Rosa, MC; Salvioli, G; Ventura, P | 1 |
Herrmann, W | 1 |
Dierkes, J; Fowler, B; Geisel, J; Herrmann, W; Pietrzik, K; Stanger, O; Weger, M | 2 |
De Santo, NG; Ingrosso, D; Perna, AF | 2 |
García-Idoate, G; Mora, C; Muros, M; Navarro, JF | 1 |
Bararpour, H; Golbahar, J; Rezaian, G | 1 |
Demant, T | 1 |
Robinson, K | 2 |
Coplon, NS; Fortmann, SP; Hornberger, JM; McCann, LM; Wrone, EM; Zehnder, JL | 1 |
Chrysohoou, C; Masoura, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C; Toutouzas, P | 1 |
Clarke, ZL; Goodfellow, J; Lang, D; Lewis, MJ; Madhavan, AK; McDowell, IF; Moat, SJ | 1 |
Andriolo, A; Franco, LJ; Gimeno, SG; Perez, AB; Sañudo, A; Tavares, EF; Vergani, N; Vieira-Filho, JP | 2 |
Austen, SK; Coombes, JS; Fassett, RG | 1 |
Afzali, B; Bakri, RS; Bharma-Ariza, P; Covic, A; Crook, MA; Dalton, N; Goldsmith, DJ; Park, WH; Sriharan, M; Sriskantharan, R; Wierzbicki, AS | 1 |
Kalra, DK | 1 |
von Eckardstein, A | 1 |
Gillum, RF | 1 |
Arnone, G; Forti, P; Maioli, F; Mariani, E; Martelli, M; Ravaglia, G; Servadei, L; Talerico, T; Zoli, M | 1 |
Brönstrup, A; Burger, M; Mensink, G; Pietrzik, K; Thierfelder, W | 1 |
Hiraoka, M; Kagawa, Y; Kato, K; Saito, Y; Yasuda, K | 1 |
Fenger, M; Husemoen, LL; Jørgensen, T; Thomsen, TF | 2 |
Arnesen, H; Bates, CJ; Knudsen, A; Larsen, TW; Mansoor, MA; Mishra, G; Seljeflot, I | 1 |
Bindler, RC; Massey, LK; Mills, PE; Short, R; Shultz, JA | 1 |
Katan, MB; Verhoef, P | 1 |
Bakun, P; Dallal, GE; Olson, B; Rosenberg, IH; Selhub, J; Tucker, KL | 1 |
Nilsen, RM; Nurk, E; Nygård, O; Refsum, H; Tell, GS; Ueland, PM; Vollset, SE | 1 |
de Bree, A; Galan, P; Hercberg, S; Mennen, LI | 1 |
Moyad, MA | 1 |
Andersen, ML; Bignotto, M; D'Almeida, V; Martins, PJ; Santos, RF; Tufik, S | 1 |
Gavendo, S; Goldstein, M; Leibovitch, I; Loewenstein, A; Sela, BA; Yeffimov, I | 1 |
Bovenzi, F | 1 |
Berkowitz, JM; Blumberg, JB; Goldberg, JP; McKay, DL | 1 |
Baró, L; Boza, JJ; Carrero, JJ; Castillo, R; Fonollá, J; González-Santiago, M; Jiménez, J; López-Huertas, E; Martínez-Férez, A | 1 |
Korzun, WJ | 1 |
De Caterina, R; Fioretti, P; Madonna, R; Vanuzzo, D; Zampolli, A | 1 |
Bossone, E; Distante, A; Mazza, A; Mazza, F | 1 |
Hennekens, CH; Lamas, GA; Splaver, A | 1 |
Alvarez-Uría, J; Fernández, S; González, S; Huerta, JM; Lasheras, C; Patterson, AM | 1 |
Cardarelli, F; Cosimi, AB; Delmonico, FL; Farrell, ML; Pascual, M; Saidman, SL; Shih, V; Tolkoff-Rubin, N; Winkelmayer, WC; Wong, W | 1 |
Durrington, P; Mackness, B; Mackness, M | 1 |
Austin, RC; Lentz, SR; Werstuck, GH | 1 |
Gustafson, L; Hultberg, B; Nilsson, K | 1 |
Divitini, ML; Knuiman, MW; O'Leary, CM | 1 |
Hahn, A; Hermann, S; Wolters, M | 1 |
Chang, L; Tang, C; Tang, X; Xu, J; Yu, F; Zhao, J | 1 |
Zák, A; Zeman, M | 1 |
Bleie, Ø; Guttormsen, AB; Nexo, E; Nordrehaug, JE; Nygård, O; Refsum, H; Schneede, J; Ueland, PM; Vollset, SE | 1 |
Boelsma, E; Katan, MB; Olthof, MR; Steenge, GR; van Vliet, T; Verhoef, P | 1 |
Ben Abdallah, T; Ben Maiz, H; Feki, H; Feki, M; Fellah, H; Kaabachi, N; Lacour, B; Massy, ZA; Mebazaa, A; Souissi, M | 1 |
Dinavahi, R; Falkner, B | 1 |
Eikelboom, JW; Hankey, GJ; Ho, WK; van Bockxmeer, FM | 1 |
Eliasziw, M; Freeman, DJ; House, AA; Spence, JD; Urquhart, BL | 1 |
McDowell, I; McKee, M; Moat, SJ | 1 |
Antoniades, C; Brown, M; Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C | 1 |
Anton, SD; Arning, E; Bottiglieri, T; Duncan, GE; Limacher, MC; Lowenthal, DT; Martin, AD; Perri, MG; Stacpoole, PW | 1 |
Kotel'nikov, MV | 1 |
Bruckert, E; Jublanc, C | 1 |
Haynes, WG; Lentz, SR | 1 |
Tepel, M; Zidek, W | 1 |
Brouns, RM; de Jonge, R; Griffioen, PH; Lindemans, J; van Zelst, B; Visser, W | 1 |
Helenius, H; Juonala, M; Laitinen, T; Marniemi, J; Raitakari, OT; Rönnemaa, T; Viikari, JS | 1 |
Kuo, HK | 1 |
De Leo, V; la Marca, A; Luisi, S; Morgante, G; Musacchio, MC; Petraglia, F | 1 |
Chrysohoou, C; Masoura, C; Panagiotakos, DB; Papademetriou, L; Pitsavos, C; Stefanadis, C; Zampelas, A; Zeimbekis, A | 1 |
Gardziejczyk, M; Głowińska, B; Szczepańiska Kostro, J; Tołwińska, J; Urban, M | 1 |
Bednarek-Tupikowska, G; Tupikowski, K | 1 |
Arcelús, R; Blanco-Vaca, F; Cubero, JM; Ordoñez-Llanos, J; Ortega, E; Pérez, A; Rodriguez-Espinosa, J; Sucunza, N | 1 |
Collins, MM; Flynn, A; Perry, IJ; Salim, A; Villegas, R | 1 |
Baker, R; Dusitanond, P; Eikelboom, JW; Gilmore, G; Hankey, GJ; Jamrozik, K; Klijn, CJ; Langton, P; Loh, K; Thom, J; van Bockxmeer, FM; Yi, Q | 1 |
Bayés, B; Bonal, J; Pastor, MC; Romero, R | 1 |
Bressler, J; Glass, TA; Schafer, JH; Schwartz, BS; Todd, AC | 1 |
Brosnan, JT | 1 |
Battaglia, G; Garozzo, M; Milone, F; Urso, S | 1 |
Barazzoni, R; Biolo, G; Ciocchi, B; Dal Mas, V; Guarnieri, G; Lorenzon, S; Piccoli, A; Stulle, M; Zanetti, M | 1 |
Calvin, CD; Conn, CA; Crossey, M; Glew, RH; Obadofin, MO; Vanderjagt, DJ; Vanderjagt, TA | 1 |
Araújo, F; Bates, CJ; Blom, HJ; Bouter, LM; Cunha-Ribeiro, LM; de Bree, A; Dekker, JM; Dierkes, J; Galan, P; Heine, RJ; Herrmann, W; Mennen, LI; Nijpels, GN; Nygard, O; Refsum, H; Stehouwer, CD; Ueland, PM; Ullrich, M; van der Put, NM; Verschuren, WM; Vollset, S; Westphal, S | 1 |
Becker, A; Bouter, LM; Dekker, JM; Heine, RJ; Henry, RM; Jakobs, C; Kostense, PJ; Nijpels, G; Smulders, YM; Spijkerman, AM; Stehouwer, CD; Teerlink, T | 1 |
Allenberg, JR; Darius, H; Diehm, C; Haberl, R; Lange, S; Pittrow, D; Schuster, A; Tepohl, G; Trampisch, HJ; von Stritzky, B | 1 |
Cases, A | 1 |
Halvorsen, B; Ranheim, T | 1 |
Geisel, J; Herrmann, W; Hübner, U; Jouma, M; Obeid, R | 1 |
Alfthan, G; Kaplan, GA; Korhonen, MJ; Mursu, J; Rissanen, TH; Salonen, JT; Virtanen, JK; Voutilainen, S | 1 |
Olthof, MR; Verhoef, P | 1 |
Oliveira, GH | 1 |
Abbate, R; Casini, A; Fedi, S; Gensini, GF; Giuliani, G; Gori, AM; Marcucci, R; Martinelli, F; Sofi, F; Surrenti, C; Vecchio, S | 1 |
Baik, SK; Cha, BS; Chang, SJ; Kang, MG; Koh, SB; Park, JK | 1 |
Coburn, SP; Cole, DE; Dosy, J; Evrovski, J; Mahuren, JD; Masse, PG | 1 |
Ergur, AR; Ertekin, A; Gun, I; Mungen, E; Tutuncu, L; Yergok, YZ | 1 |
Bellisarii, FI; De Caterina, R; Granieri, M | 1 |
Aguilar, B; Collados, MT; Rojas, JC | 1 |
Chan, IH; Lam, CW; Li, PK; Lui, SF; Sanderson, JE; Wang, AY; Wang, M; Woo, J | 1 |
Mehra, MR; Park, MH; Prasad, A; Scott, RL; Uber, PA | 1 |
Fiedler, R; Mall, M; Osten, B; Wand, C | 1 |
Dowey, L; McNulty, H; Pentieva, K; Strain, JJ; Ward, M | 1 |
Choumerianou, D; Chrysohoou, C; Dedoussis, GV; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, C | 1 |
Baviera, G; Cancellieri, F; Corrado, F; Crisafulli, A; D'Anna, R; Squadrito, F | 1 |
Duarte, N; Hoy, W; Maguire, G; McDonald, S; Wang, XL | 1 |
Blanco Vaca, F; González Sastre, F; Llevadot, J | 1 |
Ito, T; Sakuta, H; Suzuki, T; Yasuda, H | 2 |
Dobó, M; Klujber, V; Lengyel, B; Németh, A; Szabó, T | 1 |
Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Ersoy, R; Karakoç, A; Yetkin, I; Yilmaz, M | 1 |
Bickel, C; Blankenberg, S; Cambien, F; Espinola-Klein, C; Lackner, KJ; Lubos, E; Münzel, T; Rupprecht, HJ; Schnabel, R; Tiret, L; Torzewski, M | 1 |
Cucinelli, F; Lanzone, A; Mele, C; Panunzi, S; Perri, C; Ranieri, M; Suriano, R; Villa, P | 1 |
Altun, B; Arici, M; Bakkaloğlu, M; Gençtoy, G; Hayran, M; Kahraman, S; Onalan, O; Oto, A; Turgan, C; Yasavul, U; Yilmaz, R | 1 |
Katan, MB; Olthof, MR; van Vliet, T; Verhoef, P; Zock, PL | 1 |
Hellgren, M; Lindblad, U; Melander, A; Ostgren, CJ; Råstam, L | 1 |
Brenes, G; Cambronero-Gutiérrez, P; Holst-Schumacher, I; Monge-Rojas, R | 1 |
Panagiotakos, DB; Papageorgiou, C; Pitsavos, C; Soldatos, C; Stefanadis, C; Tsetsekou, E | 1 |
Biri, A; Bukan, N; Karakoç, A; Paşaoğlu, H; Sancak, B; Törüner, F; Yilmaz, M | 1 |
Ciftci, B; Ciftci, TU; Kokturk, O; Mollarecep, E | 1 |
Biondi, B; Fazio, S; Lombardi, G; Palmieri, EA | 1 |
Campbell, SB; Hawley, CM; Hollett, P; Isbel, NM; Johnson, DW; Law, B; Mudge, DW; Petrie, JJ; Price, L; Reiger, K; Rogers, R; Sullivan, M | 1 |
Clarke, R; Fowler, B; Smulders, Y; Stehouwer, CD | 1 |
Smulders, YM; Stehouwer, CD | 1 |
Blom, HJ; den Heijer, M; Gellekink, H; Heil, SG | 1 |
Czarnecka, D; Idzior-Waluś, B; Kawecka-Jaszcz, K; Małek, A; Miarka, P; Sieradzki, J; Sztefko, K; Waluś-Miarka, M | 1 |
Akgul, EO; Beyhan, Z; Bilgi, C; Cakir, E; Erbil, MK; Erturk, K; Ozcan, O; Yaman, H | 1 |
Durga, J; Klerk, M; Kluft, C; Kok, FJ; Schouten, EG; Verhoef, P | 1 |
Abbate, R; Bandini, S; Barsotti, G; Bergesio, F; Castrignano, E; Ciuti, R; Cristofano, C; Cupisti, A; Gallo, M; Gallucci, M; Guasparini, A; Marcucci, R; Monzani, G; Salvadori, M; Tosi, PL | 1 |
Boreham, CA; Kennedy, RA; Murphy, MH; Tully, M; Wallace, WF; Young, I | 1 |
Katan, MB; Olthof, MR; van Vliet, T; Verhoef, P | 1 |
Bunout, D; Hirsch, S | 1 |
Bean, JF; Kuo, HK; Yen, CJ | 1 |
Chen, KJ; Lin, BF; Pan, WH; Shaw, NS; Wei, IL; Yang, FL | 1 |
Dagnelie, PC; Garcia, AL; Hoffmann, I; Katz, N; Koebnick, C; Leitzmann, C; Lindemans, J; Strassner, C | 1 |
Scott, PM | 1 |
Krikke, EH | 1 |
Teerlink, T | 1 |
Itaya, Y; Suzuki, H; Takenaka, T | 1 |
Assmann, G; Cullen, P; Fruchart, JC; Greten, H; Naruszewicz, M; Olsson, A; Paoletti, R; Riesen, W; Stoll, M; Tikkanen, M; von Eckardstein, A | 1 |
Connelly, PW; Hanley, AJ; Harris, SB; Retnakaran, R; Zinman, B | 1 |
Fowler, B | 1 |
Chaturvedi, N; Fuller, JH; Idzior-Walus, B; Soedamah-Muthu, SS; Stehouwer, CD; Teerlink, T | 1 |
Geesey, ME; Hueston, WJ; King, DE | 1 |
Nubé, MJ; Nurmohamed, SA | 1 |
Rafflenbeul, W | 1 |
Eaton, CB | 1 |
Aygun, E; Dansuk, R; Kucukercan, I; Pirimoglu, ZM; Turan, C; Unal, O | 1 |
Fort, J | 1 |
Farkouh, ME; Geer, EB; Halperin, JL; Kim, M; Nair, AP; Nemirovsky, D; Robbins, MJ; Winston, J | 1 |
Abreu-González, P; Domínguez-Rodríguez, A; Ferrer-Hita, J; García-González, MJ | 1 |
Cho, S; Chun, OK; Chung, CE; Song, WO | 1 |
Hekimsoy, Z; Ozmen, B; Ulusoy, S | 1 |
Bowden, J; Burton, P; Thompson, JR | 1 |
Berzigotti, A; Bianchi, G; Chianese, R; Grazi, GL; Graziani, R; Mantovani, V; Nicolino, F; Passerini, G; Pinna, AD; Zappoli, P; Zoli, M | 1 |
Borni, Z; Brahim, N; Chahib, M; Habib, H; Hédi, M; Olfa, E; Oudi, M; Salem, M; Zied, A | 1 |
Acanfora, F; De Santo, NG; Ingrosso, D; Lombardi, C; Perna, AF; Satta, E | 1 |
Huang, X; Katz, SD; Zhang, Q; Zheng, H | 1 |
Mallamaci, F; Zoccali, C | 1 |
Chalopin, JM; Devillard, N; Ducloux, D; Kazory, A; Klein, A | 1 |
Arikan, E; Cakir, B; Uysal, O | 1 |
Brahmachari, V; Mahajan, A; Sengupta, S; Senthilkumar, RD; Sharma, A; Sharma, P; Sundaramoorthy, E | 1 |
Chin-Dusting, J; Dart, A; Jones, E; Kingwell, B; Shennan, J; Williams, C | 1 |
Aldred, S; Dale, C; Grant, MG; Griffiths, HR; Kitas, GD; Li, L; Nakano, E; Nugent, D; Powers, HJ; Taiwo, FA | 1 |
Dayal, S; Lentz, SR | 1 |
Arnold, JM; Bosch, J; Genest, J; Held, C; Lonn, E; McQueen, M; Micks, M; Pogue, J; Probstfield, J; Sheridan, P; Yusuf, S | 1 |
Sullivan, JL | 1 |
Bandarian, F; Fakhrzadeh, H; Ghotbi, S; Heshmat, R; Larijani, B; Nouri, M; Pourebrahim, R; Shafaee, A | 1 |
Olson, LJ; Somers, VK | 1 |
Açikgöz, Ş; Bayraktaroğlu, T; Can, M; Demirtas, S; Güven, B; Koçak, E; Mungan, G | 1 |
Potter, JD; Ulrich, CM | 1 |
Gilpin, EA; McEligot, AJ; Pierce, JP; Rock, CL | 1 |
Blom, HJ; Borm, GF; den Heijer, M; Keijzer, MB; Verhoef, P | 1 |
Duranay, M; Parpucu, H; Senes, M; Tekeli, N; Yilmaz, FM; Yilmaz, G; Yücel, D | 1 |
Roest, M; Stalenhoef, AF; van Himbergen, TM; van Tits, LJ | 1 |
Jacobsen, DW | 2 |
Chang, CK; Huang, HY; Huang, WN; Tso, TK | 1 |
Loscalzo, J | 1 |
Zeisel, SH | 1 |
Hernández Ortega, E; Hernández Trujillo, Y; Macías Reyes, A; Medina, A; Rodríguez Esparragón, F; Rodríguez Pérez, JC | 1 |
Beck, GJ; Collins, AJ; Greene, T; Kusek, JW; Levey, AS; Menon, V; Pereira, AA; Sarnak, MJ; Selhub, J; Shlipak, MG; Wang, X | 1 |
Buring, JE; Lee, IM; Mora, S; Ridker, PM | 1 |
Racek, J; Rajdl, D; Siala, K; Trefil, L | 1 |
Cummings, DM; Geesey, ME; King, DE; Mainous, AG | 1 |
Cook, S; Hess, OM | 1 |
Burlina, A; Cesari, M; Maiolino, G; Pedon, L; Pessina, AC; Rossi, GP; Seccia, TM; Sticchi, D; Zanchetta, M; Zavattiero, S | 1 |
Czekalski, S; Oko, A; Pawlaczyk, K | 1 |
de la Vega Prieto, MJ; Gaspar, MR; González-Reimers, E; Martínez-Riera, A; Rodríguez, JJ; Santolaria, F; Valls, MR | 1 |
Spence, JD | 1 |
Bekpinar, S; Genç, S; Türkmen, A; Unlüçerçi, Y | 1 |
Arvanitidou, M; Makedou, A; Mavromichalis, I; Papandreou, D; Rousso, I | 1 |
Bjelland, I; Gjesdal, CG; Nurk, E; Nygård, O; Refsum, H; Smith, AD; Tell, GS; Tverdal, A; Ueland, PM; Vollset, SE | 1 |
Heinzl, S | 1 |
Bausserman, L; Cohen, RA; Gunstad, J; Hoth, K; Jefferson, AL; Paul, RH; Poppas, A; Tate, DF | 1 |
Erzen, B; Keber, I; Poredos, P; Sabovic, M; Sebestjen, M; Simcic, S; Zegura, B | 1 |
Ferrario, G; Milani, S; Righetti, M; Serbelloni, P | 1 |
Feldman, HA; Hoelscher, DH; Luepker, RV; Lutsey, PL; Lytle, LA; Osganian, SK; Steffen, LM; Webber, LS; Zive, M | 1 |
Branca, F; Bugel, S; Dahlman-Wright, K; Dierkes, J; Ferrari, M; Hall, WL; Hallund, J; Huebner, U; Koebnick, C; Nilsson, M; Reimann, M; Vafeiadou, K; Williams, CM | 1 |
Thompson, J | 1 |
Erdmann, E; Hoppe, UC | 1 |
Gullu, S; Gursoy, A; Kamel, N; Ozduman Cin, M | 1 |
Albiger, N; Almoto, B; Bilora, F; Ferrari, M; Mantero, F; Pagnan, A; Petrobelli, F; Scaroni, C; Testa, RM | 1 |
Beyhan, Z; Bolu, E; Ertürk, K; Kutlu, M; Uçkaya, G; Yaman, H | 1 |
Bennett, PH; Fagot-Campagna, A; Gunter, EW; Hanson, RL; Knowler, WC; Looker, HC; Nelson, RG; Pfeiffer, CM; Sievers, ML | 1 |
Baracat, EC; Bittencourt, LR; Brandão, LC; D'Almeida, V; Grego, BH; Hachul de Campos, H; Tufik, S | 1 |
Bauer, K; Fischer, P; Huber, K; Jungwirth, S; Tragl, KH; Zehetmayer, S | 1 |
Carlsson, CM | 1 |
Badiou, S; Canaud, B; Cristol, JP; Delcourt, C; Dupuy, AM; Jaussent, I; Leray-Moragues, H; Maurice, F; Naudin, E; Rivory, JP; Terrier, N | 1 |
Taute, BM | 1 |
Bostom, AG; Carpenter, MA; Hunsicker, LG; Jacques, PF; Kusek, JW; Levey, AS; McKenney, J; Pfeffer, MA | 1 |
Borch-Johnsen, K; Jørgensen, T; Kristoffersen, LH; Lau, C; Toft, U | 1 |
Loscalzo, J; Maron, BA | 1 |
Demirag, NG; Ertugrul, DT; Gursoy, A; Olcay, I; Sahin, M; Tanaci, N; Yucel, M | 1 |
Kaul, S; Shah, PK; Zadeh, AA | 1 |
Cho, SE; Chung, WS; Hong, KS; Shin, GJ | 1 |
Ahotupa, M; Kallio, H; Suomela, JP; Vasankari, T; Yang, B | 1 |
Barter, PJ; Rye, KA | 1 |
Aktürk, M; Altinova, AE; Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Törüner, FB | 1 |
Bauer, JA; Groner, JA; Joshi, M | 1 |
Mann, JJ; Oquendo, MA; Sublette, ME | 1 |
Jakubowski, H; Undas, A | 1 |
Balogh, E; Bereczky, Z; Boda, K; Császár, A; Czuriga, I; Edes, I; Ferdinandy, P; Kónya, C; Koszegi, Z; Muszbek, L | 1 |
George, TW; Gordon, MH; Lovegrove, JA; Niwat, C; Parr, L; Paterson, E; Waroonphan, S | 1 |
El-Ghar, SM; Prasad, K; Qureshi, M; Shoker, A | 1 |
Hishida, A; Ikegaya, N; Kato, A; Kumagai, H; Maruyama, Y; Sakurai, M; Takita, T; Uno, S | 1 |
Guldener, CV; Stehouwer, CDA | 1 |
Al-Ozairi, E; Horton, ES; Middelbeek, RJ | 1 |
McPherson, R; Shepherd, J | 1 |
Vergès, B | 1 |
Albin, D; Alphey, D; Atkinson, G; Baic, S; Boyd, O; Cadigan, L; Clutton, L; Craig, L; Flanagan, C; Greene, P; Griffiths, E; Hooper, L; Lee, NJ; Li, M; McKechnie, L; Mead, A; Ottaway, J; Paterson, K; Perrin, L; Rigby, P; Stone, D; Vine, R; Whitehead, J; Wray, L | 1 |
Albert, MA; Buring, J; Glynn, RJ; Ridker, PM | 1 |
Law, M; Morris, JK; Wald, DS; Wald, NJ | 1 |
Colombari, E; D'Almeida, V; Perry, JC; Schoorlemmer, GH; Souza, FG; Tufik, S | 1 |
Angayarkanni, N; Lakshmi, S; Ramakrishnan, S; Selvi, R; Sulochana, KN | 1 |
Baranova, IA; Karpov, AB; Kretova, EIu; Kubat, II; Litvinenko, TM; Popov, SV; Semënova, IuV; Takhauov, RM; Zhivova, EIu | 1 |
Joubert, LM; Manore, MM | 1 |
Armitage, J; Clarke, R; Lewington, S; Sherliker, P | 1 |
Pintó, X | 1 |
Smulders, YM | 2 |
Almeida, OP; Flicker, L; Hankey, GJ; Jamrozik, K; Norman, P; van Bockxmeer, FM; Vasikaran, S | 1 |
Byśkiniewicz, K; Chazan, R; Kumor, M; Rubinsztajn, R | 1 |
Pandey, SN; Talwalkar, S; Vaidya, AD; Vaidya, RA | 1 |
Chiolero, A; Faeh, D; Paccaud, F | 1 |
Cunningham, S; Hannigan, E; McNicholas, WT; Nolan, GM; Ryan, S; Taylor, C | 1 |
Herrmann, M; Herrmann, W; Obeid, R | 1 |
Britton, J; Venn, A | 1 |
Anello, G; Benamghar, L; Bosco, P; Calabrese, S; Fontaine, T; Guéant, JL; Guéant-Rodriguez, RM; Romano, A; Spada, RS; Stella, G | 1 |
Abe, Y; Aoyagi, K; Kadota, K; Kusano, Y; Maeda, T; Morishita, Y; Nagazumi, T; Nakazato, M; Takamura, N; Yagura, C | 1 |
Belardinelli, R; Caramia, G | 1 |
Alvares Delfino, VD; Barbosa, DS; de Andrade Vianna, AC; Matsuo, T; Mise, RA; Mocelin, AJ | 1 |
Cherry, L; Crompton, P; Kane, D; Lowe, G; McInnes, IB; Sattar, N | 1 |
Buring, JE; Cheng, S; Erlich, HA; Lindpaintner, K; Mora, S; Ridker, PM; Rifai, N; Zee, RY | 1 |
Chen, BC; Chen, CW; Lin, CL; Lin, CT; Lin, TK; Lin, YL | 1 |
Lavie, L; Lavie, P | 1 |
Bots, ML; Dalmeijer, GW; Olthof, MR; van der Schouw, YT; Verhoef, P | 1 |
Cushman, M; Jenny, NS; Katz, R; Psaty, BM; Reiner, AP; Schwartz, SM; Zakai, NA | 1 |
Jacobs, DR; Kori, S; Lutsey, PL; Mayer-Davis, E; Shea, S; Steffen, LM; Szklo, M; Tracy, R | 1 |
Caballero Villarraso, J; Cortés Rodríguez, B; Fernández de la Puebla Giménez, RA; López Miranda, J; Morote Ibarrola, G; Pérez-Jiménez, F | 1 |
Akhtar, N | 1 |
Ageno, W; Dentali, F; Gianni, M | 1 |
Alvestrand, A; Axelsson, J; Barany, P; Ekström, TJ; Heimbürger, O; Johansson, S; Karimi, M; Lindholm, B; Nordfors, L; Qureshi, AR; Schalling, M; Stenvinkel, P; Suliman, M | 1 |
Allen, J; Lefevre, M; Thomson, J; Tulley, R; Welsch, M; Wilson, JB | 1 |
Gambacciani, M; Mannella, P | 1 |
Adell, J; Bhatt, S; Brennan, ML; Dogra, V; El-Bejjani, D; Hazen, SL; McComsey, GA; Nakamoto, DA; O'Riordan, M; Storer, N | 1 |
Bendini, MG; Cozzari, L; De Cristofaro, R; Farina, SM; Giordano, A; Giordano, G; Lanza, GA; Leggio, M; Mazza, A; Menichini, G; Moriconi, E | 1 |
Errasti, P; Manrique, J; Orbe, J; Páramo, JA; Rodríguez, JA | 1 |
Anastasio, R; Casuccio, A; Ciaccio, M; Cigna, V; Coco, LL; Malato, A; Siragusa, S | 1 |
Clarke, R; Ueland, PM | 1 |
Abbate, R; Falciani, M; Giambene, B; Liotta, AA; Mannini, L; Marcucci, R; Menchini, U; Poli, D; Prisco, D; Sodi, A | 1 |
Mahato, B; Muennig, P; Sohler, N | 1 |
Benjamin, EJ; Hwang, SJ; Jacques, PF; Kayalar, A; Keyes, MJ; Larson, MG; Levy, D; Mitchell, GF; Parise, H; Selhub, J; Vasan, RS; Vita, JA; Wang, TJ | 1 |
Arsenault, L; Buel, J; Buell, J; Folstein, M; Liu, T; Peter, I; Qiu, WW; Scott, T | 1 |
Budavari, AI; Hartsell, Z | 1 |
Verhoef, P | 1 |
Kothekar, MA | 1 |
Addolorato, G; Agostino, S; Cadoni, G; Cianfrone, F; Leggio, L; Lippa, S; Paludetti, G; Scipione, S | 1 |
Hauner, H | 1 |
Bouros, D; Christaki, P; Fitili, C; Froudarakis, M; Kataropoulou, M; Nena, E; Steiropoulos, P; Tsara, V | 1 |
Dierkes, J; Luley, C; Westphal, S | 1 |
Angeli, A; Borrione, P; Massazza, G; Paccotti, P; Pigozzi, F; Schonhuber, H; Viberti, G | 1 |
Cabrera-Bueno, F; de Teresa-Galván, E; Espinosa-Caliani, S; García-Pinilla, JM; Gómez-Doblas, JJ; Jiménez-Navarro, M; Reyes-Engel, A | 1 |
Marcus, J; Menon, V; Sarnak, MJ | 1 |
Chan, A; Chen, S; Rogers, EJ | 1 |
Enli, Y; Evrengul, H; Kaftan, A; Kilic, A; Kilic, M; Kirac, S; Kuru, O; Tanriverdi, H; Yuksel, D | 1 |
Halsted, CH; Nygård, OK; Peerson, JM; Refsum, H; Smith, AD; Tell, GS; Ueland, PM; Vollset, SE; Warden, CH; Wong, DH | 1 |
Degtereva, OA; Menshutina, MA; Panina, IIu; Petrishchev, NN; Rumiantsev, ASh; Smirnov, AV; Tugusheva, FA | 1 |
Chen, SS; Chen, TH; Chen, WH; Huang, CW; Lai, SL; Lin, HS; Liu, JS; Tseng, YL | 1 |
Celik, T; Isik, E; Iyisoy, A; Yuksel, UC | 1 |
Chandra, R; Rai, SK; Sharma, M; Tiwari, M | 1 |
Elliott, JO; Haneef, Z; Jacobson, MP | 1 |
de Bree, A; Draijer, R; van Mierlo, LA | 1 |
de Bree, A; de Groot, LC; de Vries, JH; Dhonukshe-Rutten, RA; van der Put, N; van Staveren, WA | 1 |
Hasegawa, H; Hashimoto, T; Shinohara, Y | 1 |
Firat, H; Ozkan, Y; Simşek, B; Torun, M; Yardim-Akaydin, S | 1 |
Bello, M; Geissler, C; Matzkin, V; Pallaro, A; Slobodianik, N | 1 |
Akay, H; Altay, M; Duranay, M; Koşar, U; Oztekin, PS; Parpucu, H; Tekeli, N; Yilmaz, FM; Yilmaz, G; Yücel, D | 1 |
Dai, J; Wang, X | 1 |
Josse, RG; Lonn, E; Ray, JG; Sawka, AM; Yi, Q | 1 |
Badiou, S; Breton, H; Charasson, V; Crespel, A; Cristol, JP; Gelisse, P; Hillaire-Buys, D; Peyriere, H | 1 |
Askin, N; Dunne, A; Flynn, CA; Hoey, L; McNulty, H; Molloy, AM; Pentieva, K; Scott, JM; Strain, J; Ward, M | 1 |
Brennan, SL; Budge, MM; Dore, GA; Elias, MF; Elias, PK; Johnston, C; Nagy, Z; Robbins, MA | 1 |
Abe, Y; Aoyagi, K; Kusano, Y; Maeda, T; Nakashima, K; Nakazato, M; Takamura, N; Wada, M | 1 |
Chen, Y; Duvvi, H; Lu, DP; Ohki, M; Omura, Y; Shimotsura, Y | 1 |
Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
Cigerim, N; Karabudak, E; Kiziltan, G | 1 |
Chatzinikolaou, AC; Hatzitolios, A; Kaiafa, GD; Ntaios, GC; Savopoulos, CG | 1 |
Medina, MA; Montañez, R; Rodríguez-Alonso, J; Rodríguez-Caso, L | 1 |
Angeli, A; Borrione, P; Dovio, A; Fagnani, F; Parisi, A; Pigozzi, F; Rizzo, M; Salvo, RA; Spaccamiglio, A; Termine, A | 1 |
Albert, MA | 1 |
Aviv, A; Brown, MJ; Gardner, JP; Kato, BS; Kimura, M; Lu, X; Richards, JB; Siva, A; Spector, TD; Valdes, AM | 1 |
Kaplan, PF; Meendering, JR; Miller, NP; Minson, CT; Torgrimson, BN | 1 |
Boeger, RH; Deussen, A; Henle, T; Pexa, A; Schwedhelm, E | 1 |
Cao, J; Jiang, J; Jiang, Y; Li, G; Li, N; Wang, S; Xiong, J | 1 |
Manore, MM; Woolf, K | 1 |
Kim, YI; Refsum, H; Smith, AD | 1 |
Belobrajdic, DP; Brinkworth, GD; Buckley, JD; Clifton, PM; Keogh, JB; Noakes, M | 1 |
Ege, E; Gözü, RO; Karadağ, M; Ozarda Ilçol, Y; Ursavaş, A; Uzaslan, E; Yavuz, Z | 1 |
Coburn, SP; Cole, DE; Jougleux, JL; Massé, PG; Tranchant, CC | 1 |
Agbedana, EO; Ebesunun, MO; Oladapo, OO; Taylor, GO | 1 |
Arnolda, LF; Eikelboom, JW; Green, DJ; Hankey, GJ; Potter, K | 1 |
Bambara, LM; Biasi, D; Caramaschi, P; Patuzzo, G; Tinazzi, I | 1 |
Champion, HC; Claeys, MJ; Kass, DA; Moens, AL; Timmermans, JP; Vrints, CJ | 1 |
Cauci, S; Culhane, JF; Di Santolo, M; Gonano, F; Guaschino, S; Stel, G | 1 |
Barbaresi, M; Bracci, M; Copertaro, A; Santarelli, L | 1 |
Aguirre, M; Aldámiz-Echevarría, L; Andrade, F; Ariceta, G; Elorz, J; Martin, S; Prieto, JA; Rodríguez-Soriano, J; Sanjurjo, P | 1 |
Hoey, L; McNulty, H; Pentieva, K; Ward, M | 1 |
Guidi, GC; Lippi, G; Montagnana, M; Salvagno, GL; Targher, G | 1 |
Baptista, AP; Bernardo, I; Cabrita, A; Cacdocar, S; Carrasqueira, H; Faísca, M; Gome, V; Morgado, E; Neves, PL; Palmeiro, H; Sampaio, S; Silva, AP | 1 |
Albert, CM; Buring, JE; Cook, NR; Danielson, E; Gaziano, JM; MacFadyen, J; Manson, JE; Zaharris, E | 1 |
Lonn, E | 1 |
Breeze, E; Clarke, R; Dangour, AD; Fletcher, AE; Shetty, PS; Uauy, R | 1 |
Lentz, SR; Rodionov, RN | 1 |
Hasić, S; Jadrić, R; Kiseljaković, E; Resić, H; Skenderi, F; Winterhalter-Jadrić, M | 1 |
Kvåle, G; Nordrehaug, JE; Nygård, O; Refsum, H; Stensvold, I; Tverdal, A; Ueland, M; Vollset, SE | 1 |
Dwyer, JT; Friedman, JA | 1 |
Moore, EG; Shipchandler, MT | 1 |
Bostom, AG; Hartman, W; Lapane, KL; Miller, JW; Nadeau, M; Prior, R; Seyoum, E; Shemin, D; Sutherland, P; Wilson, PW | 1 |
Fortin, LJ; Genest, J | 1 |
Malinow, MR; Stampfer, MJ | 1 |
Bader, CA; Chadefaux-Vekemans, B; Chevalier, A; Drüeke, TB; Kamoun, P; Kreis, H; Lacour, B; Legendre, C; Massy, ZA | 1 |
Duncan, AM; Goyette, P; Matthews, RG; Milos, R; Rosenblatt, DS; Rozen, R; Sumner, JS | 1 |
Becker, PJ; Ubbink, JB; van der Merwe, A; Vermaak, WJ | 1 |
Blom, HJ; Boers, GH; den Heijer, M; Frosst, P; Kluijtmans, LA; Rozen, R; Stevens, EM; Trijbels, FJ; van den Heuvel, LP; van Oost, BA | 1 |
Bostom, AG; Brosnan, JT; Hall, B; Nadeau, MR; Selhub, J | 1 |
Stampfer, MJ; Verhoef, P | 1 |
Bostom, AG | 1 |
Appel, LJ | 1 |
Grunwald, HW; Rosner, F | 1 |
Adams, MJ; Dickinson, CM; Oakley, GP | 1 |
Aukrust, P; Guttormsen, AB; Mansoor, MA; Müller, F; Refsum, H; Svardal, AM; Ueland, PM | 1 |
Rimm, EB; Stampfer, MJ | 1 |
Refsum, H; Ueland, PM | 3 |
Kristensen, O; Mansoor, MA; Vefring, H | 1 |
Jacotot, B; Nadler, F; Parez, N; Piolot, A | 1 |
Racek, J; Rosolová, H; Simon, J | 1 |
Sobra, J | 1 |
Bendich, A; Bostom, AG; Hume, AL; Lapane, KL; Nadeau, MR; Rosenberg, IH; Selhub, J; Shemin, D; Yoburn, D | 1 |
Bostom, AG; Chan, J; Jacques, PF; Lapane, KL; Nadeau, MR; Rosenberg, IH; Rozen, R; Selhub, J; Shemin, D; Sutherland, P; Yoburn, D | 1 |
Christophersen, B; Ose, L; Refsum, H; Sivertsen, M; Tonstad, S; Ueland, PM | 1 |
Gunby, P | 1 |
Blom, HJ; Boers, GH; Cruysberg, JR; Franken, DG; Hamel, BC; Trijbels, FJ | 1 |
Abbate, R; Gensini, GF; Micheli, S; Prisco, D | 1 |
Slivka, A; Stamler, JS | 1 |
Scott, J; Weir, D | 1 |
Penny, WJ | 1 |
Pilgeram, L | 1 |
Perry, IJ | 1 |
Boers, GH; van den Berg, M | 1 |
Fink, LM; Fonseca, V; Guba, SC | 1 |
Blom, HJ; de Rijke, YB; Demacker, PN; Rolland, R; van der Mooren, MJ | 1 |
Kvåle, G; Nordrehaug, JE; Nygård, O; Refsum, H; Stensvold, I; Ueland, PM; Vollset, SE | 1 |
Alfthan, G; Aro, A; Gey, KF | 1 |
Anker, G; Lien, EA; Lønning, PE; Refsum, H; Ueland, PM | 1 |
Connelly, PW; Hegele, RA; Tully, C; Young, TK | 1 |
Evans, AE; McMaster, D; Woodside, JV; Yarnell, JW; Young, IS | 1 |
Le, NA | 1 |
Rozen, R | 2 |
Boers, GH | 1 |
Dalton, ML; Gadson, PF; Rosenquist, TH; Wrenn, RW | 1 |
Singh, H | 1 |
Refsum, H; Tonstad, S; Ueland, PM | 1 |
McNulty, H; McPartlin, J; Scott, JM; Strain, JJ; Ward, M; Weir, DG | 2 |
Cutler, JA; Evans, RW; Hempel, JD; Kuller, LH; Shaten, BJ | 1 |
Stampfer, MJ | 1 |
Bots, ML; Grobbee, DE; Hofman, A; Launer, LJ; Lindemans, J | 1 |
Brattström, L | 1 |
Arai, H; Higuchi, S; Matsui, T; Matsushita, S; Muramatsu, T | 1 |
Bostom, AG; Dworkin, L; Jacques, PF; Nadeau, MR; Rosenberg, IH; Selhub, J; Shemin, D; Verhoef, P | 1 |
Aakvaag, A; Aanderud, S; Ericsson, UB; Lien, EA; Nedrebø, BG; Nygård, O; Refsum, H; Ueland, PM | 1 |
Arheart, KL; Dennis, VW; Gupta, A; Jacobsen, DW; Moustapha, A; Nahlawi, M; Naso, A; Robinson, K | 1 |
Beks, PJ; Bouter, LM; Heine, RJ; Hoogeveen, EK; Jakobs, C; Kostense, PJ; Mackaay, AJ; Stehouwer, CD | 1 |
McCully, KS | 1 |
Tonstad, S | 1 |
Blann, AD; Lip, GY | 1 |
Nygård, O; Refsum, H; Ueland, PM; Vollset, SE | 2 |
Nichols, TW | 1 |
Artuch, R; Camacho, JA; Campistol, J; Cardo, E; Ferrer, I; Moyano, D; Pavia, C; Pineda, M; Vilaseca, MA | 1 |
Alarcón, GS; Baggott, JE; Lee, JY; Morgan, SL | 1 |
Loscalzo, J; Welch, GN | 1 |
Oakley, GP | 1 |
Bergman, SM; Morgan, SL; Tamura, T | 1 |
Carreras, LO; Falcón, CR | 1 |
Auinger, M; Buxbaum, M; Enzenberger, B; Födinger, M; Hörl, WH; Mannhalter, C; Prischl, F; Sunder-Plassmann, G; Vychytil, A; Wiesholzer, M; Wölfl, G | 1 |
Kronenberg, F | 1 |
Bouter, LM; Donker, AJ; Heine, RJ; Hoogeveen, EK; Jager, A; Jakobs, C; Kostense, PJ; Stehouwer, CD | 1 |
Arcelús, R; Blanco-Vaca, F; Carreras, G; Chico, A; Córdoba, A; de Leiva, A; González-Sastre, F; Pérez, A | 1 |
Frishman, WH | 1 |
Berg, K | 1 |
Evans, RW; Kuller, LH | 1 |
Asscheman, H; Elbers, JM; Giltay, EJ; Gooren, LJ; Hoogeveen, EK; Stehouwer, CD | 1 |
Blache, D; Durand, P; Prost, M | 1 |
Bos, GM; Den Heijer, M; Gerrits, WB; Willems, HP | 1 |
Han, Q; Hoffman, RM; Lenz, M; Miljkovic, D; Sun, X; Tan, X; Tan, Y; Tang, L; Xu, M | 1 |
Buxton, BF; Doolan, L; Liu, JJ; Zulli, A | 1 |
Winocour, PH | 1 |
Bansal, VK; Beto, JA | 1 |
Boers, GH; de Boo, T; Smilde, TJ; Stalenhoef, AF; van den Berkmortel, FW; van Langen, H; Wollersheim, H | 1 |
Barth, CA; Galli, C; Hornstra, G; Mensink, RP; Mutanen, M; Riemersma, RA; Roberfroid, M; Salminen, K; Vansant, G; Verschuren, PM | 1 |
Gall, MA; Hougaard, P; Jakobs, C; Parving, HH; Stehouwer, CD | 1 |
Glade, MJ | 1 |
Wilcken, DE | 1 |
Scott, JM; Weir, DG | 1 |
Graham, IM; Meleady, RA | 1 |
Clarke, R; Collins, R | 1 |
Moneta, GL; Porter, JM; Schuff, RA; Sexton, GJ; Taylor, LM | 1 |
Wilcken, B; Wilcken, DE | 1 |
Applegate, WB; Elam, MB; Garrison, RJ; Kritchevsky, SB; Pahor, M | 1 |
Berthezene, F; Borson-Chazot, F; Claustrat, B; Gaume, C; Guadagnino, L; Harthe, C; Labrousse, F; Moulin, P; Teboul, F | 1 |
Winder, AF | 1 |
Cameron, DP; Gibbs, H; Hickman, PE; Kesting, JB; Marczak, M; McWhinney, B; Purdie, D; Shaw, JT; Tate, JR | 1 |
Fischer, G; Födinger, M; Hörl, WH; Rasoul-Rockenschaub, S; Schmid, R; Sunder-Plassmann, G; Wölfl, G | 1 |
Arnesen, H; Brude, IR; Drevon, CA; Finstad, HS; Hjermann, I; Nenseter, MS; Sandstad, B; Seljeflot, I; Solvoll, K | 1 |
Aarsand, AK; Carlsen, SM | 1 |
Brouwer, CB; Silberbusch, J; Smulders, YM | 1 |
Oberman, A; Oparil, S | 1 |
Bausserman, L; Cutler, JA; Feldman, HA; Lytle, LA; Montgomery, DH; Nader, PR; Osganian, SK; Rimm, E; Spiegelman, D; Stampfer, MJ; Webber, LS | 1 |
Carluccio, M; De Caterina, R; Diviacco, S; Fioretti, P; Mariani, M; Pilotto, L; Quadrifoglio, F; Vanuzzo, D | 1 |
Moustapha, A; Robinson, K | 1 |
Lonn, EM; Yusuf, S | 1 |
Odekerken, DA; Rakic, M; Sijbrands, EJ; Silberbusch, J; Slaats, EH; Smulders, YM; Stehouwer, CD; Treskes, M | 1 |
Bostom, AG; D'Agostino, RB; Jacques, PF; Rosenberg, IH; Selhub, J; Silbershatz, H; Wilson, PW; Wolf, PA | 1 |
Buring, JE; Hennekens, CH; Manson, JE; Matias, M; Ridker, PM; Shih, J | 1 |
Titus, K | 1 |
De Lucia, D; De Rosa, N; Farzati, B; Giugliano, D; Ingrosso, D; Marfella, R; Nappo, F; Perna, AF | 1 |
Kenemans, P; Mijatovic, V; Netelenbos, JC; Stehouwer, CD; van der Mooren, MJ | 1 |
Bedoucha, P; Candito, M; Chatel, M; de Franchis, R; Gibelin, P; Jambou, D; Sadoul, JL; Van Obberghen, E | 1 |
Aranda, E; Cuevas, A; Guasch, V; Leighton, F; Martínez, C; Mezzano, D; Muñoz, B; Muñoz, X; Panes, O; Pereira, J; Rodríguez, S; Strobel, P | 1 |
Gábor, D; Hricová, I; Hrnciar, J; Zacharová, M | 1 |
Holtman, V; Macer, J; Tsongalis, GJ; Wu, AH | 1 |
van den Berg, H | 1 |
Eikelboom, JW; Hankey, GJ | 1 |
Alfthan, G; Aro, A; Bogye, G; Tátrai, T | 1 |
Bouter, LM; de Jong, SC; Geurts, TW; Rauwerda, JA; Stehouwer, CD; van den Berg, M | 1 |
Rabelink, TJ; Verhaar, MC | 1 |
Cazenave, JP; Chantrel, F; Hannedouche, TP; Koehl, C; Kunz, K; Lisri, M; Moulin, B; Petitjean, P; Wiesel, ML | 1 |
Berger, R; De Meer, K; Dijkstra, DA; Donker, AJ; Jakobs, C; Kulik, W; Reijngoud, DJ; Stehouwer, CD; van Guldener, C | 1 |
Chen, P; Dibello, PM; Garrow, TA; Green, R; Jacobsen, DW; Kruger, WD; Moravec, CD; Poddar, R; Robinson, K; Tipa, EV | 1 |
Eikelboom, JW; Genest, J; Hankey, G; Lonn, E; Yusuf, S | 1 |
Harjai, KJ | 1 |
Graham, I | 1 |
Bruckert, E; Foglietti, MJ; Giral, P; Jacob, N; Turpin, G | 1 |
Reynolds, RD; Stamm, EB | 1 |
Doshi, SN; Goodfellow, J; Lewis, MJ; McDowell, IF | 1 |
Chait, A; Clark, S; Eastgard, RL; Hatton, DC; Haynes, RB; Holcomb, S; Kris-Etherton, P; Malinow, MR; McCarron, DA; McMahon, M; Metz, JA; Morris, CD; Nevin, DN; Oparil, S; Pi-Sunyer, FX; Resnick, LM; Reusser, ME; Snyder, GW; Stern, JS | 1 |
Kenemans, P; van der Mooren, MJ | 1 |
de Lorgeril, M | 1 |
Grimble, GK | 1 |
Gress, DR; Singh, V | 1 |
Korpela, R; Nittynen, L; Nurminen, ML; Vapaatalo, H | 1 |
Graham, I; Meleady, R | 1 |
Brattström, L; Nygård, O; Refsum, H; Ueland, PM; Vollset, SE | 1 |
El-Khairy, L; Nygård, O; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Devaraj, S; Jialal, I; Marangon, K; O'Byrne, D | 1 |
Andreotti, F; Burzotta, F; Manzoli, A; Robinson, K | 1 |
Lenhart, SE; Nappi, JM | 1 |
Cattaneo, M | 1 |
Tsai, MY | 1 |
Cosmi, B | 1 |
Blom, HJ; Boers, GH; Broekhuizen, R; de Jong, R; de Ruijter, E; Grubben, MJ; Katan, MB; Nagengast, FM; Swinkels, DW; van Rijt, L | 1 |
Bonham, JR; Cragg, RA; Moat, SJ; Powers, HJ | 1 |
Fleming, RM | 1 |
Braman, MA; Charles-Marcel, ZL; DeRose, DJ; Jamison, JM; Keith Mullen, J; McLane, GD; Muscat, JE | 1 |
Genest, J | 1 |
Ajani, UA; Christen, WG; Glynn, RJ; Hennekens, CH | 1 |
Hak, AE; Hofman, A; Jakobs, C; Polderman, KH; Stehouwer, CD; Westendorp, IC; Witteman, JC | 1 |
Lang, D; McDowell, IF | 1 |
Buring, JE; Hennekens, CH; Ridker, PM; Rifai, N | 1 |
Adunsky, A; Arad, M; Doolman, R; Fleissig, Y; Gavendo, S; Levenkrohn, L; Sela, BA; Weitzman, A | 1 |
Banga, JD; Biesma, DH; van der Griend, R | 3 |
Feiner, AS | 1 |
Chalopin, JM; Ducloux, D; Motte, G | 1 |
Campione, AL; Lynch, SM; Moore, MK | 1 |
Adachi, T; Duarte, N; Green, K; Hara, H; Wang, XL; Wilcken, B; Wilcken, DE | 1 |
Donnelly, JG; Isotalo, PA | 1 |
Kaplan, GA; Lakka, TA; Porkkala-Sarataho, E; Rissanen, T; Salonen, JT; Voutilainen, S | 1 |
Fiedor, P; Polakowska, MJ; Socha, MW; Socha-Urbanek, K | 1 |
Biasioli, S; Schiavon, R | 1 |
Ebenstein, D; Fukagawa, NK; Martin, JM; O'Rourke, B; Prue, AH; Wurthmann, A | 1 |
Azinheira, J; Correia, JM; Luís, AS; Pina, JE; Reis, HP; Reis, RP | 1 |
Hanefeld, M; Julius, U; Menschikowski, M; Pietzsch, J; Pixa, A | 1 |
Brattström, L; Wilcken, DE | 1 |
Beresford, SA; Refsum, H; Ueland, PM; Vollset, SE | 1 |
Scott, JM | 1 |
Clague, A; Healy, H; Morgan, C; Reith, D; Westhuyzen, J | 1 |
McKinley, MC | 1 |
Cortés, F; de la Maza, MP; Hirsch, S | 1 |
Baigent, C; Burbury, K; Wheeler, D | 1 |
Imthurn, B; Keller, PJ; Merki-Feld, GS | 1 |
Anand, S | 1 |
Bleich, S; Degner, D; Kornhuber, J; Kropp, S; Rüther, E | 1 |
Gonin, J; Kitiyakara, C; Massy, Z; Wilcox, CS | 1 |
Katan, MB | 1 |
Scott, J | 1 |
Amores-Sánchez, MI; Medina, MA | 1 |
Becker, A; Bouter, LM; Dekker, JM; Heine, RJ; Jager, A; Kostense, PJ; Nijpels, G; Stehouwer, CD; Van Hinsbergh, VW | 1 |
Cerbone, AM; Coppola, A; Davi, G; De Stefano, V; Di Minno, G; Mancini, FP | 1 |
Robinson, K; van Guldener, C | 1 |
Armitage, J; Clarke, R | 1 |
Ambrosch, A; Bosselmann, HP; Dierkes, J; Domröse, U; Luley, C; Neumann, KH; Westphal, S | 1 |
Ciani, F; De Leo, V; La Marca, A; Morgante, G; Setacci, C; Zammarchi, E | 1 |
Bobák, M; Brunner, E; Hense, HW; Marmot, M; Skodová, Z; Vojtísek, P | 1 |
Daskalakis, I; Lucock, M | 1 |
Zucchelli, P | 1 |
Födinger, M; Sunder-Plassmann, G; Winkelmayer, WC | 1 |
Bang, BK; Bostom, AG; Dwyer, JT; Han, H; Jacques, PF; Kim, YS; Park, JH; Selhub, J | 1 |
Rubba, P | 1 |
Crook, D; Godsland, IF; Lidegaard, O; Winkler, U | 1 |
Baker, DH; Scherer, CS | 1 |
Blumberg, JB; Dallal, G; McKay, DL; Perrone, G; Rasmussen, H | 1 |
Abbate, R; Bertoni, E; Brunelli, T; Evangelisti, L; Fedi, S; Gensini, GF; Marcucci, R; Pepe, G; Prisco, D; Rogolino, A; Salvadori, M; Zanazzi, M | 1 |
Caldarera, M; Cucinotta, D; Dalmonte, E; Forti, P; Grossi, G; Macini, P; Maioli, F; Ravaglia, G; Zanardi, V | 1 |
Devaraj, S; Jialal, I | 1 |
Balderston, B; Cho, EY; Chung, NS; Jang, Y; Lee, JH; Topham, D | 1 |
Kok, FJ | 1 |
Pietrzik, K | 1 |
Garber, AJ | 1 |
Bouter, LM; Dekker, JM; Donker, AJ; Heine, RJ; Jager, A; Kostense, PJ; Nijpels, G; Stehouwer, CD | 1 |
Moat, SJ; Powers, HJ | 1 |
Godsland, IF; Johnston, DG; Proudler, AJ; Rosankiewicz, JR | 1 |
Baker, PJ; Banerjee, R; Brody, LC; Garrett, L; Harris, M; Liu, ML; Shane, B; Stitzel, M; Swanson, DA; Wu, J | 1 |
Okatani, Y; Reiter, RJ; Wakatsuki, A | 1 |
Castaldo, P; De Santo, NG; Galletti, P; Ingrosso, D; Perna, AF | 1 |
Stam, F; Stehouwer, CD; van Guldener, C | 1 |
Busch, M; Fleck, C; Müller, A; Sperschneider, H; Stein, G | 1 |
Beilby, J; Rossi, E | 1 |
Sandrick, K | 1 |
Maxwell, SR | 1 |
Blom, HJ; Diekman, MJ; Tijssen, JG; van der Put, NM; Wiersinga, WM | 1 |
Brock, B; Carstensen, M; Hermansen, K; Høie, L; Søndergaard, M | 1 |
Böger, RH; Sydow, K | 1 |
Hollman, PC; Katan, MB; Olthof, MR; Zock, PL | 1 |
Bederová, A; Blazícek, P; Gasparovic, J; Raslová, K; Smolková, B | 1 |
Blom, HJ; de Bree, A; Verschuren, WM | 1 |
Eichholzer, M; Gutzwiller, F; Lüthy, J; Stähelin, HB | 1 |
Ridker, PM | 1 |
Dyerberg, J; Nexø, E; Osler, M; Rasmussen, K; Skovby, F; Stender, S | 1 |
Bogels, M; Niessen, HW; Rauwerda, JA; Stehouwer, CD; van Hinsbergh, VW; Vermeulen, EG | 1 |
Laskowska-Klita, T; Radomyska, B; Szymczak, E | 1 |
Aakhus, S; Egeland, T; Fauchald, P; Hartmann, A; Hjelmesaeth, J; Midtvedt, K; Mørkrid, L; Stenstrøm, J; Tordarson, H | 1 |
de Meer, K; Stam, F; van Guldener, C | 1 |
Blom, HJ; de Bree, A; de Graaf-Hess, A; Kromhout, D; Trijbels, FJ; Verschuren, WM | 1 |
Asztalos, L; Berczi, C; Dán, A; Kinces, Z; Löcsey, L; Sziki, G | 1 |
Pallaud, C; Pignatti, F; Sass, C; Siest, G; Stranieri, C; Visvikis, S | 1 |
Bamonti-Catena, F; Carrabba, M; Cavalca, V; Cighetti, G; Cortelezzi, A; Fracchiolla, NS; Lambertenghi Deliliers, G; Maiolo, AT; Motta, M | 1 |
Blache, D; Durand, P; Loreau, N; Lussier-Cacan, S; Prost, M | 1 |
Denisenko, AD; Tcherkas, YV | 1 |
Dijck-Brouwer, DA; Fokkema, MR; Muskiet, FA; van Doormaal, JJ; Weijer, JM | 1 |
Kes, P | 1 |
Bostom, AG; Chen, Z; Curtis Ellison, R; Eckfeldt, JH; Jacques, PF; Rozen, R; Selhub, J; Weisberg, IS | 1 |
Cieślik, G; Idzior-Waluś, B | 1 |
Blom, HJ; De Bree, A; Kromhout, D; Verschuren, WM | 1 |
Puzyrev, VP; Spiridonova, MG; Stepanov, VA | 1 |
Deleu, D | 1 |
Fowler, B; Hauptmann, B; Kuhn, W; Müller, T; Woitalla, D | 1 |
Nordrehaug, JE; Nygård, O; Refsum, H; Tell, GS; Tverdal, A; Ueland, PM; Vollset, SE | 1 |
Amores-Sánchez, MI; Medina, M; Urdiales, JL | 1 |
Blacher, J; Safar, ME | 1 |
Antony, AC | 1 |
Gadkari, M; Guttormsen, AB; Joglekar, A; Orning, L; Refsum, H; Sayyad, MG; Schneede, J; Ueland, PM; Ulvik, A; Vollset, SE; Yajnik, CS | 1 |
Duell, PB; Kario, K; Kato, H; Matsuo, T; Miyata, T; Sakata, T; Shimada, K | 1 |
Barbado Hernández, FJ; Gómez Cerezo, JF; Ríos Blanco, JJ; Suárez García, I; Vázquez Rodríguez, JJ | 1 |
Currey, R | 1 |
Krishnaswamy, K; Madhavan Nair, K | 1 |
Christodoulakos, G; Creatsas, G; Moustakarias, T; Panoulis, C; Phocas, I; Rizos, D | 1 |
Akgül, E; Aybar, F; Bükülmez, O; Kabakçi, G; Oto, A; Yarali, H; Yildirir, A | 1 |
Baigent, C; Jones, HJ; Kendall, MJ; Landray, MJ; McGlynn, FJ; Thambyrajah, J; Townend, JN; Wheeler, DC | 1 |
Bobak, M; Fobker, M; Hense, HW; Junker, R; Kuch, B; Marmot, M; von Eckardstein, A | 1 |
Ward, M | 1 |
An, GH; Kim, MS; Lee, HK; Lee, JH; Lim, S; Pak, YK; Park, KS; Song, J; Yim, MJ | 1 |
Bárány, P; Bergström, J; Lindholm, B; Suliman, ME | 1 |
Mijatovic, V; van der Mooren, MJ | 1 |
Cortese, C; Motti, C | 1 |
Molloy, AM; Scott, JM | 1 |
Ashfield-Watt, PA; Doshi, SN; McDowell, IF; Moat, SJ | 1 |
Blom, HJ; Boers, GH; den Heijer, M; Kluijtmans, LA; Lievers, KJ; Trijbels, FJ; van der Put, NM; Verhoef, P | 1 |
Wattanapenpaiboon, N | 1 |
Suzuki, M; Wilcox, BJ; Wilcox, CD | 1 |
Capdevila, A; Kerins, DM; Koury, MJ; Rana, S; Wagner, C | 1 |
Cadena, SM; Conn, CA; Crossey, M; Glew, RH; Okolo, SN; VanderJagt, DJ; Williams, M | 1 |
Audelin, MC; Genest, J | 1 |
Clarke, R; Stansbie, D | 1 |
Haneda, T; Ishida, H; Kikuchi, K; Morimoto, K; Okamoto, K | 1 |
Auer, JW; Berent, R; Eber, B | 1 |
Dai, C; Zhang, G | 1 |
Rabelink, TJ; Stroes, E; Verhaar, MC | 1 |
Black, PH; Garbutt, LD | 1 |
Brocco, G; De Pergola, G; Giorgino, R; Minenna, A; Pannacciulli, N; Sciaraffia, M; Zamboni, M | 1 |
Hiatt, WR; Regensteiner, JG | 1 |
McNulty, H; McPartlin, J; Quinlivan, EP; Scott, JM; Strain, JJ; Ward, M; Weir, DG | 1 |
Kario, K | 1 |
Chang, SJ; Chou, HF; Huang, HB; Huang, PC; Hung, CJ; Li, YH; Lin, BF; Lu, SC | 1 |
Barrera, G; Bunout, D; de la Maza, P; Gattás, V; Hirsch, S; Petermann, M | 1 |
SoRelle, R | 1 |
Du, J; Li, J; Tang, C; Yao, X; Zhang, B; Zhang, Y | 1 |
Bond, CM; Golden, MH; Rydlewicz, A; Simpson, JA; Taylor, RJ | 1 |
Kenemans, P; Mijatovic, V; Neele, SJ; Netelenbos, JC; Smolders, RG; van Baal, WM; van der Mooren, MJ; Vogelvang, TE | 1 |
Bellanuova, I; Benedetto, FA; Cataliotti, A; Fermo, I; Malatino, LS; Mallamaci, F; Soldarini, A; Tripepi, G; Zoccali, C | 1 |
DeGroot, K; Dimitrova, KR; Kim, YD; Myers, AK | 1 |
Warren, CJ | 1 |
Breteler, MM; Clarke, R; Donald, A; Holman, R; Jacques, P; Johnston, C; Lewington, S; Refsum, H; Stratton, I | 1 |
Caixàs, A; Deulofeu, R; Galdon, G; Giménez-Pérez, G; González-Clemente, JM; Mauricio, D; Mitjavila, J; Ortega, E | 1 |
Duff, GW; Kornman, KS | 1 |
Molloy, AM | 1 |
Desouza, C; Fonseca, V; Keebler, M; McNamara, DB | 1 |
Abdu, TA; Akber, M; Clayton, RN; Elhadd, TA; Hartland, A; Neary, R | 1 |
Cole, DE | 1 |
Skarlatos, SI | 1 |
Ford, ES; Mueller, PW; Smith, SJ; Steinberg, KK; Stroup, DF; Thacker, SB | 1 |
De Vriese, AS; Lameire, NH; Schrijvers, BF; Verbeke, F | 1 |
Holtzman, JL | 1 |
Guidi, G; Lippi, G | 1 |
Archetti, S; Assanelli, D; Boldini, A; Bonanome, A; Bonetti, P; Grassi, M; Pagnan, A; Pezzini, A; Ruggeri, G; Salvadori, G | 1 |
Baraldi, L; Bianchi, G; Chierici, S; Forlani, G; Manini, R; Marchesini, G; Melchionda, N; Natale, S; Sassi, S; Visani, F | 1 |
Heiss, G; Malinow, MR; Nieto, FJ; Schreiner, PJ; Stinson, VL; Szklo, M; Wu, KK | 1 |
Jackson, SH; Mangoni, AA | 1 |
Rosenberg, IH | 1 |
Ducloux, D; Massy, ZA; Motte, G | 1 |
Duan, W; Kruman, II; Mattson, MP | 1 |
Sánchez Bayle, M | 1 |
Cormio, G; Depalo, R; Lorusso, F; Loverro, G; Mei, L; Selvaggi, L | 1 |
Nurk, E; Nygård, O; Refsum, H; Tell, GS; Ueland, PM; Vollset, SE | 1 |
Dixon, JB; Dixon, ME; O'Brien, PE | 1 |
Friedman, A | 1 |
Aviv, A; Herer, P; Lavie, L; Luboshitzky, R | 1 |
Refsum, H; Ueland, PM; Ulvik, RJ | 1 |
Andersson, A; Brattström, L; Hultberg, B; Israelsson, B; Olsson, A | 1 |
Boers, GH; Eskes, TK; Steegers, EA; Steegers-Theunissen, RP; Thomas, CM; Trijbels, FJ | 1 |
Christian, JC; Malinow, MR; Reed, T; Upson, B | 1 |
Stone, JH | 1 |
368 review(s) available for homocysteine and Cardiovascular Diseases
Article | Year |
---|---|
A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system.
Topics: Biomarkers; Cardiovascular Diseases; Cardiovascular System; Chemokine CCL2; COVID-19; Creatine Kinase, MB Form; Fibrin Fibrinogen Degradation Products; Homocysteine; Humans; Interferon-gamma; Interleukin-6; L-Lactate Dehydrogenase; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; SARS-CoV-2; Troponin I; Troponin T; Tumor Necrosis Factor-alpha | 2022 |
Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks.
Topics: Carbon Cycle; Cardiovascular Diseases; Diabetes Mellitus; Epigenesis, Genetic; Female; Folic Acid; Heart Disease Risk Factors; Homocysteine; Humans; Inflammation; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Vascular Diseases; Vitamin B 12 | 2021 |
Hyperhomocysteinemia and cardiovascular diseases.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Methionine; Risk Factors | 2022 |
Early life exposure to the Chinese Famine of 1959 - 1961 is an independent risk factor of adulthood elevated homocysteine, hyperuricemia, high LDL, and hypertension.
Topics: Adult; Cardiovascular Diseases; Child; Child, Preschool; China; Cross-Sectional Studies; Famine; Female; Homocysteine; Humans; Hypertension; Hyperuricemia; Prenatal Exposure Delayed Effects; Risk Factors; Starvation; Uric Acid | 2022 |
Vitamin B-related Gene Polymorphisms and Cardiovascular Disease.
Topics: Aminohydrolases; Cardiovascular Diseases; Folic Acid; Formate-Tetrahydrofolate Ligase; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Dehydrogenase (NADP); Methylenetetrahydrofolate Reductase (NADPH2); Multienzyme Complexes; Neoplasm Proteins; Polymorphism, Genetic; Receptors, Cell Surface; Vitamin B 12; Vitamin B Complex | 2022 |
The Controversial Role of HCY and Vitamin B Deficiency in Cardiovascular Diseases.
Topics: Aged; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B 12; Vitamin B Complex; Vitamin B Deficiency | 2022 |
Cysteine and related aminothiols in cardiovascular disease, obesity and insulin resistance.
Topics: Cardiovascular Diseases; Cysteine; Homocysteine; Humans; Insulin Resistance; Obesity; Oxidation-Reduction; Sulfhydryl Compounds | 2022 |
Hyperhomocysteinemia in Cardiovascular Diseases: Revisiting Observational Studies and Clinical Trials.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12 | 2023 |
[Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease].
Topics: Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Heart Disease Risk Factors; Homocysteine; Humans; Inflammation; Inflammatory Bowel Diseases; Pulse Wave Analysis; Risk Factors; Vascular Stiffness | 2021 |
HOMOCYSTEINE AND CARDIOVASCULAR DISEASE - A CURRENT REVIEW.
Topics: Atherosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Reactive Oxygen Species | 2022 |
The interplay between prolactin and cardiovascular disease.
Topics: Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol, LDL; Dopamine Agonists; Female; Homocysteine; Humans; Hyperprolactinemia; Hypogonadism; Male; Pituitary Neoplasms; Prolactin; Prolactinoma | 2022 |
Homocysteine as a predictor and prognostic marker of atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
Topics: Aged; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Child; Endothelial Cells; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prognosis; Risk Factors; Vitamin B 12 | 2023 |
Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Topics: Adiponectin; Blood Viscosity; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Homocysteine; Humans | 2023 |
[Research progress on the role and mechanism of endothelial dysfunction in hyperhomocysteine-induced atherosclerosis].
Topics: Atherosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Risk Factors | 2023 |
Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics.
Topics: Alarmins; Antihypertensive Agents; Cardiovascular Diseases; Chromatin; Diabetes Mellitus, Type 2; DNA Methylation; Endothelium, Vascular; Epigenesis, Genetic; Extracellular Traps; Gastrointestinal Microbiome; Histones; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Hypoglycemic Agents; Insulin; Metabolic Syndrome; Renin-Angiotensin System; Risk Factors; RNA, Untranslated | 2020 |
Aberrant DNA methylation and miRNAs in coronary artery diseases and stroke: a systematic review.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Databases, Factual; Databases, Genetic; DNA Methylation; Genome-Wide Association Study; Homocysteine; Humans; Lipid Metabolism; MicroRNAs; Nitric Oxide; Stroke | 2020 |
The Link between Homocysteine and Omega-3 Polyunsaturated Fatty Acid: Critical Appraisal and Future Directions.
Topics: Animals; Cardiovascular Diseases; Cognition Disorders; Dietary Supplements; Fatty Acids, Omega-3; Fish Oils; Homocysteine; Humans; Oxidative Stress; Risk Factors; Vitamin B Complex | 2020 |
Homocysteine: Its Possible Emerging Role in At-Risk Population Groups.
Topics: Aging; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Cardiovascular Diseases; Female; Homocysteine; Humans; Infant, Newborn; Infant, Small for Gestational Age; Male; Neurodegenerative Diseases; Osteoporosis; Pre-Eclampsia; Pregnancy; Risk Factors | 2020 |
Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall.
Topics: Animals; Arteries; Cardiovascular Diseases; Cells, Cultured; Endothelium, Vascular; Homocysteine; Humans | 2020 |
The Interaction between Arachidonic Acid Metabolism and Homocysteine.
Topics: Animals; Arachidonic Acid; Biomarkers; Cardiovascular Diseases; Heart Disease Risk Factors; Homocysteine; Humans; Hyperhomocysteinemia; Prognosis; Risk Assessment | 2021 |
Metabolic Consequences of Supplemented Methionine in a Clinical Context.
Topics: Animals; Body Fluid Compartments; Cardiovascular Diseases; Dietary Supplements; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Proteins; Vitamin B Complex; Vitamin B Deficiency | 2020 |
Homocysteine levels and cardiovascular risk factors in children and adolescents: systematic review and meta-analysis.
Topics: Adolescent; Cardiovascular Diseases; Child; Cross-Sectional Studies; Heart Disease Risk Factors; Homocysteine; Humans; Pediatric Obesity; Risk Factors | 2021 |
Homocysteine and diabetes: Role in macrovascular and microvascular complications.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Nephropathies; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B 12 | 2021 |
Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Receptor, Adenosine A2A | 2021 |
Effects of betaine supplementation on cardiovascular markers: A systematic review and Meta-analysis.
Topics: Betaine; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Homocysteine; Humans; Triglycerides | 2022 |
Homocysteine and Non-Cardiac Vascular Disease.
Topics: Animals; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Artery Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Arterial Disease; Vascular Diseases | 2017 |
[Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease].
Topics: alpha-2-HS-Glycoprotein; Cardiovascular Diseases; Cytokines; HMGB1 Protein; Homocysteine; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Risk Factors; Vascular Endothelial Growth Factor A | 2017 |
Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Homocysteine; Humans; Oxidative Stress; Polycystic Ovary Syndrome; Receptor for Advanced Glycation End Products; von Willebrand Factor | 2017 |
Homocysteine: A Potential Common Route for Cardiovascular Risk and DNA Methylation in Psoriasis.
Topics: Cardiovascular Diseases; DNA Methylation; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Psoriasis | 2017 |
Hyperhomocysteinemia and cardiovascular disease in animal model.
Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Risk Factors | 2018 |
Vascular Dysfunction in Exfoliation Syndrome.
Topics: Baroreflex; Capillaries; Cardiovascular Diseases; Exfoliation Syndrome; Glaucoma, Open-Angle; Heart Rate; Homocysteine; Humans; Peripheral Vascular Diseases; Regional Blood Flow | 2018 |
Causes of hyperhomocysteinemia and its pathological significance.
Topics: Alzheimer Disease; Anemia; Animals; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2018 |
Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?
Topics: Biopterins; Cardiovascular Diseases; Dietary Supplements; Endothelium, Vascular; Folic Acid; Hemodynamics; Homocysteine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Signal Transduction; Tetrahydrofolates | 2018 |
Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
Topics: Animals; Betaine; Biomarkers; Cardiovascular Diseases; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Phenotype; Risk Factors; Tetrahydrofolates; Treatment Outcome | 2018 |
Coronary Microvascular and Cardiac Dysfunction Due to Homocysteine Pathometabolism; A Complex Therapeutic Design.
Topics: Animals; Cardiovascular Diseases; Cell Death; Coronary Vessels; Homocysteine; Humans; Neuroprotective Agents | 2018 |
The current status of homocysteine as a risk factor for cardiovascular disease: a mini review.
Topics: Atherosclerosis; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin B Complex | 2018 |
Serum homocysteine, folate and vitamin B
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Psoriasis; Vitamin B 12 | 2019 |
Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Nervous System Diseases | 2018 |
Homocysteine Modification in Protein Structure/Function and Human Disease.
Topics: Animals; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12 | 2019 |
The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
Topics: Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Homocysteine; Humans; Hydrogen Sulfide; Hyperhomocysteinemia; Methionine; Nitric Oxide; Reactive Oxygen Species; S-Adenosylhomocysteine | 2019 |
Folic Acid and Vitamin B12 Administration in CKD, Why Not?
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors; Vitamin B 12 | 2019 |
Methoxistasis: integrating the roles of homocysteine and folic acid in cardiovascular pathobiology.
Topics: Cardiovascular Diseases; Dietary Supplements; Dose-Response Relationship, Drug; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Methylation; Oxidation-Reduction; Randomized Controlled Trials as Topic; Vitamin B Complex; Vitamin B Deficiency; Vitamins | 2013 |
Effect of the vegetarian diet on non-communicable diseases.
Topics: Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet, Vegetarian; Fatty Acids, Omega-3; Feeding Behavior; Homocysteine; Humans; Neoplasms; Vitamin B 12 Deficiency | 2014 |
Honey and cardiovascular risk factors, in normal individuals and in patients with diabetes mellitus or dyslipidemia.
Topics: Animals; Antioxidants; Blood Glucose; Blood Pressure; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus; Dyslipidemias; Homocysteine; Honey; Humans; Models, Animal; Nitric Oxide; Obesity; Prostaglandins; Risk Factors | 2013 |
The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.
Topics: Biomarkers; Cardiovascular Diseases; Down-Regulation; Homocysteine; Humans; Hyperhomocysteinemia; Primary Prevention; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B Complex | 2014 |
Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.
Topics: Cardiovascular Diseases; Fatty Acids; Homocysteine; Humans; Mental Disorders; Metabolic Networks and Pathways; Oxidative Stress | 2014 |
The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis.
Topics: Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Sleep Apnea, Obstructive | 2014 |
[Hyperhomocysteinemia in patients with cardiovascular disease].
Topics: Cardiovascular Diseases; Causality; Comorbidity; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Myocardial Infarction; Risk Factors; Vitamin B 12 | 2014 |
Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Observational Studies as Topic; Odds Ratio; Prospective Studies; Young Adult | 2015 |
Role of homocysteine in the development of cardiovascular disease.
Topics: Brain; Cardiovascular Diseases; Catecholamines; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Hypothalamus; Placebos; Stroke | 2015 |
Homocysteine, iron and cardiovascular disease: a hypothesis.
Topics: Biomarkers; Cardiovascular Diseases; Cystathionine; Dietary Supplements; Folic Acid; Free Radicals; Homocysteine; Humans; Hyperhomocysteinemia; Iron; Lipoproteins, LDL; Methionine; Risk Factors; S-Adenosylhomocysteine; Vitamin B Complex | 2015 |
Interventions for lowering plasma homocysteine levels in kidney transplant recipients.
Topics: Cardiovascular Diseases; Cause of Death; Folic Acid; Homocysteine; Humans; Kidney Transplantation; Randomized Controlled Trials as Topic; Vitamin B Complex | 2015 |
Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians?
Topics: Cardiovascular Diseases; Diet, Vegetarian; Dietary Supplements; Homocysteine; Humans; Hyperhomocysteinemia; Prevalence; Risk Factors; Vegetarians; Vitamin B 12 Deficiency | 2015 |
Homocysteine-Induced Endothelial Dysfunction.
Topics: Biological Availability; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Oxidative Stress; Risk Factors; Vasodilation | 2015 |
Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview.
Topics: Adiponectin; Arginine; Blood Pressure; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Diet; Homocysteine; Humans; Oxidative Stress; Pediatric Obesity; Phenylalanine; Phenylketonurias; Risk Factors | 2016 |
Homocysteine--is it still an important risk factor for cardiovascular disease?
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors | 2015 |
What do we know about homocysteine and exercise? A review from the literature.
Topics: Cardiovascular Diseases; Exercise; Homocysteine; Humans | 2016 |
Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease.
Topics: Animals; Cardiovascular Diseases; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Homocysteine; Humans; Mitochondria | 2016 |
Interventions for lowering plasma homocysteine levels in dialysis patients.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Stroke; Venous Thrombosis; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2016 |
[Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Supplements; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Incidence; Middle Aged; Randomized Controlled Trials as Topic; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2016 |
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health.
Topics: Bone Diseases; Cardiovascular Diseases; Cerebrovascular Disorders; Gastrointestinal Diseases; Health Status; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Neoplasms; Oxidation-Reduction; Oxidative Stress; Risk Factors | 2016 |
Is folic acid supplementation useful for chronic kidney disease?
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Renal Insufficiency, Chronic; Risk Factors; Stroke | 2016 |
[Mechanisms that protect against homocysteine toxicity].
Topics: Aryldialkylphosphatase; Cardiovascular Diseases; Cysteine Endopeptidases; Homocysteine; Humans; Hydrolases; Hydrolysis | 2008 |
Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors | 2008 |
Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants.
Topics: Cardiovascular Diseases; Glomerular Filtration Rate; Homocysteine; Kidney Function Tests; Risk Factors | 2008 |
Public health significance of elevated homocysteine.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Dementia; Diet; Female; Folic Acid; Fractures, Bone; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Neural Tube Defects; Pregnancy; Public Health; Risk Factors; Vitamin B 12; Vitamin B 6 | 2008 |
Cardiovascular disease in patients with diabetic nephropathy.
Topics: Anemia; Arginine; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Enzyme Inhibitors; Glycation End Products, Advanced; Homocysteine; Humans; Prognosis; Risk Factors | 2008 |
[Updates in hemodialysis].
Topics: Biomarkers; Cardiovascular Diseases; Comorbidity; Endothelium, Vascular; Hemodiafiltration; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Lipoprotein(a); Malnutrition; Online Systems; Oxidative Stress; Quality Indicators, Health Care; Renal Dialysis; Thyroid Diseases | 2008 |
Too much folate: a risk factor for cancer and cardiovascular disease?
Topics: Adenoma; Cardiovascular Diseases; Chronic Disease; Colorectal Neoplasms; Dietary Supplements; Dose-Response Relationship, Drug; Epigenesis, Genetic; Folic Acid; Homocysteine; Humans; Neoplasms; Risk Factors | 2009 |
Protective effect of vitamin B therapy on bone and cardiovascular disease.
Topics: Bone Diseases; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Vitamin B Complex | 2009 |
Anti-inflammatory strategies for homocysteine-related cardiovascular disease.
Topics: Anti-Inflammatory Agents; Antioxidants; Cardiovascular Diseases; Homocysteine; Humans | 2009 |
[Present role of homocysteine in clinical medicine].
Topics: Adolescent; Adult; Cardiovascular Diseases; Child; Child, Preschool; Ectopia Lentis; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Infant; Infant, Newborn; Life Style; Male; Middle Aged; Myopia; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2009 |
Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Prospective Studies; Renal Dialysis; Retrospective Studies; Risk Factors; Vitamin B 12 | 2009 |
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Creatinine; Diabetes Mellitus; Dyslipidemias; Homocysteine; Humans; Hypolipidemic Agents; Metabolic Syndrome; Niacin | 2009 |
Cobalamin, folic acid, and homocysteine.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Food, Fortified; Homocysteine; Humans; Neural Tube Defects; Nutritional Requirements; Nutritional Status; Pregnancy; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2009 |
Quo vadis: whither homocysteine research?
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Hyperhomocysteinemia | 2009 |
Molecular mechanisms of homocysteine toxicity.
Topics: Animals; Apoptosis; Blood Cells; Cardiovascular Diseases; Carnosine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Neurodegenerative Diseases; Neurons; Pregnancy; Receptors, N-Methyl-D-Aspartate; Risk Factors | 2009 |
Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?
Topics: Animals; Biomarkers; Bone and Bones; Bone Diseases; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia | 2009 |
[Hyperhomocysteinemia and cardiometabolic risk].
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Deficiency; Vitamins | 2009 |
The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
Topics: Biomarkers; Cardiovascular Diseases; Epidemiologic Studies; Fibrinogen; Homocysteine; Humans; Lipoprotein(a); Oxidative Stress; Risk Factors; Seroepidemiologic Studies | 2003 |
Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials.
Topics: Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B Complex | 2010 |
Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease.
Topics: Cardiovascular Diseases; Enzymes; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Nutritional Physiological Phenomena; Polymorphism, Genetic; Risk Factors; Vitamins | 2009 |
The controversial role of B-vitamins in cardiovascular risk: An update.
Topics: Biomarkers; Cardiovascular Diseases; Dietary Supplements; Evidence-Based Medicine; Homocysteine; Humans; Hyperhomocysteinemia; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B Complex | 2009 |
[Hyperhomocysteinemia and the disturbance of haemostasis--facts and mythes].
Topics: Animals; Cardiovascular Diseases; Hemostasis; Hemostatic Disorders; Homocysteine; Humans; Hyperhomocysteinemia | 2009 |
Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.
Topics: Adiponectin; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Contraceptives, Oral, Hormonal; Female; Homocysteine; Humans; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk Factors; Venous Thrombosis | 2009 |
The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence.
Topics: Animals; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Inflammation; Nicotiana; Oxidative Stress; Risk Factors; Thrombosis; Tobacco Smoke Pollution | 2009 |
Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in children and adolescents.
Topics: Adolescent; Anticonvulsants; Biomarkers, Pharmacological; Cardiovascular Diseases; Child; Epilepsy; Homocysteine; Humans; Lipoproteins; Methylenetetrahydrofolate Reductase (NADPH2); Time Factors | 2010 |
[Disturbances of homocysteine metabolism as a risk factor of cardiovascular diseases development: effect on prognosis and possibilities of correction with drugs].
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Prognosis; Risk Factors; Russia; Vitamin B Complex | 2010 |
Homocysteine lowering in end-stage renal disease: is there any cardiovascular benefit?
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic | 2010 |
Clinical diagnostics for homocysteine: a rogue amino acid?
Topics: Animals; Avitaminosis; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Mental Disorders; Molecular Structure; Neurodegenerative Diseases; Oxidation-Reduction; Pathology, Molecular; Pregnancy; Pregnancy Complications | 2010 |
Is a low blood level of vitamin B12 a cardiovascular and diabetes risk factor? A systematic review of cohort studies.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Meta-Analysis as Topic; Risk Factors; Treatment Outcome; Vitamin B 12; Vitamin B 12 Deficiency | 2011 |
The genetics of vascular complications in diabetes mellitus.
Topics: Aryldialkylphosphatase; Blood Vessels; Cardiovascular Diseases; Diabetic Angiopathies; Haptoglobins; Homocysteine; Humans; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Polymorphism, Genetic; Retrospective Studies | 2010 |
Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
Topics: Aged; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors | 2010 |
Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.
Topics: Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Models, Biological; Neural Tube Defects; Pregnancy; Risk Factors | 2011 |
Homocysteine, cardiovascular inflammation, and myocardial remodeling.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Ventricular Remodeling | 2010 |
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Confidence Intervals; Dietary Supplements; Folic Acid; Homocysteine; Humans; Incidence; Neoplasms; Randomized Controlled Trials as Topic; Stroke; Treatment Failure; Vitamin B Complex | 2010 |
Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis.
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Supplements; Evidence-Based Medicine; Female; Folic Acid; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Patient Selection; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Assessment; Risk Factors; Treatment Outcome | 2011 |
Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Homocysteine; Humans; Hyperhomocysteinemia; Matrix Metalloproteinases; Methionine; Nitric Oxide Synthase; Oxidation-Reduction; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species | 2011 |
Copper and homocysteine in cardiovascular diseases.
Topics: Animals; Cardiovascular Diseases; Copper; Homocysteine; Humans | 2011 |
The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Primary Prevention; Vitamin B 6; Vitamin B Complex | 2010 |
Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties.
Topics: Acute Disease; Biomarkers; Cardiovascular Diseases; Chronic Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2011 |
[Coffee and caffeine - enemies or alliantes of a cardiologist?].
Topics: Blood Pressure; Caffeine; Cardiovascular Diseases; Cholesterol; Coffee; Fetal Growth Retardation; Homocysteine; Humans; Purinergic P1 Receptor Antagonists | 2011 |
Epigenetic modifications: basic mechanisms and role in cardiovascular disease.
Topics: Cardiovascular Diseases; DNA Methylation; Epigenesis, Genetic; Histones; Homocysteine; Humans | 2011 |
Focal adhesion kinase and endothelial cell apoptosis.
Topics: Adenosine; Animals; Anoikis; Apoptosis; Cardiovascular Diseases; Endothelial Cells; Enzyme Activation; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Homocysteine; Humans; Monomeric GTP-Binding Proteins; Signal Transduction | 2012 |
Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Dietary Supplements; Down-Regulation; Evidence-Based Medicine; Homocysteine; Humans; Research Design; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B Complex; Vitamin E | 2012 |
Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.
Topics: alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Comorbidity; Dyslipidemias; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homocysteine; Humans; Infections; Inflammation; Interleukin-6; Kidney Failure, Chronic; Malnutrition; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proteomics; Renal Replacement Therapy; Troponin T | 2011 |
Chemical biology of homocysteine thiolactone and related metabolites.
Topics: Amyloid; Animals; Brain Diseases; Cardiovascular Diseases; Dipeptides; Homocysteine; Humans; Methionine; Methionine-tRNA Ligase; Mice; Protein Biosynthesis; Proteins; Proteolysis | 2011 |
C(1) metabolism and CVD outcomes in older adults.
Topics: Blood Pressure; Carbon; Cardiovascular Diseases; Folic Acid; Genetic Predisposition to Disease; Genotype; Heart Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Riboflavin; Stroke; Vitamin B Complex | 2012 |
Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Randomized Controlled Trials as Topic | 2012 |
[The role of homocysteine and methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase polymorphisms in the development of cardiovascular diseases and hypertension].
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Cardiovascular Diseases; Ferredoxin-NADP Reductase; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Single Nucleotide | 2012 |
Expanding roles of glutamate receptors in neurovascular regulation.
Topics: Cardiovascular Diseases; Endothelial Cells; Glutamic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Neurons; Receptors, Glutamate | 2012 |
A review on metaanalysis of biomarkers: promises and pitfalls.
Topics: Biomarkers; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Evidence-Based Medicine; Homocysteine; Humans; Meta-Analysis as Topic; Periodicals as Topic; Triglycerides | 2012 |
[Kynurenic acid--a new tool in the treatment of hiperhomocysteinemia and its consequences?].
Topics: Atherosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Kynurenic Acid; Stroke; Tissue Distribution | 2012 |
Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.
Topics: Animals; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Treatment Outcome | 2013 |
Methylenetetrahydrofolate reductase: biochemical characterization and medical significance.
Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Arabidopsis; Cardiovascular Diseases; Catalysis; Escherichia coli; Homocysteine; Humans; Hyperhomocysteinemia; Leishmania major; Mental Disorders; Methylenetetrahydrofolate Reductase (NADPH2); Models, Molecular; Molecular Sequence Data; Neoplasms; Neural Tube Defects; Polymorphism, Single Nucleotide; Sequence Alignment; Tetrahydrofolates | 2013 |
[Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardio-cerebrovascular disease].
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic | 2012 |
Hyperhomocysteinemia in renal transplant recipients.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Transplantation; Risk Factors | 2002 |
[Prevention of cardiovascular risk in renal transplantation. Consensus document].
Topics: Alcohol Drinking; Arteriosclerosis; Cardiovascular Diseases; Diabetes Complications; Diet; Exercise; Fibrinogen; Homocysteine; Humans; Kidney Transplantation; Obesity; Risk Factors; Smoking | 2002 |
Methods for measuring sulfur amino acid metabolism.
Topics: Amino Acids, Sulfur; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kinetics; Methionine; Methylation; Models, Biological; Radioisotope Dilution Technique; Vitamin B 12 | 2002 |
Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2002 |
How progestins influence the cardiovascular effect of hormone replacement therapy.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Cardiovascular System; Coronary Disease; Estrogen Replacement Therapy; Female; Hemostasis; Homocysteine; Humans; Insulin; Lipids; Menopause; Progestins; Risk Factors | 2001 |
On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis.
Topics: Animals; Cardiovascular Diseases; Catechol O-Methyltransferase Inhibitors; Catecholamines; Homocysteine; Humans; S-Adenosylhomocysteine | 2002 |
Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2002 |
Sleep disordered breathing and risk factors for cardiovascular disease.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Homocysteine; Humans; Leptin; Metabolic Syndrome; Positive-Pressure Respiration; Risk Factors; Severity of Illness Index; Sleep Apnea Syndromes | 2002 |
Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease.
Topics: Adult; Aged; Animals; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2002 |
[New risk factors related with genetic background].
Topics: Apolipoproteins E; Cardiovascular Diseases; Genotype; Homocysteine; Humans; Lipoproteins; Risk Factors | 1999 |
Genetics of hyperhomocysteinaemia in cardiovascular disease.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Methylation; Models, Biological; Polymorphism, Genetic | 2003 |
Novel biomedical risk markers for cardiovascular disease.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Fibrinogen; Homocysteine; Humans; Interleukin-6; Natriuretic Peptide, Brain; Risk Factors; von Willebrand Factor | 2003 |
The methionine-homocysteine cycle and its effects on cognitive diseases.
Topics: Alzheimer Disease; Cardiovascular Diseases; Cognition Disorders; Dementia, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Memory Disorders; Methionine; Methionine Adenosyltransferase; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6 | 2003 |
[Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
Topics: Animals; Arteriosclerosis; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Rats | 2002 |
Vitamins, homocysteine and cardiovascular risk.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamins | 2002 |
News and views on folate and elderly persons.
Topics: Aged; Cardiovascular Diseases; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Mental Disorders; Methylation; Neoplasms; Risk Factors; Vitamin B 12 Deficiency | 2003 |
PASSCLAIM - Diet-related cardiovascular disease.
Topics: Animals; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Consensus Development Conferences as Topic; Food Industry; Hemostasis; Homocysteine; Humans; Nutritive Value; Risk Factors; Triglycerides | 2003 |
Traditional and emerging cardiovascular risk factors in end-stage renal disease.
Topics: Autonomic Nervous System Diseases; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Risk Factors; Sleep Apnea Syndromes | 2003 |
[Homocysteine and cardiovascular disease--still no evidence for a connection. An unknown risk factor can be involved according to a systemic review].
Topics: Cardiovascular Diseases; Evidence-Based Medicine; Homocysteine; Humans; Meta-Analysis as Topic; Risk Factors | 2003 |
[Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
Topics: Animals; Arteriosclerosis; Blood Circulation; Cardiovascular Diseases; Hemostasis; Homocysteine; Humans; Muscle, Smooth, Vascular; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Vasculitis | 2003 |
Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes.
Topics: Albuminuria; C-Reactive Protein; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Endothelium, Vascular; Homocysteine; Humans; Inflammation; Insulin Resistance; Risk Factors | 2003 |
Folate and homocysteine metabolism: therapeutic targets in cardiovascular and neurodegenerative disorders.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Models, Biological; Molecular Structure; Neurodegenerative Diseases | 2003 |
Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.
Topics: Adenosine; Cardiovascular Diseases; Homeostasis; Homocysteine; Humans; Hyperhomocysteinemia; Receptors, Purinergic P1; S-Adenosylhomocysteine | 2003 |
Estrogens, homocysteine, vasodilatation and menopause: basic mechanisms, interactions and clinical implications.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Female; Homocysteine; Humans; Postmenopause; Vasodilation | 2003 |
Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Plasminogen Inactivators; Platelet Aggregation; Tissue Plasminogen Activator | 2003 |
[Hyperhomocysteinemia and cardiovascular risk in diabetes mellitus].
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Thrombophilia | 2003 |
[Homocysteine as a coronary risk factor].
Topics: Alcoholic Beverages; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diet; Female; Folic Acid; Glycine max; Homocysteine; Humans; Hyperhomocysteinemia; Male; Platelet Aggregation; Risk Factors; Vitamin B 12; Vitamin B 6 | 2003 |
[Public health control of hyperhomocysteinemia and its consequences].
Topics: Alzheimer Disease; Canada; Cardiovascular Diseases; Flour; Folic Acid; Food, Fortified; Hematinics; Homocysteine; Humans; Hungary; Hyperhomocysteinemia; Neoplasms; Neural Tube Defects; Primary Prevention; Public Health; Randomized Controlled Trials as Topic; United Kingdom; United States; Vitamin B Complex; Vitamin B Deficiency | 2003 |
DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Topics: Austria; Cardiovascular Diseases; Female; Folic Acid; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Switzerland; Thrombosis; Vitamin B 12; Vitamin B 6 | 2003 |
Homocysteine and oxidative stress.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Lipoproteins, LDL; Models, Biological; Oxidative Stress; Risk Factors; Superoxide Dismutase | 2003 |
[Emerging risk factors for cardiovascular disease].
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Lipoprotein(a); Predictive Value of Tests; Risk Factors | 2004 |
Folate, homocysteine, endothelial function and cardiovascular disease.
Topics: Antioxidants; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Risk Factors; Vitamin B Complex | 2004 |
Homocysteine and cardiovascular disease in renal disease.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases | 2003 |
Homocysteine and cardiovascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Genetic Variation; Homocysteine; Humans; Hyperhomocysteinemia | 2004 |
Is there a need for novel cardiovascular risk factors?
Topics: Albuminuria; Apolipoproteins A; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Risk Assessment | 2004 |
Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
Topics: Cardiovascular Diseases; Dietary Supplements; Drug Synergism; Fatty Acids, Omega-3; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12; Vitamin B 6 | 2004 |
Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part II: what do I tell my patients?
Topics: Adult; Age Factors; Aged; Apolipoproteins; Biomarkers; C-Reactive Protein; Calcium; Cardiovascular Diseases; Cholesterol, HDL; Coronary Artery Disease; Health Status; Homocysteine; Humans; Male; Middle Aged; Physician-Patient Relations; Primary Prevention; Risk Assessment; Sensitivity and Specificity; Survival Analysis | 2004 |
New cardiovascular risk factors: homocysteine and vitamins involved in homocysteine metabolism.
Topics: Biomarkers; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamins | 2004 |
[Homocysteine and cardiovascular risk].
Topics: Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2004 |
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials.
Topics: Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2004 |
Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antioxidants; Arteriosclerosis; Aryldialkylphosphatase; Cardiovascular Diseases; Homocysteine; Humans; Lipoproteins, HDL; Models, Biological; Polymorphism, Genetic | 2004 |
Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
Topics: Animals; Apoptosis; Arteriosclerosis; Cardiovascular Diseases; Cell Adhesion; Endoplasmic Reticulum; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Models, Biological; Oxidative Stress; Protein Folding; Risk Factors; Thrombosis; Transcription Factors | 2004 |
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Topics: Cardiovascular Diseases; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Patient Care Management; Practice Guidelines as Topic; Thrombosis; Vitamin B Complex | 2004 |
[Consequences of moderate hyperhomocysteinemia in internal medicine].
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2004 |
Relationship of homocysteine with cardiovascular disease and blood pressure.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hypertension | 2004 |
Clinical usefulness of plasma homocysteine in vascular disease.
Topics: Arteriosclerosis; Australia; Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Incidence; Male; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Vascular Diseases | 2004 |
[Hyperhomocysteinemia: from theory and practice in the treatment of thrombophilias].
Topics: Administration, Oral; Anticoagulants; Blood Coagulation Tests; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Marfan Syndrome; Multicenter Studies as Topic; Mutation; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Thrombophilia; Time Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 6 | 2004 |
Homocysteine: is it a clinically important cardiovascular risk factor?
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Myocardial Infarction; Reference Values; Risk Factors; Vitamin B Complex | 2004 |
N-Acetylcysteine in nephrology; contrast nephropathy and beyond.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Contrast Media; Homocysteine; Humans; Kidney Diseases; Kidney Failure, Chronic | 2004 |
Menopause, the cardiovascular risk factor homocysteine, and the effects of treatment.
Topics: Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Folic Acid; Homocysteine; Humans; Menopause; Risk Factors; Vitamin B 12; Vitamin B 6 | 2004 |
[Homocysteine--an underestimated atheromatosis risk factor. Do sex hormones influence homocysteine concentrations?].
Topics: Atherosclerosis; Cardiovascular Diseases; Comorbidity; Female; Gonadal Steroid Hormones; Homocysteine; Hormone Replacement Therapy; Humans; Hyperhomocysteinemia; Insulin; Menopause; Obesity; Risk Factors | 2004 |
"New" cardiovascular risk factors in patients with chronic kidney disease: role of folic acid treatment.
Topics: C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipid Peroxidation; Risk Factors | 2005 |
Homocysteine and cardiovascular disease: interactions between nutrition, genetics and lifestyle.
Topics: Avitaminosis; Cardiovascular Diseases; Creatinine; Folic Acid; Homocysteine; Humans; Incidence; Kidney Diseases; Life Style; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Nutritional Physiological Phenomena; Polymorphism, Genetic; Pyridoxal; Riboflavin; Vitamin B 12 | 2004 |
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking | 2004 |
Coffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cholesterol; Coffee; Diabetes Mellitus, Type 2; Diterpenes; Health Promotion; Homocysteine; Humans; Risk Factors | 2005 |
Effects of betaine intake on plasma homocysteine concentrations and consequences for health.
Topics: Animals; Betaine; Cardiovascular Diseases; Choline; Folic Acid; Homocysteine; Humans; Lipids | 2005 |
Novel serologic markers of cardiovascular risk.
Topics: Antioxidants; Aspirin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cytokines; Drug Resistance; Fibrinogen; Homocysteine; Humans; Platelet Aggregation Inhibitors; Risk Factors; Survival Rate | 2005 |
[Group B vitamins as new variables related to the cardiovascular risk].
Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Case-Control Studies; Clinical Trials as Topic; Cross-Over Studies; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Primary Prevention; Prospective Studies; Retrospective Studies; Risk; Risk Factors; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2005 |
Metabolism of homocysteine and its relationship with cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia | 2004 |
B-vitamins, homocysteine metabolism and CVD.
Topics: Carbon-Nitrogen Ligases; Cardiovascular Diseases; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Polymorphism, Genetic; Risk Factors; Vitamin B Complex; Vitamin B Deficiency | 2004 |
[Determination and utilisation of the plasmatic concentration of homocysteine in clinical practice].
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12 | 2005 |
Subclinical hypothyroidism and cardiovascular risk: a reason to treat?
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Hypothyroidism; Lipids; Male; Risk Factors; Thyroid Gland; Thyroxine | 2004 |
Homocysteine, B-vitamins, and the risk of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Dietary Supplements; Homocysteine; Humans; Risk Factors; Vitamin B Complex | 2005 |
Folate metabolism and cardiovascular disease.
Topics: Biomarkers; Cardiovascular Diseases; DNA; Folic Acid; Homocysteine; Humans; Methylation; Risk Factors | 2005 |
Genetic determinants of plasma total homocysteine.
Topics: Cardiovascular Diseases; Genetic Markers; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors | 2005 |
Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease.
Topics: Animals; Autoantibodies; Cardiovascular Diseases; Coronary Vessels; Homocysteine; Humans | 2005 |
Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.
Topics: Animals; Arginine; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors; Sensitivity and Specificity | 2005 |
[Homocystein--an independent risk factor for cardiovascular and thrombotic diseases].
Topics: Cardiovascular Diseases; Health Behavior; Homocysteine; Humans; Risk Assessment; Risk Factors; Risk Reduction Behavior; Statistics as Topic; Thrombosis; Vitamins | 2005 |
Reverse epidemiology: paradoxical observations in haemodialysis patients.
Topics: Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Glycation End Products, Advanced; Homocysteine; Humans; Hyperlipidemias; Hypertension, Renal; Hypotension; Kidney Failure, Chronic; Risk Factors | 2005 |
[Homocysteine--risk factor or risk indicator?].
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Child; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Infarction; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Vitamin B Complex | 2005 |
Traditional and emerging risk factors for cardiovascular disease.
Topics: Age Factors; C-Reactive Protein; Cardiovascular Diseases; Diabetes Complications; Homocysteine; Humans; Incidence; Lipoprotein(a); Metabolic Syndrome; Primary Health Care; Risk Assessment; Risk Factors | 2005 |
Chronic renal failure: a cardiovascular risk factor.
Topics: Albuminuria; Anemia; Calcinosis; Cardiovascular Diseases; Glomerular Filtration Rate; Homocysteine; Humans; Hypertrophy, Left Ventricular; Inflammation; Kidney; Kidney Failure, Chronic; Metabolic Syndrome; Oxidative Stress; Prevalence; Risk Factors; Sympathetic Nervous System; Uremia | 2005 |
Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies.
Topics: Animals; Apoptosis; Atherosclerosis; Blood Coagulation; Cardiovascular Diseases; Epigenesis, Genetic; Gene Expression Regulation; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Mutation; Nervous System Diseases; Oxidative Stress; Polymorphism, Genetic; Signal Transduction | 2006 |
Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Homocystinuria; Humans; Kidney Diseases; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Vitamin B Complex | 2006 |
ADMA and hyperhomocysteinemia.
Topics: Amidohydrolases; Animals; Arginine; Cardiovascular Diseases; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Nitric Oxide Synthase Type III; Risk Factors; Superoxides; Vasodilation | 2005 |
The story of PON1: how an organophosphate-hydrolysing enzyme is becoming a player in cardiovascular medicine.
Topics: Arteriosclerosis; Aryldialkylphosphatase; Cardiovascular Diseases; Esterases; Homocysteine; Humans; Lipid Metabolism; Organophosphorus Compounds | 2006 |
Betaine supplementation and blood lipids: fact or artifact?
Topics: Betaine; Cardiovascular Diseases; Dietary Supplements; Homocysteine; Humans; Lipids; Lipotropic Agents | 2006 |
[Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Topics: Animals; Anticholesteremic Agents; Aryldialkylphosphatase; Atherosclerosis; Cardiovascular Diseases; Cholesterol; Cholesterol Esters; Disease Models, Animal; Genetic Predisposition to Disease; Homocysteine; Humans; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Male; Mice; Mice, Transgenic; Oxidative Stress; Phenotype; Polymorphism, Genetic; Receptors, Lipoprotein; Scavenger Receptors, Class B | 2006 |
Homocysteine and B vitamins.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Stroke; Vitamin B Complex | 2005 |
[Uraemic toxins and cardiovascular diseases].
Topics: Arginine; Cardiovascular Diseases; Glycosylation; Homocysteine; Humans; Uremia | 2005 |
The many facets of hyperhomocysteinemia: studies from the Framingham cohorts.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cardiovascular Diseases; Carotid Stenosis; Cohort Studies; Dementia; Diet; Female; Folic Acid; Fractures, Bone; Heart Failure; Homocysteine; Humans; Hyperhomocysteinemia; Male; Massachusetts; Middle Aged; Risk Factors; Stroke; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2006 |
The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease.
Topics: Adult; Aged; Aging; Bone Density; Cardiovascular Diseases; Cognition Disorders; Depression; Disease; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Mortality; Norway; Osteoporosis; Pregnancy; Pregnancy Complications; Risk Factors | 2006 |
Vitamins and minerals 4: overview of folate and the B vitamins.
Topics: Alzheimer Disease; Cardiovascular Diseases; Chemoprevention; Dementia, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Neoplasms; Primary Prevention; Risk Factors; Risk Reduction Behavior; Vitamin B 12; Vitamin B 6 | 2006 |
Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.
Topics: Adult; Aging; Animals; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B Complex; Vitamin B Deficiency | 2006 |
Homocysteine.
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Chromatography, Gas; Chromatography, High Pressure Liquid; Homocysteine; Humans; Immunoassay | 2006 |
Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated.
Topics: Atherosclerosis; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Folic Acid; Homocysteine; Humans; Prospective Studies; Risk Factors; Thrombosis; Treatment Outcome | 2006 |
Homocysteine and cardiovascular disease: is HDL the link?
Topics: Apolipoprotein A-I; Cardiovascular Diseases; Cholesterol, HDL; Homocysteine; Humans; Lipoproteins, HDL | 2006 |
Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents.
Topics: Adolescent; Adult; Arteries; Atherosclerosis; Cardiovascular Diseases; Child; Elasticity; Homocysteine; Humans; Inflammation; Pediatrics; Risk Factors; Tunica Intima; Vascular Diseases | 2006 |
Rational approaches to the neurobiologic study of youth at risk for bipolar disorder and suicide.
Topics: Adolescent; Adult; Bipolar Disorder; Brain; Cardiovascular Diseases; Homocysteine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Risk Factors; Suicide | 2006 |
Homocysteine and large arteries.
Topics: Arteries; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Vascular Resistance | 2007 |
Cardiovascular risk assessment in type 2 diabetes mellitus.
Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Homocysteine; Humans; Natriuretic Peptide, Brain; Risk Factors; Smoking | 2006 |
Peering through the darkened glass: success and disappointment in the management of cardiovascular risk.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2006 |
Fenofibrate therapy and cardiovascular protection in diabetes: recommendations after FIELD.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006).
Topics: Antioxidants; Cardiovascular Diseases; Dietary Fats, Unsaturated; Dietetics; Evidence-Based Medicine; Glycemic Index; Homocysteine; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; United Kingdom | 2006 |
Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence.
Topics: Cardiovascular Diseases; Causality; Cohort Studies; Evidence-Based Medicine; Folic Acid; Homocysteine; Homocystinuria; Humans; Polymorphism, Genetic; Randomized Controlled Trials as Topic | 2006 |
Biochemistry of homocysteine in health and diseases.
Topics: Animals; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Chemical; Oxidative Stress; Smoking; Thrombosis; Vitamin B 12; Vitamin B 6 | 2006 |
Exercise, nutrition, and homocysteine.
Topics: Cardiovascular Diseases; Exercise; Homocysteine; Humans; Nutritional Physiological Phenomena; Risk Factors | 2006 |
Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
Topics: Cardiovascular Diseases; Confidence Intervals; Dementia; Dose-Response Relationship, Drug; Folic Acid; Homocysteine; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B 12; Vitamin B Complex | 2007 |
Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
Topics: Biomarkers; Cardiovascular Diseases; Evidence-Based Medicine; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Randomized Controlled Trials as Topic; Risk Factors; Uncertainty; Vitamin B Complex | 2006 |
Hyperhomocysteinaemia: a critical review of old and new aspects.
Topics: Age Factors; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Neurodegenerative Diseases; Osteoporosis; Pregnancy; Pregnancy Complications; Risk Factors; Sex Factors | 2007 |
[Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].
Topics: Atherosclerosis; Cardiovascular Diseases; Drug Therapy, Combination; Endothelium; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2006 |
Homocysteine, menopause and cardiovascular disease.
Topics: Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Menopause | 2007 |
[Risk factors for cardiovascular diseases: what is the role for homocysteine?].
Topics: Cardiovascular Diseases; Folic Acid; Follow-Up Studies; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methionine; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Vitamin B 12; Vitamin B 6 | 2007 |
The homocysteine hypothesis of depression.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Child; Comorbidity; Depressive Disorder; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Mutation; Neurotransmitter Agents; Stroke; Vitamin B 12; Vitamin B 6 | 2007 |
Homocysteine in cardiovascular disease: a culprit or an innocent bystander?
Topics: Cardiovascular Diseases; Confounding Factors, Epidemiologic; Evidence-Based Medicine; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2007 |
[Nutritional medicine 2007].
Topics: Cardiovascular Diseases; Diet; Evidence-Based Medicine; Fatty Acids, Omega-3; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Stroke; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.
Topics: Antihypertensive Agents; Cardiovascular Diseases; Homocysteine; Humans; Hypolipidemic Agents; Prognosis; Risk Factors | 2007 |
Homocysteine lowering and cardiovascular disease risk: lost in translation.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors; Survival Rate; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Homocysteine and cardiovascular disease: a review of the evidence.
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Risk Assessment; Risk Factors; Treatment Outcome; Up-Regulation; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials.
Topics: Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Risk Factors; Vitamin B Complex | 2007 |
[Homocysteine metabolism].
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Betaine-Homocysteine S-Methyltransferase; Cardiovascular Diseases; Deuterium; Gas Chromatography-Mass Spectrometry; Gout; Homocysteine; Humans; Hyperhomocysteinemia; Isotope Labeling; Methionine; Oxidation-Reduction; Risk Factors; Serum Albumin; Vitamin B 12 | 2007 |
Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Renal Dialysis | 2007 |
Vitamins and stroke: the homocysteine hypothesis still in doubt.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Folic Acid; Homocysteine; Humans; Intracranial Arteriosclerosis; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2008 |
Inflammatory biomarkers, race/ethnicity and cardiovascular disease.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Ethnicity; Fibrinogen; Homocysteine; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1 | 2007 |
[Homocysteine and rheumatic disease].
Topics: Arthritis, Rheumatoid; Behcet Syndrome; Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Infant, Newborn; Male; Meta-Analysis as Topic; Prospective Studies; Rheumatic Diseases; Risk Factors; Scleroderma, Systemic | 2007 |
Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease.
Topics: Animals; Atherosclerosis; Cardiovascular Agents; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Heart Defects, Congenital; Hemodynamics; Homocysteine; Humans; Nitric Oxide; Nitric Oxide Synthase Type III | 2008 |
Homocysteine, B-vitamins and CVD.
Topics: Cardiovascular Diseases; Folic Acid; Food, Fortified; Genetic Predisposition to Disease; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Nutrition Policy; Nutritional Status; Polymorphism, Genetic; Vitamin B Complex | 2008 |
Polymorphism in methylentetra-hydrofolate reductase gene: important role in diseases.
Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Kidney; Methylenetetrahydrofolate Reductase (NADPH2); Models, Biological; Models, Genetic; Neoplasms; Neurodegenerative Diseases; Pharmacogenetics; Polymorphism, Genetic; Risk; Risk Factors | 2008 |
Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Renal Dialysis; Risk Factors | 1995 |
Measurement of homocyst(e)ine in the prediction of arteriosclerosis.
Topics: Arteriosclerosis; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Homocysteine; Homocystine; Humans; Male; Predictive Value of Tests; Risk Factors; Vascular Diseases | 1995 |
Prospective studies of homocysteine and cardiovascular disease.
Topics: Aged; Bias; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Prospective Studies; Retrospective Studies; Risk Factors | 1995 |
More folic acid for everyone, now.
Topics: Adult; Aged; Anencephaly; Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Food, Fortified; Homocysteine; Humans; Infant, Newborn; Male; Pregnancy; Risk Factors; Spinal Dysraphism; United States; Vitamin B 12; Vitamin B 12 Deficiency | 1996 |
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Homocysteine; Humans; Oxidation-Reduction; Protein Binding; Sulfhydryl Compounds | 1996 |
[Homocysteine--an independent risk factor of premature vascular disease].
Topics: Amino Acids; Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors; Thrombosis | 1996 |
[Homocysteine: relations to ischemic cardiovascular diseases].
Topics: Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Myocardial Ischemia; Risk Factors | 1996 |
[Hyperhomocysteinemia].
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Neural Tube Defects | 1996 |
Menopause and risk of cardiovascular disease.
Topics: Adult; Aged; Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Coronary Artery Disease; Diet; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Follow-Up Studies; Glucose; Hemostasis; Homocysteine; Humans; Incidence; Lipid Metabolism; Menopause; Middle Aged; Ovary; Risk; Risk Factors; Vitamins | 1996 |
Biological chemistry of thiols in the vasculature and in vascular-related disease.
Topics: Animals; Blood Vessels; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Cardiovascular System; Cholesterol; Cysteine; Glutathione; Homocysteine; Humans; Sulfhydryl Compounds | 1996 |
Homocystinuria: what about mild hyperhomocysteinaemia?
Topics: Cardiovascular Diseases; Homocysteine; Homocystinuria; Humans; Prevalence; Risk Factors | 1996 |
Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease.
Topics: Cardiovascular Diseases; Homocysteine; Homocystine; Humans; Methionine; Risk Factors; Thromboembolism; Thrombosis; Vitamins | 1996 |
Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine.
Topics: Aminoglutethimide; Antineoplastic Agents, Hormonal; Arteriosclerosis; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Coronary Disease; Estrogen Antagonists; Female; Homocysteine; Humans; Male; Myocardial Infarction; Tamoxifen | 1997 |
The effects of oral vitamin supplementation on cardiovascular risk factors.
Topics: Administration, Oral; Avitaminosis; Cardiovascular Diseases; Homocysteine; Humans; Lipoproteins, LDL; Oxidation-Reduction; Vitamins | 1997 |
Hyperlipidemia and cardiovascular disease.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperlipidemias | 1997 |
Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
Topics: Cardiovascular Diseases; Genetic Predisposition to Disease; Genetic Variation; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 1997 |
The case for mild hyperhomocysteinaemia as a risk factor.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 1997 |
Selections from current literature: homocysteine: a modifiable risk factor for cardiovascular disease.
Topics: Cardiovascular Diseases; Homocysteine; Homocystinuria; Humans; Mass Screening; Research Design; Risk Factors | 1997 |
Adverse effects of hyperhomocysteinemia and their management by folic acid.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Methylation; Risk Factors; Uremia | 1997 |
Homocysteine and cardiovascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Female; Folic Acid; Folic Acid Deficiency; Forecasting; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Peripheral Vascular Diseases; Prevalence; Risk Factors; Safety; Thromboembolism; Vitamin B 12; Vitamin B 12 Deficiency | 1998 |
Homocysteine and atherothrombosis.
Topics: Amino Acid Metabolism, Inborn Errors; Arteriosclerosis; Cardiovascular Diseases; Deficiency Diseases; Folic Acid; Homocysteine; Homocystine; Humans; Thrombosis; Vitamin B Complex | 1998 |
Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Pyridoxine; Renal Dialysis; Vitamin B 12 | 1998 |
[Moderate hyperhomocysteinemia: physiopathology of the endothelial lesion and its clinical implications].
Topics: Amino Acid Metabolism, Inborn Errors; Avitaminosis; Cardiovascular Diseases; Cerebrovascular Disorders; Endothelium, Vascular; Homocysteine; Homocystinuria; Homozygote; Humans; Methionine; Myocardial Ischemia; Peripheral Vascular Diseases; Risk Factors; Thrombophlebitis; Vitamins | 1998 |
Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Chronic Disease; Fibrinogen; Folic Acid; Homocysteine; Humans; Kidney Diseases; Lipoprotein(a); Risk Factors | 1998 |
Biologic markers as predictors of cardiovascular disease.
Topics: Biomarkers; Blood Coagulation; Cardiovascular Diseases; Cholesterol, LDL; Fibrinolysis; Homocysteine; Humans; Insulin Resistance; Lipoprotein(a); Risk Assessment; Risk Factors | 1998 |
[Molecular biology in the diagnosis of cardiovascular diseases].
Topics: Biomarkers; Cardiovascular Diseases; DNA Mutational Analysis; Fibrinogen; Genetic Variation; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Molecular Biology; Polymorphism, Genetic; Risk Factors | 1998 |
Homocysteine, vitamins, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Pyridoxine; Vitamin B 12 | 1998 |
Homocysteine and vitamins in cardiovascular disease.
Topics: Blood Vessels; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Reference Values; Risk Factors; Vitamin B Complex | 1998 |
Folate deficiencies and cardiovascular pathologies.
Topics: Cardiovascular Diseases; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Molecular Structure | 1998 |
Interventions for other risk factors: tobacco use, physical inactivity, menopause, and homocysteine.
Topics: Cardiovascular Diseases; Comorbidity; Exercise; Female; Homocysteine; Humans; Kidney Failure, Chronic; Life Style; Male; Menopause; Prevalence; Risk Factors; Smoking; United States | 1998 |
Functional food science and the cardiovascular system.
Topics: Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diet; Endothelium, Vascular; Female; Food; Homocysteine; Humans; Immune System; Insulin Resistance; Lipoproteins; Male; Middle Aged; Risk Factors | 1998 |
Recent data are not in conflict with homocysteine as a cardiovascular risk factor.
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prospective Studies; Risk Factors | 1998 |
Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
Topics: Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Risk Factors | 1998 |
Folic acid, homocysteine and one-carbon metabolism: a review of the essential biochemistry.
Topics: Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Neural Tube Defects; Pregnancy; Vitamin B 12 Deficiency | 1998 |
Homocysteine and vascular disease: nature or nurture?
Topics: Cardiovascular Diseases; Diet; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 1998 |
Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Pyridoxine; Randomized Controlled Trials as Topic; Research Design; Vitamin B 12 | 1998 |
B vitamins and homocysteine in cardiovascular disease and aging.
Topics: Aging; Cardiovascular Diseases; Diet; Folic Acid; Folic Acid Deficiency; Homocysteine; Homocystinuria; Humans; Pyridoxine; Risk Factors; Vitamin B 12; Vitamin B Deficiency | 1998 |
Emerging noninvasive biochemical measures to predict cardiovascular risk.
Topics: Biomarkers; Blood Coagulation; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Inflammation; Lipids; Oxidative Stress; Predictive Value of Tests; Racial Groups; Risk; Risk Factors; Sex Factors | 1999 |
Nontraditional cardiovascular risk factors.
Topics: Blood Coagulation Factors; C-Reactive Protein; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Homocysteine; Humans; Infections; Inflammation; Insulin Resistance; Lipoprotein(a); Renin-Angiotensin System; Risk; Risk Factors; Stress, Psychological | 1999 |
[The genetic component of coronary risk. II].
Topics: Alleles; Animals; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Genotype; Homocysteine; Humans; Models, Genetic; Mutation; Plasminogen Activators; Polymorphism, Genetic; Prospective Studies; Renin-Angiotensin System; Research; Retrospective Studies; Risk Factors; Thrombosis | 1999 |
Homocysteine: an emerging age-related cardiovascular risk factor.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Menopause; Methionine; Middle Aged; Prevalence; Primary Health Care; Risk Factors | 1999 |
Evidence based cardiology: emerging approaches in preventing cardiovascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cardiovascular Diseases; Evidence-Based Medicine; Homocysteine; Humans; Oxidative Stress; Risk Assessment; Risk Factors; Vitamin E | 1999 |
A panorama of cardiac risk.
Topics: Adult; Aged; Amyloid; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Cholesterol, LDL; Clinical Trials as Topic; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Hyperlipidemias; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Prospective Studies; Research; Retrospective Studies; Risk Factors; Time Factors; Triglycerides; Vitamin E | 1999 |
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.
Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Endothelium, Vascular; Estrogen Antagonists; Estrogens; Female; Hemostasis; Homocysteine; Hormone Replacement Therapy; Humans; Lipoprotein(a); Muscle, Smooth, Vascular; Piperidines; Progestins; Raloxifene Hydrochloride; Risk Factors | 1999 |
Homocysteine and vascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Risk Factors; Thrombosis; Vitamins | 1999 |
Future for folates in cardiovascular disease.
Topics: Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Risk Factors; Vasodilation | 1999 |
Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
Topics: Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 1999 |
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
Topics: Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypertrophy, Left Ventricular; Lipoprotein(a); Oxidative Stress; Risk Factors; Triglycerides | 1999 |
Plasma total homocyst(e)ine may not be the most appropriate index for cardiovascular disease risk.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Homocystine; Humans; Risk Factors | 1999 |
Homocysteine and endothelial function.
Topics: Aged; Cardiovascular Diseases; Endothelium, Vascular; Female; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Male; Middle Aged; Regional Blood Flow; Risk Factors; Vasodilation | 1999 |
Stroke prevention.
Topics: Cardiovascular Diseases; Fibrinolytic Agents; Homocysteine; Humans; Hypercholesterolemia; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Stroke | 1999 |
Role of arginine, taurine and homocysteine in cardiovascular diseases.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Prognosis; Risk Assessment; Risk Factors; Sensitivity and Specificity; Taurine | 1999 |
Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Meta-Analysis as Topic; Prospective Studies; Pyridoxine; Retrospective Studies; Risk; Risk Factors; Smoking; Vitamin B 12 | 1999 |
Total homocysteine and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Genotype; Homocysteine; Humans; Mutation; Prospective Studies; Risk Factors | 1999 |
Homocysteine and risk of cardiovascular disease.
Topics: Arteriosclerosis; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thrombosis | 2000 |
Vitamins for the management of cardiovascular disease: a simple solution to a complex problem?
Topics: Antioxidants; Cardiovascular Diseases; Clinical Trials as Topic; Homocysteine; Humans; Myocardial Infarction; Vitamin B Complex; Vitamin E; Vitamins | 1999 |
Moderate hyperhomocysteinemia and cardiovascular disease.
Topics: Animals; Arterial Occlusive Diseases; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thrombosis | 2000 |
Emerging risk factors associated with cardiovascular diseases.
Topics: Adult; Aged; Blood Coagulation Factors; Cardiovascular Diseases; Chlamydia Infections; Chlamydophila pneumoniae; Homocysteine; Humans; Hyperhomocysteinemia; Lipoprotein(a); Middle Aged; Risk Factors | 1999 |
Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Homocysteine; Humans; MEDLINE; Middle Aged; Predictive Value of Tests; Prospective Studies; Risk; Risk Factors | 2000 |
Homocysteine and endothelial dysfunction: a link with cardiovascular disease.
Topics: Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Methionine; Reactive Oxygen Species | 2000 |
Hyperhomocysteinaemia as a cardiovascular risk factor: an update.
Topics: Adult; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2000 |
Homocysteine in renal disease.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Diseases; Renal Dialysis | 2000 |
Hyperhomocysteinemia as a risk factor for cardiovascular diseases. The association of hyperhomocysteinemia with diabetes mellitus and renal transplant recipients.
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetic Nephropathies; Diabetic Retinopathy; Endothelium, Vascular; Heart Transplantation; Hemodynamics; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Risk Factors | 1999 |
Homocysteine as a cardiovascular risk factor.
Topics: Cardiovascular Diseases; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors; Vitamins | 2000 |
Homocysteine and cardiovascular disease: cause or effect?
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Kidney; Kidney Diseases | 2000 |
The controversy over homocysteine and cardiovascular risk.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Kidney Diseases; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Risk Factors; Vitamin B Complex | 2000 |
Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Diet; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Nutritional Status; Risk Factors; Vitamin B Complex | 2000 |
[The importance of folic acid in current medicine].
Topics: Adult; Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Folic Acid Deficiency; Hematinics; Homocysteine; Humans; Infant; Infant, Newborn; Neural Tube Defects; Pregnancy | 2000 |
Premature cardiovascular disease in chronic renal failure.
Topics: Acute-Phase Proteins; Anemia; Cardiovascular Diseases; Cause of Death; Cholesterol, HDL; Cholesterol, LDL; Homocysteine; Humans; Kidney Failure, Chronic; Lipoprotein(a); Renal Dialysis; Research Design; Risk Factors | 2000 |
Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins, LDL; Oxidative Stress; Risk Factors; Uremia | 2000 |
Nutritional interventions: the evidence.
Topics: Cardiovascular Diseases; Dietary Fats; Dietary Fiber; Homocysteine; Humans; Lipid Metabolism; Lipids; Nutritional Physiological Phenomena; Obesity; Risk Factors | 2000 |
Homocysteine and cardiovascular disease: dietary supplements for all.
Topics: Cardiovascular Diseases; Congenital Abnormalities; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Nutritional Status; Pregnancy; Risk Factors | 2000 |
Homocysteine: an emergent cardiovascular risk factor?
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2000 |
Homocysteine, coagulation, platelet function, and thrombosis.
Topics: Adolescent; Adult; Arteriosclerosis; Blood Coagulation; Cardiovascular Diseases; Cellular Senescence; Child; Endothelium, Vascular; Female; Genetic Predisposition to Disease; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Lipid Peroxidation; Lipoproteins, LDL; Male; Methyltransferases; Oxidation-Reduction; Platelet Activation; Reactive Oxygen Species; Renal Insufficiency; Risk Factors; S-Adenosylhomocysteine; Thrombophilia; Thromboxane B2; Vitamin K | 2000 |
Genetic modulation of homocysteinemia.
Topics: Amino Acid Substitution; Cardiovascular Diseases; Cystathionine beta-Synthase; Cysteine; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Methyltransferases; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymorphism, Genetic; Sulfur; Tetrahydrofolates | 2000 |
Homocysteine and renal disease.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Case-Control Studies; Child; Endothelium, Vascular; Female; Folic Acid; Folic Acid Deficiency; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Life Tables; Male; Methionine; Peritoneal Dialysis; Prospective Studies; Pyridoxine; Renal Dialysis; Survival Analysis; Thrombophilia; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency | 2000 |
Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Topics: Adult; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Double-Blind Method; Drug Synergism; Europe; Female; Folic Acid; Forecasting; Genetic Variation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; North America; Prospective Studies; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Treatment Outcome; Vitamin B 12 | 2000 |
New perspectives on folate status: a differential role for the vitamin in cardiovascular disease, birth defects and other conditions.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Infant, Newborn; Neural Tube Defects | 2000 |
The careful correction of renal insufficiency abnormalities: early is good.
Topics: Anemia; Cardiovascular Diseases; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Nutrition Disorders; Risk Factors; Smoking | 2000 |
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Pyridoxine; Renal Dialysis; Risk Factors; Vitamin B 12 | 2000 |
Anti-inflammatory action of statins and reduction of homocysteinemia by vitamin supplementation: interactions among strategies for cardiovascular prevention.
Topics: Anti-Inflammatory Agents; Arteriosclerosis; Cardiovascular Diseases; Dietary Supplements; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Vitamins | 2000 |
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.
Topics: Adult; Carbohydrate Metabolism; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Synthetic; Female; Homocysteine; Humans; Incidence; Lipid Metabolism; Myocardial Infarction; Risk Factors; Stroke; Structure-Activity Relationship; Thromboembolism | 2000 |
Folate and homocysteine.
Topics: Blood Vessels; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Polymorphism, Genetic; Risk Factors; Vitamin B Complex | 2000 |
The role of folic acid in the prevention of cardiovascular disease.
Topics: Cardiovascular Diseases; Coronary Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Male; Models, Biological; Risk | 2000 |
Antioxidants and vitamins to reduce cardiovascular disease.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Carotenoids; Homocysteine; Humans; Hyperhomocysteinemia; Oxidative Stress; Vitamins | 2000 |
Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 2001 |
Rationale for risk reduction of cardiovascular disease using homocysteine concentration in blood and plasma as biomarker: support by clinical data.
Topics: Biomarkers; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Nutrition Policy; Pyridoxine; Risk Factors; Vitamin B 12 | 2001 |
Attenuating cardiovascular risk factors in patients with type 2 diabetes.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Antioxidants; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Lipoproteins; Patient Education as Topic; Risk Factors; Smoking Cessation; Teaching Materials | 2000 |
Developments in the measurement of plasma total homocysteine.
Topics: Cardiovascular Diseases; Chromatography, High Pressure Liquid; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Immunoassay; Risk Factors; Spectrometry, Fluorescence | 2000 |
Homocysteine and transmethylations in uremia.
Topics: Acylation; Amino Acids; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Methylation; Nitroso Compounds; Oxidation-Reduction; Proteins; Uremia | 2001 |
Homocysteine metabolism in renal failure.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases | 2001 |
Number 58: homocysteine and disease.
Topics: Alzheimer Disease; Animals; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Diet; Folic Acid; Homocysteine; Humans; Neural Tube Defects | 2000 |
Getting to the heart of homocysteine testing.
Topics: Cardiovascular Diseases; Chromatography, High Pressure Liquid; Homocysteine; Humans; Hyperhomocysteinemia; Immunoenzyme Techniques; Mass Screening; Reference Values; Reproducibility of Results; Risk Factors; Specimen Handling | 2000 |
Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Coronary Disease; Diet; Homocysteine; Humans; Oxidative Stress; Randomized Controlled Trials as Topic; Reactive Oxygen Species; Vitamin E | 2000 |
[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
Topics: Adult; Aged; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibrinolysis; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Time Factors; Vitamin B Complex | 2001 |
The role of folate, antioxidant vitamins and other constituents in fruit and vegetables in the prevention of cardiovascular disease: the epidemiological evidence.
Topics: Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Clinical Trials as Topic; Epidemiologic Studies; Folic Acid; Fruit; Homocysteine; Humans; Vegetables; Vitamin E | 2001 |
[Homocysteine and cardiovascular disease].
Topics: Amino Acid Metabolism, Inborn Errors; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Myocardial Ischemia; Odds Ratio; Risk Factors | 2001 |
Impaired homocysteine metabolism and atherothrombotic disease.
Topics: Age Factors; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Models, Chemical; Risk Factors; S-Adenosylmethionine; Sex Factors | 2001 |
Hyperhomocysteinemia in end-stage renal failure.
Topics: Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Risk Factors | 2000 |
[Chronic complication of diabetes and homocysteine].
Topics: Cardiovascular Diseases; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2000 |
[Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
Topics: Alleles; Animals; Cardiovascular Diseases; Genetic Variation; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Racial Groups | 2001 |
Roles of homocysteine in cell metabolism: old and new functions.
Topics: Cardiovascular Diseases; Cell Physiological Phenomena; Female; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Methylation; Nervous System Malformations; Pregnancy; Pregnancy Complications; RNA, Transfer, Amino Acyl; S-Adenosylmethionine | 2001 |
Homocysteine, folic acid, B vitamins and cardiovascular risk.
Topics: Animals; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B Complex | 2001 |
[Homocysteine. The cardiovascular risk factor of the next millennium?].
Topics: Animals; Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Risk Factors; Thromboembolism | 2001 |
Importance of folate in human nutrition.
Topics: Biological Availability; Birth Weight; Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; India; Intestinal Absorption; Liver; Male; Meat; Neoplasms; Neural Tube Defects; Nutrition Policy; Nutritional Physiological Phenomena; Pregnancy; Prevalence; Public Health; Vegetables | 2001 |
Homocysteine, folate, and cardiovascular disease.
Topics: Antioxidants; Cardiovascular Diseases; Europe; Folic Acid; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Primary Prevention; Risk Factors; Vegetables | 2001 |
Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Homocysteine; Humans; Hyperhomocysteinemia; Models, Chemical; Mutation; Renal Insufficiency; Serum Albumin | 2001 |
Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Female; Homocysteine; Hormone Replacement Therapy; Humans; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Time Factors | 2001 |
MTHFR gene polymorphism, homocysteine and cardiovascular disease.
Topics: Apolipoproteins E; Arteriosclerosis; Cardiovascular Diseases; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prevalence; Risk Factors | 2001 |
Folates and prevention of disease.
Topics: Cardiovascular Diseases; Colorectal Neoplasms; Dietary Supplements; Folic Acid; Food, Fortified; Homocysteine; Humans; Mental Disorders; Neural Tube Defects; Treatment Outcome | 2001 |
Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Endothelium, Vascular; Folic Acid; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Nitric Oxide; Oxidoreductases Acting on CH-NH Group Donors; Vitamins | 2001 |
Protein N-homocysteinylation: implications for atherosclerosis.
Topics: Arteriosclerosis; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Methionine; Models, Biological; Proteins | 2001 |
Cardiovascular risk in the Asia-Pacific region from a nutrition and metabolic point of view: vitamin deficiencies.
Topics: Aged; Antioxidants; Asia; Avitaminosis; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Pacific Islands; Risk Factors; Vitamin B 12; Vitamin B 6 | 2001 |
Implications from and for food cultures for cardiovascular disease: longevity.
Topics: Aged; Aged, 80 and over; Aging; Antioxidants; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diet; Female; Gonadal Steroid Hormones; Homocysteine; Humans; Japan; Life Style; Longevity; Male; Neoplasms, Hormone-Dependent; Risk Factors | 2001 |
Homocysteine and cardiovascular disease in diabetes mellitus.
Topics: Biomarkers; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Female; Homocysteine; Humans; Incidence; Male; Prognosis; Risk Assessment; Risk Factors; Survival Rate | 2001 |
Assessment of homocysteine as a cardiovascular risk factor in clinical practice.
Topics: Biomarkers; Blood Chemical Analysis; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Mutation; Risk Factors; Vitamin B 12 | 2001 |
Folates and cardiovascular disease.
Topics: Arteriosclerosis; Biopterins; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Methylenetetrahydrofolate Dehydrogenase (NAD+); Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Oxidoreductases | 2002 |
Stress, inflammation and cardiovascular disease.
Topics: Acute-Phase Proteins; Adrenal Cortex Hormones; Arteriosclerosis; Brain; Cardiovascular Diseases; Catecholamines; Cytokines; Fibrinolysis; Glucagon; Homocysteine; Human Growth Hormone; Humans; Inflammation; Intercellular Adhesion Molecule-1; Neurons; Renin; Risk Factors; Stress, Psychological; Substance P; Vascular Cell Adhesion Molecule-1 | 2002 |
Current medical therapies for patients with peripheral arterial disease: a critical review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cardiovascular Diseases; Cilostazol; Diabetes Mellitus; Estrogens; Exercise; Homocysteine; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Meta-Analysis as Topic; Myocardial Ischemia; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tetrazoles | 2002 |
Is homocysteine an independent cardiovascular risk factor also in Japanese?
Topics: Asian People; Biomarkers; Cardiovascular Diseases; Carotid Artery Diseases; Homocysteine; Humans; Japan; Risk Factors | 2001 |
Estrogen and homocysteine.
Topics: Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Endothelium, Vascular; Estrogens; Female; Homocysteine; Humans; Lipids; Oxidative Stress; Risk Factors; Sex; Uterine Neoplasms | 2002 |
Emergent cardiovascular risk factor: homocysteine.
Topics: Blood Chemical Analysis; Cardiovascular Diseases; Folic Acid; Health Education; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Vitamin B 12; Vitamin B 6 | 2002 |
Candidate genes as potential links between periodontal and cardiovascular diseases.
Topics: Alleles; Blood Coagulation Factors; Cardiovascular Diseases; Chronic Disease; Environment; Genes; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Genotype; Homocysteine; Humans; Immunologic Factors; Inflammation; Interleukin-1; Lipids; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Periodontitis; Polymorphism, Genetic; Risk Factors; Wound Healing | 2001 |
Folate bioavailability and health.
Topics: Biological Availability; Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Food, Fortified; Hematinics; Homocysteine; Humans; Intestinal Absorption; Mental Disorders; Neural Tube Defects; Nutritional Requirements; Nutritional Status; Pregnancy | 2002 |
Drugs affecting homocysteine metabolism: impact on cardiovascular risk.
Topics: Anticonvulsants; Betaine; Cardiovascular Diseases; Clinical Trials as Topic; Gonadal Steroid Hormones; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Lipotropic Agents; Risk Factors | 2002 |
Homocysteine as a risk factor in cardiovascular disease.
Topics: Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Pregnancy; Risk Factors | 2001 |
Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.
Topics: Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Confounding Factors, Epidemiologic; Coronary Disease; Homocysteine; Humans; Risk Factors | 2002 |
Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
Topics: Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Hematinics; Homocysteine; Humans; Kidney Failure, Chronic | 2002 |
The role of low levels of the serum glutathione-dependent peroxidase and glutathione and high levels of serum homocysteine in the development of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Glutathione; Glutathione Peroxidase; Homocysteine; Humans; Lipoproteins, LDL | 2002 |
Homocysteine and cardiovascular disease: current evidence and future prospects.
Topics: Blood Coagulation Disorders; Cardiovascular Diseases; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Muscle, Smooth, Vascular; Risk Factors | 2002 |
Hyperhomocyst(e)inemia as a risk factor after renal transplantation.
Topics: Cardiovascular Diseases; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Transplantation; Risk Factors | 2001 |
Folic acid and homocysteine in age-related disease.
Topics: Aged; Aging; Cardiovascular Diseases; Congenital Abnormalities; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Male; Mental Disorders; Neoplasms; Neurodegenerative Diseases; Stroke | 2002 |
Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2002 |
[Routine determination of homocysteine in plasma. A new and improved possibility for risk evaluation and diagnosis of common diseases].
Topics: Adult; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Diagnosis, Differential; Homocysteine; Homocystinuria; Humans; Middle Aged; Risk Factors; Vitamin B 12 Deficiency | 1992 |
143 trial(s) available for homocysteine and Cardiovascular Diseases
Article | Year |
---|---|
Impact of wheat aleurone on biomarkers of cardiovascular disease, gut microbiota and metabolites in adults with high body mass index: a double-blind, placebo-controlled, randomized clinical trial.
Topics: Adult; Animals; Biomarkers; Body Mass Index; Cardiovascular Diseases; Dietary Fiber; Double-Blind Method; Feces; Gastrointestinal Microbiome; Homocysteine; Humans; Infant; Plant Proteins; Polyphenols; RNA, Ribosomal, 16S; Triticum | 2022 |
Adolescent Afghan Refugees Display a High Prevalence of Hyperhomocysteinemia and Associated Micronutrients Deficiencies Indicating an Enhanced Risk of Cardiovascular Disease in Later Life.
Topics: Adolescent; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Malnutrition; Micronutrients; Prevalence; Refugees; Vitamin B 12 | 2022 |
Vitamin B12 Status Upon Short-Term Intervention with a Vegan Diet-A Randomized Controlled Trial in Healthy Participants.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Cholesterol; Diet, Vegan; Fatty Acids; Female; Healthy Volunteers; Homocysteine; Humans; Inflammation; Male; Methylmalonic Acid; Micronutrients; Nutritional Status; Transcobalamins; Vitamin B 12; Vitamin B 12 Deficiency | 2019 |
Omega-3 in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis, Effects on Inflammatory Markers and Lipid Profile.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Pilot Projects; Risk Factors | 2020 |
Vitamin D
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; C-Reactive Protein; Cardiovascular Diseases; Cholecalciferol; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Disease Risk Factors; Homocysteine; Humans; Kidney Function Tests; Liver Diseases; Liver Function Tests; Middle Aged; Overweight; Treatment Outcome; Urea; Vitamin D; Vitamin D Deficiency; Young Adult | 2021 |
Long-term effects of folic acid and vitamin-B12 supplementation on fracture risk and cardiovascular disease: Extended follow-up of the B-PROOF trial.
Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Fractures, Bone; Homocysteine; Humans; Male; Odds Ratio; Osteoporotic Fractures; Placebos; Risk Factors; Vitamin B 12 | 2021 |
Nutritional supplementation alters associations between one-carbon metabolites and cardiometabolic risk profiles in older adults: a secondary analysis of the Vienna Active Ageing Study.
Topics: Aged; Aging; Betaine; Carbon; Cardiovascular Diseases; Choline; Dietary Supplements; Female; Homocysteine; Humans; Male | 2022 |
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study.
Topics: Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Diet; Dietary Supplements; Double-Blind Method; Female; gamma-Glutamyltransferase; Homocysteine; Humans; Male; Middle Aged; Nutritional Status; Phytochemicals; Russia; Trace Elements; Triglycerides; Uric Acid; Vitamins | 2018 |
Differential responses of autonomic function in sea level residents, acclimatized lowlanders at >3500 m and Himalayan high altitude natives at >3500 m: A cross-sectional study.
Topics: Acclimatization; Adult; Altitude; Autonomic Nervous System; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Electrocardiography; Heart Rate; Homocysteine; Humans; Male; Pulse; Risk Factors; Young Adult | 2018 |
Effect of Combined Treatment With Folic Acid, Vitamin B
Topics: Aged; Biomarkers; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Inflammation; Inflammation Mediators; Middle Aged; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamins | 2018 |
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial.
Topics: Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Vitamin B Complex | 2018 |
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia.
Topics: Adult; Atorvastatin; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperprolactinemia; Lipids; Metabolic Diseases; Middle Aged; Prolactin; Risk Factors | 2019 |
Vitamin D
Topics: Adult; Body Mass Index; Body Weight; Calcium; Cardiovascular Diseases; Cholecalciferol; Double-Blind Method; Female; Homocysteine; Humans; Obesity; Overweight; Parathyroid Hormone; Phosphorus; Vitamin D; Vitamin D Deficiency; Young Adult | 2018 |
Effect of a weight-loss stabilization following a weight reduction with or without meal replacement on cardiometabolic risk in overweight women. A randomized controlled trial.
Topics: Adult; Anthropometry; Cardiovascular Diseases; Diet, Reducing; Female; Folic Acid; Homocysteine; Humans; Meals; Metabolic Syndrome; Middle Aged; Overweight; Waist Circumference; Weight Loss | 2019 |
Influence of enhanced bioavailable curcumin on obesity-associated cardiovascular disease risk factors and arterial function: A double-blinded, randomized, controlled trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arteries; Biomarkers; Cardiovascular Diseases; Curcumin; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Homocysteine; Humans; Lipoproteins; Male; Obesity; Risk Factors; Young Adult | 2019 |
Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Disease Progression; Double-Blind Method; Female; France; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Time Factors | 2013 |
Reduced-energy cranberry juice increases folic acid and adiponectin and reduces homocysteine and oxidative stress in patients with the metabolic syndrome.
Topics: Adiponectin; Adult; Antioxidants; Beverages; Cardiovascular Diseases; Energy Intake; Female; Folic Acid; Fruit; Homocysteine; Humans; Lipid Peroxidation; Male; Metabolic Syndrome; Middle Aged; Oxidative Stress; Plant Preparations; Protein Carbonylation; Vaccinium macrocarpon | 2013 |
An encapsulated juice powder concentrate improves markers of pulmonary function and cardiovascular risk factors in heavy smokers.
Topics: Adult; Biomarkers; Capsules; Carbon Monoxide; Cardiovascular Diseases; Cysteine; Dietary Supplements; Female; Folic Acid; Fruit; Homocysteine; Humans; Lung; Male; Middle Aged; Plant Preparations; Powders; Respiration; Risk Factors; Smoking; Tobacco Products; Vegetables | 2013 |
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly.
Topics: Aged; Asian People; Blood Pressure; Body Mass Index; Cardiovascular Diseases; China; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Folic Acid Deficiency; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Triglycerides; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2015 |
Cardiovascular risk markers until 12 mo of age in infants fed a formula supplemented with bovine milk fat globule membranes.
Topics: Adiponectin; Animals; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cattle; Glycolipids; Glycoproteins; Homocysteine; Humans; Infant; Infant Food; Leptin; Leukocyte L1 Antigen Complex; Lipid Droplets; Lipids; Risk Factors | 2014 |
Prospective study of plasma homocysteine level and risk of age-related macular degeneration in women.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Drug Combinations; Female; Follow-Up Studies; Homocysteine; Humans; Macular Degeneration; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires; United States; Visual Acuity; Vitamin E; Vitamins; Women's Health | 2015 |
What is the influence of hormone therapy on homocysteine and crp levels in postmenopausal women?
Topics: Age Factors; Brazil; C-Reactive Protein; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Follow-Up Studies; Homocysteine; Humans; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Dropouts; Postmenopause; Progestins; Prospective Studies | 2015 |
The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.
Topics: Adult; Atorvastatin; Bromocriptine; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dopamine Agonists; Exercise; Female; Fibrinogen; Homocysteine; Humans; Hypercholesterolemia; Hyperprolactinemia; Hypoglycemic Agents; Hypolipidemic Agents; Metformin; Middle Aged; Premenopause; Risk Factors; Uric Acid | 2015 |
Effects of metformin plus gliclazide versus metformin plus glimepiride on cardiovascular risk factors in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Folic Acid; Gliclazide; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Risk Factors; Sulfonylurea Compounds | 2015 |
Effect of vitamin B-12 and n-3 polyunsaturated fatty acids on plasma homocysteine, ferritin, C-reaction protein, and other cardiovascular risk factors: a randomized controlled trial.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; China; Dietary Supplements; Fatty Acids, Omega-3; Female; Ferritins; Fish Oils; Homocysteine; Humans; Male; Risk Factors; Vitamin B 12; Vitamin B Complex; Young Adult | 2015 |
The effects of alcohol on ambulatory blood pressure and other cardiovascular risk factors in type 2 diabetes: a randomized intervention.
Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinogen; Heart Rate; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Wine | 2016 |
Folic acid supplementation reduces plasma homocysteine in postmenopausal women.
Topics: Aged; Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Healthy Volunteers; Hematinics; Homocysteine; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Risk Factors | 2016 |
Effect of seabuckthorn seed oil in reducing cardiovascular risk factors: A longitudinal controlled trial on hypertensive subjects.
Topics: Adult; Animals; Antioxidants; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Fatty Acids; Hippophae; Homocysteine; Humans; Hypertension; Longitudinal Studies; Male; Micronutrients; Middle Aged; Pilot Projects; Plant Oils; Rats; Rats, Sprague-Dawley; Risk Factors; Seeds; Triglycerides | 2017 |
Impact of Homocysteine Level on Long-term Cardiovascular Outcomes in Patients after Coronary Artery Stenting.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Stents; Survival Rate; Young Adult | 2017 |
Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
Topics: Adult; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Female; Flavonoids; Free Radicals; Homocysteine; Humans; Lipids; Middle Aged; Oxidative Stress; Perimenopause; Plant Extracts; Quality of Life; Risk Factors; Surveys and Questionnaires | 2017 |
Consumption of restructured meat products with added walnuts has a cholesterol-lowering effect in subjects at high cardiovascular risk: a randomised, crossover, placebo-controlled study.
Topics: Aged; Animals; Cardiovascular Diseases; Cattle; Cholesterol; Cross-Over Studies; Female; Folic Acid; gamma-Tocopherol; Homocysteine; Humans; Juglans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Meat Products; Middle Aged; Platelet Function Tests; Postprandial Period; Triglycerides; Vitamin B 12; Vitamin B 6 | 2008 |
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).
Topics: Aged; Biomarkers; Calcinosis; Canada; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Artery, Common; Disease Progression; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
Topics: Adult; Brazil; Canada; Cardiovascular Diseases; Chronic Disease; Cohort Studies; Creatinine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Risk Factors; Treatment Outcome; United States; Vitamin B Complex | 2009 |
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Chi-Square Distribution; Cognition; Cognition Disorders; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Psychometrics; Risk Factors; Statistics, Nonparametric; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients.
Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Chi-Square Distribution; Diet; Diet Records; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Korea; Lipids; Male; Middle Aged; Vitamins | 2008 |
Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and nutritional status in human volunteers.
Topics: Animals; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Fatty Acids; Folic Acid; Food, Fortified; Homocysteine; Humans; Milk; Nutrition Assessment; Risk Factors; Sterols; Triglycerides; Vitamins | 2009 |
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
Topics: Adult; alpha-2-Antiplasmin; Antigens; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Endothelin-1; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Homocysteine; Humans; Insulin-Like Growth Factor I; Medroxyprogesterone Acetate; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Risk Factors; Time Factors; Tissue Plasminogen Activator | 2009 |
Nitrous oxide and perioperative cardiac morbidity (ENIGMA-II) Trial: rationale and design.
Topics: Aged; Anesthetics, Inhalation; Cardiovascular Diseases; Female; Homocysteine; Humans; Length of Stay; Male; Nitrous Oxide; Pneumonia; Postoperative Complications; Research Design; Risk Assessment; Surgical Procedures, Operative; Surgical Wound Infection; Vomiting | 2009 |
Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age.
Topics: Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Composition; Cardiovascular Diseases; Cross-Over Studies; Exercise; Female; Heart Rate; Homocysteine; Humans; Insulin Resistance; Life Style; Lipids; Male; Middle Aged; Risk Factors | 2009 |
Riboflavin supplementation and biomarkers of cardiovascular disease in the elderly.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Female; Ferritins; Folic Acid; Geriatric Assessment; Homocysteine; Humans; Male; Nutritional Status; Portugal; Riboflavin; Uric Acid; Vitamin B Complex | 2009 |
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial.
Topics: Adult; Aged; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Middle Aged; Placebos; Proportional Hazards Models; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors | 2010 |
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Topics: Calcium Carbonate; Cardiovascular Diseases; Cholecalciferol; Female; Follow-Up Studies; Genistein; Homocysteine; Humans; Insulin Resistance; Lipids; Middle Aged; Osteoprotegerin; Postmenopause; Research Design; Risk Factors | 2010 |
B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.
Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Renal Dialysis; Risk; Treatment Failure; Treatment Outcome; Vitamin B Complex | 2010 |
Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.
Topics: Adult; Antioxidants; Arginine; Ascorbic Acid; beta Carotene; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Dietary Supplements; Double-Blind Method; Homocysteine; Humans; Male; Middle Aged; Protective Agents; Triglycerides; Vitamin B Complex; Vitamin E | 2010 |
Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Human Growth Hormone; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors; Serum Albumin; Treatment Outcome | 2010 |
Randomized controlled trial of the effect of short-term coadministration of methylcobalamin and folate on serum ADMA concentration in patients receiving long-term hemodialysis.
Topics: Administration, Oral; Aged; Arginine; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B 12; Vitamin B Complex | 2010 |
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Albuminuria; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Diabetes Complications; Female; Free Radical Scavengers; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Placebos; Proteins; Risk Factors; Sodium; Young Adult | 2010 |
The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
Topics: Aged; Cardiovascular Diseases; Diet Surveys; Dietary Fats; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Fatty Acids, Omega-3; Homocysteine; Humans; Kidney Failure, Chronic; Middle Aged; Phospholipids; Renal Dialysis; Risk Factors; Seafood; Self Report; Surveys and Questionnaires | 2010 |
Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Young Adult | 2011 |
The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients.
Topics: Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Solanum lycopersicum | 2011 |
Effect of consumption of tomato juice enriched with n-3 polyunsaturated fatty acids on the lipid profile, antioxidant biomarker status, and cardiovascular disease risk in healthy women.
Topics: Adult; Antioxidants; Beverages; Biomarkers; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Food, Fortified; Fruit; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipids; Middle Aged; Oxidative Stress; Risk Factors; Single-Blind Method; Solanum lycopersicum; Spain; Vascular Cell Adhesion Molecule-1 | 2012 |
Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study.
Topics: Aged; Anthropometry; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diet; Dietary Carbohydrates; Dietary Proteins; Energy Intake; Feeding Behavior; Female; Glycated Hemoglobin; Glycemic Index; Homocysteine; Humans; Insulin; Longitudinal Studies; Male; Middle Aged; Postprandial Period; Triglycerides; Weight Loss | 2011 |
Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Follow-Up Studies; Homocysteine; Humans; Hypertension; Male; Middle Aged; Overweight; Patient Compliance; Tetrahydrofolates; Vitamin B Complex | 2012 |
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
Topics: Aged; Anticholesteremic Agents; Brachial Artery; Cardiovascular Diseases; Double-Blind Method; Endothelium; Endpoint Determination; Female; Fluorobenzenes; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Patient Compliance; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation; Vitamin B Complex; Vitamins | 2012 |
Does hemodiafiltration improve the removal of homocysteine?
Topics: Adult; Aged; Aged, 80 and over; beta 2-Microglobulin; Cardiovascular Diseases; Cross-Sectional Studies; Female; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors | 2011 |
Variations on cardiovascular risk factors in metabolic syndrome after consume of a citrus-based juice.
Topics: Aged; Antioxidants; Beverages; C-Reactive Protein; Cardiovascular Diseases; Citrus; Female; Fruit; Homocysteine; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Metabolic Syndrome; Middle Aged; Photinia; Plant Extracts; Risk Factors; Spain; Time Factors | 2012 |
Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia.
Topics: Aged; Asian People; Biomarkers; Blood Glucose; Blood Urea Nitrogen; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Creatinine; Drug Combinations; Enzymes; Female; Fenofibrate; Fluorobenzenes; Hemoglobins; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipids; Liver; Male; Middle Aged; Muscle, Skeletal; Patient Selection; Pyrimidines; Republic of Korea; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome | 2012 |
A randomized trial of copper supplementation effects on blood copper enzyme activities and parameters related to cardiovascular health.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Copper; Deficiency Diseases; Dietary Supplements; Erythrocytes; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Postmenopause; Risk Factors; Salts; Superoxide Dismutase; Superoxide Dismutase-1 | 2012 |
Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults.
Topics: Adult; Cardiovascular Diseases; Ethnicity; Female; Flour; Folic Acid; Follow-Up Studies; Food, Fortified; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Prospective Studies; Risk Factors; United States | 2012 |
Therapeutic effect of forest bathing on human hypertension in the elderly.
Topics: Affect; Aged; Blood Pressure; Cardiovascular Diseases; Cities; Endothelin-1; Environment; Homocysteine; Humans; Hypertension; Inflammation; Interleukin-6; Middle Aged; Renin-Angiotensin System; Treatment Outcome; Trees; Tumor Necrosis Factor-alpha | 2012 |
Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial.
Topics: Adipokines; Aged; Apolipoproteins; Blood Glucose; Cardiovascular Diseases; Cholesterol; Cross-Over Studies; Diet; Ethanol; Fasting; Folic Acid; Glucose; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Polyphenols; Risk Factors; Triglycerides; Vitamin B 12; Wine | 2013 |
The effects of resistance training on cardiovascular disease risk factors in postmenopausal women: a randomized-controlled trial.
Topics: Aged; Analysis of Variance; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Heart Rate; Homocysteine; Humans; Interviews as Topic; Lipids; Middle Aged; Postmenopause; Resistance Training; Risk Factors; Telephone | 2012 |
Effects of walnut consumption as part of a low-fat, low-cholesterol diet on serum cardiovascular risk factors.
Topics: Analysis of Variance; Blood Proteins; Body Mass Index; Cardiovascular Diseases; Cross-Over Studies; Diet, Fat-Restricted; Female; Homocysteine; Humans; Hypercholesterolemia; Juglans; Lipids; Male; Middle Aged; Risk Factors | 2002 |
Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.
Topics: Aged; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Double-Blind Method; Female; Homocysteine; Humans; Hypothyroidism; Male; Middle Aged; Probability; Prognosis; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics, Nonparametric; Thyroxine | 2003 |
Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage.
Topics: Adult; Aged; Antioxidants; Cardiovascular Diseases; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Glutathione Peroxidase; Homocysteine; Humans; Male; Malondialdehyde; Middle Aged; Nutritional Status; Oxidation-Reduction; Reactive Oxygen Species; Risk Factors; Single-Blind Method; Superoxide Dismutase | 2003 |
Antihypertensive treatment and homocysteine concentrations.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Creatinine; Cystatin C; Cystatins; Female; Folic Acid; Homocysteine; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Vitamin B 12; Vitamin B 6 | 2003 |
Effect of supplemental phytonutrients on impairment of the flow-mediated brachial artery vasoactivity after a single high-fat meal.
Topics: Adult; Antioxidants; Brachial Artery; Cardiovascular Diseases; Cholesterol; Dietary Fats; Dietary Supplements; Double-Blind Method; Endothelium, Vascular; Female; Fruit; Homocysteine; Humans; Male; Nitrates; Nitric Oxide; Nitrites; Plant Preparations; Triglycerides; Vasodilation; Vegetables; Vitamins | 2003 |
Consumption of an oil composed of medium chain triacyglycerols, phytosterols, and N-3 fatty acids improves cardiovascular risk profile in overweight women.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dietary Supplements; Drug Combinations; Energy Metabolism; Fatty Acids, Omega-3; Female; Homocysteine; Humans; Middle Aged; Obesity; Oils; Phytosterols; Single-Blind Method; Triglycerides | 2003 |
Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease.
Topics: Cardiovascular Diseases; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2004 |
Gene-nutrient and gene-gene interactions of controlled folate intake by Japanese women.
Topics: Adult; Cardiovascular Diseases; Female; Folic Acid; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Humans; Japan; Methylenetetrahydrofolate Reductase (NADPH2); Women's Health | 2004 |
Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial.
Topics: Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Double-Blind Method; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Methionine; Middle Aged; Vitamin B 12; Vitamin B 6 | 2004 |
[Study of the effect of medicinal product "STRESSEN" on blood levels of homocysteine in patients with current cardiovascular disease].
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Drug Combinations; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Vitamin B 12 | 2004 |
Communicating cardiovascular disease risk due to elevated homocysteine levels: using the EPPM to develop print materials.
Topics: Cardiovascular Diseases; Female; Health Promotion; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Teaching Materials | 2004 |
Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia.
Topics: Aged; Animals; Antioxidants; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Lipids; Male; Malondialdehyde; Middle Aged; Milk; Oleic Acid; Risk Factors; Spain; Time Factors; Vascular Cell Adhesion Molecule-1; Vitamin B 6; Vitamin B Complex; Vitamin E | 2004 |
Oral creatine supplements lower plasma homocysteine concentrations in humans.
Topics: Administration, Oral; Adult; Cardiovascular Diseases; Creatine; Dietary Supplements; Female; Homocysteine; Humans; Male; Middle Aged | 2004 |
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
Topics: Adult; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cyclosporine; Female; Graft Survival; Homocysteine; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Period; Prednisolone; Prospective Studies; Risk Assessment; Risk Factors; Uric Acid | 2004 |
Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Geriatric Assessment; Homocysteine; Humans; Methylmalonic Acid; Middle Aged; Minerals; Risk Assessment; Vitamin B 12; Vitamin B 6; Vitamin B Complex; Vitamins | 2005 |
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Cardiovascular Diseases; Cystathionine; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Norway; Prospective Studies; Vitamin B 12; Vitamin B 6 | 2004 |
Dietary serine and cystine attenuate the homocysteine-raising effect of dietary methionine: a randomized crossover trial in humans.
Topics: Adult; Analysis of Variance; Area Under Curve; Cardiovascular Diseases; Cross-Over Studies; Cystine; Dietary Proteins; Fasting; Homocysteine; Humans; Male; Methionine; Serine | 2004 |
Dimercaptosuccinic acid for the treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
Topics: Administration, Oral; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Succimer; Vitamins | 2004 |
Effects of exercise on emerging and traditional cardiovascular risk factors.
Topics: Adult; Anthropometry; C-Reactive Protein; Cardiovascular Diseases; Diet; Exercise; Exercise Therapy; Female; Homocysteine; Humans; Insulin; Life Style; Male; Oxygen Consumption; Patient Compliance; Physical Fitness; Risk Factors | 2004 |
Evaluation of a shorter methionine loading test.
Topics: Administration, Oral; Adult; Cardiovascular Diseases; Chelating Agents; Edetic Acid; Fasting; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pre-Eclampsia; Pregnancy; Risk Factors; Time Factors | 2004 |
Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
Topics: Adolescent; Cardiomegaly; Cardiovascular Diseases; Carotid Arteries; Carotid Artery Diseases; Child; Diastole; Echocardiography; Female; Growth Disorders; Heart Function Tests; Homocysteine; Human Growth Hormone; Humans; Lipid Metabolism; Lipoproteins; Male; Organ Size; Reference Values; Risk Factors; Tunica Intima | 2004 |
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o
Topics: Biomarkers; Blood Coagulation; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Inflammation; Ischemic Attack, Transient; Pyridoxine; Risk Factors; Stroke; Vitamin B 12; Vitamin B Complex | 2005 |
S-adenosylmethionine and 5-methyltetrahydrofolate are associated with endothelial function after controlling for confounding by homocysteine: the Hoorn Study.
Topics: Aged; Brachial Artery; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Nitroglycerin; Regional Blood Flow; Risk Factors; S-Adenosylmethionine; Tetrahydrofolates; Ultrasonography; Vasodilation; Vasodilator Agents; Vitamin B 12; Vitamin B 6 | 2005 |
The effect of hormone therapy on plasma homocysteine levels: a randomized clinical trial.
Topics: Adult; Cardiovascular Diseases; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Treatment Outcome | 2005 |
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women.
Topics: C-Reactive Protein; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Genistein; Homocysteine; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Phytoestrogens; Postmenopause; Treatment Outcome | 2005 |
L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism.
Topics: Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cysteine; Energy Metabolism; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Insulin; Middle Aged; Postmenopause; Risk Factors; Risk Reduction Behavior | 2005 |
Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.
Topics: Adult; Aged; Betaine; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Lipids; Lipotropic Agents; Male; Middle Aged; Phosphatidylcholines; Placebos; Risk Factors | 2005 |
Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Over Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Male; Middle Aged; Prospective Studies; Renal Dialysis; Time Factors | 2005 |
No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Dietary Supplements; Factor VIIa; Female; Fibrin; Folic Acid; Hemostasis; Homocysteine; Humans; Inflammation; Male; Middle Aged; Placebos; Risk; Thromboplastin; Time Factors; von Willebrand Factor | 2005 |
Training effects of short bouts of stair climbing on cardiorespiratory fitness, blood lipids, and homocysteine in sedentary young women.
Topics: Adolescent; Body Composition; Cardiovascular Diseases; Exercise Therapy; Female; Homocysteine; Humans; Life Style; Lipids; Lipoproteins; Oxygen Consumption; Physical Education and Training; Physical Fitness; Risk Factors; Triglycerides; Women's Health | 2005 |
A high-protein diet increases postprandial but not fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; Cardiovascular Diseases; Cross-Over Studies; Diet, Protein-Restricted; Dietary Proteins; Dose-Response Relationship, Drug; Fasting; Homocysteine; Humans; Male; Methionine; Postprandial Period; Risk Factors | 2005 |
The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Topics: Adult; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Nandrolone; Postmenopause; Treatment Outcome | 2005 |
Homocysteine levels in acromegaly patients.
Topics: Acromegaly; Adult; Cardiovascular Diseases; Female; Glucose Tolerance Test; Growth Hormone; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Statistics, Nonparametric | 2005 |
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation | 2006 |
Effect of dietary supplementation with beta-casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease.
Topics: Adult; Aged; Aorta; Biomarkers; Blood Pressure; Cardiovascular Diseases; Caseins; Cholesterol; Cross-Over Studies; Dairy Products; Dietary Supplements; Double-Blind Method; Female; Forearm; Homocysteine; Humans; Male; Middle Aged; Protein C; Protein S; Risk Factors | 2006 |
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
Topics: Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Follow-Up Studies; Global Health; Homocysteine; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2006 |
Responsiveness of homocysteine concentrations to food and supplemental folate intakes in smokers and never-smokers enrolled in a diet intervention trial.
Topics: Adult; Cardiovascular Diseases; Counseling; Energy Intake; Feeding Behavior; Female; Folic Acid; Homocysteine; Humans; Plasma; Smoking | 2006 |
Relationship between homocysteine and mortality in chronic kidney disease.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Chronic Disease; Dietary Proteins; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Mortality | 2006 |
Effect of white wine consumption on oxidative stress markers and homocysteine levels.
Topics: Adult; Alcohol Drinking; Apolipoproteins; Aryldialkylphosphatase; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cohort Studies; Czech Republic; Glutathione; Glutathione Peroxidase; Homocysteine; Humans; Liver; Male; Oxidative Stress; Risk Factors; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Triglycerides; Wine | 2007 |
Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Proteins; Regression Analysis; Renal Dialysis; Survival Analysis; Vitamin B Complex | 2006 |
Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Recurrence; Vitamins | 2006 |
Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.
Topics: Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cohort Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypothyroidism; Insulin; Lipids; Middle Aged; Postprandial Period; Risk Factors; Thyrotropin; Triglycerides; Uric Acid | 2006 |
Absorption of flavonols derived from sea buckthorn (Hippophaë rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans.
Topics: Adult; Antioxidants; Aryldialkylphosphatase; Avena; C-Reactive Protein; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Diet; Double-Blind Method; Flavonols; Hippophae; Homocysteine; Humans; Intestinal Absorption; Lipoproteins, LDL; Male; Middle Aged; Placebos; Plant Oils; Quercetin | 2006 |
Supplementation with fruit and vegetable soups and beverages increases plasma carotenoid concentrations but does not alter markers of oxidative stress or cardiovascular risk factors.
Topics: Adult; Beverages; Cardiovascular Diseases; Carotenoids; Female; Fruit; Homocysteine; Humans; Male; Middle Aged; Oxidative Stress; Patient Compliance; Risk Factors; Single-Blind Method; Vegetables | 2006 |
Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients.
Topics: Cardiovascular Diseases; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hydrogen Peroxide; Hyperhomocysteinemia; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Renal Dialysis; Time Factors; Vitamin B Complex | 2007 |
Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study.
Topics: Adult; Apolipoprotein A-I; Arthritis, Psoriatic; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoprotein(a); Male; Middle Aged; Receptors, Tumor Necrosis Factor, Type I; Risk Factors; Sex Hormone-Binding Globulin; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha | 2007 |
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins.
Topics: Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Recurrence; Risk Factors; Time Factors; Treatment Outcome; Vitamin B Complex | 2007 |
Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Continuous Positive Airway Pressure; Female; Follow-Up Studies; Homocysteine; Humans; Lipids; Male; Middle Aged; Patient Compliance; Risk Factors; Sleep Apnea, Obstructive | 2007 |
Randomized clinical trial of homocysteine level lowering therapy and fractures.
Topics: Aged; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Fractures, Bone; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Proportional Hazards Models; Pyridoxine; Risk Factors; Treatment Outcome; Vitamin B 12 | 2007 |
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Cysteine; Dipeptides; Epilepsy; Female; Homocysteine; Humans; Male; Middle Aged; Oxcarbazepine; Risk Factors | 2008 |
Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Biomarkers; Blood Pressure; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Contraceptive Agents, Female; Drug Interactions; Endothelium, Vascular; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Heart Rate; Homocysteine; Hormone Antagonists; Humans; Injections, Subcutaneous; Lipids; Medroxyprogesterone Acetate; Oligopeptides; Reproducibility of Results; Vasodilation | 2008 |
Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity.
Topics: Abdominal Fat; Adiponectin; Adult; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Diet, Carbohydrate-Restricted; Diet, Reducing; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Obesity; Risk Factors; Treatment Outcome; Weight Loss | 2008 |
Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen.
Topics: Adult; Ascorbic Acid; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium Carbonate; Calcium, Dietary; Cardiovascular Diseases; Cholesterol; Drug Therapy, Combination; Female; Homocysteine; Humans; Middle Aged; Patient Compliance; Postmenopause; Proline; Pyridoxic Acid; Risk Factors; Vitamin B 6 | 2008 |
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Drug Combinations; Female; Folic Acid; Homocysteine; Humans; Middle Aged; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Creatinine; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Male; Middle Aged; Retrospective Studies; Risk Factors | 1994 |
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia.
Topics: Adult; Aged; Cardiovascular Diseases; Cystathionine beta-Synthase; Dose-Response Relationship, Drug; Double-Blind Method; Folic Acid; Folic Acid Deficiency; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Pyridoxine; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6 Deficiency | 1993 |
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Kidney Diseases; Middle Aged; Renal Dialysis; Risk Factors; Vitamin B Complex | 1996 |
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives.
Topics: Age of Onset; Apolipoproteins B; Cardiovascular Diseases; Cause of Death; Child; Creatinine; Cysteine; Diet; Female; Homocysteine; Humans; Lipids; Lipoprotein(a); Male; Medical History Taking; Social Class; Surveys and Questionnaires; Vitamin B Complex | 1996 |
Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid.
Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Drug Administration Schedule; Folic Acid; Homocysteine; Humans; Male; Middle Aged | 1997 |
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Folic Acid Antagonists; Folic Acid Deficiency; Homocysteine; Humans; Male; Methotrexate; Middle Aged | 1998 |
Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Diet; Double-Blind Method; Fatty Acids, Omega-3; Glutathione Peroxidase; Homocysteine; Humans; Hyperlipidemias; Leukocytes, Mononuclear; Male; Middle Aged; Risk Factors; RNA, Messenger; Smoking; Vitamins | 1999 |
Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Female; Folic Acid; Hematinics; Homocysteine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Vitamin B 12 | 1998 |
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Topics: Acute Disease; Adult; Antioxidants; Arginine; Ascorbic Acid; Blood Coagulation; Blood Viscosity; Cardiovascular Diseases; Cross-Over Studies; Endothelium, Vascular; Female; Hemodynamics; Homocysteine; Humans; Male; Methionine; Platelet Aggregation; Risk Factors; Single-Blind Method; Vitamin E | 1999 |
[Plasma homocysteine concentration in healthy middle-aged men and its presumed association with cardiovascular mortality].
Topics: Adult; Cardiovascular Diseases; Finland; Homocysteine; Humans; Hungary; Male; Middle Aged; Risk Factors | 1999 |
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Pyridoxine; Risk Factors; Vitamin B 12 | 1999 |
Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial.
Topics: Adult; Aged; Alanine Transaminase; Cardiovascular Diseases; Coffee; Cross-Over Studies; Diet; Female; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk Factors; Vitamins | 2000 |
Cardiac troponin T predicts mortality in patients with end-stage renal disease.
Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; Survival Rate; Troponin T | 2000 |
Low-dose folic acid supplementation reduces plasma levels of the cardiovascular risk factor homocysteine in postmenopausal women.
Topics: Cardiovascular Diseases; Dose-Response Relationship, Drug; Female; Folic Acid; Hematinics; Homocysteine; Humans; Middle Aged; Postmenopause; Risk Factors | 2000 |
Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet.
Topics: Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Cerebrovascular Disorders; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Minerals; Nutritional Status; Pyridoxal Phosphate; Risk Factors; Vitamin B 12; Vitamin B Complex; Vitamins | 2000 |
Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.
Topics: Aged; Apolipoprotein B-100; Apolipoproteins B; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Dietary Supplements; Double-Blind Method; Fasting; Female; Homocysteine; Humans; Insulin; Lipids; Male; Middle Aged; Placebos; Risk Factors; Soybean Proteins; Triglycerides | 2001 |
Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans.
Topics: Adult; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Cross-Over Studies; Fasting; Female; Flavonoids; Folic Acid; Glucosides; Homocysteine; Humans; Male; Phenols; Polymers; Postprandial Period; Pyridoxine; Quercetin; Risk Factors; Tea; Vitamin B 12 | 2001 |
Biological cardiovascular risk factors and plasma homocysteine levels in the general Dutch population.
Topics: Adult; Aged; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Female; Homocysteine; Humans; Incidence; Male; Middle Aged; Netherlands; Risk Factors; Surveys and Questionnaires; Urban Population | 2001 |
[Study on homocysteine metabolism related enzymes gene mutations in Chinese patients with ischemic cardiovascular and cerebrovascular diseases].
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Asian People; Brain Ischemia; Cardiovascular Diseases; Cerebrovascular Disorders; Cystathionine beta-Synthase; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Myocardial Ischemia; Oxidoreductases Acting on CH-NH Group Donors | 2001 |
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vitamin B 12 | 2002 |
The effect of folic acid supplementation on plasma homocysteine in an elderly population.
Topics: Aged; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Hematinics; Homocysteine; Humans; Linear Models; Male; Methylmalonic Acid | 2002 |
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine.
Topics: Cardiovascular Diseases; Double-Blind Method; Estrogens, Conjugated (USP); Female; Homocysteine; Hormone Replacement Therapy; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cholesterol; Female; Homocysteine; Humans; Hypothyroidism; India; Lipids; Middle Aged; Prospective Studies; Risk Factors; Thyrotropin; Thyroxine; Triglycerides | 2002 |
Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study.
Topics: Adult; Cardiovascular Diseases; Causality; Contraceptives, Oral; Desogestrel; Fasting; Female; Homocysteine; Humans; Norpregnenes; Pyridoxal Phosphate; Vitamin B 12 | 1992 |
767 other study(ies) available for homocysteine and Cardiovascular Diseases
Article | Year |
---|---|
The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States.
Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Nutrition Surveys; Risk Factors; United States | 2022 |
Association between high BMI and high homocysteine levels in Chinese patients with bipolar disorder.
Topics: Bipolar Disorder; Body Mass Index; Cardiovascular Diseases; China; Homocysteine; Humans | 2021 |
Distribution characteristics and influencing factors of homocyteine in an apparently healthy examined population.
Topics: Adult; Age Factors; Aged; Biomarkers; Cardiovascular Diseases; China; Cholesterol, HDL; Creatinine; Female; Healthy Volunteers; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Male; Middle Aged; Risk Assessment; Risk Factors; Sex Factors; Uric Acid; Young Adult | 2021 |
Further comment on articles pertaining to: "Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19".
Topics: Cardiovascular Diseases; COVID-19; Heart Disease Risk Factors; Homocysteine; Humans; Risk Factors; SARS-CoV-2 | 2021 |
Variation of homocysteine levels in rheumatoid arthritis patients: relationship to inflammation, cardiovascular risk factors, and methotrexate.
Topics: Adult; Arthritis, Rheumatoid; Cardiovascular Diseases; Creatine; Cross-Sectional Studies; Folic Acid; Heart Disease Risk Factors; Homocysteine; Humans; Inflammation; Male; Methotrexate; Middle Aged; Risk Factors; Vitamin B 12 | 2023 |
A study on serum homocysteine and oxidized LDL as markers of cardiovascular risk in patients with overt hypothyroidism.
Topics: Adult; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Heart Disease Risk Factors; Homocysteine; Humans; Hypothyroidism; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Risk Factors; Thyroid Hormones; Thyrotropin; Triglycerides; Young Adult | 2022 |
Association of Homocysteine and Insulin Resistance with Increased Risk of Mortality in a Nondiabetic Population: Third National Health and Nutrition Examination Survey.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Insulin Resistance; Nutrition Surveys; Risk Factors | 2022 |
Plasma metal concentrations and their interactions with genetic susceptibility on homocysteine levels.
Topics: Cardiovascular Diseases; Cross-Sectional Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Metals; Selenium | 2022 |
Occupational exposure to particles and biomarkers of cardiovascular disease-during work and after vacation.
Topics: Air Pollutants, Occupational; Biomarkers; Cardiovascular Diseases; Dust; Environmental Monitoring; Homocysteine; Humans; Inhalation Exposure; Male; Occupational Exposure; Silicon Dioxide | 2022 |
Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation.
Topics: Annexin A5; Cardiovascular Diseases; Extracellular Vesicles; Glucose; Heart Disease Risk Factors; Homocysteine; Humans; Hypertension; Lipids; Pulse Wave Analysis; Risk Factors | 2022 |
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men.
Topics: Adipose Tissue, Brown; Alanine Transaminase; Cardiovascular Diseases; Cholesterol, LDL; Cold Temperature; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Homocysteine; Humans; Insulins; Male; Positron Emission Tomography Computed Tomography; Triglycerides; Young Adult | 2022 |
Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study.
Topics: Androgens; Atorvastatin; C-Reactive Protein; Cabergoline; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Insulin Resistance; Pilot Projects; Prolactin; Risk Factors; Uric Acid | 2022 |
Association of Serum Homocysteine with Cardiovascular and All-Cause Mortality in Adults with Diabetes: A Prospective Cohort Study.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Neoplasms; Nutrition Surveys; Prospective Studies; Risk Factors | 2022 |
The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperuricemia; Insulins; Lipids; Male; Metabolic Syndrome; Retrospective Studies; Risk Factors; Uric Acid | 2022 |
Mean platelet volume modifies the contribution of homocysteine to cardiovascular disease: A real-world study.
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Hypertension; Male; Mean Platelet Volume; Risk Factors | 2023 |
Associations of Serum Folate and Homocysteine Concentrations with All-Cause, Cardiovascular Disease, and Cancer Mortality in Men and Women in Korea: the Cardiovascular Disease Association Study.
Topics: Adult; Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Neoplasms; Prospective Studies; Republic of Korea; Risk Factors | 2023 |
Elevated levels of total homocysteine after ischemic stroke: a potential marker for in-hospital outcomes.
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Ischemic Stroke; Logistic Models; Male; Risk Factors; Stroke | 2023 |
The Associations of Habitual Intake of Sulfur Amino Acids, Proteins and Diet Quality with Plasma Sulfur Amino Acid Concentrations: The Maastricht Study.
Topics: Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cystathionine; Cysteine; Diabetes Mellitus, Type 2; Diet; Female; Homocysteine; Humans; Methionine; Obesity; Taurine | 2023 |
CARDIOVASCULAR RISK IN WOMEN WITH PREECLAMPSIA.
Topics: Cardiovascular Diseases; Female; Heart Disease Risk Factors; Homocysteine; Humans; Pre-Eclampsia; Pregnancy; Prospective Studies; Risk Factors | 2022 |
Joint Association of Serum Homocysteine and High-Sensitivity C-Reactive Protein with Arterial Stiffness in Chinese Population: A 12-Year Longitudinal Study.
Topics: Adult; Ankle Brachial Index; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; China; Female; Homocysteine; Humans; Linear Models; Longitudinal Studies; Male; Multivariate Analysis; Pulse Wave Analysis; Risk Factors; Vascular Stiffness | 2019 |
Homocysteine is an independent predictor of long-term cardiac mortality in patients with stable coronary artery disease in the era of statins.
Topics: Acute Coronary Syndrome; Aged; Arrhythmias, Cardiac; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Coronary Stenosis; Female; Greece; Homocysteine; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Ischemic Stroke; Male; Middle Aged; Myocardial Revascularization; Prognosis; Proportional Hazards Models; Registries | 2020 |
S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset.
Topics: Amyloid Neuropathies, Familial; Cardiomyopathies; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Homocysteine; Humans; Methionine; Mutation; Myocytes, Cardiac; Prealbumin; Protein Conformation; Protein Stability; Stroke; Structure-Activity Relationship | 2020 |
Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome.
Topics: Acute Coronary Syndrome; Age Factors; Cardiovascular Diseases; Female; Homocysteine; Humans; Incidence; Middle Aged; Predictive Value of Tests; Risk Assessment | 2019 |
Investigation of the Association Between Carotid Artery Intima-Media Thickness (IMT) and Cardiac Risk Factors in Patients with Systemic Lupus Erythematosus.
Topics: Adolescent; Adult; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol; Heart Disease Risk Factors; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Triglycerides; Young Adult | 2020 |
Systemic Oxidative Stress Is Increased in Postmenopausal Women and Independently Associates with Homocysteine Levels.
Topics: Adult; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Middle Aged; Obesity; Oman; Oxidative Stress; Postmenopause; Premenopause; Risk Factors; Sulfhydryl Compounds | 2020 |
Effects of Turmeric on Cardiovascular Risk Factors, Mental Health, and Serum Homocysteine in Overweight, Obese Females.
Topics: Body Mass Index; Cardiovascular Diseases; Curcuma; Female; Heart Disease Risk Factors; Homocysteine; Humans; Mental Health; Obesity; Overweight; Plant Extracts; Risk Factors | 2021 |
Association of Serum Folate Levels With Cardiovascular Mortality Among Adults With Rheumatoid Arthritis.
Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Causality; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; United States | 2020 |
Association of Homocysteine, Methionine, and MTHFR 677C>T Polymorphism With Rate of Cardiovascular Multimorbidity Development in Older Adults in Sweden.
Topics: Age Factors; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Multimorbidity; Polymorphism, Single Nucleotide; Prospective Studies; Risk Factors; Sweden | 2020 |
Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19.
Topics: Biomarkers; Cardiovascular Diseases; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Homocysteine; Humans; Pandemics; Pneumonia, Viral; Risk Assessment; Risk Factors | 2020 |
COMMENT ON AN ARTICLE: "Homocysteine as a potential predictor of cardiovascular risk in patients with COVID-19".
Topics: Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Homocysteine; Humans; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2 | 2020 |
Analysis of serum homocysteine in the laboratory practice - comparison of the direct chemiluminescence immunoassay and high performance liquid chromatography coupled with fluorescent detection.
Topics: Adult; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Homocysteine; Humans; Immunoassay; Luminescent Measurements; Male; Reagent Kits, Diagnostic; Regression Analysis; Spectrometry, Fluorescence | 2020 |
PON1 status and homocysteine levels as potential biomarkers for cardiovascular disease.
Topics: Aryldialkylphosphatase; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Mexico | 2020 |
Comparison of Lifestyle of Catholics and Seventh-Day Adventists and the Relationship with Homocysteine as Risk Factor for Cardiovascular Diseases, a Cross-Sectional Study in Polish Males and Females.
Topics: Adult; Cardiovascular Diseases; Catholicism; Cross-Sectional Studies; Female; Homocysteine; Humans; Life Style; Male; Middle Aged; Poland; Protestantism; Risk Factors | 2021 |
Hyperhomocysteinemia and its relations to conventional risk factors for cardiovascular diseases in adult Nigerians: the REMAH study.
Topics: Adolescent; Adult; Aged; Biomarkers; Black People; Blood Pressure; Cardiovascular Diseases; Cholesterol, HDL; Dyslipidemias; Heart Disease Risk Factors; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Middle Aged; Nigeria; Prevalence; Risk Assessment; Young Adult | 2021 |
Cardiovascular manifestations of intermediate and major hyperhomocysteinemia due to vitamin B12 and folate deficiency and/or inherited disorders of one-carbon metabolism: a 3.5-year retrospective cross-sectional study of consecutive patients.
Topics: Adult; Cardiovascular Diseases; Child, Preschool; Cross-Sectional Studies; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolism, Inborn Errors; Methylmalonic Acid; Middle Aged; Retrospective Studies; Vitamin B 12 | 2021 |
Associations of Early Pregnancy and Neonatal Circulating Folate, Vitamin B-12, and Homocysteine Concentrations with Cardiometabolic Risk Factors in Children at 10 y of Age.
Topics: Cardiometabolic Risk Factors; Cardiovascular Diseases; Child; Female; Folic Acid; Glucose; Homocysteine; Humans; Infant, Newborn; Micronutrients; Overweight; Pregnancy; Prospective Studies; Risk Factors; Vitamin B 12; Vitamins | 2021 |
The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Heart Disease Risk Factors; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prognosis; Risk Assessment; Taiwan; Time Factors; Up-Regulation | 2021 |
Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage.
Topics: Cardiovascular Diseases; Copper; Glutathione; Homocysteine; Humans; Hydrogen; Oxidation-Reduction; Sulfhydryl Compounds | 2021 |
Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Mendelian Randomization Analysis; Risk Factors; Vitamin B 12; Vitamin B Complex | 2021 |
Homocysteine and copper ions: is their interaction responsible for cardiovascular-related damage?
Topics: Cardiovascular Diseases; Copper; Drug Interactions; Homocysteine; Humans | 2021 |
Reply to homocysteine and copper ions: is their interaction responsible for cardiovascular‑related damage?
Topics: Cardiovascular Diseases; Copper; Drug Interactions; Homocysteine; Humans | 2021 |
Association between Coffee Consumption and Its Polyphenols with Cardiovascular Risk Factors: A Population-Based Study.
Topics: Adult; Beverages; Blood Glucose; Blood Pressure; Brazil; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Coffee; Cross-Sectional Studies; Diet; Female; Homocysteine; Humans; Life Style; Logistic Models; Male; Middle Aged; Nutrition Assessment; Polyphenols; Risk Factors; Surveys and Questionnaires; Triglycerides | 2017 |
Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults.
Topics: Aged; Aged, 80 and over; Betaine; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol; Choline; Cross-Sectional Studies; Diabetes Mellitus; Female; Homocysteine; Humans; Hypertension; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphatidylcholines; Risk Factors; Triglycerides; Waist Circumference | 2017 |
1,25-Dihydroxyvitamin D
Topics: Animals; Antioxidants; Calcitriol; Cardiovascular Diseases; Cell Survival; Energy Metabolism; Heart; Homocysteine; Lipid Peroxidation; Male; Mitochondria; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Rats, Wistar; Reactive Oxygen Species; Receptors, Calcitriol; Vitamin D | 2017 |
Association between plasma homocysteine concentration and the risk of all-cause death in adults with diastolic dysfunction in a community: A 13-year cohort study.
Topics: Aged; Aged, 80 and over; Area Under Curve; Asian People; Biomarkers; Cardiovascular Diseases; Echocardiography; Female; Follow-Up Studies; Homocysteine; Humans; Male; Multivariate Analysis; Prognosis; Proportional Hazards Models; Prospective Studies; ROC Curve; Taiwan | 2017 |
Studying the association between methylenetetrahydrofolate reductase (MTHFR) 677 gene polymorphism, cardiovascular risk and lichen planus.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Lichen Planus; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Polymorphism, Genetic; Risk Factors | 2017 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Dyslipidemias; Glycine; Homocysteine; Hypercholesterolemia; Lipids; Liver; Lysine; Male; Methionine; Nitric Oxide; Organ Size; Rats, Wistar | 2017 |
Does Serum Homocysteine Explain the Connection Between Sexual Frequency and Cardiovascular Risk?
Topics: Adult; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up Studies; Health Promotion; Homocysteine; Humans; Linear Models; Male; Middle Aged; Nutrition Surveys; Risk Factors; Sexual Behavior; United States; Young Adult | 2017 |
Methionine-supplemented diet affects the expression of cardiovascular disease-related genes and increases inflammatory cytokines in mice heart and liver.
Topics: Animals; Biomarkers; Cardiovascular Diseases; Cytokines; Diet; Dietary Supplements; Female; Gene Expression Regulation; Heart; Homocysteine; Liver; Methionine; Mice; Myocardium; Oxidative Stress | 2017 |
Quality specification and status of internal quality control of cardiac biomarkers in China from 2011 to 2016.
Topics: Biomarkers; Blood Chemical Analysis; Cardiovascular Diseases; Creatine Kinase; Homocysteine; Humans; Laboratories; Muscle Proteins; Quality Control; Reproducibility of Results | 2018 |
Associations Among Cardio-Ankle Vascular Index, Carotid Intima-Media Thickness, and Fibroblast Growth Factor-21 Levels in Kidney Transplant Patients.
Topics: Adult; Aged; Ankle Brachial Index; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Fibroblast Growth Factors; Homocysteine; Humans; Kidney Transplantation; Male; Middle Aged; Renal Insufficiency, Chronic; Risk Factors; Vascular Stiffness | 2017 |
Predictive abilities of cardiovascular biomarkers to rapid decline of renal function in Chinese community-dwelling population: a 5-year prospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Independent Living; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Population Surveillance; Predictive Value of Tests; Prospective Studies; Risk Factors; Time Factors | 2017 |
Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?
Topics: Adolescent; Anthropometry; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Child; Cross-Sectional Studies; Female; Folic Acid; Glucocorticoids; Homocysteine; Humans; Lipids; Lupus Erythematosus, Systemic; Nutritional Status; Proteomics; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
Concurrent Presence of Obstructive Sleep Apnea and Elevated Homocysteine Levels Exacerbate the Development of Hypertension: A KoGES Six-year Follow-up Study.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Hypertension; Incidence; Longitudinal Studies; Male; Middle Aged; Polysomnography; Prevalence; Prospective Studies; Risk Factors; Sleep Apnea, Obstructive | 2018 |
Elevated Total Homocysteine in All Participants and Plasma Vitamin B12 Concentrations in Women Are Associated With All-Cause and Cardiovascular Mortality in the Very Old: The Newcastle 85+ Study.
Topics: Aged, 80 and over; Aging; Biomarkers; Cardiovascular Diseases; Correlation of Data; Demography; Erythrocytes; Female; Folic Acid; Health Status Disparities; Homocysteine; Humans; Male; Risk Assessment; Risk Factors; Sex Factors; Socioeconomic Factors; United Kingdom; Vitamin B 12 | 2018 |
Role of Genetic Background in Cardiovascular Risk Markers Changes in Water Polo Players.
Topics: Adult; Advanced Oxidation Protein Products; Aryldialkylphosphatase; Cardiovascular Diseases; Creatine Kinase; Genotype; Homocysteine; Humans; L-Lactate Dehydrogenase; Male; Methylenetetrahydrofolate Reductase (NADPH2); Muscle, Skeletal; Oxidative Stress; Polymorphism, Single Nucleotide; Risk Factors; Water Sports; Young Adult | 2018 |
Direct correlation between serum homocysteine level and insulin resistance index in patients with subclinical hypothyroidism: Does subclinical hypothyroidism increase the risk of diabetes and cardio vascular disease together?
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Female; Homocysteine; Humans; Hypothyroidism; Insulin Resistance; Male; Middle Aged; Risk Factors | 2018 |
Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
Topics: Aged; Aging; Arginine; Austria; Cardiovascular Diseases; Female; Homocysteine; Humans; Incidence; Intermittent Claudication; Lower Extremity; Male; Prospective Studies; Risk Factors; Survival Rate | 2018 |
Folic Acid-Containing Dietary Supplement Consumption and Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients: NHANES 1999-2014.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Middle Aged; Nutrition Surveys; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; United States; Vitamin B Complex | 2019 |
The co-existence of elevated high sensitivity C-reactive protein and homocysteine levels is associated with increased risk of metabolic syndrome: A 6-year follow-up study.
Topics: Adult; Aged; Asian People; C-Reactive Protein; Cardiovascular Diseases; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Prevalence; Republic of Korea; Risk Factors | 2018 |
Long-term exposures to Hypersaline particles associated with increased levels of Homocysteine and white blood cells: A case study among the village inhabitants around the semi-dried Lake Urmia.
Topics: Air Pollutants; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Homocysteine; Humans; Inhalation Exposure; Iran; Lakes; Leukocyte Count; Leukocytes; Male; Middle Aged; Particulate Matter; Random Allocation; Rural Population; Salinity; Time Factors | 2019 |
The association between homocysteine levels, Mediterranean diet and cardiovascular disease: a case-control study.
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aged; Aging; Cardiovascular Diseases; Case-Control Studies; Diet, Mediterranean; Female; Homocysteine; Humans; Life Style; Logistic Models; Male; Middle Aged; Regression Analysis; Sex Factors | 2019 |
High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; China; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Risk Factors; Stroke | 2019 |
The relationship between plasma homocysteine levels and MTHFR gene variation, age, and sex in Northeast China.
Topics: Adult; Age Factors; Aged; Asian People; Cardiovascular Diseases; China; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Sex Factors; Stroke | 2019 |
Does weight loss affect the parameters that are metabolically related to cardiovascular diseases?
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Insulin; Leptin; Male; Middle Aged; Obesity; Triglycerides; Uric Acid; Weight Loss | 2019 |
The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgens; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Dehydroepiandrosterone Sulfate; Female; Fibrinogen; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pilot Projects; Risk Factors; Testosterone; Uric Acid; Vitamin D | 2019 |
Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Topics: Cardiovascular Diseases; Female; Germany; Health Surveys; Homocysteine; Humans; Inflammation; Male; Middle Aged; Risk Assessment; Telomere Shortening; Vitamin B 6 | 2020 |
Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Donors; Cardiovascular Diseases; Cross-Sectional Studies; Educational Status; Female; Health Status; Homocysteine; Humans; Italy; Life Style; Lipoprotein(a); Male; Middle Aged; Prognosis; Risk Assessment; Risk Factors; Social Determinants of Health; Time Factors; Young Adult | 2019 |
Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; Dyslipidemias; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; India; Male; Middle Aged; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2013 |
Aldosterone levels and inflammatory stimulation in essential hypertensive patients.
Topics: Adult; Aged; Aldosterone; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Essential Hypertension; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Inflammation; Leukocyte Count; Male; Middle Aged; Renin; Risk Factors | 2013 |
Serum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate/product ratios.
Topics: Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cysteine; Dipeptides; Female; Glomerular Filtration Rate; Glutathione; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Assessment; Sulfhydryl Compounds; Sulfur; Taurine | 2013 |
Increased carotid intima-media thickness and plasma homocysteine levels predict cardiovascular and all-cause death: a population-based cohort study.
Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Cause of Death; Cohort Studies; Female; Homocysteine; Humans; Male; Proportional Hazards Models; Risk Factors | 2013 |
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Celiac Disease; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet, Gluten-Free; Female; Folic Acid; gamma-Glutamyltransferase; Homocysteine; Humans; Insulin Resistance; Male; Middle Aged; Retrospective Studies; Risk Factors; Triglycerides; Vitamin B 12; Young Adult | 2013 |
Plasma homocysteine and folate levels and dietary folate intake in adolescents and young adults who underwent kidney transplantation during childhood.
Topics: Adolescent; Adolescent Nutritional Physiological Phenomena; Age Factors; Biomarkers; Cardiovascular Diseases; Child; Child Nutritional Physiological Phenomena; Cross-Sectional Studies; Diet; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Japan; Kidney; Kidney Transplantation; Linear Models; Male; Nutrition Assessment; Nutritional Status; Prevalence; Risk Factors; Time Factors; Treatment Outcome; Vitamin B Deficiency; Young Adult | 2014 |
Nutrition throughout life: folate.
Topics: Biological Availability; Cardiovascular Diseases; Drug Stability; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Neural Tube Defects; Nutrition Policy; Nutritional Physiological Phenomena; Nutritional Requirements; Nutritional Status; Pregnancy | 2012 |
Changes in body composition predict homocysteine changes and hyperhomocysteinemia in Korea.
Topics: Adipose Tissue; Body Composition; Body Mass Index; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Republic of Korea | 2013 |
Lack of association of homocysteine concentrations with oxidative stress, alterations in carotid intima media thickness and endothelial reactivity in prepubertal children.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Brachial Artery; Cardiovascular Diseases; Carotid Intima-Media Thickness; Child; Cross-Sectional Studies; Endothelium, Vascular; Female; Homocysteine; Humans; Lipids; Male; Nutritional Status; Obesity; Overweight; Oxidative Stress; Risk Factors; Vasodilation; Waist Circumference | 2013 |
Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population.
Topics: Acute Disease; Aged; Asian People; Cardiovascular Diseases; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Retinal Vein Occlusion; Risk Factors; Vitamin B 12 | 2013 |
Influence of maternal vitamin B12 and folate on growth and insulin resistance in the offspring.
Topics: Adiposity; Adolescent; Adult; Animals; Body Weight; Carbon; Cardiovascular Diseases; Child; Chronic Disease; Diabetes Mellitus; Female; Folic Acid; Folic Acid Deficiency; Growth; Homocysteine; Humans; India; Infant; Infant, Newborn; Insulin Resistance; Maternal Nutritional Physiological Phenomena; Neural Tube Defects; Nutritional Status; Pregnancy; Pregnancy Complications; Vitamin B 12; Vitamin B 12 Deficiency; Young Adult | 2013 |
Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
Topics: Age Factors; Atherosclerosis; Blood Coagulation; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Diabetes Complications; Dyslipidemias; Homocysteine; Humans; Lipids; Lipoproteins; Medical History Taking; Risk Factors; Smoking | 2013 |
Mass spectrometry evidence for formation of estrogen-homocysteine conjugates: estrogens can regulate homocysteine levels.
Topics: Alkylation; Cardiotonic Agents; Cardiovascular Diseases; DNA; Estradiol Congeners; Estrogens; Estrogens, Catechol; Glutathione; Homocysteine; Mass Spectrometry; Oxidation-Reduction; Peroxidase; Quinones | 2013 |
Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cysteine; Dyslipidemias; Energy Intake; Female; Folic Acid; Homocysteine; Humans; Lupus Erythematosus, Systemic; Multivariate Analysis; Nutritional Status; Puberty; Risk Factors; Triglycerides; Vitamin B 12; Waist Circumference; Young Adult | 2013 |
Dietary protein and plasma total homocysteine, cysteine concentrations in coronary angiographic subjects.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Coronary Angiography; Cross-Sectional Studies; Cysteine; Dietary Proteins; Female; Homocysteine; Humans; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Multivariate Analysis; Surveys and Questionnaires | 2013 |
The relationship between 25-hydroxyvitamin D and homocysteine in asymptomatic adults.
Topics: Adult; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Nutrition Surveys; Risk Factors; Vitamin D | 2014 |
Hyperhomocysteinemia and hyperlipoproteinemia (a) in obese South Indian men: an indication for increased cardiovascular risk.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipoproteinemias; India; Lipoprotein(a); Male; Obesity; Risk Factors; Up-Regulation; Waist Circumference; Waist-Hip Ratio; Young Adult | 2014 |
Homocysteine and other cardiovascular risk factors in patients with lichen planus.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Female; Fibrinogen; Homocysteine; Humans; Lichen Planus; Male; Metabolic Syndrome; Middle Aged; Risk Factors | 2014 |
Homocysteinylation score of high-molecular weight plasma proteins.
Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Molecular Weight; Protein Binding | 2014 |
Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case-control study.
Topics: Adipokines; Adiponectin; Biomarkers; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Child; Cholesterol; Female; Fibrinogen; Homocysteine; Human Growth Hormone; Humans; Inflammation; Leptin; Male; Prospective Studies; Risk Factors; Treatment Outcome | 2014 |
MTHFR C677T genotype and cardiovascular risk in a general population without mandatory folic acid fortification.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Denmark; Dyslipidemias; Female; Folic Acid; Follow-Up Studies; Genotype; Genotyping Techniques; Homocysteine; Humans; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Stroke; Triglycerides; Vitamin B 12; Young Adult | 2014 |
Circadian rhythm of homocysteine is hCLOCK genotype dependent.
Topics: Adult; Cardiovascular Diseases; Circadian Rhythm; CLOCK Proteins; Ethnicity; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2) | 2014 |
S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population.
Topics: Asymptomatic Diseases; Atherosclerosis; Cardiovascular Diseases; Female; Glomerular Filtration Rate; Homocysteine; Humans; Male; Middle Aged; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine | 2014 |
Plasma total homocysteine, high-sensitivity C-reactive protein and thyroid function in metabolic syndrome patients.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Thyroid Hormones; Thyrotropin | 2013 |
Oxidative stress: a link between cardiovascular disease and psychiatric illness?
Topics: Cardiovascular Diseases; Fatty Acids; Homocysteine; Humans; Mental Disorders; Metabolic Networks and Pathways; Oxidative Stress | 2014 |
Dietary carotenoids are associated with cardiovascular disease risk biomarkers mediated by serum carotenoid concentrations.
Topics: Adult; beta Carotene; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotenoids; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diet; Female; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Lutein; Lycopene; Male; Nutrition Surveys; Risk Factors; United States; Xanthophylls; Zeaxanthins | 2014 |
Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: a case-control study.
Topics: Adolescent; Adult; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Lipids; Lipoprotein(a); Polycystic Ovary Syndrome; Risk; Thyroid Gland | 2014 |
What is new in obstetric antecedents of chronic disease? Best articles from the past year.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetes, Gestational; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension, Pregnancy-Induced; Kidney Diseases; Obesity; Pregnancy; Premature Birth | 2014 |
Differences in vitamin D concentration between metabolically healthy and unhealthy obese adults: associations with inflammatory and cardiometabolic markers in 4391 subjects.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Homocysteine; Humans; Inflammation; Insulin Resistance; Iran; Lipids; Liver; Male; Metabolic Syndrome; Middle Aged; Obesity; Vitamin D; Waist Circumference | 2014 |
Prevalence and determinants of hypertension in Estonian adults.
Topics: Adult; Aged; Apolipoproteins B; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Estonia; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Prevalence; Risk Factors; Triglycerides; Young Adult | 2014 |
Cardiovascular disease biomarkers in patients with inborn errors of protein metabolism: a pilot study.
Topics: Adolescent; Biomarkers; Cardiovascular Diseases; Child; Child, Preschool; Cholesterol; Cross-Sectional Studies; Dietary Proteins; Female; Homocysteine; Humans; Infant; Lipoproteins; Male; Metabolism, Inborn Errors; Nutrition Assessment; Pilot Projects; Risk Factors; Triglycerides | 2015 |
Functional analysis of single-nucleotide polymorphisms in the regulation of coactivator-associated arginine methyltransferase 1 expression and plasma homocysteine levels.
Topics: Adult; Alleles; Cardiovascular Diseases; China; Early Growth Response Protein 1; Epigenesis, Genetic; Female; Gene Expression Regulation; Genetic Variation; Genotype; Haplotypes; HEK293 Cells; Homocysteine; Humans; Male; Middle Aged; Plasmids; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Risk Factors | 2014 |
Fatty acid status and its relationship to cognitive decline and homocysteine levels in the elderly.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cognition; Cognition Disorders; Dementia; Diet; Docosahexaenoic Acids; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Geriatric Assessment; Homocysteine; Humans; Lipids; Male; Memory; Nutritional Status; Risk Factors | 2014 |
Dietary patterns and cardiovascular risk factors in adolescents and young adults: the Northern Ireland Young Hearts Project.
Topics: Adolescent; Adult; Biomarkers; Blood Pressure; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Diet; Diet Records; Diet, Western; Feeding Behavior; Female; Health; Homocysteine; Humans; Male; Northern Ireland; Pulse Wave Analysis; Risk Factors; Triglycerides; Young Adult | 2014 |
Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis.
Topics: Adult; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Risk Assessment; Ultrasonography, Doppler | 2014 |
Subclinical hypothyroidism and cardiovascular risk.
Topics: Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Erythrocytes; Female; Fibrinogen; Healthy Volunteers; Homocysteine; Humans; Hypothyroidism; Immunoenzyme Techniques; Inflammation; Male; Middle Aged; Regression Analysis; Risk Factors; Thyrotropin; Viscosity | 2014 |
Comparative study of risk factors related to cardiovascular disease in children from Bogotá, Colombia and Toluca, Mexico.
Topics: Blood Glucose; Body Mass Index; Cardiovascular Diseases; Child; Colombia; Cross-Sectional Studies; Feeding Behavior; Female; Homocysteine; Humans; Lipids; Male; Mexico; Motor Activity; Obesity; Prospective Studies; Risk Factors | 2014 |
The association of homocysteine with metabolic syndrome in a community-dwelling population: homocysteine might be concomitant with metabolic syndrome.
Topics: Beijing; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypertension; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prospective Studies; Residence Characteristics; Risk Factors | 2014 |
Comparison of insulin resistance in the various stages of chronic kidney disease and inflammation.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; C-Reactive Protein; Cardiovascular Diseases; Female; Homocysteine; Humans; Inflammation; Insulin; Insulin Resistance; Kidney Function Tests; Male; Middle Aged; Renal Insufficiency, Chronic; Risk Factors; Statistics as Topic; Turkey | 2015 |
Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cystathionine beta-Synthase; Dietary Supplements; Fasting; Female; Folic Acid; Folic Acid Deficiency; Genotyping Techniques; Heterozygote; Homocysteine; Homocystinuria; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Prevalence; Risk Factors; Taiwan; Vitamin B 12 | 2015 |
Distribution and determinants of plasma homocysteine levels in rural Chinese twins across the lifespan.
Topics: Adolescent; Adult; Age Factors; Aged; Asian People; Cardiovascular Diseases; Child; China; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Homocysteine; Humans; Linear Models; Longevity; Male; Metabolic Syndrome; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Rural Population; Sex Factors; Smoking; Young Adult | 2014 |
Evaluation of plasma concentrations of homocysteine, IL-6, TNF-alpha, hs-CRP, and total antioxidant capacity in patients with end-stage renal failure.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Risk Factors; Tumor Necrosis Factor-alpha | 2014 |
Association Between Leukocyte Telomere Length and Plasma Homocysteine in a Singapore Chinese Population.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Leukocytes; Male; Middle Aged; Prognosis; Risk Factors; Singapore; Telomere; Telomere Homeostasis | 2015 |
Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study.
Topics: Adult; Belgium; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Diet; Diet Surveys; Female; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Risk Factors; Up-Regulation | 2015 |
Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Lipids; Macular Degeneration; Male; Middle Aged; Ranibizumab; Risk Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
Homocysteine influences blood clot properties alone and in combination with total fibrinogen but not with fibrinogen γ' in Africans.
Topics: Black People; Blood Coagulation; Cardiovascular Diseases; Cross-Sectional Studies; Fibrin Clot Lysis Time; Fibrinogen; Fibrinogens, Abnormal; Genotype; Hemostasis; Homocysteine; Humans; Polymorphism, Single Nucleotide; Risk Factors | 2015 |
Dysfunction of blood pressure regulation in hyperhomocyteinemia model in rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cardiovascular Diseases; Disease Models, Animal; Elastic Tissue; Epinephrine; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Oxidation-Reduction; Rats, Sprague-Dawley; Risk Factors; Thiobarbiturates | 2015 |
Assessment of the body composition and parameters of the cardiovascular risk in juvenile idiopathic arthritis.
Topics: Adipose Tissue; Adolescent; Arthritis, Juvenile; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Carotid Intima-Media Thickness; Case-Control Studies; Female; Homocysteine; Humans; Interleukin-6; Lipids; Male; Risk; Risk Factors | 2015 |
Multimarker Analysis for New Biomarkers in Relation to Central Arterial Stiffness and Hemodynamics in a Chinese Community-Dwelling Population.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; China; Cholesterol, HDL; Female; Hemodynamics; Homocysteine; Humans; Independent Living; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Pulse Wave Analysis; Risk Factors; Triglycerides; Vascular Stiffness; Young Adult | 2015 |
Association of clearance of middle- and large-molecular-weight substance with arterial stiffness and left ventricular mass in children receiving renal replacement therapy.
Topics: Adolescent; beta 2-Microglobulin; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Child; Child, Preschool; Female; Heart Ventricles; Homocysteine; Humans; Kidney Failure, Chronic; Male; Molecular Weight; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Risk Factors; Time Factors; Toxins, Biological; Vascular Stiffness | 2017 |
Fitting homocysteine to disease models, as well as adjusting the models to the disease.
Topics: Animals; Cardiovascular Diseases; Disease Models, Animal; Folic Acid; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Oxidative Stress; Risk Factors; Signal Transduction; Vitamin B 12 | 2015 |
Short Sleep Duration Is Related to Emerging Cardiovascular Risk Factors in Obese Children.
Topics: Adipokines; Adolescent; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Homocysteine; Humans; Insulin; Male; Metabolic Syndrome; Obesity, Abdominal; Pediatric Obesity; Retinol-Binding Proteins, Plasma; Risk Factors; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Thyrotropin | 2015 |
[Prognostic value of serum homocysteine levels in elderly hospitalized patients].
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Comorbidity; Female; Homocysteine; Hospitalization; Humans; Inpatients; Kaplan-Meier Estimate; Male; Middle Aged; Nutritional Status; Prognosis; Prospective Studies; Risk Factors | 2015 |
Pyridoxal-5'-phosphate deficiency is associated with hyperhomocysteinemia regardless of antioxidant, thiamine, riboflavin, cobalamine, and folate status in critically ill patients.
Topics: Adult; APACHE; Biomarkers; Cardiovascular Diseases; Critical Illness; Female; Homocysteine; Humans; Hyperhomocysteinemia; Intensive Care Units; Male; Middle Aged; Nutritional Status; Oxidative Stress; Prevalence; Prospective Studies; Pyridoxal Phosphate; Risk; Spain; Vitamin B 6 Deficiency | 2016 |
Association of Vitamin B12 Deficiency with Homozygosity of the TT MTHFR C677T Genotype, Hyperhomocysteinemia, and Endothelial Cell Dysfunction.
Topics: Adult; Cardiovascular Diseases; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Physical Endurance; Polymorphism, Genetic; Prospective Studies; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency; Vitamins | 2015 |
Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.
Topics: Asian People; Cardiovascular Diseases; Cholesterol, HDL; Female; Hemodynamics; Homocysteine; Humans; Independent Living; Male; Triglycerides; Vascular Stiffness | 2015 |
Smoking and Arterial Stiffness.
Topics: Asian People; Cardiovascular Diseases; Cholesterol, HDL; Female; Hemodynamics; Homocysteine; Humans; Independent Living; Male; Triglycerides; Vascular Stiffness | 2015 |
Erythrocyte fatty acid profiles and plasma homocysteine, folate and vitamin B6 and B12 in recurrent depression: Implications for co-morbidity with cardiovascular disease.
Topics: Adult; Cardiovascular Diseases; Comorbidity; Depressive Disorder, Major; Erythrocytes; Fatty Acids; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Oxidative Stress; Recurrence; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2015 |
MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3.
Topics: Apoptosis; Cardiovascular Diseases; Caspase 3; Cell Line; Coronary Vessels; Endothelial Cells; Gene Expression Regulation; Homocysteine; Humans; MicroRNAs | 2015 |
[A nested case-control study on the relationship of three kinds of cytokines and risk of cardio-cerebrovascular events among Inner Mongolians].
Topics: Cardiovascular Diseases; Case-Control Studies; Cytokines; Homocysteine; Humans; Hypertension; Intercellular Adhesion Molecule-1; Logistic Models; Prevalence; Risk; Risk Factors; Stroke; von Willebrand Factor | 2015 |
Influence of MTHFR polymorphisms on cardiovascular risk markers in elite athletes.
Topics: Advanced Oxidation Protein Products; Aryldialkylphosphatase; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Sports | 2016 |
Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Atherosclerosis; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Triglycerides | 2015 |
Association of homocysteine level and vascular burden and cognitive function in middle-aged and older adults with chronic kidney disease.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Cognition; Cognition Disorders; Cognitive Dysfunction; Executive Function; Female; Homocysteine; Humans; Male; Middle Aged; Neuropsychological Tests; Renal Insufficiency, Chronic; Risk Factors; Vascular Diseases | 2016 |
Association of exposure to particulate matter (PM2.5) air pollution and biomarkers of cardiovascular disease risk in adult NHANES participants (2001-2008).
Topics: Adult; Air Pollutants; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Environmental Exposure; Female; Fibrinogen; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nutrition Surveys; Ozone; Particulate Matter; Risk Factors; United States; Young Adult | 2016 |
Serum folate levels and fatality among diabetic adults: A 15-y follow-up study of a national cohort.
Topics: Aged; Cardiovascular Diseases; Cotinine; Diabetes Mellitus; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Neoplasms; Nutrition Surveys; Proportional Hazards Models; Retrospective Studies; Risk Factors; Socioeconomic Factors; Vitamin B 12 | 2016 |
Positive Association of Plasma Homocysteine Levels with Cardio-Ankle Vascular Index in a Prospective Study of Japanese Men from the General Population.
Topics: Ankle; Atherosclerosis; Biomarkers; Blood Pressure; Cardiovascular Diseases; Female; Genotype; Homocysteine; Humans; Japan; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Prospective Studies; Risk Factors; Vascular Stiffness | 2016 |
Prognostic Value of Cardiovascular Disease Risk Factors Measured in the First-Trimester on the Severity of Preeclampsia.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Fetal Growth Retardation; Homocysteine; Humans; Pre-Eclampsia; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Risk Factors; ROC Curve; Severity of Illness Index | 2016 |
Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure.
Topics: Adult; Biomarkers; Blood Glucose; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Continuous Positive Airway Pressure; Glucose Tolerance Test; Glycated Hemoglobin; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Fragments; Polysomnography; Proinsulin; Risk Factors; Sleep Apnea, Obstructive; Treatment Outcome; Triglycerides | 2016 |
Folic Acid and Vitamins D and B12 Correlate With Homocysteine in Chinese Patients With Type-2 Diabetes Mellitus, Hypertension, or Cardiovascular Disease.
Topics: Aged; Aged, 80 and over; Asian People; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Hypertension; Male; Vitamin B 12; Vitamin D | 2016 |
Single and combined associations of accelerometer-assessed physical activity and muscle-strengthening activities on plasma homocysteine in a national sample.
Topics: Actigraphy; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Down-Regulation; Exercise; Female; Fitness Trackers; Homocysteine; Humans; Male; Middle Aged; Muscle Contraction; Muscle Strength; Muscle, Skeletal; Nutrition Surveys; Protective Factors; Resistance Training; Risk Factors; Surveys and Questionnaires; Time Factors; United States | 2017 |
Long-term prognostic significance of homocysteine in middle-aged and elderly.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Disease-Free Survival; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Factors | 2016 |
Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Carotid Intima-Media Thickness; Case-Control Studies; Endothelium; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Pulse Wave Analysis; Risk Factors; Tissue Plasminogen Activator | 2016 |
Homocysteine Levels and Arterial Stiffness in the General Population.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Vascular Stiffness | 2016 |
Comparative case-control study of homocysteine, vitamin B
Topics: Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Case-Control Studies; Epilepsy; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Vitamin B 12 | 2017 |
Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
Topics: Adolescent; Biomarkers; Blood Glucose; Blood Pressure; Body Weight; Brazil; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Logistic Models; Male; Metabolic Syndrome; Overweight; Risk Factors; Socioeconomic Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment.
Topics: Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Male; Warfarin | 2016 |
Association of serum calcium concentrations with fibrinogen and homocysteine in nondiabetic Korean subjects.
Topics: Biomarkers; Calcium; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up Studies; Healthy Volunteers; Homocysteine; Humans; Incidence; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Odds Ratio; Republic of Korea; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors | 2016 |
Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk.
Topics: Adult; Animals; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; C-Reactive Protein; Carboxylic Ester Hydrolases; Cardiovascular Diseases; Dietary Fats; Fatty Acids, Omega-3; Feeding Behavior; Homocysteine; Humans; Lipoprotein(a); Lipoproteins, LDL; Male; Middle Aged; Red Meat; Risk Factors; Swine; Tumor Necrosis Factor-alpha; Volunteers | 2016 |
The Effect of Serum 25-Hydroxyvitamin D on Elevated Homocysteine Concentrations in Participants of a Preventive Health Program.
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Supplements; Female; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Nutrition Surveys; Preventive Health Services; Primary Prevention; Risk Factors; Vitamin D; Vitamin D Deficiency | 2016 |
Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group.
Topics: Biomarkers; Cardiovascular Diseases; Cholesterol, HDL; Clinical Decision-Making; Homocysteine; Humans; Models, Statistical; Practice Guidelines as Topic; Predictive Value of Tests; Risk Assessment; Women's Health | 2016 |
Cardiovascular Diseases Risk Prediction by Homocysteine in Comparison to other Markers: A Study from Madhya Pradesh.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Glycated Hemoglobin; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Risk Assessment; Sensitivity and Specificity | 2015 |
Disturbed nitric oxide and homocysteine production are involved in the increased risk of cardiovascular diseases in the F1 offspring of maternal obesity and malnutrition.
Topics: Animals; Animals, Newborn; Cardiovascular Diseases; Female; Homocysteine; Malnutrition; Nitric Oxide; Obesity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar | 2017 |
Testing for homocysteine in clinical practice.
Topics: Alzheimer Disease; Blood Chemical Analysis; Cardiovascular Diseases; Cognition Disorders; Delivery of Health Care; Homocysteine; Humans; Hyperhomocysteinemia; Practice Patterns, Physicians' | 2017 |
Relationship of oxidative stress with elevated level of DNA damage and homocysteine in cardiovascular disease patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Deoxyguanosine; DNA Damage; Female; Homocysteine; Humans; Lipids; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Up-Regulation | 2016 |
The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cotinine; Cross-Sectional Studies; Cytokines; Early Diagnosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Linear Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Risk Assessment; Risk Factors; Smoking; Troponin T; United States; Vascular Stiffness; Vasodilation | 2017 |
Factors influencing cardiometabolic risk profile in patients with psoriasis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Body Surface Area; Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitus; Female; Homocysteine; Humans; Insulin Resistance; Male; Menopause; Metabolic Syndrome; Middle Aged; Prevalence; Prospective Studies; Psoriasis; Risk Factors; Severity of Illness Index; Smoking; Spain; Waist Circumference; Young Adult | 2018 |
Association of Pseudoexfoliation With Systemic Vascular Diseases in a South Indian Population.
Topics: Aged; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cataract Extraction; Cholesterol; Cross-Sectional Studies; Electrocardiography; Exfoliation Syndrome; Female; Homocysteine; Humans; Hypertension; India; Male; Middle Aged; Prospective Studies; Risk Factors | 2017 |
Biomarkers of cardiovascular and metabolic diseases in otherwise healthy overweight subjects in Bangladesh.
Topics: Adult; Bangladesh; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Metabolic Diseases; Middle Aged; Overweight; Triglycerides | 2017 |
Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
Topics: Aged; Arginine; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Peroxidase; Renal Dialysis; Risk Factors | 2008 |
Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Confidence Intervals; Female; Fibrinogen; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Ohio; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate | 2008 |
Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
Topics: C-Reactive Protein; Cardiovascular Diseases; Creatinine; Female; Follow-Up Studies; Homocysteine; Humans; Inflammation; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Malnutrition; Middle Aged; Nutritional Status; Prospective Studies; Renal Dialysis; Risk Factors; Serum Albumin; Treatment Outcome | 2008 |
Homocysteinemia in hypertensive patients with renal target organ damage (mild renal dysfunction).
Topics: Adult; Aged; Cardiovascular Diseases; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged | 2008 |
Improved and simplified LC-ESI-MS/MS method for homocysteine determination in human plasma: application to the study of cardiovascular diseases.
Topics: Adult; Calibration; Cardiovascular Diseases; Chromatography, Liquid; Female; Homocysteine; Humans; Male; Middle Aged; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2008 |
Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chronic Disease; Female; Homocysteine; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Predictive Value of Tests; S-Adenosylhomocysteine; S-Adenosylmethionine; Sensitivity and Specificity; Severity of Illness Index | 2008 |
[Asymmetric dimethil-arginine (ADMA) as a link between insulin resistance and atherosclerosis].
Topics: Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Carotid Stenosis; Chromatography; Enzyme Inhibitors; Female; Homocysteine; Humans; Insulin Resistance; Linear Models; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography, Doppler, Color | 2008 |
Plasma total homocysteine: instigator or indicator of cardiovascular disease?
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Inflammation; Risk Factors | 2008 |
[Assessment of plasma homocysteine levels in shift healthcare workers].
Topics: Adult; Alanine Transaminase; Biomarkers; Body Weight; Cardiovascular Diseases; Homocysteine; Humans; Mass Screening; Nurses; Occupational Diseases; Occupational Exposure; Risk Factors; Systole; Time Factors; Work Schedule Tolerance | 2008 |
Homocysteine levels, paraoxonase 1 (PON1) activity, and cardiovascular risk.
Topics: Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cardiovascular Diseases; Homocysteine; Humans; Oxidative Stress; Risk Assessment; Risk Factors | 2008 |
A priori-defined dietary patterns and markers of cardiovascular disease risk in the Multi-Ethnic Study of Atherosclerosis (MESA).
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biomarkers; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Diet; Diet Surveys; Ethnicity; Factor Analysis, Statistical; Feeding Behavior; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Linear Models; Male; Middle Aged; Nutrition Assessment; Risk Factors; Surveys and Questionnaires; Tunica Intima; United States | 2008 |
[Cardiovascular risk markers in schoolchildren from five provinces of eastern Colombia].
Topics: Adolescent; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Child, Preschool; Colombia; Female; Homocysteine; Humans; Lipids; Male; Public Health; Risk Factors | 2008 |
Endothelial dysfunction and reduced antioxidant protection in an animal model of the developmental origins of cardiovascular disease.
Topics: Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Diet, Protein-Restricted; Endothelium, Vascular; Female; Gene Expression Regulation, Developmental; Guanylate Cyclase; Hemodynamics; Homocysteine; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Organ Size; Pregnancy; Protein Carbonylation; Rats; Rats, Wistar; RNA, Messenger; Sex Characteristics; Weight Gain | 2008 |
Cardiovascular disease--the silent killer in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Coronary Artery Disease; Endothelium, Vascular; Homocysteine; Humans; Leptin | 2008 |
Homocysteine enhances LDL fatty acid peroxidation, promoting microalbuminuria in type 2 diabetes.
Topics: Aged; Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fatty Acids; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Middle Aged; Oxidants; Peroxides; Risk Factors; Thiobarbituric Acid Reactive Substances | 2008 |
Homocysteine is not so paradoxical.
Topics: Animals; Cardiovascular Diseases; Copper; Dietary Supplements; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B Complex | 2008 |
Effect of folic acid and B vitamins on cardiovascular disease in women.
Topics: Adult; Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Vitamin B Complex | 2008 |
Using brachial-ankle pulse wave velocity to associate arterial stiffness with cardiovascular risks.
Topics: Adult; Age Factors; Aged; Ankle; Atherosclerosis; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Elasticity; Female; Heart Rate; Homocysteine; Humans; Lipoproteins, HDL; Logistic Models; Male; Middle Aged; Odds Ratio; Pulsatile Flow; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan | 2009 |
Serum homocysteine: relationship with circulating levels of cortisol and ascorbate.
Topics: Aging; Ascorbic Acid; Cardiovascular Diseases; Female; Folic Acid; Health Status; Homocysteine; Humans; Hydrocortisone; Linear Models; Male; Middle Aged; Nutritional Status; Risk Factors | 2008 |
Association of recreational physical activity with homocysteine, folate and lipid markers in young women.
Topics: Adolescent; Adult; Biomarkers; Cardiovascular Diseases; Exercise; Female; Folic Acid; Homocysteine; Humans; Lipids; Motor Activity; Recreation; Risk Factors | 2009 |
Nitrous oxide and postoperative cardiovascular morbidity.
Topics: Anesthetics, Inhalation; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Folic Acid; Homocysteine; Humans; Nitrous Oxide; Postoperative Complications | 2008 |
Oxidative damage indices for the assessment of subclinical diabetic macrovascular complications.
Topics: Aged; Antioxidants; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Fibrin Fibrinogen Degradation Products; Glutathione; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Oxidative Stress; Retrospective Studies | 2008 |
The value of lipoprotein (a), homocysteine, and Doppler of carotid and femoral arteries in assessment of atherosclerosis in asymptomatic cardiovascular risk patients.
Topics: Age Factors; Albuminuria; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Diabetes Complications; Femoral Artery; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Lipoprotein(a); Middle Aged; Obesity; Risk Factors; Smoking; Ultrasonography, Doppler, Color | 2008 |
Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus.
Topics: Adult; Autoantibodies; Biomarkers; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Female; Fibrinolysis; Heart Rate; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Oxidative Stress; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Risk Factors; Triglycerides; Up-Regulation | 2009 |
Fasting total homocysteine (tHcy) concentration and mortality in older Mexican Americans.
Topics: Aged; Aged, 80 and over; Biomarkers; California; Cardiovascular Diseases; Female; Homocysteine; Humans; Longitudinal Studies; Male; Mexican Americans; Mexico; Middle Aged; Proportional Hazards Models | 2008 |
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Dyslipidemias; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Homocysteine; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Optic Neuropathy, Ischemic; Risk Factors; Thrombophilia; Vitamin B 12; Vitamin B 6 | 2009 |
Chronic plaque psoriasis is associated with increased arterial stiffness.
Topics: Adult; Arteries; Atherosclerosis; Biomarkers; Blood Flow Velocity; Blood Pressure Determination; Cardiovascular Diseases; Carotid Arteries; Cholesterol; Chronic Disease; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypertension; Italy; Male; Middle Aged; Prevalence; Psoriasis; Pulsatile Flow; Risk Factors; Triglycerides; Vascular Resistance | 2009 |
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease.
Topics: Adult; Anthropometry; Antiretroviral Therapy, Highly Active; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolic Syndrome; Predictive Value of Tests; Prospective Studies; Risk Assessment | 2009 |
Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Homocysteine; Humans; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Risk Factors; Troponin T; Young Adult | 2008 |
Predictors for cardiovascular morbidity and overall mortality in Tunisian ESRD patients: a six year prospective study.
Topics: Adolescent; Adult; Aged; Albumins; Black People; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Female; Hemoglobins; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Proportional Hazards Models; Prospective Studies; Tunisia; Young Adult | 2009 |
Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Syndrome | 2010 |
[Novel risk factors for cardiovascular disease and tobacco smoke].
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Causality; Comorbidity; Environmental Monitoring; Epidemiological Monitoring; Fibrinogen; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking; Tobacco Smoke Pollution | 2008 |
Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
Topics: Adult; Aryldialkylphosphatase; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Multivariate Analysis; Radioimmunoassay; Triglycerides; Tunisia; Vitamin B 12 | 2009 |
Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events.
Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk; Survival Analysis; Survival Rate; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Homocysteine: turns out not to B so simple.
Topics: Cardiovascular Diseases; Homocysteine; Humans | 2006 |
Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Chronic Disease; Dementia; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastritis; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Risk Factors; Sweden | 2010 |
Homocysteine increases the risk associated with hyperlipidaemia.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Europe; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipids; Logistic Models; Male; Middle Aged; Odds Ratio; Pilot Projects; Risk Assessment; Risk Factors; Triglycerides; Up-Regulation | 2009 |
Serum homocysteine level in patients with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Methotrexate; Middle Aged; Severity of Illness Index; Spondylitis, Ankylosing; Sulfasalazine | 2009 |
Relation of plasma homocysteine to arterial stiffness in black and white young adults (from the Bogalusa Heart Study).
Topics: Adult; Aorta, Abdominal; Black People; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Echocardiography, Doppler; Female; Femoral Artery; Fluorescence Polarization Immunoassay; Follow-Up Studies; Homocysteine; Humans; Louisiana; Male; Prognosis; Reference Values; Retrospective Studies; Risk Factors; Vascular Resistance; White People; Young Adult | 2009 |
The relation between coronary lesion distribution and risk factors in young adults.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipoprotein(a); Logistic Models; Male; Risk Factors; ROC Curve; Smoking | 2009 |
Vitamin B-12 and homocysteine status among vegetarians: a global perspective.
Topics: Anemia, Pernicious; Atherosclerosis; Cardiovascular Diseases; Diet, Vegetarian; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2009 |
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Collagen; Collagen Type III; Cross-Sectional Studies; Data Collection; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Homocysteine; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Middle Aged; Natriuretic Peptide, Brain; Plasminogen Activator Inhibitor 1; Protein Precursors; Renin; Renin-Angiotensin System; Tissue Inhibitor of Metalloproteinase-1; Ventricular Remodeling | 2009 |
Serum homocysteine in Indian adolescents.
Topics: Adolescent; Age Factors; Cardiovascular Diseases; Child; Cross-Sectional Studies; Diet; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; India; Logistic Models; Male; Mass Screening; Odds Ratio; Probability; Risk Assessment; Sex Factors; Young Adult | 2009 |
Association between cholesterols, homocysteine and silent brain infarcts.
Topics: Adult; Aged; Aged, 80 and over; Blood Chemical Analysis; Brain Infarction; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Lipoproteins, LDL; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Sex Factors; Vitamin B 12; Young Adult | 2009 |
Cardiorespiratory fitness and plasma homocysteine levels in adult males and females.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Exercise Test; Exercise Tolerance; Female; Health Surveys; Homocysteine; Humans; Male; Middle Aged; Oxygen Consumption; Physical Fitness; Predictive Value of Tests; Risk Factors | 2009 |
Family history of premature cardiovascular disease as a sole and independent risk factor for increased carotid intima-media thickness.
Topics: Cardiovascular Diseases; Carotid Arteries; Child; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Insulin Resistance; Linear Models; Lipids; Male; Oxidative Stress; Risk Factors; Sample Size; Tunica Intima; Tunica Media | 2009 |
Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Apolipoproteins A; Blood Glucose; Cardiovascular Diseases; Cholesterol; Data Collection; Female; Homocysteine; Humans; Italy; Lipase; Lipoprotein(a); Male; Middle Aged; Prevalence; Risk Factors; Sex Distribution; Smoking; Uric Acid; Young Adult | 2009 |
Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort.
Topics: Age Factors; Aged; Arginine; Cardiovascular Diseases; Chromatography, Liquid; Cohort Studies; Female; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Reference Standards; Sensitivity and Specificity; Sex Factors; Tandem Mass Spectrometry | 2009 |
Folic acid supplementation and cardiovascular disease: the state of the art.
Topics: Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic | 2009 |
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study.
Topics: Aging; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Insulin; Middle Aged; Postmenopause; Vitamin B Complex | 2009 |
Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Cardiovascular Diseases; Cross-Sectional Studies; Eating; Female; Folic Acid; Heptanoic Acids; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Lipoprotein(a); Lovastatin; Male; Middle Aged; Pyrroles; Renal Dialysis; Risk Factors; Vitamin B 6; Vitamin B Complex; Young Adult | 2009 |
The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Pulse; Risk Factors; Young Adult | 2010 |
Changes in lifestyle, biological risk factors and total homocysteine in relation to MTHFR C677T genotype: a 5-year follow-up study.
Topics: Adult; Alcohol Drinking; Beer; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Coffee; Cross-Sectional Studies; Denmark; Feeding Behavior; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Life Style; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Smoking; Tea; Waist Circumference | 2009 |
Dietary patterns and cardiovascular risk markers in the UK Low Income Diet and Nutrition Survey.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Diet; Factor Analysis, Statistical; Fast Foods; Feeding Behavior; Female; Health Behavior; Homocysteine; Humans; Linear Models; Male; Middle Aged; Nutrition Surveys; Nutritional Status; Poverty; Risk Assessment; Risk Factors; Triglycerides; United Kingdom | 2010 |
[Homocysteine as health risk: who is affected?].
Topics: Cardiovascular Diseases; Child; Child, Preschool; Homocysteine; Humans; Hyperhomocysteinemia; Infant; Reference Values; Risk Factors | 2009 |
Increases in plasma holotranscobalamin can be used to assess vitamin B-12 absorption in individuals with low plasma vitamin B-12.
Topics: Adult; Body Height; Body Weight; Cardiovascular Diseases; Child; Diabetes Mellitus, Type 2; Fathers; Female; Folic Acid; Hemoglobins; Homocysteine; Humans; Intestinal Absorption; Male; Maternal Nutritional Physiological Phenomena; Mother-Child Relations; Transcobalamins; Vitamin B 12; Vitamin B 12 Deficiency | 2009 |
The metabolic syndrome is not associated with homocysteinemia: the Persian Gulf Healthy Heart Study.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Indian Ocean; Iran; Male; Metabolic Syndrome; Middle Aged; Prevalence; Risk Factors | 2009 |
Elevated homocysteine is a predictor of all-cause mortality in a prospective cohort of renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Female; Homocysteine; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Period; Predictive Value of Tests; Risk Assessment; Survival Analysis | 2010 |
Increased plasma endothelin level as an endothelial marker of cardiovascular risk in patients with active acromegaly: a comparison with plasma homocysteine.
Topics: Aged; Biomarkers; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cholesterol; Endothelin-1; Endothelium, Vascular; Female; Homocysteine; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Risk Assessment; Triglycerides | 2009 |
Observational study on markers of cardiovascular risk in renal patient: conventional hemodialysis vs. haemofiltration online.
Topics: Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Cross-Sectional Studies; Female; Folic Acid; Hemodiafiltration; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Obesity; Online Systems; Renal Dialysis; Risk Assessment; Risk Factors; Treatment Outcome; Vitamin B 12 | 2009 |
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.
Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome | 2010 |
Novel cardiac markers.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Causality; Homocysteine; Humans; Lipoprotein(a); Mass Screening; Nurse Practitioners; Patient Selection; Predictive Value of Tests; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; United States | 2009 |
Effects of cyclosporine-tacrolimus switching in posttransplantation hyperlipidemia on high-density lipoprotein 2/3, lipoprotein a1/b, and other lipid parameters.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cyclosporine; Female; Homocysteine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoprotein(a); Lipoproteins, HDL; Male; Patient Selection; Postoperative Complications; Tacrolimus; Treatment Outcome; Triglycerides; Young Adult | 2009 |
Homocysteine thiolactone induces cardiac dysfunction: role of oxidative stress.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Male; Oxidative Stress; Rats; Rats, Wistar | 2010 |
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Peritoneal Dialysis; Renal Dialysis; Risk Assessment; Risk Factors; Serum Albumin; Uremia | 2010 |
Gene polymorphisms in association with emerging cardiovascular risk markers in adult women.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Demography; Female; Fibrinogen; Genotype; Homocysteine; Humans; Linear Models; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Uric Acid | 2010 |
Homocystamides promote free-radical and oxidative damage to proteins.
Topics: Alzheimer Disease; Cardiovascular Diseases; Congenital Abnormalities; Free Radicals; Homocysteine; Humans; Hydrogen Bonding; Kinetics; Lysine; Osteoporosis; Oxidative Stress; Protein Processing, Post-Translational; Renal Insufficiency; Serum Albumin | 2010 |
Homocysteine and pro-inflammatory cytokine concentrations in acute heart disease.
Topics: Cardiovascular Diseases; Case-Control Studies; Demography; Folic Acid; Homocysteine; Humans; Inflammation; Interleukin-2; Interleukin-6; Middle Aged; ROC Curve; Vitamin B 12 | 2010 |
Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults.
Topics: Carbamoyl-Phosphate Synthase (Ammonia); Cardiovascular Diseases; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genome-Wide Association Study; Health Surveys; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mothers; Nutrition Surveys; Philippines; Polymorphism, Single Nucleotide; Quantitative Trait Loci; Reproducibility of Results; Young Adult | 2010 |
Are dietary choline and betaine intakes determinants of total homocysteine concentration?
Topics: Betaine; Cardiovascular Diseases; Choline; Cognition Disorders; Diet; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Vitamin B 12; Vitamin B 6 | 2010 |
Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice.
Topics: Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; Connexins; Diet; Disease Models, Animal; Echocardiography; Heart Ventricles; Homocysteine; Hyperhomocysteinemia; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neural Conduction; Random Allocation; Telemetry; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate.
Topics: Adult; Aged; Boston; Cardiovascular Diseases; Cognition Disorders; DNA Damage; Female; Folic Acid; Genetic Variation; Genotype; Homocysteine; Humans; Hypertension; Life Style; Male; Memory; Methionine Adenosyltransferase; Middle Aged; Puerto Rico; Stroke; Vitamin B 6 | 2010 |
Homocysteine: to measure or not to measure? Focus on "functional NMDA receptors in rat erythrocytes".
Topics: Animals; Calcium; Cardiovascular Diseases; Cell Shape; Cell Size; Erythrocytes; Homocysteine; Humans; Hyperhomocysteinemia; Intermediate-Conductance Calcium-Activated Potassium Channels; Kinetics; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidation-Reduction; Rats; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Superoxides | 2010 |
Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy.
Topics: Age Factors; Angioplasty; Animals; Anticoagulants; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolysin; Heart-Assist Devices; Hemorrhage; Homocysteine; Humans; Inflammation; Peptide Fragments; Risk Factors; Thrombosis | 2010 |
Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Fibrinogen; Homocysteine; Humans; Incidence; Leukocyte Count; Lipoproteins; Male; Middle Aged; Platelet Count; Prognosis; Reference Values; Retrospective Studies; Risk Assessment; Risk Factors; United States | 2010 |
Homocysteine--what does it mean and have we been led astray?
Topics: Biomarkers; Cardiovascular Diseases; Homocysteine; Homocystinuria; Humans; Risk Factors | 2010 |
[Homocysteine as a residual risk factor in cardiovascular diseases].
Topics: Biomarkers; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B 12; Vitamin B 6 | 2010 |
Reduced kidney function estimated by cystatin C and clinical outcomes in hypertensive patients with coronary artery disease: association with homocysteine and other cardiovascular risk factors.
Topics: Aged; Cardiovascular Diseases; Coronary Artery Disease; Cystatin C; Female; Homocysteine; Humans; Hypertension; Kidney; Male; Middle Aged; Risk Factors; Treatment Outcome | 2010 |
[Homocysteine and von Willebrand factor in chronic alcoholism].
Topics: Adult; Alcoholism; Cardiovascular Diseases; Homocysteine; Humans; Male; Risk Factors; von Willebrand Factor | 2010 |
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?
Topics: Cardiovascular Diseases; Drug Therapy, Combination; Everolimus; Female; Homocysteine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Postoperative Complications; Sirolimus | 2010 |
Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Psoriasis; Risk Factors; Severity of Illness Index; Vitamin B 12 | 2011 |
Serum adiponectin is associated with homocysteine in elderly men and women, and with 5,10-methylenetetrahydrofolate reductase (MTHFR) in a sex-dependent manner.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adiponectin; Aged; Biomarkers; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Sex Factors | 2010 |
Cardiovascular disease and CKD: core curriculum 2010.
Topics: Acute Coronary Syndrome; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiac Catheterization; Cardiovascular Diseases; Cholesterol, LDL; Comorbidity; Diabetic Nephropathies; Dyslipidemias; Electrocardiography; Heart Failure; Heart Valve Diseases; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Life Style; Myocardial Ischemia; Oxidative Stress; Pericarditis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Smoking; Troponin T | 2010 |
Effect of Ocimum sanctum on homocysteine levels and lipid profile in healthy rabbits.
Topics: Administration, Oral; Animal Feed; Animals; Blood Glucose; Cardiotonic Agents; Cardiovascular Diseases; Dyslipidemias; Female; Homocysteine; Hyperhomocysteinemia; Lipid Metabolism; Lipoproteins; Male; Ocimum; Plant Leaves; Rabbits; Triglycerides | 2011 |
Comparison of the effects of surgical and natural menopause on carotid intima media thickness, osteoporosis, and homocysteine levels.
Topics: Aged; Bone Density; Cardiovascular Diseases; Carotid Arteries; Female; Homocysteine; Humans; Hysterectomy; Linear Models; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Ovariectomy; Postmenopause; Radiography; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2011 |
A view at the future--a dynamical, protocol-based and computationally intensive approach in cardiovascular risk assessment.
Topics: Algorithms; Blood Cell Count; Blood Chemical Analysis; Cardiovascular Diseases; Cholesterol; Diabetes Complications; Forecasting; Glycated Hemoglobin; Health Status; Homocysteine; Humans; Hypertension; Life Style; Risk Assessment; Triglycerides; Urologic Diseases | 2010 |
Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance.
Topics: Adolescent; Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Carotid Stenosis; Case-Control Studies; Female; Homocysteine; Humans; Insulin Resistance; Ischemia; Polycystic Ovary Syndrome; Risk Factors; Serum Albumin; Young Adult | 2011 |
Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease.
Topics: Aged; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Chronic Disease; Dyslipidemias; Female; Homocysteine; Humans; Kidney Diseases; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Proteinuria; Risk Factors | 2010 |
Therapy: Vitamin B6, B9 and B12 in diabetic nephropathy--beware.
Topics: Cardiovascular Diseases; Diabetic Nephropathies; Disease Progression; Down-Regulation; Folic Acid; Homocysteine; Humans; Randomized Controlled Trials as Topic; Vitamin B 12; Vitamin B 6; Vitamins | 2010 |
The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians.
Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hypertension; Indians, North American; Male; Middle Aged; Oklahoma; Risk Factors; Statistics, Nonparametric; White People | 2011 |
Hyperhomocysteinemia and cardiovascular risks in hemodialysis patients.
Topics: Adult; Aortic Valve Insufficiency; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Echocardiography, Doppler; Echocardiography, Doppler, Color; Female; Homocysteine; Humans; Hyperhomocysteinemia; Iran; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Renal Dialysis; Risk Assessment; Risk Factors; Stroke Volume; Up-Regulation; Ventricular Function, Left | 2010 |
The vital amines: too much of a good thing?: comment on "Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality".
Topics: Cardiovascular Diseases; Cause of Death; Folic Acid; Homocysteine; Humans; Neoplasms; Randomized Controlled Trials as Topic; Stroke; Vitamin B Complex | 2010 |
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study.
Topics: Aged; Aging; Alzheimer Disease; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Dementia; Female; Folic Acid; Homocysteine; Humans; Longitudinal Studies; Male; Mental Status Schedule; Odds Ratio; Risk Factors; Transcobalamins | 2010 |
Prevention: B vitamins and CVD--failure to find a simple solution.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12; Vitamin B Complex | 2010 |
Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease.
Topics: Adult; Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hypertension; Male | 2011 |
Effect of antioxidant vitamins on the plasma homocysteine level in a free-living elderly population.
Topics: Aged; Aging; Antioxidants; Ascorbic Acid; beta Carotene; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Germany; Glomerular Filtration Rate; Homocysteine; Humans; Longitudinal Studies; Male; Vitamin E; Vitamins | 2010 |
Cystatin C, cardiometabolic risk, and body composition in severely obese children.
Topics: Adolescent; Alanine Transaminase; Analysis of Variance; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Chi-Square Distribution; Child; Cholesterol, HDL; Cystatin C; Female; Glomerular Filtration Rate; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Obesity; Risk Factors; Triglycerides; Uric Acid | 2011 |
Aqueous normal phase chromatography improves quantification and qualification of homocysteine, cysteine and methionine by liquid chromatography-tandem mass spectrometry.
Topics: Cardiovascular Diseases; Chromatography, Liquid; Cysteine; Homocysteine; Humans; Hydrophobic and Hydrophilic Interactions; Immunoassay; Linear Models; Methionine; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2011 |
Folate, vitamin B₁₂ and total homocysteine levels in Arab adolescent subjects: reference ranges and potential determinants.
Topics: Adolescent; Age Factors; Arabs; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Diet; Female; Folic Acid; Homocysteine; Humans; Kuwait; Logistic Models; Male; Motor Activity; Reference Values; Risk Factors; Sex Factors; Socioeconomic Factors; Vitamin B 12; Vitamin B Complex; Young Adult | 2012 |
The relationship between diet and subclinical atherosclerosis: results from the Asklepios Study.
Topics: Adult; Atherosclerosis; Belgium; Blood Pressure; Cardiovascular Diseases; Carotid Artery Diseases; Diet; Female; Femoral Artery; Homocysteine; Humans; Inflammation; Lipids; Male; Middle Aged; Nutrition Policy; Risk Factors; Sex Factors; Surveys and Questionnaires; Ultrasonography; Waist-Hip Ratio | 2011 |
Methylenetetrahydrofolate reductase variants associated with hypertension and cardiovascular disease interact with dietary polyunsaturated fatty acids to modulate plasma homocysteine in puerto rican adults.
Topics: Adult; Aged; Cardiovascular Diseases; Dietary Fats; Fatty Acids, Unsaturated; Female; Genotype; Homocysteine; Humans; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide | 2011 |
Association of haptoglobin genotype and common cardiovascular risk factors with the amount of iron in atherosclerotic carotid plaques.
Topics: Aged; Cardiovascular Diseases; Carotid Stenosis; Diabetes Mellitus; Endarterectomy, Carotid; Female; Genetic Predisposition to Disease; Greece; Haptoglobins; Hemosiderin; Homocysteine; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Iron; Linear Models; Male; Middle Aged; Oxidative Stress; Phenotype; Plaque, Atherosclerotic; Risk Assessment; Risk Factors; Severity of Illness Index; Sex Factors; Staining and Labeling | 2011 |
Homocysteine levels and the metabolic syndrome in a Mediterranean population: a case-control study.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolic Syndrome; Middle Aged | 2011 |
Loneliness and vascular biomarkers: the Dublin Healthy Ageing Study.
Topics: Aged; Aged, 80 and over; Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Glycated Hemoglobin; Homocysteine; Humans; Lipids; Loneliness; Male | 2012 |
Serum folate is significantly correlated with plasma cysteine concentrations in healthy industry workers.
Topics: Adult; Aged; Aging; Cardiovascular Diseases; Cysteine; Extraction and Processing Industry; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Neoplasms; Norway; Risk Factors; Triglycerides; Young Adult | 2011 |
Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Self Report; Smoking | 2011 |
Simultaneous, noninvasive, and transdermal extraction of urea and homocysteine by reverse iontophoresis.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; In Vitro Techniques; Iontophoresis; Kidney Diseases; Nanomedicine; Skin; Swine; Urea | 2011 |
Hyperhomocysteinemia impairs endothelium-derived hyperpolarizing factor-mediated vasorelaxation in transgenic cystathionine beta synthase-deficient mice.
Topics: Animals; Biological Factors; Cardiovascular Diseases; Cell Line; Cystathionine beta-Synthase; Gene Deletion; Homocysteine; Humans; Hyperhomocysteinemia; Mesenteric Arteries; Mice; Mice, Transgenic; Nitrogen Oxides; Vasodilation | 2011 |
Homocysteine, B vitamins, and the risk of cardiovascular disease.
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Homocysteine; Humans; Hyperhomocysteinemia; Peripheral Vascular Diseases; Risk; Vitamin B Complex | 2011 |
Endothelial (dys)function: the target of physical exercise for prevention and treatment of cardiovascular disease.
Topics: Cardiovascular Diseases; Case-Control Studies; Endothelium, Vascular; Exercise; Homocysteine; Humans; Nitric Oxide | 2011 |
Association between dietary folate intake and blood status of folate and homocysteine in Malaysian adults.
Topics: Adult; Asian People; Cardiovascular Diseases; Cross-Sectional Studies; Diet; Diet Records; Diet Surveys; Erythrocytes; Female; Folic Acid; Homocysteine; Humans; Linear Models; Malaysia; Male; Middle Aged; Neural Tube Defects; Nutritional Status; Sex Factors; Surveys and Questionnaires; Vitamin B 12; Vitamin B 6; Vitamin B Complex; Young Adult | 2011 |
Endothelial function after 10 days of bed rest in individuals at risk for type 2 diabetes and cardiovascular disease.
Topics: Acetylcholine; Adenosine; Adult; Bed Rest; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Endothelium, Vascular; Forearm; Homocysteine; Humans; Hyperinsulinism; Infant, Low Birth Weight; Infant, Newborn; Insulin; Intercellular Adhesion Molecule-1; Male; Regional Blood Flow; Risk; Vascular Cell Adhesion Molecule-1; Vasodilation | 2011 |
Persistent homocysteine metabolism abnormality accelerates cardiovascular disease in hemodialyzed patients--the Nishinomiya Study.
Topics: Body Mass Index; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Middle Aged; Prospective Studies; Renal Dialysis; Vitamin B 12 | 2012 |
Homocysteine metabolism in polycystic ovary syndrome.
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperandrogenism; Hyperhomocysteinemia; Insulin Resistance; Polycystic Ovary Syndrome; Risk Factors | 2012 |
Associations of urinary 6-sulfatoxymelatonin with biomarkers related to cardiovascular disease in Japanese women.
Topics: Asian People; Biomarkers; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Exercise; Female; Homocysteine; Humans; Leukocyte Count; Lipids; Melatonin; Middle Aged; Surveys and Questionnaires; Uric Acid; Women's Health | 2012 |
Homocysteine and reclassification of cardiovascular disease risk.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Nutrition Surveys; Risk Assessment; United States | 2011 |
Homocysteine and cardiovascular risk an old foe creeps back.
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Male | 2011 |
Predictors of residual cardiovascular risk in patients on statin therapy for primary prevention.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cholesterol, LDL; Coronary Artery Disease; Elasticity; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Primary Prevention; Risk Factors; Vascular Calcification; Vascular Stiffness; Waist Circumference | 2011 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
Erythrocyte glutathione transferase: a potential new biomarker in chronic kidney diseases which correlates with plasma homocysteine.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Erythrocytes; Female; Glutathione Transferase; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Young Adult | 2012 |
Effect of regular physical activity on non-lipid (novel) cardiovascular risk factors.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Cytokines; Exercise; Folic Acid; Homocysteine; Humans; Iran; Military Personnel; Risk Factors; Sedentary Behavior; Testosterone; Vitamin D; Young Adult | 2011 |
Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study.
Topics: Adult; Aged; Aged, 80 and over; Alu Elements; Aminohydrolases; Cardiovascular Diseases; DNA Methylation; Folic Acid; Formate-Tetrahydrofolate Ligase; Gene Regulatory Networks; Genetic Association Studies; Genetic Variation; Genotype; Homocysteine; Humans; Long Interspersed Nucleotide Elements; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multienzyme Complexes; Phenotype; Polymorphism, Single Nucleotide; Sarcosine Dehydrogenase; Vitamin B 6 | 2011 |
Plasma retinol: a novel marker for cardiovascular disease mortality in Australian adults.
Topics: Aged; Australia; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Carotenoids; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Incidence; Life Style; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Regression Analysis; Risk Factors; Surveys and Questionnaires; Vitamin A | 2012 |
Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Endothelium, Vascular; Female; Homocysteine; Humans; Male; Nitric Oxide; Nitrites; Panic Disorder; Platelet Aggregation; Risk Factors; Spectrophotometry | 2012 |
Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Germany; Homocysteine; Humans; Male; Middle Aged; Prevalence; Risk Assessment; Risk Factors | 2012 |
Fortification of flours with folic acid reduces homocysteine levels in Brazilian women.
Topics: Adult; Biomarkers; Brazil; Cardiovascular Diseases; Cross-Sectional Studies; Diet; Dietary Fiber; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Middle Aged; Nutrition Assessment; Nutrition Policy; Obesity; Triticum; Zea mays | 2011 |
Suppression of homocysteine levels by vitamin B12 and folates: age and gender dependency in the Jackson Heart Study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Black or African American; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Linear Models; Male; Middle Aged; Mississippi; Sex Factors; Vitamin B 12; Young Adult | 2012 |
Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Data Interpretation, Statistical; Homocysteine; Humans; Kidney; Meta-Analysis as Topic; Methylenetetrahydrofolate Dehydrogenase (NADP); Polymorphism, Genetic; Reproducibility of Results; Risk Assessment; Stroke; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B Complex | 2011 |
Familial genetic risk factors in premature cardiovascular disease: a family study.
Topics: Adult; Cardiovascular Diseases; Demography; Family; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Factors | 2012 |
Plasma homocysteine level and hepatic sulfur amino acid metabolism in mice fed a high-fat diet.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adenosylhomocysteinase; Amino Acids, Sulfur; Animals; Cardiovascular Diseases; Cystathionine beta-Synthase; Cysteine Dioxygenase; Diet, High-Fat; Dipeptides; Down-Regulation; Homocysteine; Lipid Peroxidation; Liver; Male; Methionine Adenosyltransferase; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Inbred C57BL; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine; Triglycerides; Up-Regulation | 2013 |
Low density lipoprotein S-homocysteinylation is increased in acute myocardial infarction patients.
Topics: Acute Coronary Syndrome; Aged; Apolipoproteins B; Biomarkers; Cardiovascular Diseases; Cysteine; Electrophoresis, Capillary; Female; Homocysteine; Humans; Italy; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sulfhydryl Compounds | 2012 |
Hepatitis C virus co-infection and sexual risk behaviour are associated with a high homocysteine serum level in HIV-infected patients.
Topics: Adult; Cardiovascular Diseases; Coinfection; Cross-Sectional Studies; Female; Folic Acid; Hepacivirus; Hepatitis C; HIV; HIV Infections; Homocysteine; Humans; Male; Risk Factors; Risk-Taking; Sexual Behavior; Vitamin B 12 | 2012 |
Aronia melanocarpa extract suppresses the biotoxicity of homocysteine and its metabolite on the hemostatic activity of fibrinogen and plasma.
Topics: Adult; Anticoagulants; Antioxidants; Blood Coagulation; Cardiovascular Diseases; Coagulants; Dietary Supplements; Fibrinogen; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Oxidative Stress; Photinia; Plant Extracts; Poland; Polymerization; Resveratrol; Stilbenes | 2012 |
Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU).
Topics: Adolescent; Arginine; Atherosclerosis; Blood Glucose; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Homocysteine; Humans; Lipid Metabolism; Male; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Phenylalanine; Phenylketonurias | 2012 |
Total homocysteine levels and cardiovascular risk factors in healthy Tunisians.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Risk Factors; Tunisia | 2011 |
[Effects of folic acid on cerebrovascular and cancer risks].
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Neoplasms; Vitamin B Complex | 2012 |
Homocysteine, grey matter and cognitive function in adults with cardiovascular disease.
Topics: Aged; Aged, 80 and over; Atrophy; Brain; Cardiovascular Diseases; Cognition Disorders; Cross-Sectional Studies; Female; Homocysteine; Humans; Magnetic Resonance Imaging; Male; Middle Aged | 2012 |
Influence of oral contraceptive pills on homocysteine and nitric oxide levels: as risk factors for cardiovascular disease.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral; Dosage Forms; Female; Homocysteine; Humans; Nitric Oxide; Risk Factors; Young Adult | 2012 |
Effect of lifestyle modification and metformin therapy on emerging cardiovascular risk factors in overweight Indian women with polycystic ovary syndrome.
Topics: Adolescent; Adult; C-Reactive Protein; Cardiovascular Diseases; Female; Homeostasis; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Life Style; Lipids; Maximum Tolerated Dose; Metformin; Overweight; Polycystic Ovary Syndrome; Radioimmunoassay; Risk Factors | 2012 |
A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol, HDL; Dietary Fiber; Dietary Supplements; Female; Fruit; Glutathione; Homocysteine; Humans; Lipoproteins, HDL; Male; Middle Aged; Pilot Projects; Risk | 2012 |
Use of serum homocysteine to predict cardiovascular disease in Korean men with or without metabolic syndrome.
Topics: Adult; Area Under Curve; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Dietary Supplements; Homocysteine; Humans; Linear Models; Male; Metabolic Syndrome; Middle Aged; Predictive Value of Tests; Republic of Korea | 2012 |
Exposure to polycyclic aromatic hydrocarbons and serum inflammatory markers of cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Female; Fibrinogen; Fluorenes; Homocysteine; Humans; Leukocyte Count; Linear Models; Male; Middle Aged; Naphthalenes; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Pyrenes; United States | 2012 |
Folate network genetic variation predicts cardiovascular disease risk in non-Hispanic white males.
Topics: Adult; Carbon; Cardiovascular Diseases; Folic Acid; gamma-Glutamyl Hydrolase; Genetic Association Studies; Genetic Predisposition to Disease; Glycine Hydroxymethyltransferase; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Regression Analysis; Risk Factors; Thymidylate Synthase; White People | 2012 |
The polyphenol-rich extracts from black chokeberry and grape seeds impair changes in the platelet adhesion and aggregation induced by a model of hyperhomocysteinemia.
Topics: Adult; Antioxidants; Blood Platelets; Cardiovascular Diseases; Collagen; Dietary Supplements; Fibrinogen; Fruit; Grape Seed Extract; Homocysteine; Humans; Hyperhomocysteinemia; Photinia; Plant Extracts; Platelet Activation; Platelet Aggregation Inhibitors; Polyphenols; Seeds; Superoxides; Vitis; Young Adult | 2013 |
The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
Topics: Aged; Basal Ganglia; Cardiovascular Diseases; Female; Hippocampus; Homocysteine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers; Parkinson Disease; Poland; Risk Factors; Supranuclear Palsy, Progressive; White People | 2013 |
Pathological and behavioral risk factors for higher serum C-reactive protein concentrations in free-living adults--a Brazilian community-based study.
Topics: Abdominal Fat; Adult; Aged; Aged, 80 and over; Anthropometry; Blood Glucose; Body Mass Index; Brazil; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Feeding Behavior; Female; Homocysteine; Humans; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Leukocyte Count; Male; Metabolic Syndrome; Middle Aged; Neutrophils; Nutrition Assessment; Obesity; Proportional Hazards Models; Risk Factors; Triglycerides; Uric Acid | 2013 |
Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Gout; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Risk Factors | 2013 |
Relationship between homocysteine and non-dipper pattern in patients with type 2 diabetes mellitus.
Topics: Blood Glucose; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2012 |
Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2012 |
[The diagnostic value of laboratory markers of epithelium damage in patients passing the program hemodialysis].
Topics: Adult; Aged; Cardiovascular Diseases; Epithelium; Female; Homocysteine; Humans; Male; Middle Aged; Renal Dialysis; Risk Factors; von Willebrand Factor | 2012 |
Homocysteine concentration and the risk of death in the adult Polish population.
Topics: Adult; Cardiovascular Diseases; Cause of Death; Comorbidity; Female; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Longitudinal Studies; Male; Middle Aged; Poland; Population Surveillance; Risk Factors; Smoking; Surveys and Questionnaires; Survival Rate | 2012 |
Plasma ω-3 fatty acid levels negatively and ω-6 fatty acid levels positively associated with other cardiovascular risk factors including homocysteine in severe obese subjects.
Topics: Adult; Algorithms; Body Mass Index; Cardiovascular Diseases; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Female; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Male; Middle Aged; Obesity; Risk Factors; Severity of Illness Index; Turkey; Vitamin B 12 Deficiency; Young Adult | 2012 |
Homocysteine and cysteine levels in prepubertal children: association with waist circumference and lipid profile.
Topics: Biomarkers; Brazil; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cysteine; Female; Homocysteine; Humans; Lipids; Male; Multivariate Analysis; Obesity, Abdominal; Overweight; Prevalence; Risk Factors; Triglycerides; Waist Circumference | 2013 |
The impact of intratracheally instilled carbon black on the cardiovascular system of rats: elevation of blood homocysteine and hyperactivity of platelets.
Topics: Air Pollutants, Occupational; Animals; Biomarkers; Blood Coagulation; Carcinogens, Environmental; Cardiovascular Diseases; Cardiovascular System; Dose-Response Relationship, Drug; Homocysteine; Hyperhomocysteinemia; Instillation, Drug; Lung; Male; Organ Specificity; Particle Size; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Soot | 2012 |
Lowering homocysteine levels may prevent cardiovascular impairments? Possible therapeutic behaviors.
Topics: Acetylcysteine; Aspirin; Blood Vessels; Cardiovascular Diseases; Clopidogrel; Diuretics; Fatty Acids, Omega-3; Folic Acid; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Metformin; Platelet Aggregation Inhibitors; S-Adenosylmethionine; Ticlopidine; Vitamin B 12; Vitamin B 6 | 2012 |
Relationship of fasting total homocysteine, high sensitivity C-reactive protein and features of the metabolic syndrome in Trinidadian subjects.
Topics: Adult; Aged; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Fasting; Female; Homocysteine; Humans; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Risk Factors; Trinidad and Tobago; Waist Circumference; Young Adult | 2013 |
Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; C-Reactive Protein; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Schizophrenia | 2013 |
Homocysteine levels in Takayasu arteritis -- a risk factor for arterial ischemic events.
Topics: Adult; Aryldialkylphosphatase; Cardiovascular Diseases; Cross-Sectional Studies; Cysteine; Female; Homocysteine; Humans; Middle Aged; Risk Factors; Takayasu Arteritis | 2013 |
Efficacy of adding folic acid to foods.
Topics: Cardiovascular Diseases; Diet; Folic Acid; Folic Acid Deficiency; Food, Fortified; Homocysteine; Humans; Neoplasms; Neural Tube Defects; Vitamin B 12 Deficiency | 2012 |
A possible genetic link between MTHFR genotype and smoking behavior.
Topics: Adult; Behavior, Addictive; Cardiovascular Diseases; Female; Genetic Linkage; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Smoking | 2012 |
Dietary antioxidant capacity is associated with improved serum antioxidant status and decreased serum C-reactive protein and plasma homocysteine concentrations.
Topics: Adult; Aged; Antioxidants; C-Reactive Protein; Cardiovascular Diseases; Carotenoids; Cross-Sectional Studies; Dietary Supplements; Female; Homocysteine; Humans; Male; Middle Aged; Nutrition Assessment; Nutrition Surveys; Proanthocyanidins; United States; Young Adult | 2013 |
[Correlation between plasma concentrations of homocysteine and diabetic polyneuropathy evaluated with the Semmes-Weinstein monofilament test in patients with type 2 diabetes mellitus].
Topics: Age Factors; Aged; Alcohol Drinking; Cardiovascular Diseases; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Folic Acid; Glycated Hemoglobin; Homocysteine; Humans; Hyperhomocysteinemia; Hypesthesia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Overweight; Physical Examination; Risk Factors; Severity of Illness Index; Smoking; Vitamin B 12 | 2013 |
Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults.
Topics: Age Factors; Aged; Asian People; Brain; Cardiovascular Diseases; Cognition Disorders; Female; Folic Acid; Homocysteine; Humans; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Neuropsychological Tests; Organ Size; Singapore; Vitamin B 12 | 2013 |
Homocysteine in lipoprotein apheresis patients--retrospective data analysis in apheresis center of a university hospital.
Topics: Aged; Analysis of Variance; Biomarkers; Blood Component Removal; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Female; Germany; Homocysteine; Hospitals, University; Humans; Hyperhomocysteinemia; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome; Triglycerides; Vitamin B Complex | 2013 |
Transsulfuration pathway thiols and methylated arginines: the Hunter Community Study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aging; Amidohydrolases; Arginine; Australia; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Community Medicine; Cysteine; Dipeptides; Female; Glutathione; Homocysteine; Humans; Male; Middle Aged; Taurine | 2013 |
Paradigm of vascular aging: conceptual strides slowed by technical limitations.
Topics: Aging; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Endothelium, Vascular; Exercise; Homocysteine; Humans | 2002 |
Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors.
Topics: Adipose Tissue; Adult; Aged; Body Composition; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Fibrinogen; Glucose; Homocysteine; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Obesity; Risk Factors; Triglycerides; von Willebrand Factor | 2002 |
Analysis of two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia--heterogeneous distribution in the South African population.
Topics: Cardiovascular Diseases; Genetic Predisposition to Disease; Genetics, Population; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; South Africa | 2002 |
Hypocholesterolemia in Nigerian children with sickle cell disease.
Topics: Adolescent; Anemia, Sickle Cell; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Electric Impedance; Female; Homocysteine; Humans; Lipids; Male; Nigeria; Risk Factors; Triglycerides | 2002 |
Effects of an 8-week weight-loss program on cardiovascular disease risk factors and regional body composition.
Topics: Absorptiometry, Photon; Adult; Body Composition; Body Constitution; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Energy Intake; Exercise; Female; Folic Acid; Homocysteine; Humans; Insulin; Leptin; Lipids; Male; Obesity; Risk Factors; Sex Factors; Weight Loss | 2002 |
Serum lipid profiles and risk of cardiovascular disease in three different male populations in northern Nigeria.
Topics: Adult; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Nigeria; Risk Factors; Triglycerides; Vitamin B 12 | 2002 |
Clinical trials testing the homocysteine hypothesis.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Clinical Trials as Topic; Edible Grain; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2002 |
The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism.
Topics: Adult; Amenorrhea; Biomarkers; Blood Chemical Analysis; Cardiovascular Diseases; Case-Control Studies; Estrogens; Female; Follicle Stimulating Hormone; Homocysteine; Humans; Hyperandrogenism; Luteinizing Hormone; Probability; Prognosis; Reference Values; Sensitivity and Specificity; Testosterone | 2002 |
The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Genetic Predisposition to Disease; Genotype; Heterozygote; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prevalence; Renal Dialysis; Risk Factors | 2002 |
Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
Topics: Adult; Amino Acids, Sulfur; Cardiovascular Diseases; Cross-Sectional Studies; Cysteine; Deficiency Diseases; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Nutrition Assessment; Nutrition Disorders; Nutritional Status; Prevalence; Protein-Energy Malnutrition; Renal Dialysis; Serum Albumin | 2002 |
Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C-->T) on plasma homocysteine, folate and vitamin B(12) levels and its relationship to cardiovascular disease risk.
Topics: Adult; Analysis of Variance; Antigens, Surface; Carboxypeptidases; Cardiovascular Diseases; Case-Control Studies; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Glutamate Carboxypeptidase II; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Probability; Reference Values; Risk Assessment; Sensitivity and Specificity; Vitamin B 12 | 2002 |
Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Fluorescence; Hemodynamics; Homocysteine; Hydrolases; Hyperhomocysteinemia; Kidney; Rats; Rats, Sprague-Dawley; Reference Standards; Risk Factors; Tubercidin | 2002 |
Homocysteine in chronic renal failure in relation to renal anemia and to oxidative stress parameters 4-hydroxynonenal and malondialdehyde.
Topics: Aldehydes; Anemia; Cardiovascular Diseases; Female; Hemoglobins; Homocysteine; Humans; Kidney Failure, Chronic; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Dialysis; Risk Factors | 2002 |
Relation of plasma total homocysteine to cardiovascular mortality in a French population.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Female; Follow-Up Studies; France; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Statistics as Topic; Survival Analysis | 2002 |
Smoking and plasma homocysteine.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Smoking; Vitamin B 12; Vitamin B 6 | 2002 |
By the way, doctor. One of my neighbors just had his homocysteine level checked. I'm wondering if I should get the same test?
Topics: Biomarkers; Cardiovascular Diseases; Homocysteine; Humans | 2002 |
Homocysteine and ADMA--emerging risk factors for cardiovascular disease?
Topics: Arginine; Cardiovascular Diseases; Homocysteine; Humans; Predictive Value of Tests; Risk Factors | 2002 |
Lowering plasma homocyst(e)ine may affect atherosclerotic disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Risk Factors | 2002 |
Plasma homocyst(e)ine, folate and vitamin B(12) levels among school children in Taiwan: The Taipei Children Heart Study.
Topics: Adolescent; Analysis of Variance; Anthropometry; Blood Pressure; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Male; Risk Factors; Sex Characteristics; Statistics, Nonparametric; Surveys and Questionnaires; Taiwan; Vitamin B 12 | 2002 |
Homocysteine. A factor in cardiovascular and memory health?
Topics: Cardiovascular Diseases; Dementia; Homocysteine; Humans; Vitamin B Complex | 2002 |
Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk.
Topics: Adult; Aged; Biomarkers; Cardiovascular Diseases; Female; Fibrinolysis; Hemostasis; Homocysteine; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Tissue Plasminogen Activator | 2002 |
Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study.
Topics: Adult; Aging; Alcohol Drinking; Antioxidants; Apolipoproteins B; Blood Glucose; Body Constitution; Body Mass Index; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Coffee; Dietary Fiber; Dietary Supplements; Energy Intake; Erythrocytes; Exercise; Fasting; Female; Folic Acid; France; Homocysteine; Humans; Male; Middle Aged; Minerals; Risk Factors; Sex Characteristics; Triglycerides; Vitamin B 12; Vitamin B 6; Vitamins | 2002 |
Fruit and vegetable intake and chronic disease risk in Portugal.
Topics: Antioxidants; Biomarkers; Cardiovascular Diseases; Carotenoids; Female; Folic Acid; Fruit; Homocysteine; Humans; Male; Middle Aged; Morbidity; Neoplasms; Portugal; Risk Factors; Surveys and Questionnaires; Vegetables; Vitamin B 12; Vitamin B 6; Vitamin E | 2002 |
Plasma total homocysteine, folate, and vitamin B12 status in Korean adults.
Topics: Adult; Age Factors; Aged; Area Under Curve; Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Korea; Male; Middle Aged; Nutritional Status; Prevalence; Sex Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2002 |
Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Europe; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 2003 |
Predictors of change in plasma total cysteine: longitudinal findings from the Hordaland homocysteine study.
Topics: Adult; Age Factors; Aged; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cysteine; Female; Homocysteine; Humans; Life Style; Longitudinal Studies; Male; Middle Aged; Risk Factors; Sex Factors | 2003 |
Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects.
Topics: Biomarkers; Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Prospective Studies; Risk Factors | 2002 |
Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Netherlands; Prevalence; Risk Factors | 2003 |
Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency.
Topics: Animals; Betaine; Cardiovascular Diseases; Choline; Dose-Response Relationship, Drug; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Liver; Male; Methylenetetrahydrofolate Dehydrogenase (NAD+); Mice; Mice, Knockout; Models, Biological; Oxidoreductases; Phosphorylcholine | 2003 |
Novel cardiovascular risk factors: do they add value to your practice?
Topics: C-Reactive Protein; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2003 |
[Homocysteine and alcohol consumption. An ambiguous relationship and a new paradox].
Topics: Alcohol Drinking; Beer; Cardiovascular Diseases; Epidemiologic Studies; Homocysteine; Humans; Risk Factors | 2003 |
Circulating homocysteine levels in sustained and white coat hypertension.
Topics: Adult; Blood Pressure Determination; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypertension; Male; Middle Aged; Stress, Psychological | 2003 |
Hyperlipidemia and cardiovascular disease.
Topics: Cardiovascular Diseases; Cholesterol; Environment; Homocysteine; Humans; Hyperlipidemias; Male | 2003 |
Vitamin C protects low-density lipoprotein from homocysteine-mediated oxidation.
Topics: Ascorbic Acid; Cardiovascular Diseases; Copper; Dehydroascorbic Acid; Dose-Response Relationship, Drug; Free Radicals; Homocysteine; Humans; Iron; Lipoproteins; Lipoproteins, LDL; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Temperature; Thiobarbituric Acid Reactive Substances; Time Factors; Vitamin E | 2003 |
Peanut consumption improves indices of cardiovascular disease risk in healthy adults.
Topics: Adult; Arachis; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Diet, Fat-Restricted; Dietary Fats, Unsaturated; Erythrocyte Membrane; Fatty Acids, Monounsaturated; Female; Folic Acid; Homocysteine; Humans; Magnesium; Male; Risk Factors; Triglycerides | 2003 |
Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.
Topics: Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Endothelium, Vascular; Homocysteine; Humans; Inflammation Mediators; Kidney; Kidney Failure, Chronic; Risk Factors | 2003 |
Low diagnostic value of fasting and post-methionine load homocysteine tests. A study in Dutch subjects with homocysteine test indications.
Topics: Adult; Cardiovascular Diseases; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Netherlands; Prevalence; Reference Values; Retrospective Studies; Risk Factors; Sensitivity and Specificity | 2003 |
Determinants and distributions of plasma total homocysteine concentrations among school children in Taiwan.
Topics: Adolescent; Age Factors; Anthropometry; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Folic Acid; Folic Acid Deficiency; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Schools; Sex Factors; Taiwan; Vitamin B 12; Vitamin B 12 Deficiency | 2003 |
n-3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans.
Topics: Adult; Animals; Antioxidants; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Fatty Acids, Omega-3; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Middle Aged; Milk; Oleic Acid; Oxidation-Reduction; Risk Factors; Vascular Cell Adhesion Molecule-1; Vitamin B 6; Vitamin E | 2003 |
Homocysteine concentrations lowered following dietary intervention in an aboriginal community.
Topics: Adult; Cardiovascular Diseases; Cohort Studies; Community Health Services; Diet; Erythrocytes; Female; Folic Acid; Homocysteine; Humans; Life Style; Longitudinal Studies; Male; Native Hawaiian or Other Pacific Islander; Racial Groups; Regression Analysis; Risk Factors | 2003 |
Folate and risk of cardiovascular disease. Study results were misinterpreted.
Topics: Cardiovascular Diseases; Cohort Studies; Coronary Disease; Data Interpretation, Statistical; Folic Acid; Homocysteine; Humans; Meta-Analysis as Topic; Risk Factors | 2003 |
Betaine. Monograph.
Topics: Betaine; Cardiovascular Diseases; Fatty Liver; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Liver Diseases, Alcoholic; Obesity | 2003 |
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Odds Ratio; Smoking; United States | 2003 |
Summaries for patients. Associations between smoking and newer risk factors for cardiovascular disease.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Smoking; United States | 2003 |
Effects of diet in lowering homocysteine levels and cardiovascular disease.
Topics: Aged; Cardiovascular Diseases; Female; Hispanic or Latino; Homocysteine; Humans; Male; New Mexico; White People | 2003 |
Serum homocysteine levels and mortality in outpatients with or without coronary artery disease: an observational study.
Topics: Aged; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Proportional Hazards Models; Risk Factors | 2003 |
B vitamins and plasma homocysteine concentrations in an urban and rural area of Costa Rica.
Topics: Adult; Aged; Alcohol Drinking; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Costa Rica; Diet; Educational Status; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Nutritional Status; Physical Fitness; Risk Factors; Rural Population; Sex Characteristics; Smoking; Urban Population; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2003 |
Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
Topics: Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Renal Dialysis; Risk; Thrombosis | 2003 |
Free radical disease prevention and nutrition.
Topics: Adult; Antioxidants; Ascorbic Acid; Cardiovascular Diseases; Diet; Diet, Vegetarian; Female; Free Radicals; Homocysteine; Humans; Male; Middle Aged; Random Allocation; Trace Elements; Vitamin E | 2003 |
Homocysteine plasma levels after suspension of vitamin treatment.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Clinical Protocols; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Vitamin B 12 | 2003 |
Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.
Topics: Cardiovascular Diseases; DNA Methylation; Homocysteine; Humans; Male; Middle Aged; S-Adenosylhomocysteine | 2003 |
Adenosine-the missing link to understanding homocysteine pathogenicity or more smoke on the horizon?
Topics: Adenosine; Cardiovascular Diseases; Cardiovascular System; Homocysteine; Humans; Hyperhomocysteinemia | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; E-Selectin; Female; Homocysteine; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Multivariate Analysis; Regression Analysis; Risk Factors; Time Factors; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2003 |
Increased plasma homocysteine levels in shift working bus drivers.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Genomics; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Occupational Diseases; Risk Factors; Sleep Disorders, Circadian Rhythm; Transportation | 2003 |
Lowering plasma homocysteine.
Topics: Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B 12 | 2003 |
Age dependence of the influence of methylenetetrahydrofolate reductase genotype on plasma homocysteine level.
Topics: Adolescent; Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Spinal Dysraphism | 2003 |
Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism.
Topics: Adolescent; Adult; Aortic Aneurysm; Aortic Dissection; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Logistic Models; Male; Marfan Syndrome; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Phenotype; Polymorphism, Genetic; Severity of Illness Index | 2003 |
[Serum homocysteine in children and adolescents. Relation with family history of cardiovascular disease].
Topics: Adolescent; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Lipoproteins; Male; Risk Factors; Vitamin B 12 | 2003 |
The role of plasma thiol compounds and antioxidant vitamins in patients with cardiovascular diseases.
Topics: Antioxidants; beta Carotene; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cysteine; Female; Homocysteine; Humans; Male; Middle Aged; Vitamins | 2003 |
Cardiovascular risk of young growth-hormone-deficient adolescents. Differences in growth-hormone-treated and untreated patients.
Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol, HDL; Cholesterol, LDL; Dietary Fats; Eating; Fasting; Female; Fibrinogen; Folic Acid; Homocysteine; Hormone Replacement Therapy; Human Growth Hormone; Humans; Male; Plasminogen Activator Inhibitor 1; Postprandial Period; Risk Assessment; Time Factors; Triglycerides; Vitamin B 12 | 2003 |
Homocysteine level and other biochemical parameters in cardiovascular disease patients with diabetes mellitus.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Diabetic Angiopathies; Female; Folic Acid; Homocysteine; Humans; Lipids; Male; Risk Factors; Vitamin B 12 | 2003 |
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years.
Topics: Adult; Apolipoproteins; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diet Records; DNA Primers; Homocysteine; Humans; Male; Middle Aged; Motor Activity; Polymerase Chain Reaction; Polymorphism, Genetic; Triglycerides | 2003 |
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins.
Topics: Apolipoproteins; Biomarkers; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Homocysteine; Humans; Male; Middle Aged; Protein Binding; Reference Values; Triglycerides | 2003 |
Where are we standing in homocysteine research?
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Research; Risk Factors | 2003 |
Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
Topics: Adult; Aged; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Heptanoic Acids; Homocysteine; Humans; Hypercholesterolemia; Kidney Failure, Chronic; Lipid Metabolism; Lipids; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Prospective Studies; Pyrroles; Renal Dialysis; Risk Factors | 2003 |
Distribution of plasma total homocysteine concentrations in the healthy Iranians.
Topics: Adolescent; Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Iran; Male; Middle Aged; Risk Factors; Sex Factors | 2004 |
Renal disease, homocysteine, and cardiovascular complications.
Topics: Acetylcysteine; Antioxidants; Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic; Risk Factors | 2004 |
Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study.
Topics: Adult; Arteriosclerosis; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Greece; Health Surveys; Homocysteine; Humans; Inflammation Mediators; Leukocyte Count; Lipoproteins, LDL; Male; Middle Aged; Multivariate Analysis; Risk Factors; Tobacco Smoke Pollution | 2004 |
Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: the relationship of homocysteine with other cardiovascular risk factors.
Topics: Adult; Brazil; Cardiovascular Diseases; Female; Folic Acid Deficiency; Health Status Indicators; Homocysteine; Humans; Hyperhomocysteinemia; Indians, South American; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Sex Factors; Smoking; Vitamin B 12 | 2004 |
Risk factors for heart disease.
Topics: Brazil; Cardiovascular Diseases; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Indians, South American; Risk Factors; Vitamin B 12 | 2004 |
Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Female; Fibrinogen; Homocysteine; Humans; Inflammation Mediators; Kidney Transplantation; Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors | 2004 |
Distribution of total serum homocysteine and its association with parental history and cardiovascular risk factors at ages 12-16 years: the Third National Health And Nutrition Examination Survey.
Topics: Adolescent; Cardiovascular Diseases; Child; Female; Homocysteine; Humans; Male; Nutrition Surveys; Parents; Risk Factors; United States | 2004 |
Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Dementia; Female; Homocysteine; Humans; Inflammation; Male; Regression Analysis | 2004 |
Alcohol consumption and its relation to cardiovascular risk factors in Germany.
Topics: Adult; Age Distribution; Aged; Alcohol Drinking; Analysis of Variance; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Germany; Health Surveys; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk Factors; Sex Distribution; Smoking; Social Class | 2004 |
Effect of lifestyle factors on plasma total homocysteine concentrations in relation to MTHFR(C677T) genotype. Inter99 (7).
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Coffee; Cross-Sectional Studies; Denmark; Exercise; Feeding Behavior; Female; Genotype; Health Surveys; Homocysteine; Humans; Life Style; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Restriction Fragment Length; Risk Factors; Smoking; Surveys and Questionnaires; Tea | 2004 |
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia.
Topics: Acute Disease; Administration, Oral; Adult; Cardiovascular Diseases; Cell Adhesion Molecules; Comorbidity; Dietary Fats; Drug Synergism; Endothelium; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Inflammation; Male; Methionine; Middle Aged; P-Selectin; Risk Factors; Triglycerides | 2004 |
Homocysteine in a multi-ethnic sample of school-age children.
Topics: Adolescent; Cardiovascular Diseases; Child; Diet; Ethnicity; Fasting; Female; Folic Acid; Hispanic or Latino; Homocysteine; Humans; Indians, North American; Male; Nutrition Policy; School Health Services; Vitamin B 12; Vitamin B 6; White People | 2004 |
A healthy lifestyle lowers homocysteine, but should we care?
Topics: Aged; Cardiovascular Diseases; Coffee; Dietary Supplements; Female; Homocysteine; Humans; Life Style; Male; Middle Aged; Smoking; Vitamin B Complex; Weight Loss | 2004 |
Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study.
Topics: Adult; Aged; Cardiovascular Diseases; Coffee; Cohort Studies; Cross-Sectional Studies; Dietary Supplements; Female; Follow-Up Studies; Homocysteine; Humans; Life Style; Male; Norway; Prospective Studies; Risk Factors; Smoking; Vitamin B Complex; Vitamins | 2004 |
Effects of paradoxical sleep deprivation on blood parameters associated with cardiovascular risk in aged rats.
Topics: Age Factors; Aging; Animals; Blood Viscosity; Cardiovascular Diseases; Cholesterol; Folic Acid; Homocysteine; Lipoproteins; Male; Rats; Rats, Wistar; Risk Factors; Sleep Deprivation; Triglycerides; Vitamin B 12 | 2004 |
Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy.
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Diabetic Retinopathy; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prevalence; Prospective Studies; Time Factors | 2004 |
Serum selenium is associated with plasma homocysteine concentrations in elderly humans.
Topics: Aged; Aged, 80 and over; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Energy Intake; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Selenium; Vitamin B 12 | 2004 |
Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Disease Progression; Female; Homocysteine; Humans; Male; Regression Analysis; Statistics, Nonparametric; Time Factors | 2004 |
Homocysteine and cardiovascular disease: a 17-year follow-up study in Busselton.
Topics: Adult; Aged; Aged, 80 and over; Australia; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Confounding Factors, Epidemiologic; Coronary Disease; Creatinine; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors; Stroke | 2004 |
Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats.
Topics: Animals; Anions; Calcium; Calcium-Transporting ATPases; Cardiovascular Diseases; Catalase; Homocysteine; Hydrogen Peroxide; Male; Malondialdehyde; Manganese; Methionine; Microscopy, Electron; Mitochondria; Mitochondria, Heart; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Succinate Dehydrogenase; Superoxide Dismutase; Superoxides; Taurine; Time Factors | 2004 |
Classical and "non-classical" cardiovascular risk factors in Tunisian patients with end stage renal disease: prevalence and association with cardiovascular events.
Topics: Adult; Age Factors; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Lipoprotein(a); Male; Risk Factors; Tunisia | 2004 |
Statins and micronutrients: unanswered questions.
Topics: Cardiovascular Diseases; Cholesterol, LDL; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Micronutrients; Nitric Oxide | 2004 |
Evidence for association between endothelial nitric oxide synthase gene polymorphism (G894T) and inflammatory markers: the ATTICA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Point Mutation; Polymorphism, Genetic; Serum Amyloid A Protein | 2004 |
Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parameters.
Topics: C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Coronary Disease; Endothelium, Vascular; Fibrinolysis; Homocysteine; Humans; Hypothyroidism; Risk Factors; Thyroid Hormones; Thyroxine; von Willebrand Diseases | 2004 |
Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.
Topics: Adolescent; Adult; Arteriosclerosis; Blood Glucose; Body Mass Index; Brachial Artery; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Child; Child, Preschool; Cholesterol; Cohort Studies; Coronary Disease; Cross-Sectional Studies; Endothelium, Vascular; Female; Finland; Follow-Up Studies; Hemorheology; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sampling Studies; Sex Factors; Smoking; Tunica Intima; Tunica Media; Ultrasonography; Vasodilation; Waist-Hip Ratio | 2004 |
Relationship between homocysteine and cardiovascular diseases in older adults.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Stroke | 2004 |
The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: the 'ATTICA' study.
Topics: Adult; Cardiovascular Diseases; Feeding Behavior; Female; Greece; Homocysteine; Humans; Life Style; Male; Middle Aged; Motor Activity; Risk Factors; Smoking | 2004 |
Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism.
Topics: Adult; Aged; Apolipoproteins B; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Homocysteine; Humans; Hypothyroidism; Lipoprotein(a); Male; Middle Aged; Risk Factors; Thyrotropin-Releasing Hormone | 2004 |
Dietary patterns in middle-aged Irish men and women defined by cluster analysis.
Topics: Alcohol Drinking; Anthropometry; Blood Glucose; Cardiovascular Diseases; Cluster Analysis; Cross-Sectional Studies; Dietary Fats; Feeding Behavior; Female; Health Surveys; Homocysteine; Humans; Ireland; Lipids; Male; Middle Aged; Risk Factors; Smoking; Social Class; Surveys and Questionnaires | 2004 |
Blood lead is a predictor of homocysteine levels in a population-based study of older adults.
Topics: Aged; Cardiovascular Diseases; Central Nervous System; Cognition Disorders; Cross-Sectional Studies; Female; Homocysteine; Humans; Lead; Longitudinal Studies; Male; Middle Aged | 2005 |
Cardiovascular risk markers in hemodialysis patients.
Topics: Aged; Cardiovascular Diseases; Creatine Kinase; Creatine Kinase, MB Form; Female; Homocysteine; Humans; Isoenzymes; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Renal Dialysis; Risk Factors; Troponin I; Uremia | 2004 |
Metabolic consequences of physical inactivity.
Topics: Amino Acids; Bed Rest; Cardiovascular Diseases; Dietary Proteins; Energy Metabolism; Exercise; Exercise Therapy; Homocysteine; Humans; Insulin Resistance; Metabolic Syndrome; Metabolism; Models, Biological; Muscle Proteins; Muscular Atrophy; Protein Biosynthesis; Risk Factors | 2005 |
Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria.
Topics: Adult; Aged; Cardiovascular Diseases; Diet; Female; Folic Acid; Homocysteine; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Nigeria; Risk Factors; Rural Population; Triglycerides; Urban Population; Vitamin B 12 | 2004 |
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations.
Topics: Adult; Age Factors; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Europe; Female; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Male; Middle Aged; Prevalence; Risk Factors; Sex Factors | 2005 |
Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level.
Topics: Aged; Aged, 80 and over; Ankle; Arm; Biomarkers; Brachial Artery; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Odds Ratio; Peripheral Vascular Diseases; Primary Health Care; Prospective Studies; Risk Factors; Ultrasonography | 2005 |
Homocysteine in relation to C-reactive protein and low-density lipoprotein cholesterol in assessment of cardiovascular risk.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cardiovascular System; Case-Control Studies; Cholesterol, LDL; Coronary Disease; Female; Germany; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Risk; Risk Factors; Syria; Time Factors | 2004 |
Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study.
Topics: Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Epidemiologic Methods; Homocysteine; Humans; Male; Middle Aged; Smoking | 2005 |
Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the 'Florence' diet is not Mediterranean.
Topics: Cardiovascular Diseases; Cross-Sectional Studies; Diet; Diet, Mediterranean; Feeding Behavior; Female; Homocysteine; Humans; Italy; Life Style; Lipids; Male; Middle Aged; Nutrition Surveys; Reference Values; Risk Factors; Sex Factors; Statistics, Nonparametric; Surveys and Questionnaires; Vitamins | 2005 |
Job stress and cardiovascular risk factors in male workers.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Homocysteine; Humans; Korea; Male; Middle Aged; Multivariate Analysis; Occupational Diseases; Regression Analysis; Risk Factors; Smoking; Socioeconomic Factors; Stress, Psychological; Triglycerides; Workload | 2005 |
Elevation of plasma homocysteine in natural menopause can not be explained by a lack of vitamin coenzyme availability: relevance to the risk of cardiovascular disease.
Topics: Adult; Cardiovascular Diseases; Coenzymes; Diet; Estrogens; Female; Folic Acid; Homocysteine; Humans; Menopause; Middle Aged; Risk Factors; Vitamin B 12; Vitamin B 6 | 2005 |
Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cause of Death; Cholesterol, LDL; Comorbidity; Female; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Hong Kong; Humans; Hypertrophy, Left Ventricular; Kidney; Kidney Failure, Chronic; Life Tables; Lipids; Male; Middle Aged; Mortality; Peritoneal Dialysis, Continuous Ambulatory; Proportional Hazards Models; Prospective Studies; Risk; Serum Albumin; Solubility; Survival Analysis; Treatment Outcome; Ultrasonography; Vascular Cell Adhesion Molecule-1 | 2005 |
Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Female; Heart Transplantation; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Nicotiana; Risk; Risk Factors; Smoking; Smoking Cessation; Surveys and Questionnaires; Thrombosis; Time Factors | 2005 |
Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism.
Topics: Adult; Aged; Anti-Inflammatory Agents; Atherosclerosis; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Fatty Acids, Omega-3; Female; Fibrinolytic Agents; Heart Rate; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Lipoproteins, VLDL; Male; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2005 |
An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease.
Topics: C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrinogen; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Serum Amyloid A Protein | 2005 |
Homocysteine, renal disease and cardiovascular disease in a remote Australian Aboriginal community.
Topics: Adult; Albuminuria; Arteriosclerosis; Australia; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Native Hawaiian or Other Pacific Islander; Polymorphism, Genetic; Regression Analysis; Rural Population; Vitamin B 12 | 2005 |
Adiponectin levels and cardiovascular risk factors in Japanese men with type 2 diabetes.
Topics: Adiponectin; Adult; Aging; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Folic Acid; gamma-Glutamyltransferase; Glycated Hemoglobin; Homocysteine; Humans; Intercellular Signaling Peptides and Proteins; Japan; Leukocyte Count; Lipids; Male; Middle Aged; Risk Factors; Smoking | 2005 |
[The plasma homocysteine, folic acid and vitamin B12 levels in young people with high risk for cardiovascular disease and its relation to metylentetrahydrofolate reductase (MTHFR) gene polymorphism].
Topics: Adult; Cardiovascular Diseases; Cytosine; Female; Folic Acid; Heterozygote; Homocysteine; Humans; Immunoassay; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors; Thymine; Vitamin B 12 | 2005 |
Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Topics: Adiponectin; Adult; Blood Pressure; Cardiovascular Diseases; Family; Family Health; Female; Glucose Intolerance; Homocysteine; Hormones, Ectopic; Humans; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Lipids; Male; Middle Aged; Polycystic Ovary Syndrome; Prevalence; Resistin; Risk Factors | 2005 |
Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study.
Topics: Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Cardiovascular Diseases; Coronary Disease; Early Diagnosis; Female; Follow-Up Studies; Germany; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Assessment; Survival Rate | 2005 |
Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Topics: Adult; Cardiovascular Diseases; Carotid Arteries; Cytokines; Female; Genotype; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Polymorphism, Genetic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Tunica Intima | 2005 |
Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project.
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Exercise; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Kidney; Life Style; Male; Metabolic Syndrome; Risk Factors; Sex Factors; Sulfonylurea Compounds | 2005 |
Genetic, dietary, and other lifestyle determinants of serum homocysteine levels in young adults in Costa Rica.
Topics: Adult; Cardiovascular Diseases; Costa Rica; Cross-Sectional Studies; Diet; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Male; Risk Factors | 2005 |
Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety; Biomarkers; Blood Coagulation; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Interleukin-6; Leukocyte Count; Male; Middle Aged; Risk Factors; Tumor Necrosis Factor-alpha | 2006 |
Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Apolipoproteins A; Apolipoproteins B; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Homocysteine; Humans; Insulin; Lipoprotein(a); Lipoproteins; Luteinizing Hormone; Obesity; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 2005 |
Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome.
Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Homocysteine; Humans; Lipids; Male; Middle Aged; Obesity; Risk Factors; Sleep Apnea, Obstructive | 2006 |
[Arterial wave velocity and coronary risk factors in patients with type-2 diabetes].
Topics: Aged; Aged, 80 and over; Albuminuria; Blood Flow Velocity; Cardiovascular Diseases; Compliance; Coronary Vessels; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 2005 |
The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Topics: Adolescent; Adult; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Enzyme Inhibitors; Female; Homocysteine; Hormone Replacement Therapy; Humans; Hypothyroidism; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Nitric Oxide; Risk Factors; Thyrotropin; Thyroxine; Triiodothyronine | 2005 |
Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Diet, Vegetarian; Female; Homocysteine; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Regression Analysis; Risk Factors; Serum Albumin; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamins | 2005 |
Are we losing homocysteine as a cardiovascular risk factor?
Topics: Atherosclerosis; Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Assessment; Risk Factors | 2005 |
Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey 1999-2002.
Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Energy Metabolism; Exercise Test; Exercise Tolerance; Female; Health Surveys; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Muscle, Skeletal; Physical Fitness; Sex Factors; United States | 2005 |
Association of B vitamins status and homocysteine levels in elderly Taiwanese.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Folic Acid Deficiency; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nutrition Surveys; Nutritional Status; Sex Factors; Taiwan; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Complex | 2005 |
[Nutrition as heart issue: micronutrients protect women's hearts].
Topics: Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Micronutrients; Nutritional Requirements; Risk Factors; Sex Factors; Vitamin B 12 | 2005 |
Long-term consumption of a raw food diet is associated with favorable serum LDL cholesterol and triglycerides but also with elevated plasma homocysteine and low serum HDL cholesterol in humans.
Topics: Adult; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diet, Vegetarian; Female; Folic Acid; Fruit; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Triglycerides; Vegetables; Vitamin B 12 | 2005 |
White blood cell count is associated with plasma total homocysteine in Japanese men.
Topics: Cardiovascular Diseases; gamma-Glutamyltransferase; Homocysteine; Humans; Japan; Leukocyte Count; Male; Middle Aged; Risk Factors | 2005 |
What is homocysteine and why is it important in terms of atherosclerosis?
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Vitamin B Complex | 2005 |
Measuring the homocysteine level.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Hematologic Tests; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 2005 |
Preventing adverse cardiovascular outcomes.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Vitamins | 2005 |
Young hemodialysis patients are exposed to hyperhomocysteinemia.
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cross-Sectional Studies; Electrocardiography; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Myocardial Ischemia; Prognosis; Prospective Studies; Renal Dialysis; Risk Factors | 2005 |
Implications of emerging risk factors for therapeutic intervention.
Topics: Advisory Committees; Algorithms; Anticholesteremic Agents; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Europe; Health Care Costs; Homocysteine; Humans; International Cooperation; Lipoprotein(a); Practice Guidelines as Topic; Reference Values; Risk Assessment; Risk Factors; Sensitivity and Specificity; United States | 2005 |
Cigarette smoking and cardiovascular risk factors among Aboriginal Canadian youths.
Topics: Adolescent; Adolescent Behavior; Adult; Blood Pressure; Cardiovascular Diseases; Child; Cross-Sectional Studies; Female; Homocysteine; Humans; Indians, North American; Male; Ontario; Risk Factors; Smoking | 2005 |
Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
Topics: Adult; Albuminuria; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hypertension; Male; Microcirculation; Prospective Studies; Risk Factors | 2005 |
Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Chi-Square Distribution; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypothyroidism; Inflammation; Linear Models; Male; Middle Aged; Thyrotropin; Thyroxine | 2005 |
Proceedings of the Fourth Conference on Hyperhomocysteinemia. Saarbrücken, Germany. April 14-16, 2005.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2005 |
Changes in lifestyle and total homocysteine in relation to MTHFR(C677T) genotype: the Inter99 study.
Topics: Adult; Alcohol Drinking; Carbon-Nitrogen Ligases; Cardiovascular Diseases; Coffee; Cross-Sectional Studies; Denmark; Exercise; Feeding Behavior; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Life Style; Male; Middle Aged; Risk Factors; Smoking; Tea | 2006 |
Elevated homocysteine levels in patients with end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Statistics, Nonparametric; Vitamin B 12 | 2005 |
[Is homocysteine an independent risk factor for cardiovascular disease?].
Topics: Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2005 |
Serum homocysteine concentration of US adults associated with fortified cereal consumption.
Topics: Adult; Age Factors; Cardiovascular Diseases; Cross-Sectional Studies; Edible Grain; Erythrocytes; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Mental Recall; Middle Aged; Multivariate Analysis; Nutrition Surveys; Nutritional Requirements; Regression Analysis; Sex Factors; United States | 2005 |
Using pseudo-data to correct for publication bias in meta-analysis.
Topics: Cardiovascular Diseases; Computer Simulation; Data Interpretation, Statistical; Homocysteine; Humans; Meta-Analysis as Topic; Methylenetetrahydrofolate Reductase (NADPH2); Publication Bias | 2006 |
Plasma total homocysteine and cardiovascular risk in patients submitted to liver transplantation.
Topics: Adult; Age Distribution; Aged; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Homocysteine; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Male; Middle Aged; Patient Selection; Postoperative Care; Postoperative Complications; Preoperative Care; Prevalence; Proportional Hazards Models; Risk Assessment; Sex Distribution; Statistics, Nonparametric; Transplantation Immunology; Treatment Outcome | 2006 |
[Homocysteinaemia and degenerative complications in non insulin dependent diabetes mellitus].
Topics: Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Homocysteine; Humans; Male | 2005 |
Increased plasma protein homocysteinylation in hemodialysis patients.
Topics: Adult; Aged; Blood Proteins; Cardiovascular Diseases; Case-Control Studies; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; In Vitro Techniques; Male; Middle Aged; Models, Molecular; Protein Binding; Protein Processing, Post-Translational; Renal Dialysis; Serum Albumin; Uremia; Vitamin B 12; Vitamin B 6; Xenobiotics | 2006 |
Homocysteine and risk in end-stage renal disease: a matter of context.
Topics: Blood Pressure; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Kidney Failure, Chronic; Malnutrition; Risk Factors | 2006 |
Impact of malnutrition-inflammation on the association between homocysteine and mortality.
Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Male; Malnutrition; Middle Aged; Prospective Studies; Renal Dialysis; Risk Factors | 2006 |
Plasma total homocysteine level and its association with carotid intima-media thickness in obesity.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cross-Sectional Studies; Female; Homocysteine; Humans; Insulin Resistance; Male; Obesity; Platelet Factor 4; Risk Factors; Sex Characteristics; Tunica Intima; Waist-Hip Ratio | 2005 |
Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blotting, Western; Cardiovascular Diseases; Case-Control Studies; Cells, Cultured; Chromatography, High Pressure Liquid; Copper; Electrophoretic Mobility Shift Assay; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Lipoproteins, LDL; Male; Methionine; Middle Aged; Nitrites; Osteoarthritis; Receptors, Scavenger; Tyrosine; Umbilical Veins | 2006 |
Is homocysteine an iron-dependent cardiovascular risk factor?
Topics: Adult; Cardiovascular Diseases; Chelating Agents; Endothelium, Vascular; Female; Ferritins; Homocysteine; Humans; Iron; Iron Deficiencies; Male; Methionine; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Sex Characteristics; Vasodilation | 2006 |
Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study.
Topics: Adult; Age Factors; Cardiovascular Diseases; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Iran; Male; Middle Aged; Nutrition Surveys; Prevalence; Sex Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2006 |
Modulation of cardiovascular risk factors by obstructive sleep apnea.
Topics: C-Reactive Protein; Cardiovascular Diseases; Continuous Positive Airway Pressure; Homocysteine; Humans; Risk Factors; Sleep Apnea, Obstructive | 2006 |
Serum cardiovascular risk factors in obstructive sleep apnea.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Echocardiography; Homocysteine; Humans; Lipids; Male; Middle Aged; Prognosis; Risk Factors; Sleep Apnea, Obstructive | 2006 |
Folate supplementation: too much of a good thing?
Topics: Carcinogens; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Food, Fortified; Homocysteine; Neoplasms; Neural Tube Defects; Preconception Care; Vitamin B Complex | 2006 |
No added value of the methionine loading task in assessment for venous thrombosis and cardiovascular disease risk.
Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Practice Guidelines as Topic; Risk; ROC Curve; Venous Thrombosis | 2006 |
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Topics: Adult; Aging; Apolipoproteins A; Apolipoproteins B; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Hypertension; Kidney Diseases; Lipoprotein(a); Male; Peritoneal Dialysis; Renal Dialysis; Risk Factors | 2005 |
Homocysteine targeting of plasma proteins in hemodialysis patients.
Topics: Blood Proteins; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Protein Processing, Post-Translational; Renal Dialysis | 2006 |
Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
Topics: Adult; Analysis of Variance; Biomarkers; Blood Flow Velocity; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Diastole; Female; Homeostasis; Homocysteine; Humans; Hypertension; Insulin; Insulin Resistance; Interleukin-18; Lipids; Lupus Erythematosus, Systemic; Risk Factors; Statistics, Nonparametric; Triglycerides | 2006 |
Homocysteine trials--clear outcomes for complex reasons.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Methylation; Myocardial Infarction; Secondary Prevention; Vascular Diseases; Vitamin B 12; Vitamin B 6 | 2006 |
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
Topics: Biomarkers; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Exercise; Female; Fibrinogen; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Lipoproteins; Middle Aged; Overweight; Risk Factors | 2006 |
Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Fasting; Female; Health Surveys; Heart Failure; Homocysteine; Humans; Insulin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Regression Analysis; Risk Factors; United States | 2006 |
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postmenopause; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Time Factors; White People | 2006 |
Clinical significance of homocysteine in elderly hospitalized patients.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Creatinine; Female; Hemoglobins; Homocysteine; Humans; Lymphocyte Count; Male; Neutrophils; Nutritional Status; Predictive Value of Tests; Risk Factors; Serum Albumin; Statistics, Nonparametric; Survival Analysis; Triazoles; Vitamin B 12 | 2006 |
Folate supplementation and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Hematinics; Homocysteine; Humans; Randomized Controlled Trials as Topic; Stroke; Vitamin B 12; Vitamin B 6 | 2006 |
Cardiovascular risk assessment and homocysteine and leptin levels in peritoneal dialysis and hemodialysis patients.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Leptin; Lipids; Peritoneal Dialysis; Renal Dialysis; Risk Assessment; Risk Factors; Vitamin B Complex | 2005 |
Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Topics: Adolescent; Adolescent Nutritional Physiological Phenomena; Age Factors; Aging; Blood Pressure; Cardiovascular Diseases; Child; Child Nutritional Physiological Phenomena; Female; Folic Acid; Greece; Health Surveys; Homocysteine; Humans; Hyperhomocysteinemia; Male; Reference Values; Risk Factors; Sex Factors; Social Class; Vitamin B 12; Vitamin B Complex | 2006 |
[The uses of clinical studies].
Topics: Cardiovascular Diseases; Drug Industry; Homocysteine; Humans; Myocardial Infarction; Risk Factors | 2006 |
C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease.
Topics: Aged; Aged, 80 and over; C-Reactive Protein; Cardiovascular Diseases; Cognition Disorders; Female; Homocysteine; Humans; Male; Middle Aged; Neuropsychological Tests; Prospective Studies | 2006 |
Role of endothelial function and inflammation in patients with cardiovascular risk factors, with and without a history of myocardial infarction.
Topics: Adult; Analysis of Variance; Blood Flow Velocity; Brachial Artery; Cardiovascular Diseases; Cholesterol; Endothelium, Vascular; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Male; Middle Aged; Myocardial Infarction; Risk Factors; Statistics, Nonparametric; Ultrasonography | 2007 |
Serum homocysteine is related to food intake in adolescents: the Child and Adolescent Trial for Cardiovascular Health.
Topics: Adolescent; Cardiovascular Diseases; Diet; Diet Surveys; Female; Food Analysis; Health Behavior; Health Promotion; Homocysteine; Humans; Linear Models; Male; Surveys and Questionnaires; Vitamin B Complex | 2006 |
Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide.
Topics: Aged; Arginine; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Folic Acid; Genetic Variation; Genotype; Homocysteine; Humans; Linkage Disequilibrium; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Single Nucleotide; Postmenopause; Risk Factors; Vitamin B 12 | 2006 |
[Cardiology -- an update].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Cardiovascular Diseases; Diagnosis, Differential; Homocysteine; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Stents; Treatment Outcome; Vitamin B Complex | 2006 |
Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?
Topics: C-Reactive Protein; Cardiovascular Diseases; Cohort Studies; Cross-Sectional Studies; Fibrin Fibrinogen Degradation Products; Fibrinogen; Homocysteine; Humans; Hypothyroidism; Middle Aged; Risk Factors; Thyrotropin; Thyroxine | 2006 |
Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors.
Topics: Adolescent; Adult; Aged; Aorta; Atherosclerosis; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Cushing Syndrome; Female; Femoral Artery; Homocysteine; Humans; Lipids; Lipoprotein(a); Male; Middle Aged; Research Design; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2006 |
Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Female; Homocysteine; Humans; Hypothyroidism; Lipoprotein(a); Lipoproteins, LDL; Male; Middle Aged; Risk Factors; Thyrotropin; Thyroxine | 2006 |
Homocysteine and vitamin B(12) concentrations and mortality rates in type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Arizona; Cardiovascular Diseases; Cause of Death; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Folic Acid; Homocysteine; Humans; Indians, North American; Infections; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Serum Albumin; Vitamin B 12 | 2007 |
Sleep disturbances, oxidative stress and cardiovascular risk parameters in postmenopausal women complaining of insomnia.
Topics: Cardiovascular Diseases; Catalase; Female; Folic Acid; Homocysteine; Humans; Middle Aged; Oxidative Stress; Polysomnography; Postmenopause; Risk Factors; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin B 6 | 2006 |
Relation between vascular risk factors and cognition at age 75.
Topics: Aged; Aging; Alzheimer Disease; Austria; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cognition Disorders; Cohort Studies; Comorbidity; Cross-Sectional Studies; Female; Glycated Hemoglobin; Homocysteine; Humans; Hyperlipidemias; Hypertension; Lipoproteins; Male; Neuropsychological Tests; Risk Factors; Smoking; Statistics as Topic; Triglycerides | 2006 |
Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cohort Studies; Female; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sulfhydryl Compounds | 2006 |
[Markers predicting progression of disease in PAD: Which of them are both relevant to clinical practice and economically justifiable?].
Topics: Arterial Occlusive Diseases; Biomarkers; Cardiovascular Diseases; Cost of Illness; Disease Progression; Germany; Homocysteine; Humans; Multivariate Analysis; Peripheral Vascular Diseases; Risk Factors | 2006 |
The Dietary Quality Score: validation and association with cardiovascular risk factors: the Inter99 study.
Topics: Adult; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Denmark; Diet; Female; Homocysteine; Humans; Lipids; Male; Mass Screening; Middle Aged; Myocardial Ischemia; Risk Factors; Surveys and Questionnaires | 2007 |
The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea.
Topics: Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Creatine Kinase; Creatinine; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Isoenzymes; Korea; L-Lactate Dehydrogenase; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Natriuretic Peptide, Brain; Troponin I | 2006 |
Patient information. The importance of homocysteine.
Topics: Biological Availability; Cardiovascular Diseases; Causality; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Nurse Practitioners; Risk Reduction Behavior; Tetrahydrofolates | 2006 |
Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
Topics: Adiponectin; Adult; Apolipoproteins B; Apoprotein(a); Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Female; Fibrinogen; Homocysteine; Humans; Hyperthyroidism; Hypothyroidism; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Risk Factors | 2006 |
Letter by Undas and Jakubowski regarding article, "Relationship between homocysteine and mortality in chronic kidney disease".
Topics: Cardiovascular Diseases; Homocysteine; Humans; Kidney Failure, Chronic | 2006 |
[Increase of homocysteine in cardiovascular diseases in Hungary].
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; COUP Transcription Factor II; Diabetes Mellitus, Type 2; Factor XIII; Female; Folic Acid; Homocysteine; Humans; Hungary; Hyperhomocysteinemia; Linear Models; Male; Middle Aged; Patient Selection; Polymorphism, Genetic; Retrospective Studies; Risk Factors; Vitamin B 12 | 2006 |
Oxidative stress in renal transplant patients who develop cardiovascular disease.
Topics: Adult; Age Factors; Aged; Biomarkers; Canada; Cardiovascular Diseases; Case-Control Studies; Erythrocytes; Female; Glutathione; Homocysteine; Humans; Kidney Transplantation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Postoperative Complications; Reactive Oxygen Species | 2006 |
Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Topics: Arginine; Atherosclerosis; Cardiovascular Diseases; Comorbidity; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide Synthase; Proportional Hazards Models; Regression Analysis; Renal Dialysis; Risk Factors | 2006 |
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Educational Status; Female; Homocysteine; Humans; Income; Lipids; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Socioeconomic Factors | 2006 |
Consequences of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats.
Topics: Animals; Blood Gas Analysis; Body Weight; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Chronic Disease; Cysteine; Folic Acid; Homocysteine; Hypoxia; Male; Rats; Rats, Wistar; Risk Factors; Sleep Apnea Syndromes; Sleep Deprivation; Sleep, REM; Triglycerides; Vitamin B 12 | 2007 |
[Preclinical diagnosis of cardiovascular diseases in workers engaged into industries with radiation danger].
Topics: Adult; Algorithms; C-Reactive Protein; Cardiovascular Diseases; Chemical Industry; Chi-Square Distribution; Cohort Studies; Data Interpretation, Statistical; Homocysteine; Humans; Lipids; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Platelet Aggregation; Radiation Effects; Risk Factors; Siberia; Smoking; Time Factors | 2006 |
[Vitamins to reduce homocysteine levels and prevent cardiovascular disease: food or supplementation?].
Topics: Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Food; Homocysteine; Humans; Vitamins | 2006 |
[Uncertain effects of folic acid on disorders other than neural-tube defects].
Topics: Animals; Cardiovascular Diseases; Dose-Response Relationship, Drug; Evidence-Based Medicine; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Randomized Controlled Trials as Topic; Time Factors | 2006 |
Association of cardiovascular risk factors and disease with depression in later life.
Topics: Age of Onset; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Cross-Sectional Studies; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Homocysteine; Humans; Male; Myocardial Infarction; Risk Factors; Stroke; Surveys and Questionnaires; Triglycerides | 2007 |
[The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome].
Topics: Biomarkers; Cardiovascular Diseases; Continuous Positive Airway Pressure; Homocysteine; Humans; Leptin; Male; Middle Aged; Polysomnography; Risk Factors; Sleep Apnea, Obstructive | 2006 |
Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; India; Middle Aged; Risk Assessment; Risk Factors; Vitamin B 12 | 2006 |
I think I should take folic acid supplements to lower my risk of heart disease. A friend told me not to bother. Who's right?
Topics: Cardiovascular Diseases; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Risk Factors | 2006 |
Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans; Male; Obesity; Positive-Pressure Respiration; Prospective Studies; Risk Factors; Sleep Apnea, Obstructive | 2007 |
Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults.
Topics: Adult; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cotinine; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Leukocyte Count; Male; Middle Aged; Risk Factors; Tobacco Smoke Pollution | 2007 |
Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily.
Topics: Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Diabetes Mellitus; Folic Acid; Homocysteine; Humans; Middle Aged; Neoplasms; Peripheral Vascular Diseases; Sicily; Stroke; Vitamin B 12 | 2007 |
Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults.
Topics: Adolescent; Adult; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Japan; Regression Analysis; Risk Factors; Tunica Intima | 2007 |
Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.
Topics: Cardiovascular Diseases; Data Interpretation, Statistical; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Genotype; Homocysteine; Humans; Incidence; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Prospective Studies; Risk Factors; Vitamin B Complex | 2007 |
Total cardiovascular risk profile of Taiwanese vegetarians.
Topics: C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Diet, Vegetarian; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Nutritional Status; Risk Assessment; Risk Factors; Taiwan; Vitamin B 12; Vitamin B 12 Deficiency | 2008 |
Elevated plasma homocysteine in older shift-workers: a potential risk factor for cardiovascular morbidity.
Topics: Adult; Aging; C-Reactive Protein; Cardiovascular Diseases; Demography; Employment; Homocysteine; Humans; Israel; Male; Middle Aged; Morbidity; Regression Analysis; Risk Factors; Sleep Disorders, Circadian Rhythm | 2007 |
Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women.
Topics: Aged; Betaine; Cardiovascular Diseases; Choline; Cohort Studies; Diet; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Middle Aged; Netherlands; Nutrition Surveys; Odds Ratio; Postmenopause; Prospective Studies; Surveys and Questionnaires | 2008 |
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study.
Topics: Aged; Aging; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Cohort Studies; Factor VIII; Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Inflammation Mediators; Interleukin-6; Leukocyte Count; Lipoprotein(a); Male; Prospective Studies; Risk Factors | 2007 |
Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: The MESA Study.
Topics: Aged; Aged, 80 and over; Albuminuria; Body Mass Index; C-Reactive Protein; Calcinosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus; Diet; Edible Grain; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Prospective Studies | 2007 |
[Endothelial dysfunction is associated with insulin resistance in patients with rheumatoid arthritis].
Topics: Adult; Arthritis, Rheumatoid; Biomarkers; Blood Sedimentation; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Data Interpretation, Statistical; Endothelium, Vascular; Homocysteine; Humans; Insulin Resistance; Lipids; Middle Aged; Risk Factors | 2007 |
Is homocysteine a risk factor for atherothrombotic cardiovascular disease?
Topics: Atherosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors; Thrombosis | 2007 |
Folic acid supplementation and cardiovascular diseases.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Risk; Vitamin B Complex | 2007 |
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
Topics: Biomarkers; Cardiovascular Diseases; Chronic Disease; DNA Methylation; DNA-Cytosine Methylases; Epigenesis, Genetic; Female; Folic Acid; Homocysteine; Humans; Inflammation; Kidney Diseases; Male; Middle Aged; Oxidative Stress; Reproducibility of Results; Risk Factors | 2007 |
The association of homocysteine and related factors to brachial artery diameter and flow-mediated dilation.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Aged; Brachial Artery; Cardiovascular Diseases; Dilatation, Pathologic; DNA; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Point Mutation; Polymerase Chain Reaction; Ultrasonography; Vitamin B 12; Vitamin B 6 | 2007 |
Increased carotid intima media thickness and cardiac biomarkers in HIV infected children.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Body Composition; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Artery, Common; Carotid Artery, Internal; Child; Child, Preschool; Cross-Sectional Studies; Drug Administration Schedule; Female; HIV Infections; Homocysteine; Humans; Lipids; Male; Peroxidase; Tunica Intima; Tunica Media; Ultrasonography | 2007 |
Folic acid and B vitamins improve hyperhomocysteinemia-induced cardiovascular risk profile in renal transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Kidney Transplantation; Male; Middle Aged; Risk Factors; Vitamin B Complex | 2007 |
Homocysteine and cardiovascular risk: considering the evidence in the context of study design, folate fortification, and statistical power.
Topics: Cardiovascular Diseases; Data Interpretation, Statistical; Dietary Supplements; Epidemiologic Methods; Evidence-Based Medicine; Folic Acid; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prospective Studies; Research Design; Risk Factors; Twin Studies as Topic; Vitamin B Complex | 2007 |
Cardiovascular and thrombophilic risk factors in patients with retinal artery occlusion.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Middle Aged; Odds Ratio; Pilot Projects; Polymorphism, Single Nucleotide; Retinal Artery Occlusion; Risk Factors; Smoking; Thrombophilia | 2007 |
Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES.
Topics: Adult; Aged; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Educational Status; Female; Fibrinogen; Homocysteine; Humans; Income; Lipoproteins, HDL; Logistic Models; Male; Middle Aged; Nutrition Surveys; Risk Factors; Social Class; Stress, Psychological; United States | 2007 |
Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.
Topics: Adrenomedullin; Aged; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Manometry; Massachusetts; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Protein Precursors; Risk Factors | 2007 |
Can B vitamin therapy help to prevent future vascular events?
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B 12 | 2007 |
Homocysteine--an indicator of a healthy diet?
Topics: Aged; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Diet; Dietary Fats; Fatty Acids; Fatty Acids, Omega-3; Homocysteine; Humans; Middle Aged; Vitamin B Complex | 2007 |
Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients.
Topics: Adult; Aged; Analysis of Variance; Antioxidants; Audiometry; Cardiovascular Diseases; Cholesterol; Coenzymes; Female; Hearing Loss, Sensorineural; Homocysteine; Humans; Italy; Lipoproteins, LDL; Male; Middle Aged; Prospective Studies; Risk Factors; Ubiquinone | 2007 |
Hyperhomocysteinemia in winter elite athletes: a longitudinal study.
Topics: Adult; Cardiovascular Diseases; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Male; Methylenetetrahydrofolate Reductase (NADPH2); Physical Exertion; Prevalence; Risk Factors; Seasons; Sex Distribution; Sports | 2007 |
Influence of 677 C-->T polymorphism of methylenetetrahydrofolate reductase on medium-term prognosis after acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Female; Follow-Up Studies; Genetic Predisposition to Disease; Homocysteine; Humans; Kaplan-Meier Estimate; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Syndrome; Time Factors | 2007 |
Folate deficiency and plasma homocysteine during increased oxidative stress.
Topics: Alzheimer Disease; Animals; Apolipoproteins E; Cardiovascular Diseases; Disease Models, Animal; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Mice; Mice, Transgenic; Oxidative Stress; Risk Factors | 2007 |
Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection.
Topics: Adult; Blood Flow Velocity; Cardiovascular Diseases; Coronary Circulation; Female; Folic Acid; Helicobacter Infections; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Vitamin B 12 | 2007 |
Relations of glutamate carboxypeptidase II (GCPII) polymorphisms to folate and homocysteine concentrations and to scores of cognition, anxiety, and depression in a homogeneous Norwegian population: the Hordaland Homocysteine Study.
Topics: Alcohol Drinking; Animals; Antigens, Surface; Anxiety; Cardiovascular Diseases; Cognition; Depression; DNA; DNA Primers; Exons; Female; Folic Acid; Genotype; Glutamate Carboxypeptidase II; Homocysteine; Humans; Linkage Disequilibrium; Male; Norway; Polymorphism, Genetic; Temperance | 2007 |
[Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease].
Topics: Adult; Annexins; Biomarkers; Cardiovascular Diseases; Carotid Artery, Common; Disease Progression; Endothelium, Vascular; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Risk Factors; Tunica Intima; Ultrasonography, Doppler | 2007 |
The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Cardiovascular Diseases; Creatinine; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors | 2007 |
Homocysteine-lowering vitamins and cardiovascular mortality: are they really effective?
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Vitamins | 2008 |
Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats.
Topics: Animals; Aorta; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Caveolin 2; Cholesterol; Cysteine; Homocysteine; Hydroxymethylglutaryl CoA Reductases; Hyperhomocysteinemia; In Vitro Techniques; Leukotrienes; Liver; Male; Methionine; Nitric Oxide; Rats; Rats, Wistar; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2Y2; Resistin; Tunica Media | 2007 |
Cardiovascular risk factors and homocysteine in epilepsy.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Body Mass Index; Cardiovascular Diseases; Epilepsy; Homocysteine; Humans; Hypercholesterolemia; Hypertension; Meta-Analysis as Topic; Middle Aged; Prevalence; Risk Factors; Smoking | 2007 |
Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Diet; Europe; Folic Acid; Homocysteine; Humans; Middle Aged; Nutritional Requirements; Vitamin B 12; Young Adult | 2009 |
Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS).
Topics: Arginine; Body Mass Index; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Polysomnography; Severity of Illness Index; Sleep Apnea, Obstructive | 2008 |
Risk factors for cardiovascular disease in patients with anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Body Mass Index; Cardiovascular Diseases; Cholesterol; Colorimetry; Cushing Syndrome; Female; Homocysteine; Humans; Risk Factors; Triglycerides | 2007 |
Carotid atherosclerosis and cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery Diseases; Female; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; N-Acetylneuraminic Acid; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Thiobarbituric Acid Reactive Substances; Tunica Intima; Ultrasonography | 2007 |
Immunoregulatory effects of homocysteine on cardiovascular diseases.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Macrophages; Nitric Oxide; Oxidative Stress | 2007 |
Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Erythrocytes; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Neural Tube Defects; Nutrition Policy; Nutritional Status; Vitamin B 12; Vitamin B 6 | 2007 |
Homocysteine and cognitive performance: modification by the ApoE genotype.
Topics: Adult; Aged; Aged, 80 and over; Apolipoprotein E4; Cardiovascular Diseases; Cognition; Cross-Sectional Studies; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Neuropsychological Tests; Risk Factors; Vitamin B Complex | 2008 |
Determinants of plasma homocysteine levels and carotid intima-media thickness in Japanese.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Chromatography, High Pressure Liquid; Creatinine; Female; Homocysteine; Humans; Japan; Male; Middle Aged; Risk Factors; Sex Factors; Tunica Intima; Tunica Media; Ultrasonography | 2007 |
Anatomical relationship between traditional acupuncture point ST 36 and Omura's ST 36 (True ST 36) with their therapeutic effects: 1) inhibition of cancer cell division by markedly lowering cancer cell telomere while increasing normal cell telomere, 2) im
Topics: Acupuncture; Acupuncture Points; Blood Cell Count; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cell Division; Electroacupuncture; Gastric Fundus; Homocysteine; Humans; Hypertriglyceridemia; Lasers; Lipids; Myocardium; Neoplasms; Telomere; Troponin I; Uric Acid | 2007 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
A comparison of some of the cardiovascular risk factors in vegetarian and omnivorous Turkish females.
Topics: Adult; Cardiovascular Diseases; Diet; Diet Records; Diet, Vegetarian; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Middle Aged; Nutritional Status; Risk Factors; Turkey; Vitamin B 12 | 2008 |
Homocysteine is a potent modulator of plasma membrane electron transport systems.
Topics: Animals; Antineoplastic Agents; Cardiovascular Diseases; Cattle; Cell Line, Tumor; Cell Membrane; Electron Transport; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; NADPH Oxidases; Neoplasm Proteins; Neoplasms; Oxidation-Reduction; Risk Factors | 2008 |
Sport-related hyperhomocysteinaemia: a putative marker of muscular demand to be noted for cardiovascular risk.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Interleukin-6; L-Lactate Dehydrogenase; Male; Muscle, Skeletal; Risk Factors; Sports; Vitamin B 12 | 2008 |
Homocysteine levels and leukocyte telomere length.
Topics: Adult; Cardiovascular Diseases; Cohort Studies; Female; Homocysteine; Humans; Leukocytes; Male; Middle Aged; Models, Biological; Obesity; Oxidative Stress; Sex Factors; Smoking; Telomere | 2008 |
Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats.
Topics: Animals; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Diet; Homocysteine; Hyperhomocysteinemia; Male; Mesenteric Arteries; Methionine; Rats; Rats, Wistar; Vasodilation | 2008 |
Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes.
Topics: Azacitidine; Base Sequence; Cardiovascular Diseases; Cells, Cultured; Cholesterol; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Primers; Epigenesis, Genetic; Foam Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Homocysteine; Humans; Hydrogen Peroxide; Hydroxamic Acids; Lipoproteins, LDL; Methyl-CpG-Binding Protein 2; Models, Biological; Monocytes; RNA, Messenger; Superoxide Dismutase | 2008 |
Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Diet Records; Erythrocytes; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Lipids; Middle Aged; Nutritional Status; Pyridoxal Phosphate; Risk Factors; Transcobalamins; Vitamin B 12; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Complex | 2008 |
Is folic acid good for everyone?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cognition; Epigenesis, Genetic; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Neoplasms; Neural Tube Defects; Nutrition Policy; Nutritional Requirements; Public Health; Vitamin B 12 Deficiency | 2008 |
[Homocysteine levels in patients with obstructive sleep apnea syndrome].
Topics: Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Polysomnography; Prospective Studies; Risk Factors; ROC Curve; Sleep Apnea, Obstructive | 2008 |
Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD.
Topics: Adipose Tissue; Adult; Anthropometry; Blood Pressure; Body Composition; Cardiovascular Diseases; Female; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Muscle, Skeletal; Nephelometry and Turbidimetry; Nigeria; Risk Factors; Sex Factors; Skinfold Thickness; Socioeconomic Factors; Waist-Hip Ratio | 2008 |
Homocysteine or renal impairment: which is the real cardiovascular risk factor?
Topics: Aged; Aged, 80 and over; Biomarkers; Brachial Artery; Cardiovascular Diseases; Carotid Arteries; Cross-Sectional Studies; Cystatin C; Cystatins; Female; Folic Acid; Follow-Up Studies; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Male; Middle Aged; Predictive Value of Tests; Regional Blood Flow; Regression Analysis; Risk Factors; Vitamin B 12; Vitamin B 6 | 2008 |
Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Risk Factors; Triglycerides | 2008 |
Assessment of cardiovascular risk in shift healthcare workers.
Topics: Adult; Aged; Cardiovascular Diseases; Circadian Rhythm; Female; Health Personnel; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Metabolic Syndrome; Middle Aged; Occupational Diseases; Prevalence; Risk Assessment; Risk Factors; Work Schedule Tolerance | 2008 |
The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Case-Control Studies; Child; Creatine; Creatinine; Female; Glycine; Homocysteine; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Methylation; Risk Factors | 2008 |
Plasma gamma-glutamyl transferase activity predicts homocysteine concentration in a large cohort of unselected outpatients.
Topics: Cardiovascular Diseases; Cohort Studies; Female; gamma-Glutamyltransferase; Homocysteine; Humans; Male; Middle Aged; Outpatients; Predictive Value of Tests; Retrospective Studies; Risk Factors | 2008 |
Inflammation, homocysteine and carotid intima-media thickness.
Topics: Aged; Cardiovascular Diseases; Carotid Arteries; Female; Homocysteine; Humans; Inflammation; Kidney Failure, Chronic; Male; Risk Factors; Tunica Intima; Tunica Media | 2008 |
Homocysteine-lowering B vitamin therapy in cardiovascular prevention--wrong again?
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cohort Studies; Female; Folic Acid; Homocysteine; Humans; Male; Risk Factors; United Kingdom; Vitamin B 12 | 2008 |
The homocysteine paradox.
Topics: Animals; Arginine; Cardiovascular Diseases; Cystatin C; Cystatins; Disease Models, Animal; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases; Risk Factors; Vitamin B 12; Vitamin B 6 | 2008 |
Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.
Topics: Adult; Age Factors; Aged; Blood Pressure; Cardiovascular Diseases; Diet; Female; Health Surveys; Homocysteine; Humans; Male; Mass Screening; Middle Aged; Norway; Physical Fitness; Prospective Studies; Reference Values; Risk Factors; Sex Factors; Smoking; Statistics as Topic | 1995 |
Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer.
Topics: Autoanalysis; Calibration; Cardiovascular Diseases; Fluorescence Polarization Immunoassay; Homocysteine; Humans; Risk Factors; Sensitivity and Specificity | 1995 |
Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Confidence Intervals; Embolism, Cholesterol; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Prevalence; Renal Dialysis; Risk Factors; Serine; Vitamin B Complex | 1995 |
Can lowering homocysteine levels reduce cardiovascular risk?
Topics: Aged; Cardiovascular Diseases; Carotid Stenosis; Folic Acid; Homocysteine; Humans; Male; Risk Factors; Vitamin B 12 | 1995 |
Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification.
Topics: Amino Acid Sequence; Animals; Bacterial Proteins; Base Sequence; Cardiovascular Diseases; Chromosome Mapping; Chromosomes, Human, Pair 1; DNA, Complementary; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Molecular Sequence Data; Nervous System Diseases; Oxidoreductases Acting on CH-NH Group Donors; Pedigree; Point Mutation; Sequence Homology, Amino Acid; Swine | 1994 |
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.
Topics: Alleles; Amino Acid Metabolism, Inborn Errors; Base Sequence; Cardiovascular Diseases; Confidence Intervals; Cystathionine beta-Synthase; DNA Primers; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Molecular Sequence Data; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Prevalence; Reference Values; Risk Factors | 1996 |
Renal metabolism of homocysteine in vivo.
Topics: Animals; Biological Transport, Active; Cardiovascular Diseases; Glomerular Filtration Rate; Homocysteine; Humans; Kidney; Kidney Failure, Chronic; Rats; Renal Plasma Flow | 1995 |
Folic acid fortification of food.
Topics: Cardiovascular Diseases; Folic Acid; Food, Fortified; Homocysteine; Humans | 1996 |
Folic acid fortification of food.
Topics: Cardiovascular Diseases; Folic Acid; Food, Fortified; Homocysteine; Humans | 1996 |
Folic acid fortification of food.
Topics: Cardiovascular Diseases; Folic Acid; Food, Fortified; Homocysteine; Humans | 1996 |
Folate and cardiovascular disease. Why we need a trial now.
Topics: Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans | 1996 |
[Increased plasma level of homocysteine as cardiovascular risk factor].
Topics: Amino Acids; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 1996 |
[Homocysteine, a less well-known risk factor in cardiac and vascular diseases].
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Disease; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 1996 |
Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Topics: Adult; Aged; Amino Acid Sequence; Cardiovascular Diseases; Cholesterol, HDL; Comorbidity; Creatinine; DNA Mutational Analysis; Female; Folic Acid; Glucose Intolerance; Homocysteine; Humans; Hypertension; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Peritoneal Dialysis; Polymorphism, Restriction Fragment Length; Prevalence; Renal Dialysis; Risk Factors; Smoking; Vitamin B 12 | 1996 |
Lipoprotein patterns, plaque, homocysteine, and hormones among ongoing cardiology studies.
Topics: Apolipoproteins E; Atrial Fibrillation; Cardiac Rehabilitation; Cardiology; Cardiovascular Diseases; Depression; Electrocardiography; Estrogens; Female; Homocysteine; Humans; Lipoproteins; Male; Obesity; Risk Factors; Sleep Apnea Syndromes; Tomography, Emission-Computed | 1996 |
Prevalence of familial mild hyperhomocysteinemia.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Cardiovascular Diseases; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Pedigree | 1996 |
Homocysteine and cardiovascular disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Aged; Cardiovascular Diseases; Diet; Female; Folic Acid; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases; Risk Factors; Vitamin B Deficiency | 1996 |
Hyperlipidaemia and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Hyperlipidemias | 1996 |
Perspective: a mechanism underlying homocysteinemia and increased risk of coronary artery and cerebrovascular disease.
Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Risk Factors | 1996 |
Serum total homocysteine concentration and risk of stroke.
Topics: Cardiovascular Diseases; Case-Control Studies; Coronary Disease; Homocysteine; Humans; Male; Odds Ratio; Risk Factors; United Kingdom | 1996 |
Homocyst(e)ine is bad for blood vessels, but how come?
Topics: Arteriosclerosis; Blood Vessels; Cardiovascular Diseases; Cysteine; Homocysteine; Homocystine; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Methionine; Risk Factors | 1996 |
The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women.
Topics: Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Lipids; Longitudinal Studies; Middle Aged; Oxidation-Reduction; Postmenopause; Prospective Studies | 1997 |
Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol; Coffee; Cohort Studies; Dose-Response Relationship, Drug; Female; Homocysteine; Humans; Male; Middle Aged; Norway; Pregnancy; Pregnancy Outcome; Risk Factors; Surveys and Questionnaires | 1997 |
Plasma homocysteine and cardiovascular disease mortality.
Topics: Adult; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 1997 |
V677 mutation of methylenetetrahydrofolate reductases and cardiovascular disease in Canadian Inuit.
Topics: Adult; Alleles; Canada; Cardiovascular Diseases; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Inuit; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prevalence | 1997 |
Homocysteine signal cascade: production of phospholipids, activation of protein kinase C, and the induction of c-fos and c-myb in smooth muscle cells.
Topics: Aorta, Abdominal; Aorta, Thoracic; Cardiovascular Diseases; Cell Division; Diglycerides; Dizocilpine Maleate; DNA; Enzyme Activation; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Genes, fos; Glutamic Acid; Homocysteine; Humans; Immunoblotting; Muscle, Smooth, Vascular; N-Methylaspartate; Oncogenes; Pipecolic Acids; Polymerase Chain Reaction; Precipitin Tests; Protein Kinase C; Receptors, N-Methyl-D-Aspartate; RNA | 1997 |
Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia.
Topics: Adolescent; Age Distribution; Cardiovascular Diseases; Child; Diet; Family Health; Female; Folic Acid; Heterozygote; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Multivariate Analysis; Oxidoreductases Acting on CH-NH Group Donors; Parents; Point Mutation; Prevalence; Risk Factors; Sex Distribution; Vitamin B 12 | 1997 |
Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Diet; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Risk Factors | 1997 |
Homocysteine levels and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Pyridoxine; Vitamin B 12; Vitamins | 1997 |
Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study.
Topics: Aged; Arteriosclerosis; Blood Pressure; Cardiovascular Diseases; Carotid Stenosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Medical History Taking; Middle Aged; Myocardial Infarction; Netherlands; Prevalence | 1997 |
Common mutation in the methylenetetrahydrofolate reductase gene offers no support for mild hyperhomocysteinemia being a causal risk factor for cardiovascular disease.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 1997 |
The frequency of the methylenetetrahydrofolate reductase-gene mutation varies with age in the normal population.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cardiovascular Diseases; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Homocysteine; Humans; Hypertension; Japan; Longevity; Male; Mass Screening; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors | 1997 |
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
Topics: Adult; Aged; Arteriosclerosis; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cohort Studies; Comorbidity; Diabetes Mellitus; Fasting; Female; Folic Acid; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Proportional Hazards Models; Prospective Studies; Pyridoxine; Renal Dialysis; Single-Blind Method; Smoking; Treatment Outcome; Vitamin B 12 | 1997 |
Plasma total homocysteine levels in hyperthyroid and hypothyroid patients.
Topics: Adult; Aged; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Folic Acid; Homocysteine; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Aged; Multivariate Analysis; Risk Factors; Thyroxine; Triiodothyronine; Vitamin B 12 | 1998 |
Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Disease-Free Survival; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Risk Factors | 1998 |
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Homocysteine; Humans; Male; Middle Aged; Population Surveillance; Risk; Sex Factors | 1998 |
Homocysteine, folate, vitamin B6, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Nutritional Status; Pyridoxine; Risk Factors | 1998 |
Correlates of plasma total homocysteine in patients with hyperlipidaemia.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Regression Analysis; Sex Factors; Vitamin B 12 | 1997 |
Hyperhomocysteinaemia: a cardiovascular risk factor needing a large intervention trial?
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors | 1997 |
Drug utilization.
Topics: Arteriosclerosis; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Risk Factors | 1997 |
Selective screening for hyperhomocysteinemia in pediatric patients.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Anemia, Megaloblastic; Anorexia Nervosa; Cardiovascular Diseases; Child; Child, Preschool; Cystathionine beta-Synthase; Diabetes Mellitus, Type 1; Environment; Homocysteine; Humans; Infant; Marfan Syndrome; Mass Screening; Reference Values; Renal Insufficiency; Risk Factors | 1998 |
Eat right and take a multivitamin.
Topics: Cardiovascular Diseases; Congenital Abnormalities; Dietary Supplements; Edible Grain; Folic Acid; Food, Fortified; Homocysteine; Humans; Nutrition Policy; United States; Vitamins | 1998 |
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Osmolar Concentration; Oxidoreductases; Peritoneal Dialysis; Polymorphism, Genetic; Vitamin B 12 | 1998 |
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study.
Topics: Aged; Albuminuria; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dietary Proteins; Female; Glucose Tolerance Test; Homocysteine; Humans; Hypertension, Renal; Male; Middle Aged; Prevalence; Risk Factors | 1998 |
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Biomarkers; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Homocysteine; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Proteinuria; Regression Analysis; Vitamins | 1998 |
Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects.
Topics: Adolescent; Adult; Body Weight; Cardiovascular Diseases; Cholesterol, HDL; Female; Homocysteine; Humans; Insulin Resistance; Male; Risk Factors; Triglycerides | 1998 |
[The recommended daily intake of folic acid is insufficient for optimum homocysteine level].
Topics: Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia | 1998 |
High expression, purification, and properties of recombinant homocysteine alpha, gamma-lyase.
Topics: Animals; Carbon-Sulfur Lyases; Cardiovascular Diseases; Chromatography; Cloning, Molecular; Cysteine; Enzyme Stability; Escherichia coli; Homocysteine; Hydrogen-Ion Concentration; Hyperhomocysteinemia; Kinetics; Methionine; Protein Conformation; Protozoan Proteins; Pseudomonas putida; Pyridoxal Phosphate; Recombinant Proteins; Substrate Specificity; Temperature; Trichomonas vaginalis | 1998 |
Augmented effects of methionine and cholesterol in decreasing the elastic lamina while thickening the aortic wall in the rat aorta.
Topics: Analysis of Variance; Animals; Aorta; Cardiovascular Diseases; Cholesterol; Diet; Drug Synergism; Elastic Tissue; Homocysteine; Methionine; Rats; Rats, Inbred WKY | 1998 |
Nutrition and therapeutics.
Topics: Cardiovascular Diseases; Diet Therapy; Female; Folic Acid; Homocysteine; Humans; Male; Nutritional Status; Pyridoxine | 1998 |
Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia.
Topics: Adult; Age Factors; Aged; Blood Pressure; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Compliance; Cross-Sectional Studies; Femoral Artery; Homocysteine; Humans; Middle Aged; Risk Factors; Smoking | 1998 |
Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
Topics: Adult; Aged; Albuminuria; Cardiovascular Diseases; Denmark; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis | 1999 |
Workshop on Folate, B12, and Choline. Sponsored by the Panel on Folate and other B vitamins of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine, Washington, D.C., March 3-4,
Topics: Biological Availability; Biomarkers; Cardiovascular Diseases; Choline; Congenital Abnormalities; Female; Folic Acid; Folic Acid Deficiency; Food, Fortified; Homocysteine; Humans; Male; Neoplasms; Neural Tube Defects; Nutrition Policy; Nutritional Status; Vitamin B 12; Vitamin B 12 Deficiency | 1999 |
Homocysteine and cardiovascular disease. Overview.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors | 1998 |
Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.
Topics: Aged; Analysis of Variance; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Disease Progression; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Mortality; Multivariate Analysis; Peripheral Vascular Diseases; Prospective Studies; Risk Factors; Single-Blind Method | 1999 |
Abbott introduces new test for cardiac diagnostic: first automated test to measure levels of homocysteine in blood.
Topics: Biomarkers; Cardiovascular Diseases; Homocysteine; Humans | 1999 |
Occurrence of hyperhomocysteinemia 1 year after gastroplasty for severe obesity.
Topics: Adult; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Female; Folic Acid; Gastroplasty; Homocysteine; Humans; Insulin; Lipoprotein(a); Male; Nutritional Status; Obesity; Risk Factors; Triglycerides; Weight Loss | 1999 |
Homocysteine and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans | 1998 |
Plasma homocysteine levels in indigenous Australians.
Topics: Adult; Age Distribution; Cardiovascular Diseases; Creatine; Cross-Sectional Studies; Female; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Queensland; Risk Factors; Sex Distribution; Smoking; Urban Health; Vitamin B 12 Deficiency | 1999 |
Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Homozygote; Humans; Kidney Transplantation; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Tissue Donors; Vitamin B 12 | 1999 |
Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus?
Topics: Albuminuria; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Homocysteine; Humans | 1999 |
Food labeling: health claims; B-complex vitamins, lowered homocysteine levels, and the risk in adults of cardiovascular disease--FDA. Interim final rule.
Topics: Adult; Cardiovascular Diseases; Drug Approval; Food Labeling; Homocysteine; Humans; Risk Factors; United States; United States Food and Drug Administration; Vitamin B Complex | 1998 |
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health.
Topics: Adolescent; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Health Surveys; Homocysteine; Humans; Male; Pyridoxine; Reference Values; Regression Analysis; Risk Factors; Vitamin B 12 | 1999 |
Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and cardiovascular disease.
Topics: Administration, Oral; Adult; Aged; Albuminuria; Analysis of Variance; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Retinopathy; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Middle Aged; Postmenopause; Premenopause; Pyridoxal Phosphate; Regression Analysis; Risk Factors; Vitamin B 12 | 1999 |
Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Female; Homocysteine; Humans; Male; Middle Aged; Minnesota; Risk; Risk Factors | 1999 |
Homocysteine and risk of cardiovascular disease among postmenopausal women.
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Female; Homocysteine; Humans; Middle Aged; Myocardial Infarction; Postmenopause; Prospective Studies; Risk | 1999 |
Fasting, postprandial, and post-methionine-load homocysteinaemia and methylenetetrahydrofolate reductase polymorphism in vascular disease.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Fasting; Female; Heterozygote; Homocysteine; Homozygote; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Postprandial Period | 1999 |
Vegetarians and cardiovascular risk factors: hemostasis, inflammatory markers and plasma homocysteine.
Topics: Adult; alpha 1-Antitrypsin; Cardiovascular Diseases; Carrier Proteins; Diet, Vegetarian; Female; Hemostasis; Homocysteine; Humans; Male; Middle Aged; Risk Factors | 1999 |
[Homocysteine--a routine biochemical parameter in cardiovascular diseases?].
Topics: Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 1999 |
Homocysteine screening of a female Hispanic population.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol, HDL; Connecticut; Female; Genetic Testing; Hispanic or Latino; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Pedigree; Polymorphism, Genetic; Risk Factors | 1999 |
Vitamin B6 status and requirements in older adults.
Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Liver; Male; Nutritional Requirements; Nutritional Status; Proteins; Pyridoxic Acid; Pyridoxine; Risk Factors; Vitamin B 6 Deficiency | 1999 |
Homocysteine. More answers...and questions.
Topics: Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Vitamin B Complex | 1999 |
Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
Topics: Adult; Age of Onset; Aged; Arterial Occlusive Diseases; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyridoxine; Risk; Risk Factors | 1999 |
Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
Topics: Aged; Biomarkers; Cardiovascular Diseases; Cohort Studies; Endothelium, Vascular; Female; Folic Acid; Hematinics; Hemostasis; Homocysteine; Homocystine; Humans; Male; Middle Aged; Morbidity; Nutritional Status; Renal Dialysis; Risk Factors; Time Factors | 1999 |
Homocysteine and methionine metabolism in ESRD: A stable isotope study.
Topics: Adult; Aged; Carbon Isotopes; Cardiovascular Diseases; Case-Control Studies; Deuterium; Female; Homocysteine; Humans; Kidney Failure, Chronic; Kinetics; Male; Methionine; Methylation; Middle Aged; Renal Dialysis; Risk Factors | 1999 |
Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease.
Topics: Animals; Betaine-Homocysteine S-Methyltransferase; Blood Vessels; Cardiovascular Diseases; Cardiovascular System; Cells, Cultured; Cystathionine beta-Synthase; Homocysteine; Humans; Methyltransferases; Muscle, Smooth, Vascular; Myocardium; Rats; RNA, Messenger | 1999 |
Homocysteine in health and disease.
Topics: Cardiovascular Diseases; Health Status; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Vitamin B Complex | 1999 |
Cysteine is a cardiovascular risk factor in hyperlipidemic patients.
Topics: Adult; Age Distribution; Aged; Arteriosclerosis; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Comorbidity; Confidence Intervals; Confounding Factors, Epidemiologic; Cysteine; Female; Homocysteine; Humans; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Assessment; Risk Factors; Sex Distribution | 1999 |
Homocysteine and fibrinolysis in acute occlusive coronary events.
Topics: Cardiovascular Diseases; Female; Homocysteine; Hormone Replacement Therapy; Humans; Postmenopause | 1999 |
Homocysteine and fibrinolysis in acute occlusive coronary events.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Homocysteine; Humans | 1999 |
The creative tension between the analyst and the clinician.
Topics: Cardiovascular Diseases; Chemistry, Analytic; Homocysteine; Humans; Hyperhomocysteinemia; Research | 1998 |
Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study.
Topics: Adult; Age Factors; Aged; Blood Pressure; Cardiovascular Diseases; Cholesterol; Coffee; Cross-Sectional Studies; Cysteine; Female; Homocysteine; Humans; Life Style; Male; Middle Aged; Norway; Risk Factors; Sex Factors | 1999 |
Validation of an immunoassay for measurement of plasma total homocysteine.
Topics: Autoanalysis; Bilirubin; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Freezing; Homocysteine; Humans; Quality Control; Renal Insufficiency; Risk Factors; Sensitivity and Specificity; Smoking; Triglycerides; Venous Thrombosis | 1999 |
Homocysteine and cardiovascular diseases.
Topics: Cardiovascular Diseases; Coronary Disease; Homocysteine; Humans; Male; Risk Factors | 1999 |
[Blood homocysteine as a cardiovascular risk factors].
Topics: Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 1999 |
Homocysteine, B vitamins, and risk of cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Risk Factors; Vitamin B Complex | 2000 |
Elevated plasma homocysteine elicits an increase in antioxidant enzyme activity.
Topics: Adolescent; Adult; Aged; Antioxidants; Cardiovascular Diseases; Catalase; Child; Cysteine; Erythrocytes; Female; Glutathione Peroxidase; Homocysteine; Humans; Male; Middle Aged; Risk Factors; Superoxide Dismutase | 2000 |
The Fleming Unified Theory of Vascular Disease: a link between atherosclerosis, inflammation, and bacterially aggravated atherosclerosis (BAA)
Topics: Arteriosclerosis; Bacterial Infections; Blood Coagulation Factors; Blood Proteins; Cardiovascular Diseases; Complement Activation; Diet; Homocysteine; Humans; Leukotrienes; Oxidants; Vasculitis | 2000 |
Vegan diet-based lifestyle program rapidly lowers homocysteine levels.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Diet; Diet, Vegetarian; Female; Homocysteine; Humans; Life Style; Male; Middle Aged; Risk Factors | 2000 |
Increased plasma homocysteine after menopause.
Topics: Adult; Age Distribution; Cardiovascular Diseases; Confidence Intervals; Female; Homocysteine; Humans; Linear Models; Middle Aged; Netherlands; Postmenopause; Premenopause; Risk Assessment; Sampling Studies; Surveys and Questionnaires | 2000 |
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Topics: Analysis of Variance; Apolipoproteins; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Lipids; Middle Aged; Prospective Studies; Protein Precursors; Risk; Serum Amyloid A Protein | 2000 |
The relation of plasma total homocysteine levels to prevalent cardiovascular disease in older patients with ischemic stroke.
Topics: Age Distribution; Aged; Brain Ischemia; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Reference Values; Retrospective Studies; Sex Distribution; Stroke | 2000 |
Homocyst(e)ine and cardiovascular disease.
Topics: Anemia, Pernicious; Blood Coagulation; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2000 |
Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
Topics: Arteriosclerosis; Cardiovascular Diseases; Cholesterol Esters; Cysteine; Electrophoresis, Agar Gel; Glutathione; Hemin; Homocysteine; Humans; Lipoproteins, LDL; Oxidation-Reduction; Sulfhydryl Compounds; Thiobarbituric Acid Reactive Substances | 2000 |
Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk.
Topics: Adolescent; Adult; Cardiovascular Diseases; Child; Cystathionine beta-Synthase; Female; Homocysteine; Homocystinuria; Humans; Male; Methionine; Middle Aged; Oxidative Stress; Risk Factors; Superoxide Dismutase | 2000 |
Occurrence of hyperhomocysteinaemia in cardiovascular, haematology and nephrology patients: contribution of folate deficiency.
Topics: Cardiovascular Diseases; Folic Acid Deficiency; Hematologic Diseases; Homocysteine; Humans; Immunoenzyme Techniques; Kidney Diseases; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors; Reference Values; Sensitivity and Specificity | 2000 |
Low serum folate concentrations are associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Topics: Adult; Cardiovascular Diseases; Carotenoids; Cohort Studies; Coronary Disease; Finland; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Lycopene; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors | 2000 |
Sex-related differences in methionine metabolism and plasma homocysteine concentrations.
Topics: Absorptiometry, Photon; Adult; Breath Tests; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Methionine; Methylation; Premenopause; Reference Values; Sex Characteristics | 2000 |
[Influence of smoking on homocysteinemia at baseline and after methionine load].
Topics: Adult; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Methionine; Pyridoxine; Risk Factors; Smoking | 2000 |
Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism.
Topics: Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fasting; Folic Acid; Homocysteine; Humans; Insulin; Male; Methionine; Middle Aged; Proinsulin; Risk Factors; Time Factors; Vitamin B 12 | 2000 |
[High homocysteine level is not a risk factor of cardiovascular disease].
Topics: Biomarkers; Cardiovascular Diseases; Homocysteine; Humans; Risk Factors | 2000 |
Homocysteine and cardiovascular risk.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 2000 |
Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
Topics: Acute-Phase Proteins; Adult; Aged; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Female; Homocysteine; Humans; Kidney Failure, Chronic; Male; Metalloproteins; Middle Aged; Prevalence; Regression Analysis; Renal Dialysis; Risk Factors | 2000 |
The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels.
Topics: Adult; Cardiovascular Diseases; Endothelin-1; Ethinyl Estradiol; Female; Homocysteine; Humans; Menstrual Cycle; Nitric Oxide; Risk Factors; Vasodilation | 2000 |
New risk markers for predicting vascular disease--help or hindrance?
Topics: Biomarkers; Cardiovascular Diseases; Cholesterol; Homocysteine; Humans; Myocardial Infarction; Risk Factors | 2000 |
Red wine, spirits, beer and serum homocysteine.
Topics: Alcohol Drinking; Alcoholic Beverages; Alcoholism; Beer; Cardiovascular Diseases; Homocysteine; Humans; Pyridoxine; Risk Factors; Stroke; Wine | 2000 |
Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cell Adhesion Molecules; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Risk Factors; von Willebrand Factor | 2000 |
The (non-)sense of the methionine loading test for detecting hyperhomocysteinaemia.
Topics: Cardiovascular Diseases; Fasting; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Methionine | 2000 |
[Antioxidants and cardiovascular diseases in the Czech population].
Topics: Adult; Antioxidants; Austria; Cardiovascular Diseases; Czech Republic; Female; Homocysteine; Humans; Male; Middle Aged; United Kingdom | 1999 |
Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Fasting; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Kidney Transplantation; Korea; Male; Middle Aged; Prevalence; Pyridoxal Phosphate; Serum Albumin; Vitamin B 12 | 2000 |
Homocysteine & heart disease.
Topics: Cardiovascular Diseases; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Vitamin B Complex | 2000 |
Excess dietary methionine markedly increases the vitamin B-6 requirement of young chicks.
Topics: Animals; Cardiovascular Diseases; Chickens; Dietary Proteins; Growth; Homocysteine; Methionine; Models, Animal; Nutritional Requirements; Pyridoxine; Soybean Proteins; Weight Gain | 2000 |
Risk factors for cardiovascular disease in renal transplant recipients: new insights.
Topics: Autoantibodies; Biomarkers; Cardiovascular Diseases; Female; Folic Acid; Glomerular Filtration Rate; Hemostasis; Homocysteine; Humans; Kidney Transplantation; Lipoprotein(a); Male; Middle Aged; Plasminogen Activator Inhibitor 1; Postoperative Complications; Reference Values; Risk Factors; Vitamin B 12 | 2000 |
Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects.
Topics: Aged; Aged, 80 and over; Aging; Cardiovascular Diseases; Cognition; Dementia; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Risk Factors; Vitamin B 12 | 2000 |
Differences in body fat distribution and antioxidant status in Korean men with cardiovascular disease with or without diabetes.
Topics: Adipose Tissue; Adult; Aged; Antioxidants; Biomarkers; Body Composition; Body Constitution; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Health Status; Homocysteine; Humans; Insulin; Korea; Male; Middle Aged; Risk Factors | 2001 |
Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study.
Topics: Age Factors; Aged; Albuminuria; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucose Intolerance; Homocysteine; Humans; Least-Squares Analysis; Male; Middle Aged; Prospective Studies; Sex Factors | 2001 |
Prevention of vitamin B-12 deficiency in old age.
Topics: Aged; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Food, Fortified; Homocysteine; Humans; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2001 |
Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men.
Topics: Adult; Analysis of Variance; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cohort Studies; Gas Chromatography-Mass Spectrometry; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Reference Values; Risk Factors | 2001 |
Targeted disruption of the methionine synthase gene in mice.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Base Sequence; Cardiovascular Diseases; DNA Primers; Embryonic and Fetal Development; Female; Folic Acid; Gene Targeting; Heterozygote; Homocysteine; Homozygote; Humans; Methionine; Mice; Mice, Knockout; Neural Tube Defects; Pregnancy; Risk Factors; Vitamin B 12 Deficiency | 2001 |
Melatonin counteracts potentiation by homocysteine of KCL-induced vasoconstriction in human umbilical artery: relation to calcium influx.
Topics: Antioxidants; Calcium Signaling; Cardiovascular Diseases; Drug Interactions; Female; Free Radical Scavengers; Free Radicals; Homocysteine; Humans; Hyperhomocysteinemia; In Vitro Techniques; Mannitol; Melatonin; Potassium Chloride; Pregnancy; Umbilical Arteries; Vasoconstriction | 2001 |
Homocysteine, its metabolites, and B-group vitamins in renal transplant patients.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Risk Factors; Vitamin B Complex | 2001 |
Clinical relevance of the methionine loading test for assessment of hyperhomocysteinaemia.
Topics: Cardiovascular Diseases; Fasting; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Methionine; Risk Factors | 2000 |
Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Creatinine; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperthyroidism; Hypothyroidism; Linear Models; Male; Metabolic Clearance Rate; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Polymorphism, Genetic; Prospective Studies; Risk Factors; Sex Factors; Smoking; Thyroid Function Tests; Thyroxine; Vitamin B 12 | 2001 |
Effect of diet and 677 C-->T 5, 10-methylenetetrahydrofolate reductase genotypes on plasma homocyst(e)ine concentrations in slovak adolescent population.
Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol, Dietary; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Intake; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Mutation; Pyridoxine; Risk Factors; Slovakia; Surveys and Questionnaires | 2000 |
Effect of supplemental methionine on plasma homocysteine concentrations in healthy men: a preliminary study.
Topics: Adult; Cardiovascular Diseases; Diet; Dietary Supplements; Dose-Response Relationship, Drug; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Risk Factors | 2001 |
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Topics: Algorithms; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Circadian Rhythm; Clinical Trials as Topic; Cohort Studies; Europe; Evaluation Studies as Topic; Female; Homocysteine; Hormone Replacement Therapy; Humans; Inflammation; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Obesity; Predictive Value of Tests; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Smoking; Stroke; United States | 2001 |
Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hyperhomocysteinemia.
Topics: Adult; Aged; Biopsy; Cardiovascular Diseases; Comorbidity; Endothelium, Vascular; Extracellular Matrix; Female; Femoral Artery; Homocysteine; Humans; Hyperhomocysteinemia; Immunohistochemistry; Male; Middle Aged; Muscle, Smooth, Vascular; Peripheral Vascular Diseases; Risk Factors | 2001 |
Serum homocysteine and lipoprotein (a) concentrations in hypercholesterolemic and normocholesterolemic children.
Topics: Adolescent; Cardiovascular Diseases; Case-Control Studies; Child; Child, Preschool; Female; Homocysteine; Humans; Hypercholesterolemia; Lipoprotein(a); Male; Risk Factors | 2001 |
Metabolic cardiovascular syndrome after renal transplantation.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Glucose Intolerance; Homocysteine; Humans; Insulin; Kidney Transplantation; Lipids; Lipoproteins; Male; Medical Records; Metabolic Diseases; Middle Aged; Prospective Studies; Risk Factors; Syndrome | 2001 |
Hyperhomocysteinemia and cardiovascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Diseases | 2001 |
The homocysteine distribution: (mis)judging the burden.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Middle Aged; Netherlands; Reproducibility of Results; Specimen Handling; Statistical Distributions | 2001 |
[Changes in cardiovascular risk factors after renal transplantation].
Topics: Adult; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Creatinine; Cystatin C; Cystatins; Electric Impedance; Female; Homocysteine; Humans; Hypertension; Kidney Transplantation; Lipids; Male; Middle Aged; Risk Factors; Time Factors; Uric Acid | 2001 |
Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population.
Topics: Alleles; Blood Viscosity; Cardiovascular Diseases; Cohort Studies; Female; France; Gene Frequency; Homocysteine; Humans; Italy; Leukocytes; Lipid Metabolism; Lipids; Male; Platelet Aggregation; Polymorphism, Genetic; Renin-Angiotensin System | 2001 |
Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease.
Topics: Analysis of Variance; Autoimmunity; Cardiovascular Diseases; Case-Control Studies; Fasting; Homocysteine; Humans; Hyperhomocysteinemia; Lipid Peroxidation; Malondialdehyde; Myelodysplastic Syndromes; Oxidative Stress | 2001 |
Simultaneous determination of several amino acids, including homocysteine, cysteine and glutamic acid, in human plasma by isocratic reversed-phase high-performance liquid chromatography with fluorimetric detection.
Topics: Cardiovascular Diseases; Chromatography, High Pressure Liquid; Cysteine; Glutamic Acid; Homocysteine; Humans; o-Phthalaldehyde; Sensitivity and Specificity; Spectrometry, Fluorescence | 2001 |
Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Pyridoxine; Vitamin B 12; Vitamins | 2001 |
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine.
Topics: Blotting, Western; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Culture Techniques; DNA, Complementary; Gene Expression; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Sensitivity and Specificity | 2001 |
Alcohol consumption and plasma homocysteine: what's brewing?
Topics: Adult; Aged; Alcohol Drinking; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Netherlands; Risk Factors | 2001 |
Hyperhomocysteinemia: another independent vascular risk factor.
Topics: Cardiovascular Diseases; Homocysteine; Humans; Hyperhomocysteinemia; Lipid Peroxidation; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Research Design; Risk Factors; Saudi Arabia | 2000 |
Decrease of methionine and S-adenosylmethionine and increase of homocysteine in treated patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Cardiovascular Diseases; Dopa Decarboxylase; Down-Regulation; Drug Interactions; Enzyme Inhibitors; Female; Homocysteine; Humans; Levodopa; Male; Methionine; Middle Aged; Parkinson Disease; S-Adenosylmethionine; Up-Regulation | 2001 |
Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Neoplasms; Norway; Prospective Studies; Risk Factors | 2001 |
Prevalence of cobalamin (vitamin B-12) and folate deficiency in India--audi alteram partem.
Topics: Cardiovascular Diseases; Diet, Vegetarian; Ethnicity; Folic Acid Deficiency; Homocysteine; Humans; India; Prevalence; Reference Standards; Risk Factors; Socioeconomic Factors; Vitamin B 12 Deficiency | 2001 |
Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus; Diet, Vegetarian; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; India; Male; Methylmalonic Acid; Middle Aged; Prevalence; Surveys and Questionnaires; Vitamin B 12; Vitamin B 12 Deficiency | 2001 |
High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage.
Topics: Aged; Aged, 80 and over; Aging; Asian People; Biomarkers; Blood Coagulation; Cardiovascular Diseases; Endothelium, Vascular; Factor VIIa; Female; Homocysteine; Humans; Japan; Male; Middle Aged; Peptide Fragments; Prothrombin; Risk Factors | 2001 |
Here comes tomorrow. Advances in cardiovascular medicine.
Topics: Body Surface Potential Mapping; Cardiovascular Diseases; Genetic Therapy; Homocysteine; Humans; Risk Factors | 2000 |
Homocysteine and folate levels in postmenopausal women.
Topics: Adult; Age Distribution; Age Factors; Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Menopause; Middle Aged; Smoking; Time Factors | 2001 |
A statement of homocyst(e)ine and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 2001 |
Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome.
Topics: Adult; Area Under Curve; Biomarkers; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diastole; Echocardiography; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Homocysteine; Humans; Insulin; Lipoproteins; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Prospective Studies; Reference Values; Risk Assessment; Risk Factors; Triglycerides | 2001 |
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, HDL; Cohort Studies; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus; Female; Hemoglobin A; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Peripheral Vascular Diseases; Prevalence; Prospective Studies | 2001 |
Associations between homocysteine and coagulation factors--a cross-sectional study in two populations of central Europe.
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Cross-Sectional Studies; Europe; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostatics; Homocysteine; Humans; Linear Models; Male; Middle Aged; Risk Factors | 2001 |
Correlation of plasma homocysteine and mitochondrial DNA content in peripheral blood in healthy women.
Topics: Adolescent; Adult; Body Constitution; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; DNA, Mitochondrial; Female; Homocysteine; Humans; Insulin Resistance; Leukocytes; Middle Aged; Reference Values; Regression Analysis; Risk Factors | 2001 |
A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk.
Topics: Adult; Cardiovascular Diseases; Fasting; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 2001 |
Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Creatinine; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk Factors; S-Adenosylhomocysteine; S-Adenosylmethionine; Sensitivity and Specificity; Vitamin B 12 | 2001 |
Cardiovascular disease risk factors and diet of Fulani pastoralists of northern Nigeria.
Topics: Adolescent; Adult; Aged; Body Composition; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Diet; Dietary Fats; Electric Impedance; Energy Intake; Exercise; Female; Folic Acid; Food Analysis; Homocysteine; Humans; Lipids; Male; Mental Recall; Middle Aged; Nigeria; Risk Factors; Surveys and Questionnaires; Vitamin B 12 | 2001 |
Changes in plasma homocysteine in arthritis patients starting treatment with low-dose methotrexate subsequently supplemented with folic acid.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Hematinics; Homocysteine; Humans; Male; Methotrexate; Middle Aged; Risk Factors | 2001 |
Methylenetetrahydrofolate reductase gene polymorphism, hyperhomocysteinemia, and cardiovascular diseases in chronic hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidoreductases Acting on CH-NH Group Donors; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Renal Dialysis; Risk Factors; Statistics as Topic; Vitamin B 12 | 2002 |
Lack of association of increased C-reactive protein and total plasma homocysteine.
Topics: C-Reactive Protein; Cardiovascular Diseases; Homocysteine; Humans | 2001 |
Bibliography. Current world literature. Nutrition and metabolism.
Topics: Alcohols; Animals; Apolipoproteins E; Arteriosclerosis; Biomarkers; Carbohydrate Metabolism; Cardiovascular Diseases; Dietary Fats, Unsaturated; Fatty Acids, Omega-3; Feeding Behavior; Fish Oils; Flavonoids; Garlic; Genes; Glycine max; Health Education; Homocysteine; Humans; Hyperlipidemias; Insulin Resistance; Leptin; Life Style; Lipid Metabolism; Nutritional Physiological Phenomena; Obesity; Phenols; Polymers; Polyphenols; Probiotics | 2002 |
Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal women.
Topics: Adolescent; Adult; Blood Pressure; Body Constitution; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Middle Aged; Obesity; Premenopause; Risk Factors | 2001 |
Plasma homocysteine levels in Taiwanese vegetarians are higher than those of omnivores.
Topics: Adult; Amino Acids; Cardiovascular Diseases; Diet, Vegetarian; Fasting; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Nutritional Status; Regression Analysis; Risk Factors; Taiwan; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6; Vitamin B 6 Deficiency | 2002 |
The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people.
Topics: Aged; Cardiovascular Diseases; Chile; Cholesterol, HDL; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nutritional Status; Prevalence; Prospective Studies; Vitamin B 12; Vitamin B 12 Deficiency | 2002 |
Fortification of food with vitamin B12 in addition to folic acid might reduce cardiovascular disease risk.
Topics: Cardiovascular Diseases; Folic Acid; Food, Fortified; Homocysteine; Humans; Ireland; United Kingdom; Vitamin B 12 | 2002 |
Effect of homocysteine on the L-arginine/nitric oxide synthase/nitric oxide pathway in human platelets.
Topics: Adult; Arginine; Biomarkers; Blood Platelets; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nitric Oxide; Nitric Oxide Synthase; Risk Factors | 2002 |
The Hordaland Homocysteine Studies.
Topics: Adult; Aged; Aging; Blood Pressure; Cardiovascular Diseases; Cholesterol; Coffee; Cohort Studies; Diet; Exercise; Female; Homocysteine; Humans; Life Style; Male; Middle Aged; Norway; Pregnancy; Pregnancy Outcome; Risk Factors; Sex Characteristics; Surveys and Questionnaires; Vitamins | 2001 |
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.
Topics: Adult; Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Factors | 2002 |
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies.
Topics: Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Epidemiologic Studies; Female; Homocysteine; Humans; Male; Middle Aged; Regression Analysis; Risk Assessment | 2001 |
Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease.
Topics: Aged; Albuminuria; Blood Glucose; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Homocysteine; Humans; Male; Middle Aged; Reference Values | 2002 |
Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Creatinine; Female; Folic Acid; Growth Hormone; Homocysteine; Humans; Lipids; Male; Middle Aged; Risk Factors; Statistics, Nonparametric; Vitamin B 12 | 2001 |
Homocysteine: an emerging risk factor.
Topics: Biomarkers; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Prognosis; Risk Factors; Sensitivity and Specificity | 2002 |
Commentary: an updated review of the published studies of homocysteine and cardiovascular disease.
Topics: Cardiovascular Diseases; Case-Control Studies; Homocysteine; Humans | 2002 |
Risk factors for cardiovascular disease.
Topics: Aged; Cardiovascular Diseases; Cholesterol; Homocysteine; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Predictive Value of Tests; Risk Factors | 2002 |
Premature arterial and venous events in three families. Effect of folate levels and MTHFR mutation mediated by family/generation and homocysteine levels.
Topics: Adolescent; Adult; Cardiovascular Diseases; Family Health; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Italy; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Pedigree | 2002 |
Homocysteine and psychological traits: a study in obesity.
Topics: Adolescent; Adult; Body Mass Index; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Middle Aged; Obesity, Morbid; Personality Inventory; Psychiatric Status Rating Scales; Psychometrics; Risk Factors; Severity of Illness Index; Sex Characteristics; Surveys and Questionnaires; Weight Loss | 2002 |
Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study.
Topics: Age Factors; Arteriosclerosis; Blood Coagulation Factors; Cardiovascular Diseases; Carotid Artery Diseases; Cross-Sectional Studies; Ethnicity; Female; Hemostasis; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Sex Factors; Smoking; Ultrasonography | 2002 |
Is it time to standardize and to measure blood homocysteine levels in patients with heart disease?
Topics: Adult; Cardiovascular Diseases; Health Policy; Homocysteine; Humans; Hyperhomocysteinemia; Mass Screening; Reference Standards; Reproducibility of Results; United States | 2002 |
[Homocysteine as a cardiovascular risk factor].
Topics: Cardiovascular Diseases; Child; Homocysteine; Humans; Risk Factors | 2002 |
The plasma homocysteine levels are increased in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Female; Homocysteine; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome; Risk Factors | 2002 |
Plasma total homocysteine and hospitalizations for cardiovascular disease: the Hordaland Homocysteine Study.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Female; Follow-Up Studies; Homocysteine; Hospitalization; Humans; Male; Norway; Prospective Studies; Reference Values; Risk Factors; Surveys and Questionnaires | 2002 |
Reduced plasma homocysteine in obese red wine consumers: a potential contributor to reduced cardiovascular risk status.
Topics: Adult; Alcohol Drinking; Alcoholic Beverages; Beer; Cardiovascular Diseases; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Obesity, Morbid; Risk; Vitamin B 12; Wine | 2002 |
Strategies to improve outcomes after renal transplantation.
Topics: Cardiovascular Diseases; Cyclosporine; Homocysteine; Humans; Immunosuppressive Agents; Kidney Transplantation; Risk Factors; Transplantation Tolerance | 2002 |
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Estradiol Congeners; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Prostatic Neoplasms; Risk Factors; Vitamin B 12 | 1992 |
Estimates of heritability of plasma homocyst(e)ine levels in aging adult male twins.
Topics: Aged; Cardiovascular Diseases; Genetic Variation; Homocysteine; Humans; Longitudinal Studies; Male; Middle Aged; Risk Factors; Twins, Dizygotic; Twins, Monozygotic; Veterans | 1991 |
[Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy].
Topics: Arteriosclerosis; Cardiovascular Diseases; Drug Therapy; Homocysteine; Humans; Risk Factors | 1989 |
Ectopia lentis, cardiology, and "the sign of the tremulous iris".
Topics: Cardiovascular Diseases; Collagen Diseases; Eye Injuries; Homocysteine; Humans; Iris; Lens, Crystalline; Marfan Syndrome; Ophthalmoscopy | 1966 |